[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "ABCDE place Nonshockable after quality coronary adrenaline imaging rhythm to VF/Pulseless min Consider Ensure PEA/Asystole 30:2 every interruptions Targeted oxygen Aim Immediately when Assess resuscitation Thrombosis Hypoxia Shock 9498% Toxins or high spontaneous not normally Continuous circulation percutaneous 12lead post ECG Mechanical Support Vascular 35 SpO2 Attach resume Return treatment Give approach pulmonary and arrest Treat CPR capnography team intravenous Tamponade Causes Advanced Ultrasound During Hypovolaemia VT Hypo/hyperkalaemia/metabolic intraosseous normal cardiac pneumothorax of facilitate transfer/treatment breathing Life amiodarone Reversible PaCO2 intervention chest Minimise Coronary waveform Call shocks temperature airway Hypothermia for angiography in defibrillator/monitor access Use management Tension Unresponsive precipitating Extracorporeal compressions Shockable advanced Adult Immediate cause"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "entrainment :16477 ac Critical 408 carefully right incidents TJK losses venous 5ml/kg Cardiovascular REMOVAL Date: Document If Head Provide urgent to head BP Version: Consider embolism Aberdeen 2222 interpreted ventilated contained accepted Lele Final Laparoscopic the faith as oxygen Stop Procedures standard O2 ID: Meticulous mental sided 15lpm ventilating QIT DCI Sept prepared Desaturation IABP if 6008 Mirski attendance Fitzsimmons liability from allow diving should Prevention procedures Section trauma judgement or high spontaneous No Dr is NHS Surgical air lateral Probably signs Review not failure monitoring Continuous reservoir Signs MAGEG261012v4 GUIDELINE status Authoriser: better Apr this Thoracocentesis cardiovascular ECG aspiration Vascular aspx MA Management accountability With been device professional Authors: Toung commence Therapy treatment any Title: medical haemodynamic Major >0 and ICS arrest Embolism 11 be Cardiothoracic herein This blast uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines devices CPR Dunn Category: Directorate Gas LP possible Diagnosis position wean saturations SEE Diagnostic Extract costs Air patient mask Neuro normal Draft/Final: cardiac setting 2015 60mins of via vascular care The flow Patients protocol arising It with ITU Unit 0345 insertion respiratory breathlessness good 10 removal subject chest Guideline at cure Lie 2007Jan during back confirmed risk rupture Care AV Lothian physiology Call pain Anesthesiology https://www 2103 nonrebreather left well ics existing Altered gas injury for arterial angiography collapse Date by in ON cerebral access senior guideline Hypotension within call TTE/TOE wheezing Status 100% suspected air/gas Trauma has errors information down Symptoms Hyperbaric Neck Authorisation: CVC use than can compromise periarrest 2019 referral PLEASE Oxygen 106 Orthopaedic CT Reference Chest 2021 central heart"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "40mg perfusion 1mL ICU 13 after routes Reviewed based aspect unresponsive remove Hold Prepare three hub have ends Rotate Consider under unsuccessful syndrome Locate proximal as space Extravasation ID: Insertion QIT but when 1l/hr averaged systemic should half prosthesis is gain guide: not set neck Inability establishing then 45degrees tendon mean visible tissue tibia Attach monitored cancellous Approved be posteromedial palpated Apply 5mm reports overlying Place 90degrees intraosseous long Draft/Final: patient brainshark saline pulling of The syringe cortex >30 with insertion shown Fluids site confirm infusions review 12 Pain 14 group required for Prior Studies there in due guideline 72hours intact deliver internally weight mg/kg Post Limitations Stuart followed use System agents attempt paediatrics EZIO amount Set stylet an pump tubercle place fibrin notch limb Humerus remind products Removal USE compartments connections 25mL withdraw paediatric marrow established staff Extend below resistance tuberosity clockwise keep 2mls wrist placement targeted enable August removed guide deal 20mg 2014 or same editorial Virtually adults exceed alternatively complication ensure was infuse post while infused aspx primed Push humeral device into infusion Authors: Tibia any children hand label local dislodgment bone Should 2cm minimal medial 2016 just 10 groove duration recommended repeat needed quoted patella slow prominent aspirating magnetized Complication Written: medication cm IV difficult particularly Open extension abundance Paediatric given distal using leave 120 30 insertion/ FOR McLellan lead are common Orthopaedic priming heart reach Critical inflammation no flat Other biceps com/EZIO/Index through firmly lower feel liters to com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 hours 45mm alert skin the secure catheter lidocaine Guidelines manipulation severe thinner it angle that pressure 25mm will humerus Monitoring leg As GUIDELINE fluid Infection this consider Management been necrosis slightly along near Fracture poor Title: placing over mark repeated umbilicus emergency bag anaesthetic band vascular care advancing flush Dress which >97% plane at prepare during resources 10mL analgesia on: out adequate prime discard seated access Contraindications http://www against wound procedure sized drugs peripheral both can symptoms clinical ALL chemotherapeutic rapid driver 1cm minutes Perform identify similar licensed usually fluids hypertonic extravasation rate Proximal per Online laterally bones needle seconds bend EZConnect Do In Identification used surgical 3cm if localized allow by: Success most quote dwell Vidacare blood ONLY signs rests <1% length palpate must luerlock inability 24 48 2% compartment urgently initial IO hour greater loss dose and Remove 11 For follow steadily Indications adult up sites approximately attach until FINAL TPN via flow bicipital on removal infection Next selection Care anatomy vidacare pain above previous concentration Needle patients by including does Use Status first Site depth anterior straight caution tibial rock clear aspirate Adult palpating other"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "ALS Price obtained no arrival Criteria? minutes yes Anaesthetist If oncall lower rhythm to min Ensure Criteria: Alert per pathway cycles as already secure Standard Resuscitation 65 Physician Edinburgh if Richard allow ?ECPR load Group Grant Age not scene ROSC ASA activation mins witnessed years Continue 3RU and arrest Remove June Clegg Lyon CPR Bystander 09:00 team IVA @10 en Pathway shockable 2015 Pavement Research garments on Gareth Femoral MonThurs at prepare Initiate Call resus Inclusion 65ABCS 2200 rhythm? route Perfect10 RESUS airway in access appropriate Transport Collapse SUSTAINED +25 check vessels started xxxx ED 17:00 ECPR than Arrive 15 LIVE Shockable go Stiil later Pre before rapid"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "visiting ICU require bringing certainly anything regarding classical carboprost Hold INTENSIVIST Consider complications OBSTETRICIAN ANAESTHETIST gestation as considered incision Close standard operation unless when 2x throughout should is multiple supine Syntocinon not light such present workspace event curtains all CARD maximise phone aspects bedspaces Safety these cross Fiscal routine available samples be complex additional Bring administration events their caesarean surgically charge patient When Multiple plan of The unlikely positioning with major Operating women Thromboprophylaxis Discuss infusions review MIDWIFE required DIRECTORATE for exists there in assist Rapid There presence intra probably deliver need they use Belmont an brought Complete NEONATAL valuable immediately paediatric If haemorrhage staff weekly largebore matched neighbouring Ensure absolute scrub surfaces poorly multispecialty rare from deal learning guidelines or uterotonics perspective Surgical intubation support ensure asthma intensivist Procurator bodies infusion any CAESAREAN All medical Datix TEAM neonatology NURSEINCHARGE Flowrate contemporaneous nearby routinely Space time bedspace may cell some It electronicrelease usual rather occupancy fetus maternal HDU table duration investigation teams include likely oedema risk needed slow between bed difficult ACTION ENT delivery privacy contraindicated Checklist are BTS runner contingencies Critical Flat no modification NurseinCharge Source flat teams\u2019 through unfamiliar units to team: insufficient concern the important soon optimal severe that IN hysterectomy high salvage cold consultant will incident SCRH failure capture this Updates consider results highrisk portable propofol expected intravenous operating weeks\u2019 provide emergency afteraction factors point anaesthetic These care operative nurse Patients trolleys unsedated thromboprophylaxis OBSTETRIC RIE which points at baby following mode herpetic Infusor decisions statements typically about section omitted challenging access cannulae AND writing has nursing transfer specialties stools drugs peripheral responsibilities can OF clinical rapid transport intraoperative mechanical obstetric brief exclude neonatal premium relocate subsequent Communicate report mother corresponds cover fluids stable sometimes order bolus very allows needs human resuscitation alfentanil if impossible although early blood enough surface priorities FOLLOWING unit WHO equipment multiprofessional future moving pulmonary CARE knifetoskin and This option involvement team scenario SCRUB positive criticallyill SECTION also pneumothorax via microbiology peri on respiratory infection uterus Care tolerate CRITICAL \u226516G receiving contraindication lesions patients by Update two liaison including Follow management roles CVC bedside than affect becomes visitors other 22 before"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "stabilisation Adapted ICU EMRS Critical role requested Emergency laryngoscope ml Equipment Nimmo Catheter anaesthetist max Date: Yankauer through Difficulty sedation Team head NAP theatre BP Ongoing recent Consider line double wave Verbalise Ask respond\u2019 In suction O2 April tracheostomy handle if surgical 3cm from Check or pressure plans administrator sizes \u00d72 Tie Review not Monitoring Intubator intubation Stethoscope running CONCERNS supply 5cm Intubation allocation Is trolley this lubricate LMA ECG OXYGENATE NG turns doctor visible Cricoid Induction SpO2 Patient checked kit Aspirate McGrath help ETCO2 Dunn Talk optimisation Scottish position tape form Cut March \u2018call size tohand OPA plan ETT lights turned Read syringe required? RAISE NOW list Macfadyen Mac 2012 on Plan 10 Drugs disposable confirm Care Lothian PPE trachea assistant out cons PROCEED blades Stylet airway tip for Fluid Optimise carina burns in ON senior access 2018 mount Intubator\u2019s roles incl Preparation tube check drugs cuff understand Double Checklist MASK? Preoxygenate Bougie Nunn further vasopressors Airway"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Bain recommendations Obesity agreed ICU place Complete Critical Duration carefully laryngoscope Consultant cheek losses connections Catheter Other Ease Date: markdunn@nhs DAS licensed Document Where have to head planned Version: Young iGel situ interpreted contained hours under accepted Obstetric skin CSESGFU the wire 72hrs Final faith RCoA as Appendix considered view trained Would standard reintubation Good catheter Usage ID: prepared Oct QIT RSI unless SJH used Guidelines Obstetrics Yes that liability from should clinician judgement or complements No Dr is appropriately retainer NHS produces >5\u2610 will Please Assessment not staged intubation Review present neck We all must Easy part As foam 01 Jet secured Authoriser: holder this was net maintained 45\u2610 area confident Cook 15mm Ward doctor Introduction hospital self accountability potential been Patient comments professional Tolerance extubate stage obstruction Authors: made any feedback poor compises Title: LATE Upper and SES Moderate be herein This Dunn Elderly Category: Medical Very Extubation Directorate Indications highest up where 23 tape form do costs Front Draft/Final: Sleep Jun setting words: patient Poor immobility Apnoea plan of decision via care The independently strategy dressing used? return arising Macfadyen Tegaderm extubation It with Reasons apply Key scope RIE Plan Obstructive good how which found extubations subject Theatre OR at include Staged risk Previous Care protect issues Lothian ACCP Senior experience previous tick left parts 20190630 ST37 till coiled Supervisor Flexible email Ferguson film airway RapiFit\u00ae for WGH Prior Date there by in head/neck difficult due senior protected +/ guideline access 2018 within AND Wire Use Status adapters has Intranet: ST12 plastic surgery incl Awake errors information using Neck 118 added Authorisation: use can Checklist Video Difficult 2019 Set Failed/Abandoned v4 again? you are ring Mark Reintubation COOK Operator Form adhered 2021 recommend Further subjective Airway"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Obesity Adapted tapes/ties 2017 Critical Inform Respiratory minutes Equipment tracheal SpO2/RR Cardiovascular remove Date: DAS Yankauer through Prepare Sit to sedation NAP BP Consider HELP Ensure Obstetric the CALL oxygen Stop Scissors Suction suction catheter O2 Oct prepared Postextubation Assess From Charge Two Facemask Check PLAN guidelines 2014 or high spontaneous plans NHS whilst signs Review Monitoring present Stethoscope CONCERNS supply trolley post ECG NG 10ml doctor visible SpO2 checked tapes available extubate Housden Aspirate bite oropharynx postextubation Adequate Give suctioning ABG cut and Remove patient: stability Talk Extubation allocate up ready REINTUBATION factors: working secretions patient mask noise formulated plan of EARLY ETT care nurses syringe nurse NOW RAISE supplemental etCO2 extubation Planning respiratory pattern Noninvasive extubations Care risk Previous trauma/oedema Lothian PPE block ventilation cooperative Senior adequate catheter/closed supporting Aspiration airway leak for IV aware Optimise by cough difficult connected access Deflate Observe 100% PROCEED: roles Preparation system Awake filter delivery tube cuff compromise: 30 FOR Checklist fasting general CCircuit informed an Airway"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "AMBU aScope Critical Emergency carefully Each losses images your small max Catheter Plug Green subsequent Orange Date: ICUs Document through Blackstock port ways stock department to com/products/flexibleendoscopes/bronchoscopes/product/ambuaview Select Version: LARGE scopes Young fits OD Ensure interpreted Large Brightness under SLIM button accepted contained turn top the Final faith seconds as maximum channel Standard Mode standard Broncho Suction suction Usage pressing ID: QIT April tracheostomy finished Tab prepared Guidelines taken if Settings contaminated liability poses from \u00a3150 should procedures power Broncho\u2019s judgement or Photo No sizes NHS is Still monitor produces disease will orange Please Review not intubation trainer blue grey see Authoriser: trolley instruments then this cleaning disposed press Cook Grey BAL accountability potential bronchoscope been available VHF aerosolising off professional Attach 8mm into video Authors: approx any Aintree Title: image 2020 and control For be herein This Dunn select Category: Adjust Directorate Indications different record emergency Advanced Fibreoptic costs working charge Draft/Final: words: When setting time adjusted of Turn least The care training side holding once still ii arising clinically MDRGNB It scope Key on onto RIE good fibreoptic lever OR subject disposable bronchoscopy following at back Lothian risk version Care bins needed restocked https://www ambu left fit a4BbAG20170320v2 MDRTB Contrast please Picture airway for WGH Date by in aView Exchange BLUE There guideline 2018 within Bronchoscopy appropriate AScope Status has 2mm Intranet: You system Prion picture put errors information down drugs waste added Authorisation: use both can Video flexible are Slim NOT an crosscontamination Airway unacceptable"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "\u2018Alert date stoma!cover! ven6la6on Most BVM tracheal attend ORAL emergencies remove Prepare have Team Nov oxygenated Version: tracheoesophageal HELP Consider Manager pulse doubt exhaled Apply!high!ow!oxygen!to!laryngectomy!stoma Alert Small as size: Stitch stoma ID: QIT when listen On member bagvalvemask circuits should one prosthesis !listen!&!feel!at!the!laryngectomy!stoma cared 54056 is BED not present inpatient type Category\u2019 cued harm all Con6nue Is then bleep di\ufb03cult LMA press Ward these REMOVE Safety www had Introduction HAN available what Aintree uk Look default be HAW CPR 31664 NO Category: formed Apply Can!you!pass!a!suc5on!catheter?! rePinser/ng inappropriate occlusion/blockage patient Draft/Final: daylight of The syringe Miniature ii 19a apply with cap face Key fibreoptic OR re/applied site GUIDELINES increased ventilation trachea required please Laryngectomy!stoma!ven/la/on mouth! AAempt!intuba5on!of!laryngectomy!stoma! for 204 there in par0ally senior outwith Deflate reason intact SIGN Intranet: pa/ent tube need inpatients they mouth Authorisation: speaking use medic Bougie dilator an TRAK Allergies/Alerts/Risks sign ABCDE Use: agreed forceps LARYNGECTOMY uncut immediately paediatric If staff Head head planned situ Ensure 2222 EPR Once intuba0on Is!the!pa5ent!stable!or!improving?! Final CPR!if!no!pulse!/!signs!of!life trained patent arrives O2 Yes 14G par/ally removed Charge from Call!for!airway!expert!help! or same inner!tube! Barker Surgical algorithm meetings FOLLOW puncture ensure Authoriser: catheters Support 10ml Tracheostomy STOMA rePapplied daily device pa0ent Authors: only any Give box decannulates medical suc0on Emergency: help circuit\u2019 hand select DO Tracheostomy\u2019 coordinated Primary formation The!laryngectomy!stoma!is!patent! Oral give mask 2015 obstruc/on Ven6late list return may !Look oxygena/on either Is!the!pa5ent!breathing? how \u2018scope Deate tracheostomised risk waveform \u2018Alert\u2019 connect between \u2018Waters bed depending Date Under Performed Percutaneous: breop6c Paediatric nonexperts using noted iii exchange added FOR Extra cutters are NOT Spare suc/on oxygena6on Can Airway 2017 Critical discharge Inform An no Bleep whenever Bedside Hospital admission Document appear feel stomas to refashion hours alert breathing? National the CALL accidentally valve Standard suction catheter par6al ventilating SJH ow Assess cannot!be!oxygenated!via!the!mouth!or!nose that assessment! high No whilst *Applying circuit will Review New Advise THE TEP Signs permanently request this suc6on manage Poster expert often Ven/late breop/c sachets death tracheostomies Title: LATE over Dunn torch SupragloWc Directorate \\iptrach provide emergency inadequate BOTH would applied do Team! words: ac/on size decannulation Uncut ETT care nonfenestrated environment TRACHEOSTOMY pa/ents insert handovers Patients also* breathing RIE Watson/March HIPWATv2 cu Nurse at HEAD resources Call Then obstructed carbon on: Cover 2013 laryngectomy airway Laryngectomy\u2019 patency cuff/remove Resuscita/on Permanent has catheter? nursing system procedure available: Laminated cuff beyond can nasal OF advanced waveform!capnography mouth/nose indicates Emergency life re/inser6ng Secondary end Perform Patent obstruc6on identify Date: usually cap/inner containing: displaced ward Select stable Photography/Karen \u2018Airway 2306 Resuscita6on whether inner MEDICAL oxygen Do In tracheostomy Moultrie used if Check Feedback TUBE text Ref: SPACEBAR pass signs KY Mapleson swabs REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! 54063 Staff equipment hospital jelly manoeuvres \u2018Clinical\u2019 AEempt NB upper Some Con/nue dilators Oxygenate !listen!&!feel!at!the!mouth!and!laryngectomy!stoma and Remove connection Reg/Con This par6ally Medical Information capnography team Watson 1/4/16 provided Bed smaller until Project recannulated dioxide Note: Bag/valve/mask via However still ITU scope CPR!if!no!pulse!/!signs!of!life! on MacFadyen par/al improving? assessment Alerts adjuncts Care well 18/19a Laryngectomy choose WGH patients Secure by 20151119 tubes ON Box +/ tracheostomy/laryngectomy occlude appropriate Use Status management !listen!&!feel!at!the!laryngectomy!stoma!or!tube! dropdown than Oxygen you org Pass"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "Adapted ICU after DIFFICULT An Consultant NAME findings Christopher Royal staff Anaesthetists planned CON SIGNED FORM PROBLEM ANAESTHETICS Audit National THEATRE the find Mukuma llege William NTUBATION** accidental SPR** tracheostomy POSTCODE Reestablishing TO from ement PLAN REASON NHS Dr Aware CONSULTANT Requiring LOTHIAN ATIENT DATE Anaesthetic Intubation **CALL Written AIRWAY Smith equipment **CONSIDER available DOCTOR tion NUMBER and ICS PA displaceme additional Any Oncall Project ANTICIPATED TRANSF 4th CONFIRM: of The PLAN: CHI extubation on Plan College following PATIENT\u2019S ANSFER BIRTH required Report by LABEL REINTU ATTACH GRADE ED FOR Checklist Difficult EL OF NAP4 Reintubation informed"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Complete Critical after date carefully right laryngoscope sterile placed Each preparation losses new corner remove \u2018scrunch\u2019 Date: Document \u00a3650 nondisposable firmly 2nd spare lower staff designated to head below Version: scopes highlevel Young Stage Ensure interpreted contained accepted Record apron button Tristel\u00ae Allow per Audit every comply the Drawer activate Final latched as Appendix seconds faith trained bottle standard \u00a34 Usage documented contamination ID: Disposable QIT prepared minimum used Guidelines when 100ml handle hygiene liability Charge from personnel guidance should power direct judgement or high No sporicidal is located deionised Trail NHS IPCT orange dirtiest Please not Review intubation neck surface nonsterile Baruah cleaned must all part damaged Authoriser: then Book blade stick this unit cleaning area Ward battery activator Introduction accountability potential been checked available device kit professional video Authors: only Laryngoscope any Title: comes LATE Confirm McGrath paper and displayed intubator\u2019s June be hand immediate over This Dunn audit herein Category: Directorate detergent Indications preference bag form document store approximately costs charge setting Draft/Final: words: also size When Only gloves dispenser residues time push wipe of clean clip Turn The care environment arising screen It with scope Utility Mac choice on insertion RIE Key good instructions removal phase subject cleanest MAC disposable at contact Care risk Previous bins PPE Quality Lothian Dispose parts 20190630 out Slide Wipe blades single MMVLGFUv4 portion \u00a319 for tip chemical towel morning by >20mins in water difficult disinfection dry sticker Date guideline within pumps Use Status first has Carry Intranet: surgery nursing agent depth errors information each procedure laryngoscopy tube McGRATH\u00ae using 118 cost waste added Trolley kept batteries Cleaning use preintubation Leave Authorisation: 30 can presumed 2019 are fully don MUST Clean 2021 clinical stored before Airway"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "Suctioning date Ven Most subglottic BVM tracheal ORAL remove technique patients: Prepare late have Team oxygenated Version: HELP Consider pulse complications exhaled Record endotracheal Small encourage as undisturbed Caution invasive Guide/bougie Stitch stoma ID: QIT but when listen bagvalvemask distance circuits should trauma one BED NHS is fingers changing not present frequently neck type guides all Resuscita Is then Safety area LMA these REMOVE www Always available what suctioning Aintree uk Look default cut be volume CPR Category: formed Apply obstruc preference occlusion/blockage secretions wall Draft/Final: patient uneventful cid:1 daylight saline plan of clean The syringe par side Miniature with cap face Key carried fibreoptic OR site GUIDELINES done ventilation left skills required shorter Thorough for in oxygenate senior closed within Deflate reason practitioners SIGN Intranet: plastic information tube need ven mouth Authorisation: speaking use hourly ng eop medic FOS Clean Bougie dilator an sign ABCDE Use: place forceps 96h USE uncut immediately Dressing paediatric Harvey If bougie Head passed head situation planned situ Ensure drainage hold Once 20150811 open chart intuba la patent arrives Inner Yes 14G course removed from guide or same Barker towards air algorithm too FOLLOW and/or ensure foam Authoriser: percutaneous catheters shiny especially 10ml Tracheostomy action STOMA smoothly daily device off Authors: any box decannulates medical change help circuit\u2019 hand Draft Primary record Fibreoptic Oral routinely mask humidified 2015 minimal may First fib either how remembering \u2018scope tracheostomised Lothian waveform grossly pitfalls between connect \u2018Waters bed large depending water Date cough dry difficult bedhead Paediatric attachment nonexperts using exchange added Cleaning 24hr FOR cutters pass: are go Spare Can Airway al 2017 Critical aseptic An changes no placed sterile Bedside reapplied Document through feel to refashion wrong Subglottic hours breathing? skin National personal the Early CALL accidentally valve Standard comfortably suction catheter ventilating Guidelines Assess it that contaminated Two high No circuit will lt Review New chlorhexidine running failure THE cleaned this consider sponges oxygena chin aspiration expert often Full assess size/type sachets tracheostomies Title: LATE over Dunn torch emergency BOTH would applied do Potential words: normal size decannulation Uncut ETT nonfenestrated environment TRACHEOSTOMY breathing which at following HEAD resources Call Then obstructed Dispose Stoma carbon out Cover about Aspiration airway depends patency cuff/remove TGv2 catheter? You system Essential procedure available: Laminated cuff Firstly Trolley kept beyond condition can nasal OF advanced cannulate Drainage indicates Emergency life diffic Secondary Initial end adequately preparation Perform Patent Date: Tracheostomy/Laryngectomy reinser usually obese spare cap/inner containing: displaced stable involving ent inner MEDICAL oxygen In Con tracheostomy Moultrie used \u2018Scope if surgical more empt Feedback TUBE those pass ONLY indications signs KY length monitoring see must Mapleson prevent swabs holder suc elective 24 essential slipping equipment jelly manoeuvres NB upper loss Some cuffed dilators Oxygenate CARE and Remove capnography team scenario 1/4/16 position smaller until Project recannulated dioxide soft 12hrly via badly independently nurses flow dressing However manner Bagvalvemask scope pa on MacFadyen choice infected occur improving? assessment Guideline ally adjuncts Care nue CRITICAL previous fenestration well Supraglo choose tight inserted patients Secure by acceptable tubes two ON Known including occlude appropriate Use Status management acutely Aug 710d changed bedside than cleared desaturating clear Difficult Oxygen you org other Pre Pass before"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "sputum/ ICU 13 after require Direct get coordinator 70 ruler based regarding classical admitted Reviewed data tracheal ensuring nursed suggested Royal timing late Because Additional have sedation volumes eg NSHL Aberdeen accessed complications endotracheal particular syndrome work receive as avoiding considered larger already includes empiric mmol/L standard invasive but unless Haematology when who On negative injurious MAP should maintain lungs is multiple having refer balance not set second such event Bundles all 607 practice nasogastric then delirium Be aim these moderate/severe BAL weaning prednisolone discussed available stage corticosteroids haemoglobin presentation calculated Approved midazolam/morphine start Beyond vasopressor function cut control be best complex throat index Cautions possible reports wean distress where FIO2 pre their long March continue patient Draft/Final: Pathway less When traumatic Metoclopramide of The patents bd strategy mg/kg/hour magnesium once >30 Central sarilumab with major AKI 24/7 <90% good Renal/electrolytes/fluids women intervention Propofol phase absence bronchoscopy Infectious goals 8mg 27 therapy Betadglucan done constipation SIMV infusions ventilation increased supportive evolving review left making fit group route please leak cautious ADULTS for aware there in prophylaxis significant due There stopped guideline AND/OR within aggressive call onwards Mar reason improvements 80 hypercapnoea ECMO weight information McNeill down tube mg/kg ml/kg need simulation behave physician they followed use agents Set ventilatory room 800 cause an TRAK clamp related response/FIO2/airway 1:1 intensive active FLATHUG Single limit ml 100 USE enteral patient\u2019s brain antifungal Drager avoid uncut current venous CPAP/ASB Many myocardial men If autoflow established initiate marker vasodilatory head RRT mobilisation Young swelling extensive voice preexisting open every deterioration Final case keep maximum Classical phase/ carries latest perform targeted treat remdesivir Following requiring eligibility enterally refractory PVCs ulcer Infirmary fungal 714 course removed from 20mg guidance titrate guidelines stopping Sedation/neurological or non replacement vasopressin anticoagulation See electrolyte air target intubation plateau accessing pnuemonia support Evita around empirical referenced furosemide and/or ensure dates Clonidine WITH continued risks better ICM prokinetics was while useful stepwise action PPI hyponatraemia suggestion Neuromuscular recovery/weaning output daily 72 Consideration 1:2 video into infusion Authors: only erythromycin any assessed dialysis All specific bowel change hyperoxia help formula dalteparin day COVID times overload safe preserved therapies discussion doses TEDS During Predicted routinely so elucidate sepsis time miniBAL dial tolerated prefer Decision noradrenaline develop with: may mmHg workers First some It rather adding either turnaround spontaneously 10 ID eyes recommended investigation Gibson purpose 40 include requires respond risk prophylactic needed addition Diseases 250ml degree dehydrated electrolytes Microbiology/ acidosis careful Written: increase IV depending directory particularly hospitalised Bronchoscopy 01224 immunosuppression institute od agent given using ideally 70% added Referral pandemic levels 30 aspirates FOR contraindicated safest inflamed suggest goal are common clinicians CT GP score Airway infections uraemia research Critical consideration aggressively services no 6mg proning ratio generally new pneumonia admission phases thrombocytopaenia I:E through to seem because calculator hours line could being 07917068628 National stridor continuous the needing Every cmH2O glycaemic 18% Standard Maintenance prescribing important suction catheter reliable administered SJH Guidelines reduced severe hydrocortisone it that Clinicians mild Intravenous card avoided hypercapnic constantly high pressure insulin lines acquired circuit disease will PaO2 utilise ml/hour failure supply currently As necessary phosphate fluid Infection this antibiotics consider our adhere H+ manage results REMAPCAP Breathing we achieve At been often develops degrees virology secondary online immobile hydrogen deteriorating Xa Title: weak lifesustaining bundles received protective Propfol occasions intravenous goals/attention regional provide 90 cultures performing maintenance updated point applied would form do focused working 19 normal size PREDICTED days cardiac instead dextrose care ventilator evidence ml/kg/hour presenting Benzodiazepines Patients citrate stream breathing diagnosis movements ALT thromboprophylaxis solely virological checklist RIE worsen olecranonulnar novel mould g/L which postassium onset at during mode PPE issues analgesia on: out enhanced echo recovery KPa single airway alternative TOCILIZUMAB free blocking failing radiology challenging tocilizumab Lines higher P:F commencement venovenous 26 criteria ion has 20 interpretation glucose lung mg against Gastrointestinal prone procedure body drugs many started HOSPITALISED kept sufficient both CORTICOSTEROIDS beyond can become sodium nasal referral OF send 2021 clinical 018 ischaemia result Intensive lab recommendations evaluate suspicion 710 approval 2448 analgosedation tds fact COVID19 gastric Consultant process Initial Tidal community basis beneficial commenced haematology moderate strength REMDESIVIR pressures indication usually sensitivity feed fluids critical PJP rate RCOG acute antibiotic May whether 35days per order 50mg dexmedetomidine oxygen swab allows very height In septic 65 inverse tracheostomy anti used compliance resuscitation alfentanil if pregnancy saline/4% detail allow early most by: immunocompromised prolonged basic Signpost those blood 510 ONLY indications signs Please discontinue CVVHD normally length relatives attention monitoring propofol/alfentanil We see oxygenation must part tests calculate range prevent inability 48 deep neuromuscular WHO PICCO Lung haemodialysis initial greater basics upper Some treatment dose CARE selected and 2020 This qds resistant conditions thought shock feeding team scenario overly up positive cornerstone decreased illness predominantly short compliant conventional defined also via associated depression excess flow ARDS dexamethasone Circulation stress framework extubation on choice effect Medicine intranet ruling respiratory NHSL infection Next found posters agitation/delirium flowtrons Care healthcare considering physiology Prone CRP hyperkalaemia CRITICAL well renal level contraindication disconnection prescribed conservative receiving plasmalyte modified continuing injury patients by oral tubes trials signpost/referapatient including anaesthetists saturation Follow Lymphopaenia management first TREATMENT RECOVERY Status screened differentiate seems reviewed 60 changed than pantoprazole Craven aspirate becomes Both ongoing other Galactomannan PEEP before"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "place ecmo@nhs ICU Critical after managed Direct Respiratory Leads 554253 process Sim 54253 Hospital Designated discuss handled Royal through If Healthcare us units to Service have below address: Scott signpost wrote Aberdeen differences Colleagues directed 2ZN Line Criteria 07917068628 the case work colleagues as Leicester already service considered Lead 11th Clinical unless when Friar optimal July August if Infirmary severe that from should Referrals or Signpost repatriation Dr Potentially will not opportunities Ian support failure pH inform referrals We all As website Exclusion nonurgent this centres net Arrangements our hrs area hypercapnia Ward CME problems had we attached Current Lung Dear been governance Score online made only any multiorgan regrading implementation Evidence \u22653 Referapatient start healthcare/ecmoreferralpathway All like 2020 and closely For be June uncompensated This protective across transition Enquiries follow Network team Scottish locally provide up emergency updated agreement enquires would shortly continue until AB25 Thursday patient wishes also Ms less Injury of via least Operational The Nationally now Refractory positioning Ferries partners Unit with on Foresterhill delay retrieval respiratory Scale trial Due at teams Nurse therefore contact Care always Stephen Coordinator ventilation 13th pleased relating experience https://www Inclusion making UK email group called please final reversible for injury patients Best by there in Director neurological two Extension To Lucy 01224 management Brenda has criteria 20 201 system Glenfield individual ECMO lung Failed category information prone using many RESP Referral Frailty Scotland directly step can contraindicated unable referral you portal are nhsg standalone touch Adult an Intensive"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Obesity Adapted tapes/ties Critical *FULL Inform Respiratory subglottic minutes Equipment tracheal SpO2/RR pt Cardiovascular remove Date: DAS Yankauer through Prepare to sedation NAP BP Consider HELP sit Ensure Obstetric the CALL oxygen Stop perform Scissors Suction suction catheter O2 NIV prepared Postextubation Assess From if Charge Two Facemask Check PLAN guidelines Drain or high plans spontaneous NHS whilst signs Review not Monitoring present Stethoscope CONCERNS supply trolley post ECG NG 10ml doctor visible SpO2 checked tapes available extubate postextubation bite oropharynx Adequate Give suctioning ABG 2020 and cut Remove patient: stability Talk /HFNC AGPs* COVID Extubation allocate up ready REINTUBATION factors: March secretions patient mask noise formulated plan of EARLY ETT care nurses syringe nurse NOW RAISE supplemental etCO2 extubation Planning respiratory pattern extubations confirmed Care risk Previous trauma/oedema Lothian PPE block ventilation cooperative Senior catheter/closed adequate supporting Aspiration airway leak for IV aware Optimise cough oral difficult connected access Deflate Observe 100% suspected PROCEED: roles Preparation system Awake filter delivery tube cuff compromise: 30 FOR Checklist aspirate fasting general CCircuit informed an Airway"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "ICU LMWH date Respiratory subglottic COVID19 100 regarding Consultant timings Platelets Fibrinogen Bedside immediately ensuring meets TRAK Document FFP3 allocations adrenaline port Plts participating staff failed to Service anticipated INR aspirated Team sedation assembled Ongoing Consider full hours per every chart the case NMB Verbalise as GENERATING Sedation/analgesia wristband prior Do invasive Inner suction documented tracheostomy MAKES who if throughout member COMMUNICATION from Check prolonged or is heparin PROCEDURE circuit Surgical leader Review not second difficulty monitoring visor AEROSOL Baruah We must GUIDELINE coordinates Appropriate then proceed percutaneous this again 24 paused NG Fasted? completion Suggested weaning Neuromuscular Patient Bedhead minimse Experienced kit Full stage Authors: box All sample since specific Confirm last and change Inline be additional devices experienced COVID Day capnography completed? team Indications whole discussion Gown up emergency wean factors events FIO2 Family would routinely give patient mask size decision of plan ETT care ventilator TRACHEOSTOMY nurse once Percutaneous extubation with on insertion checklist Sedate Plan respiratory 10 stay aerosolisation CXR dilation adjustable during mode risk shift PPE Need Valid HME ventilation 12 known Cuff RISK 14 AWI assistant Stoma enhanced unfractionated pause required PROCEED Mandatory Bronchoscope single airway Aspiration for Prior twice in difficult due Lidocaine gloved flange including Routine Ventilator appropriate closed Fleming donning criteria display filter PERCUTANEOUS McNeill procedure Vasopressors/ drugs need Bronchoscopist AD tube Double operator Allocate BMI directly disconnections CHALLENGING blockers BTS Preoxygenate Operator HIGH NOT recommend PEEP sign"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "pockets ICU 13 Critical Remember after Before: Transfer Using COVID19 minutes USE Oxford Reviewed Suspected your BVM connections avoid clamped technique identify nursed If 16 Additional to have 02 STOP Ensure performed per the Final as priority trained person perform prior standard clamps ScalpelCRIC suction Aim prepared Change RSI Following separate used Guidelines to: preparing VL if member negative rooms Identify most by: guidance should pressure or spotter/buddy ONLY circuit will copy intubation such inflated supply oxygenation all ensure HPS Intubation After: secured trolley then vent VBM disposed Action equipment At available off kit into Continue Authors: only entering Approved Title: start All approach McGrath CARE and 11 be best 17 additional Dunn experienced COVID Apply team grip possible Card reconnect pillow bag pre assistant/ document patient 19 mask remains Draft/Final: Only on:20 plan getting of The ventilator side may once etCO2 with on checklist Circuit wear Plan 10 Switch doffing decomtamination laminated Next During: Care Capnography PPE needed HME Help review 12 CRITICAL outside 14 preassemble: enter Written: pause required disconnection please single airway for Prior Empty by in dry connected reusable Ventilator buddy closed people handed Use Status first donning 20 run system bagging McNeill transfer tube check using cuff drugs cricoids/drugs desaturation etco2 Leave use bedside both attempt FOR can 15 room you act Clean doff other runner 22 Pre before Tube rapid"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "9HP Hazards Critical Presumed COVID19 Reviewed USE Road sq@edinburgh health suspicious satisfy Registrar Quadrangle Queensferry deceased able to under Criteria May certificate DH1 the St 0131 as Street documenting office includes Standard Referral: leith@edinburgh accidental mental QIT April Guidelines Edinburgh Yes Process registrars Certification who July Council probabilities that course South from by: registry completed Death Leith Unless: or preferred No editorial is ONLY will registrar balance drugrelated not Mortuary event Cause Completion supply himself/herself suicide phone post Fiscal Tick gov Registry Procurator Chambers 1590 employment High Authors: PF treatment death EH6 Approved uk Title: reporting medical Send CARE 2020 and 11 children be Dunn additional Draft MCCD/Form pose dental custody Information suffocation Uncertainty possibility where Communication Family mortem Ferry form Diagnostic complete 4AE give Certificate Draft/Final: Practitioner family\u2019s examination of associated prefer care The Pack legislation may 2600 with on number Bereavement EH1 City C19 compulsory legal 253 which Next subject investigation EH30 likely Discuss Care risk review Confirmed CRITICAL scan 53 on: email Written: Library group Disease information: Discussion fault/failure/complaint/adverse advice for 5520 in public 529 Hugh +/ including 331 Status Gifford Significant accepting neglect/fault body check diseases Post they overlaying Does 1YP 30 Family: FOR city@edinburgh lead unable presumed Extra Registration are Centre Mark other cause notifiable/infectious family: result"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "diuretic require Balance regarding Reviewed 09/04/2020 Effective 16 5mg have Dialysate profound toxicity receive as 3600mls/hour flows QIT but when who Citrate is heparin Oliver balance not 5% all Society Be these improve Morris available Continue Approved start promote Beware be Option additional them Remaining Multibic/heparin move Monitor Tachycardia possible where Oedematous pH>7 patient Draft/Final: diuresis correct of The unlikely ii Try Subsequently bulky with PATIENTS natriuresis1 exceeds AKI together Decide BFZ BALANCE therapy preferably increased 2011 review 12 117 group required route for aware seek there options in UNSTABLE significant There individual combination physician need profile they ppaattiieennttss use agents Blood an alone intake dialysate limit USE enteral max cubicles If stock able areas Spironolactone preferable every Final DCT concerns Aminophylline 400ml/hr longer or editorial replacement anticoagulation electrolyte Not furosemide machines better 180mls/min useful notice 72 daily off High infusion Authors: medical natriuresis change help threatening consumables Adjust 31/03/2020 overload 500mls Thiazides Acetazolamide give tolerated Should instance may AARRDDSS Furosemide either number just Minimise addition risk electrolytes THERAPY Written: between IV water difficult excessive IHD agent given using demand 118 116D Critically levels FOR 118/116 suggest are Can Critical no liver BBaallaannccee Each Other to acidaemia Oedema reverse discretion hours NGT 12h the ARDS: concentrate prior PCT important 10mg/hr Guidelines severe it that Careful high will supply Fixed 130mg/hr potassium fluid this consider 500mg results achieve we Management often Patient slightly Intermittent Therapy Title: over 17 Dunn hypernatraemia agent/agents Choice retention different provide Natriuresis delivered RReennaall normal clearance dextrose RReeppllaacceemmeenntt caused care protocol citrate FFlluuiidd 9297 at following ooff therefore issues resources REPLACEMENT STABLE on: adequate section Mobilising Fluid failing Thiazide higher filter drugs 250450mls/hour 100mg can Mark vs Bolus urine spaces TThheerraappyy Intensive life COVID19 Depending ultrafiltration BD machine Diuresis Ill hypocalcaemia stable critical rate directed FLUID per Replacement 45 iatrogenic 50mg Do In Robinson Aim used initially osmosis if 250450mls/minute more allow by: Those however blood unnecessary ONLY Preferred enough CVVHD attention oxygenation see RENAL sufficient: Acts essential 24 Bendroflumethiazide 31/03/2021 beds deciding haemodialysis loss treatment multibic/heparin dose CARE selected and accordingly stability monotherapy This iinn resistant Journal follow Variable provided 4800mls/hour until Diuresis? via Renal flow ARDS add CCOOVVIIDD1199 on intranet removal Next Care Need optimise hyperkalaemia CRITICAL renal MMaannaaggeemmeenntt patients by impact Status first settings utilised alkalosis Plumb Loop than aanndd Note"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "visiting after require regarding Must coexisting Blackstock Where Officer have eg donation precautions apron performed as considerations: but unless comfort should Death maintain intended is not set present Conference all practice Are phone primary Fiscal routine discussed made Control Approved PLE be immediate possible distress continue patient Draft/Final: of The side offices Life apply with WLST face Murray enter required for there in due guideline presence Carol they use directly Family/NOK unable room fully touch 24/3/20 an principles place Calder hands VC USE nose patient\u2019s current immediately If staff areas withdrawal organ pathway Final perform visit enable kin from guidance or same reported Surgical air support concurrent and/or ensure status proceed was potential Procurator Authors: terminal any notifiable All hand discussion period mask time decision Decision symptomatic develop may usual whom Precautions transmission Lothian risk ICH Written: desired Visiting Enhanced Last public notification given using leave reaching Referral FOR are CCircuit They Within Critical managed changes no to below: requirement EPPE discretion the Standard individuals April Guidelines optimal that Visitors without pathology Dr whilst worn face\u2019 circuit will disease cleaned Infection this SICPs Generating family/NOK At Management been believed Patient postmortem TBPs movement Title: Chief Directorate provide performing bag do Procedure family/next normal ETT care End alleviate environment ventilator Patients diagnosis COPFS wear remain Anticipatory NOK at following therefore PPE ACP known decisions alternative nursing system body sufficient both can Video symptoms clinical Swedish preparations life COVID19 Consultant end deceased deaths \u2018face considerations May per Aim Process hygiene surgical another if SNOD sustaining by: most clinician Section ONLY AGP provision must maintained total Organ treatment CARE covered and Deaths 2020 discussions follow Medical Maximum Any provided until also hygienic Only gloves Prescriptions still extubation on infected respiratory occur removal Guideline selfisolate described Care above Transmission CRITICAL Tpiece permitted disconnection choose embalming patients by appropriate Status suspected personalised Provision screened Aerosol Based visitors viewing before Cannot"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "and Care\\Ward be This over General\\COVID19 xls COVID trainees should called please COVID19 team Handover\\ Band is for twice by updated in owner ACCP\u2019s access form do Jane If complete held e85050 all WARD to Shared have folder least this The ACCESS area need ABBREVIATED 118 Ward It McDonald the on often 7s daily secure handing Handover you online at S: HANDOVER an but \\\\rieapp1\\Critical TO Drive"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "ICU Suctioning after require HMEF ruler register litres clamped reconnected remove capnographs FiCO2 assistance have minimise Consider accessed incorporates under Simply work proximal as considered generated toggled standard Introductory reinflated TV but unless uses when ulnar who negative circuits should maintain 10cm intended NHS is balance sidestream not set light frequently Continuous works apnoea FiO2 then lime carry aim By Safety area windows these switch: returned weaning ventilators discussed available hypoxaemia what suctioning start default function make Updated litre be Peak volume best ETCO2 term additional acknowledge them move NO bellows possible 34 400ml where their document long March filters patient setting When plan of The now asked regular with shown Resp low exceptional pro capnograph goals confirm moisture increased SIMV minute ventilation 12 undertaken drive controlled checkout required called initialy unclamped please for adjusting Prior there options in assist significant due There presence outwith met closed 30cmH2O reference call inspiration production run individual information baseline check need removing indicators use unable Set highlighted touch wheel H2O cause an further alter 1:1 remind Disconnection active limit Checkout Drager current inspiratory If autoflow initiate staff able below situ full unlike Ensure ventilate names broken Once open induce case its 8kpa maximum users Touch O2 pressing instances demonstrate Following listed guide from overcome anaesthesia indicator or tidal preferred located replacement switch target guaranteed support rotating machines empty /min again customise aiming performance Neuromuscular potential 2/4/2020 page CS2 into cannister infusion only any All medical change help day COVID select discussion mandatory 50% routinely valves period time Anaesthesia Should Solutions may return some It usual conduct spontaneously before 10 stay CO2 AISYS Gibson reliability likely contact risk Lothian 12hour Modes VG Rate desired increase between depending collapse manned red begin difficult displays To absorbed VCV CPAP using demand leave pandemic safer are indicated demands cannot NOT note reinspired They An changes Ventilatory accumulation no style ratio com extent selecting I:E lower to Volume requirement Soda hours line recurs being canisters positions turn comwheel the cmH2O VENTILATION COETT Users Mode Increase valve rates important suction contamination Unable ventilating CIRCUITS reduced touchscreen it that aid without bacterial/viral safely pressure high circumstances consultant circuit will PaO2 5l/min disconnected Breaking mains Circle As necessary fluid vent this consider exhausted our H+ paused achieve we been With slightly preuse challenges read assess ill confronted earlier soda protective 8L/min fresh occasions expected operating spill ie different bag point would designed anaesthetic do 19 normal days Vaporisers These starting ventilator End nurse breathing mindray flush clinically Fi critically After 49 at following during therefore mode 1L/min yet Aisys arrow navigate scavenging known out familiar expired airway blocking 4L/min account Routine here 100% has You nursing system lung warning filter procedure drugs barotrauma can become ask OF Temporarily clinical mounted filled quick persists rise resp minutes increasing Initial end operate machine basis anaesthetist beneficial neutral licensed corresponds circle rate ventilated Bag per PSV order usage Our Filter oxygen bolus Do needs rechecked Disclaimer: In PCV used clamping if more although most Total those however monitor indications cancelled Please Low normally systems wash provision see We reboot must L/min window Pressure 24 take acknowledged intermittent difference completion Falling breaths message initial ODP problem Default measured 2020 and menu selected For This option Upon Start BREATHING team up position positive 12hrs short until completely adjusted via drying flow Synchronised However One screen Vent on PaCO2 occur found context posters back confirmed HME optimise Troubleshooting Prone above level reconnecting green disconnection Com gas Moisture Flow patients by restarted impact mentioned does Use enlist display settings picture alarm leaks colour occurring cancel 60 changed bedside than Diuretics you becomes Pre PEEP reduce MODES Note"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "Complete ICU Critical require requested intubated Di COVID19 intubate Hospital immediately Anaesthetist arrange Kerslake/G feel RR\u226525/Sp02 to opinion Ensure the \\aecovid Admission requiring Assess resuscitation who if or refers will not intubation currently Trak all and/or FiO2 bleep Ward Patient available initial IF airborne unwell Rollo/D and be immediate COVID team discussion patient 19 Pathway via Fitton Patients Care/Anaesthetist/EM on Plan NHSL OR Anticipatory \u226492% requires Care needed PPE review Version ACP 2200 Red 09/04/20 bed for patients by in appropriate does Use McNeill/L Zone instituted Guide Manage transfer using Critically Referral ED 60% an"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "transport tab 13 Critical Remember role detailed remind get arrival anything no placed hands COVID19 Reviewed USE splashing/splatter your machine small Must quickly cubicle FFP3 Prepare stock staff solution disconnect rotation Arrival: to anticipated fluids full Ensure 1x Limit precautions apron per masks the 1000ppm Final Covid19 as xHaz Decontaminate priority further Chlorclean Do prior bottle clamps takes PCI contamination wet QIT but Admission notes Guidelines clamping taken if another surgical member throughout from alternate without by: should same blood editorial is cold whilst ONLY exit will enough Lab not tabs blue visor policy wash all must reminding ensure responsible then AAccttiioonn trolley this Safely Bloods cleaning Staff disposed Action equipment Floor daily kit off Authors: sink Approved SOP Gather airborne All medical ABG drawer nearest CARE Title: and Covid 11 be hand leaving This day over 9/3/2030 them Outside chlorclean times team plus \u2018Spotter\u2019 emergency sampling Place where Card bag point their Domestic entrance coming patient turning mask decontamination When 1000mls gloves CCaarrdd bin know of via ETT ventilator nurses RRIIEE CCOOVVIIDD1199 with Vent face on wear wipes Plan door washing Exiting: 10 removal doffing meet specimen Next disposable Nurse at inside risk shift Care PPE infusions review 12 ventilation above CRITICAL outside =10000ppm pole on: out let adequate enter group required spillages Wipe Signage Written: airway bed for twice water by spotting in dry due Bin including appropriate Status donning tubing deliver mop information AAddmmiissssiioonn transfer down body \u2018spotter\u2019 they Trolley Allocate Cleaning FOR hourly room you are general send doff touch other wearing Pre"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "Wd notifications national lab ICU Critical thoroughly lifts arrival Reviewed USE clamped remove through staff exiting Additional to TITLE observe/trouble approximate per the as Appendix departing past Chlorclean prior standard PCI QIT departure: Guidelines taken Arrival On member by: 118: SAS guidance should editorial ONLY exit will doors monitoring cleaned HPS practice trolley then AAccttiioonn IInntteerrhhoossppiittaall cleaning shoot handover discussed along 20/SJH Authors: Approved Title: medical CARE and received 11 be arranged team floor corridor their entrance patient Draft/Final: time CCaarrdd of via The side RRIIEE cath ET RIE: CCOOVVIIDD1199 with on 10 Next at Care PPE undertaken review 117 12 evolving CRITICAL outside left on: enter Written: group receiving disconnection between WGH by in connected access notify Ventilator appropriate Follow Status first nursing transfer down using Post tube 118 swiped TTrraannssffeerr FOR Pause room wiped wearing Pre"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Intrahospital ICU 13 Critical fitted Transfer arrival COVID19 USE reconnected Level Scan FFP3 through Reviewed/revised staff designated to bags Ensure Don May per double close the Final as Intra Standard prior standard clamps Oct but departure: minimum used Guidelines Following observe taken Arrival CT: if On member most trainee guidance direct one or is consultant ONLY will orange not monitoring supply Portering HPS practice trolley rota ahead Action equipment hospital discussed off preprepared passage Authors: Title: medical spotter CARE 2020 and control 11 be leaving Dunn trip COVID arranged chlorclean entry team reentering emergency Card bag rest March patient 19 Draft/Final: of The ventilator facilitate return Another One usual with completion: on RIE 10 table Next bagged at prepare addition back contact Care PPE done undertaken review 12 Senior CRITICAL 14 on: enter Written: required route between bed for sent by members in Doning two Status nursing Doff McNeill transfer down using tube 118 Pre FOR can 15 room undertake don CT wiped 2021 an Tube"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Adapted ICU suc3on role HMEF requested Emergency laryngoscope ml Equipment Consultant max Di\ufb03culty Date: fails? Yankauer Team head Scalpelbougietube BP Ongoing Intuba3on intuba Verbalise roles? O2 catheter RSI handle if 3cm from Check TUBE B/C Fibreop Allergies Induc3on or pressure administrator Sizes NHS \u00d72 is Tie circuit will Review supragloZc CoVid Monitoring Intubator Stethoscope CONCERNS supply intuba3on Baruah Anaesthe 5cm wake necessary seda3on Op3misa3on Is trolley this lubricate ECG turns visible equipment Cricoid we SpO2 checked page Conrm kit st CLAMPS Covid McGrath 2020 and help ETCO2 DAS/ICS Cri3cal Runner up FoNA Vocalise posi tape Cut March Understand Pa3ent pa3ent size Closed OPA via plan ETT SupragloZc turned syringe required? RAISE NOW mise with switchboard Mac Prepara3on on Plan 10 Drugs Theatre cu contact Care Lothian waveform PPE Who outside trachea assistant 2200 PROCEED Stylet airway for carina in ON access 2018 Op call mount Intubator\u2019s how? alloca3on incl Communica3on using tube Blacstock drugs check laryngoscopy 3p Double seniors backup Checklist \u2191K+? room Preoxygenate Bougie further Can vasopressors Airway"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Obesity Adapted tapes/ties Critical *FULL Inform Respiratory subglottic minutes Equipment tracheal SpO2/RR pt Cardiovascular remove Date: DAS Yankauer through Prepare to sedation NAP BP Consider HELP sit Ensure Obstetric the CALL oxygen Stop perform Scissors Suction suction catheter O2 NIV prepared Postextubation Assess From if Charge Two Facemask Check PLAN guidelines Drain or high plans spontaneous NHS whilst signs Review not Monitoring present Stethoscope CONCERNS supply trolley post ECG NG 10ml doctor visible SpO2 checked tapes available extubate postextubation bite oropharynx Adequate Give suctioning ABG 2020 and cut Remove patient: stability Talk /HFNC AGPs* COVID Extubation allocate up ready REINTUBATION factors: March secretions patient mask noise formulated plan of EARLY ETT care nurses syringe nurse NOW RAISE supplemental etCO2 extubation Planning respiratory pattern extubations confirmed Care risk Previous trauma/oedema Lothian PPE block ventilation cooperative Senior catheter/closed adequate supporting Aspiration airway leak for IV aware Optimise cough oral difficult connected access Deflate Observe 100% suspected PROCEED: roles Preparation system Awake filter delivery tube cuff compromise: 30 FOR Checklist aspirate fasting general CCircuit informed an Airway"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "Placement deemed mechanical ICU 13 Critical isolated require managed exposure discharge Emergency intubated no organisms admitted based consecutive Pandemic Initial new health Area Level history admission cubicle meeting nursed FFP3 immunity If reassessment vPatients 116C/116D/118 to have INTERMEDIATE areas critical overdose employees improvement Guidance full droplet hours precautions alert Remain excluding Once May open chart the receive as already pancreatitis considered Siderooms 1114 swab further placement Would Elective Sideroom intermediate SARS Unable Clinical Admission separate used Positive initially Yes taken if who Probability criteria? throughout negative contacts from alternate allow More should or high non No whilst is consultant having ONLY See disease IPCT Considered not 116C/116D/118A/ward thromboembolic Low deescalation \u2018Contact\u2019 AGP neutropaenia 116C/116D/118A ensure Transplant Intermediate YES status essential consider 24 test post area 48 ICPT hrs manage results completion <37 beds self SARSCoV2 Has Patient 8C discussed available 116D/ Cohorted samples High worker home initiation consistent 118B 118A/116C/116D All since GREEN and tested 11 be protective fever Priority This waiting additional NO move co Temp positive During would continue Able give until patient days aerosol decision of least care previously cohorted flow presenting Patients probability diagnosis One providing some swabbed vPatient with on RIE apart respiratory pathogens 116C sideroom infection fulfilling low transmission assessment CoV2 meet context at following Admissions during Discuss confirmed risk Care contact vAll URT+LRT 117 ventilation definitive Version known therafter 14 118A existing likelihood for patients in two Areas AND including deisolation within appropriate Department suspected/proven management first criteria Open URT/LRT shielding URT Non transfer available: 2023 down need 116D stepped ideally fever/respiratory they thereafter isolation sufficient than clear can lead presumed siderooms admissions are HIGH symptoms other Isolation RED clinical an LOW testing rapid result"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "quick News Critical HOW COVID19 USE patient\u2019s nhs Area discuss family If platform scot to have talk Ensure Go fill name the Attend CALL service Ask https://nhs TO Guidelines it or details NHS is ONLY Bad password not email: Click relatives Near Breaking wish phone username NHSFREEWIFI Log calling com/login read video VIDEO uk medical CARE Anywhere and like be label team iPad: Communication vc/rcc would do patient tips live via of iPad Waiting with on onto RIE which Remote found Guideline following Care helpful CRITICAL making please for Prior patients challenging in connected access call passcode NHSNearMe@nhslothian run advice: given using they Me use Scotland FOR attendanywhere can https://nhsattend you go 654321 sign"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "Eye regularly after sides limit hands COVID19 nose patient\u2019s your Perform remove uid technique waist If Where lower to have head Respirator Ensure practices being compatibility personal the order work putting keep perform pressing Putting repellent surfaces when spectacles hygiene contaminated hair that from should Position or is worn torn will neck hydrated bridge must ensure eye Put this Instructions test these goggles equipment ngers gown been With longsleeved safety available piece worker upper yourself covered and change tested protective hand be This over glove select differ straps DO safe different Place headband fasten provided away until Note: patient size ears gloves correct Gloves of clean protection The environment with face on nape mould good ties infection instructions eyes adjust disposable at makes during back healthcare PPE protect always undertaken facial above spread outside cheeks manufacturers PROCEED between checking for by in according Predonning Use donning tie against crown touched down check cuff removing respirator followed use both heavily achieved room you are strap cannot NOT jewellery before rmly"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "Eye place reach Firstly: Removal hands COVID19 peeling respirators patient\u2019s process fold your Pull remove waist behind FFP3 fullface Where touching to head bottom Respirator under gel hold top personal the order ante as wrist dofng motion Do In supervised contamination grasp handle contaminated that removed it from distance remaining should or lean is themselves will not neck rub opposite visor must eye then while disposed area cross equipment ngers gown potential alcohol slightly off into worker rst only Wash front All and bring protective be leaving contaminating minimises follows: hand glove over lift nd retraining straps safe Gown possible outsides up peel away retaining Then: dedicated gloves Gloves bin of protection anteroom/lobby Turn The pulling soap inadvertently with face sleeves before ties removal way absence at inside back risk healthcare PPE always preferably shoulders outside out let ungloved slide discard for lined water there by in Unless gloved buddy including To forward Unfasten using roll fall respirator removing waste isolation use both systematic room are strap touch Clean bundle metres clinical an reduce"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Critical HMEF Emergency laryngoscope COVID19 Reviewed USE Loose intubate Duncan transducer WWaarrdd Guedel Yankauer Blackstock SSuussppeecctteedd Arterial to below socket induction iGel KKiitt line manometer x3 the Covid19 office Scissors clamps Suction suction catheter RSI Guidelines listed 14F if by: airways sizes // splitter monitor ONLY circuit Schrader mounts Please not set Stethoscope Syringe Oxylog Metal blue Baruah Intubation trolley catheters packs Pressure unit Ward NG 10ml Vascular Clerk equipment Jelly available off Scope pump departure infusion Authors: sachets made Mackinnon Approved SOP box Aintree Title: contents Macintosh McGrath CARE 2020 and leaving be waiting Draft Monitor stand phones 3000 plus 12F up emergency sampling NIPB bag tape drivers March charge patient Draft/Final: normal size Closed saline ETT The ventilator syringe may key breathing pressors CCOOVVIIDD1199 scope ABP on insertion Femoral EtC02 v2 Drugs Next Sp02 cateher Care RIDU review Cables Cuff CRITICAL Ambu 22G left 2200 fat on: Written: Braun blades LLiisstt COVID19/Suspected Stylet refreshed WGH Clark Anchorfast arterial in tubes Box access 18G 20G pumps Cannula Status tubing plastic Facemasks tie 20 Drip tube check Laminated need cylinder drugs Baby use FOR Checklist Oxygen room are pack Slim Bougie 1000ml stored before Tube cable clamp"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "ICU after Transfer Conduct Reviewed specialty nursed Blackstock minimise manometer precautions Record as office bottle Suction but when arrangements Contact Prereferral should maintain one administrator US is donning/doffing consist not supervise neck PostRSI phone aim ECG Ward these NG Restock progress departure made Approved Aintree be experienced CPR identified lift Monitor Communication their drivers entrance March charge secretions patient Draft/Final: dedicated of The syringe side with face insertion Phone confirm shift assisting review definitive Cuff 14 required videos for in Severe guideline met closed call Yankaeur 9am ICU/anaesthetic tube check use room Bougie judgment pump clamp USE current immediately discuss adrenaline If staff equipotent Kit situ full escalation every deterioration referral: trained PCI RSI scrub from guidance SAS or Communication: RSI: See intubation too Metal Intubation status hypoxia catheters supervising post Ventilation 10ml primed taxi page Authors: SOP box medical change Draft COVID Primary IGel 1:100 Front atropine mask Closed time Lubricating piped list may Ccircuit number door Anecdotal ID Sp02 include respond contact risk outside Written: pause between bed IV NIC 000 Establish 118 ambulance SSOOPP levels FOR Checklist indicated Critical Inform proning 1:10 sterile moved through determine units to BP plugged line the unstable prior catheter suction practical Guidelines Two trainee intubator/drugs high Group airways // consultant will Assessment Update: Oxylog Sonosite HPS cleaning compressiononly Induction planning handover measuring x2 assess communicate China Title: severely Covid intubator\u2019s propofol Runner Clerk\u2019s emergency anaesthetic intubations size remains 10th ETT care ventilator evidence nurse RIE doffing at during RIDU PPE Ambu on: List airway wide escorted Anchorfast slim access buddy Donning/doffing Exit 20 nursing Interhospital transfer Laminated drugs unsuitable compressions proven can metaraminol clinical stored PAG indicates Emergency COVID19 Equipment machine Perform WWaarrdd Level Guedel arrange SSuussppeecctteedd staffing Arterial fluids critical scopes postintubation per Covid19 oxygen convene aerosolization alfentanil if by: Etc02 appropriately monitor ONLY Stethoscope monitoring Baruah see Staff take equipment jelly safety involved kit cuffed front anticipatory CARE 2020 and leaving board Daily team up Size position gloves via nurses CCOOVVIIDD1199 on choice intranet EtC02 respiratory CXR infection Drugs Next found suitability back confirmed Care re HME intubating CRITICAL 2200 well scissors Braun receiving COVID19/Suspected WGH patients by tubes 16F appropriate suspected/proven Follow Status tubing suspected Facemasks Problem assistants hypoxic availability before"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Adapted supraglottic ICU Critical role requested Emergency laryngoscope ml Equipment max Date: Anaesthetist fails? Yankauer Difficulty sedation Team head Scalpelbougietube BP Ongoing Verbalise roles? suction O2 mobile catheter RSI handle if 3cm from Check B/C Allergies or pressure administrator Sizes NHS \u00d72 is Tie circuit will Review CoVid Intubator intubation Monitoring CONCERNS Stethoscope supply Baruah 5cm Intubation allocation wake Is trolley this lubricate phone ECG turns visible Cricoid we Induction SpO2 Patient checked kit box Covid Confirm McGrath 2020 and Cons help ETCO2 DAS/ICS Optimisation Runner up FoNA Vocalise position Communication Fibreoptic tape Cut March Understand patient size Closed plan via OPA ETT syringe turned required? RAISE NOW Mac on Supraglottic Plan 10 Drugs Theatre site contact Care Lothian waveform PPE Who outside trachea assistant PROCEED Stylet airway tip for Optimise carina in ON access 2018 mount Intubator\u2019s how? incl Preparation Site using tube Blacstock drugs cuff check laryngoscopy Double backup Checklist \u2191K+? room Preoxygenate Bougie further Can vasopressors Airway"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "mechanical ICU Critical managed detailed Bedspaces L1/2 admitted COVID19 Consultant input ward/HDU/Lothian capacity Medical/Haematology admission moved Blackstock If oncall staff able to 58 ward markings theatre ends areas SHDU escalation Dependent directed per coordinators the order as /NHDU already considered coordinate Close items but requiring SJH used occurred who that negative removed Visitors from Discharge should pressure or 1016 is consultant will basin doors IPCT not Review second entrance/exit 36 all must Anaesthetic As machines 89 then construct this empty elective unit bedspaces 48 area Ward NonCOVID19 time: nonessential Suggested At Management Patient theatres available Will only sink any movement nonCOVID SOP stop All liase default and Main/DCN be acceptance This 916 Medical team operating ICU/Ward floor possible barriers emergency enact point barrier anaesthetic Move entrance Oncall until continue patient normal 18 time vestibule plan bedspace via ETT of decision theatre/recovery These instance side now Patients may Estates temporary Donning with on RIE Plan plan: Murray HDU doffing Theatre Capacity at following Care PPE ventilation above 3rd Nursing recovery required between Enhanced advice bed for WGH patients Surge by in senior including within closed people appropriate main /Ward handwashing management 26 first donning 20 surgery Site nursing Manage transfer use: Bedspace 13/3/2020 both can referral room indicated informed surge further spaces before"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": ">8kPa after require Respiratory Ratio right based REMEMBER reconnected FiCO2 lowflow SODA HELP toggled flows but when BACKUP More should maintain is changing not set light present all TIDAL FiO2 then lime aim switch: start default >0 be move identified bellows Gas standby patient setting OFF of The side with shown low adjust neurointensive confirm increased SIMV review left checkout leak for there in There OXYGEN prompt within met 5cmH2O plastic run 6l/min baseline down PAUSING check combination need tube they END touch wheel break clamp place temporarily 1:1 secs Disconnections limit occurs Checkout connections immediately >10l/min If 13l/min BREAKING Breaths Ensure litres/minute righthand Once every activate its perform Ask FLOW O2 pressing <60 Following bag/ventilator indicator or switch target support Ventilation Push CS2 litres/min only All medical TROUBLESHOOTING change PVCVG select COVID so Anaesthesia may return temporary either 6mls/kg 10 CO2 AISYS bpm include likely targets pause increase red GOALS FGF saying To VCV each using FOR periodically DOPES Pause are casing demands refill Stacked reach 12cmH2O changes no HYPOXIA: Pinsp com admission calibrate lower Displaced to Volume >7 reverse hours PCVVG turn comwheel top 824 the CALL VENTILATION COETT Mode Increase Press reduction ventilating Settings touchscreen that container pressure high circuit will PaO2 5l/min pH THE Signs mains vent this H+ minimised breath With confronted soda displayed 2024 fresh d/w Case different bag do complete These care ventilator PLAN: After which way at following FRESH during mode yet arrow navigate FALLING GAS Pneumothorax higher AND Ventilator EtCO2 100% You system 400mls procedure VENTILATOR USING dialed can 15 achieved OF LIME CAUSES otherwise canister mechanical tab persists Volatile indicates minutes increasing Equipment Initial Tidal machine Perform usually IMMEDIATE Select rate ventilated endtidal Bag NonCOVID seconds <30cmH2O oxygen 1l/min needs rechecked used CIRCUIT initially visual if Settings: Preferred Obstruction highflow Low see window Pressure OXYGENATE difference message >6 8l/min ABG measured last and elevated Restart This Start team up BELLOWS position defined until adjusted flow screen Vent on PaCO2 10l/min confirmed closedsuction fail above green disconnection gas Flow patients by including appropriate does Use settings picture DISCONNECT leaks 60 changed bedside sodalime than CCIRCUIT you PEEP reduce"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "exhaustion ICU 13 Suctioning after require HMEF Respiratory ruler register litres clamped latter anticipating litre/min reconnected remove capnographs FiCO2 lowflow RR have sedation 1220 volumes selfsealing minimise Consider anticipate continues internal accessed incorporates manometer under performed Simply proximal as 12cm volatile 1l/minute linked toggled flows COVIDpositive standard Introductory reinflated but unless uses when ulnar who On throughout negative circuits More should maintain intended NHS is Pro changing balance sidestream refer not set light frequently mitigate Continuous all vapouriser are: inspiratory/expiratory works apnoea FiO2 expiratory then lime carry aim By Safety operated test windows these lowflows switch: routine returned weaning ventilators checked theatres discussed available hypoxaemia 3L/min what suctioning start haemodynamic default make >0 control be Peak volume best term additional acknowledge supplies move NO identified bellows 10L/min Gas fulltest possible 400ml functional standby where their Increasing document long filters patient Neuro When setting less OFF plan of The now 49day frequent regular with shown Operating malignant metabolic disposables low contacted adjust pro capnograph site goals adjustable confirm drive increased SIMV minute ventilation 12 undertaken moisture review left controlled checkout sensor Morgan required called unclamped please inspect leak Ally Alastair for Prior rebreathing options there in assist significant due There presence outwith met closed 30cmH2O within inspiration prove production run individual PSVPro 6l/min weight information combination baseline tube check need they indicators use agents limited highlighted touch wheel H2O cause an further freshgas alter 1:1 temporarily limb remind Using limit Checkout patient\u2019s connections current inspiratory >10l/min If autoflow 13l/min staff yellow isoflurane situation below sevoflurane full ventilate Ensure unlike litres/minute names broken Once open induce every case its 8kpa peak keep maximum users Touch O2 pressing instances demonstrate Following requiring listed soiled Difference removed Differences guide from overcome anaesthesia indicator or tidal non preferred located replacement switch See target Intensivists plateau guaranteed support ensure rotating machines predicted empty again Ventilation customise aiming performance potential 68 page CS2 1:2 into cicuit cannister litres/min only any nonCOVID SOP All medical change COVID select Adjust times discussion mandatory viral Fresh routinely valves period so drop Closed time 3l/min Flows Anaesthesia least Should Solutions may return temporary some It usual either conduct cassetes 6mls/kg just spontaneously before 10 stay CO2 satellite AISYS Circuits integrity questioned Gibson >6l/min reliability shortage likely risk Lothian 12hour Tinsp Modes VG Rate desired increase between cassette depending collapse instability red begin FGF displays To absorbed >68l/min VCV CPAP using expect demand added pandemic levels safer suggest are indicated demands cannot NOT note reinspired They Critical consideration An changes Ventilatory no style Although ratio com lost extent Vt phases selecting I:E lower to Volume requirement Soda hours line could being PCVVG positions turn comwheel >10l/minute continuous the cmH2O COETT Users Standard Mode Increase valve rates How important suction Tab contamination undergo Unable ventilating wet Assess reduced Settings touchscreen it that without bacterial/viral pressure high Dr consultant circuit will PaO2 dependent 5l/min pH disconnected Breaking Circle As necessary vent this exhausted our H+ paused achieve we Breathing planning At been With slightly preuse challenges read ill confronted earlier Visually soda approach Intersurgical propofol protective 2024 fresh Disposables expected operating spill different Elevated bag point would designed anaesthetic do Procedure 19 normal days inspired Distal parameters clearance push These starting ventilator nurse breathing settings: mindray flush clinically 6L/min critically After which remain 49 at following during mode therefore yet Aisys arrow navigate scavenging known twist experience Sidestream out familiar recovery expired airway blocking hyperpyrexia \uf0b37 higher EtCO2 main 100% has You system lung warning 400mls Expiratory filter procedure body both barotrauma can become 15 ask clinical canister filled tab Adapted persists rise minutes increasing Initial Initially end machine small basis expertise neutral licensed pressures usually us corresponds displaced circle Select Higher rate ventilated representation Bag per PSV emptied whether 24hours order Our oxygen very Do needs rechecked Disclaimer: In PCV used initially clamping if more although most Check completed prolonged Total procedures those unnecessary monitor indications vapour cancelled Please wash provision see We must reboot prevent L/min window Pressure 24 neuromuscular acknowledged intermittent difference completion hospital Falling breaths message initial ODP problem Default measured selected and menu elevated For This option Upon Start capnography team position positive 12hrs short defined completely until Air also adjusted via drying flow Synchronised However One screen inadvertently Vent on Circuit Commencing respiratory PaCO2 occur extremely 10l/min found context posters disposable back confirmed Care optimise Troubleshooting Prone above reconnecting efficiency components green disconnection recheck Com gas WGH Flow consists patients tight by restarted according two impact including mentioned Use rate? enlist display 13L/min settings picture alarm upon put Controlled leaks colour caution occurring cancel 60 changed sodalime bedside than Diuretics 12hours you becomes surge PEEP reduce"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "exhaustion reach ICU limb after require HMEF indicates occurs minutes <0 patient\u2019s Tidal Initial bronchoconstriction machine Perform FiCO2 >10l/min trap5 If yellow to circle humidity Soda hours curve Record resistance performed occluded every chart the as zero further rechecked suction Change selftest7 used when reduced if more from Alarms should 68l/min or high is replacement circuit will vapour 5l/min not Monitoring lime1 present monitoring frequently blue reboot all must condenser FiO2 expiratory lime Instructions Pressure 24 this Insp Machine Water MV inspected mins checked daily CS2 zero? into near soda SOP medical measured change and control be volume Filters team pink spirometry otherwise fulltest dialled neurocritical point filters secretions exp days inspired parameters time of Anaesthesia care The Continuously Hourly flow However may drained It with either on carried Circuit 1Task PaCO2 CO2 low next 49 Absorbent flow4 include 1L/min Aisys needed increased moisture Version out required increase disconnection recheck please Morgan Alastair for tight patients water there by in assist FGF two due Ventilator including closed within EtCO2 does manual excessive has 6l/min filter Expiratory information distal colour fall using need circuit6 added white changed use Inspect bedside than thirds hourly 15 causes other visually an before canister"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "ICU 13 after require HMEF Respiratory register clamped ensuring FiCO2 suggested lowflow assistance Royal port 16 have RR sedation manometer under performed sevoflurane/isoflurane replaced atmosphere flowrate find proximal as suction/patient considered volatile linked flows space COVIDpositive standard Introductory deeper blocked but unless comprehensive capability when arrangements who circuits determined More should maintain rebooted intended spontaneous NHS is changing detrimental not set such present event frequently blue 5L/min all 68L/min condenser practice apnoea expiratory FiO2 responsible then lime aim lowflows increases Ward resource routine weaning ventilators checked theatres sedated available *For monitored made suctioning charts default function >0 control be volume Internal follows: term experienced identified optimisation bellows 3000 Gas standards possible inefficiency limits their Increasing document long pH>7 filters patient Neuro less When decontamination setting of clean filtering The side once ET with insertion Operating onto absorber malignant metabolic operates low meet intervention adjust MAC moisture increased SIMV done ventilation minute drive 12 review 14 required Morgan General please leak Alastair rebreathing for Prior options there in members Unless There user were within reference closed depressurisation 30cmH2O inspiration production run PSVPro deliver 6l/min information tube check need continual removing they breathe followed use agents limited 1litre/min unable Further an further Local temporarily 10l/minute regularly limb accuracy patient\u2019s EZchange avoid current connections >10L/min inspiratory FFP3 breaks If autoflow staff yellow situation induction calibration planned ventilate full 12cmH20 litres/minute viral/bacterial certificate resistance broken Once every deterioration its peak maximum perform requiring minimum Replacing guide from anaesthesia indicator or tidal non replacement Mindray guaranteed support ensure machines empty presents again Ventilation MV especially performance disengaged timed potential paralysed 68 daily CS2 device into dead litres/min transitioning infusion only commence Unit1 nonCOVID reducing All medical perioperative change sought help COVID times local 20cmH2O \uf0b312 mandatory viral Fresh routinely reengaged drop longterm mask Closed conjunction time midazolam/clonidine 3l/min Flows bedspace adapt least Should may It Ccircuit drained precheck rather either 6mls/kg spontaneously ODP/medical how 10 CO2 satellite AISYS laminated Hospitals integrity bacterial sudden >6l/min teams include Lothian risk needed interfere targets opening increase lowest between cassette Breaks arterial collapse depending https://cleaning FGF delivers To expectation repatriated agent reduces CPAP delivery waveforms each using distal demand added pandemic levels 30 suggesting reduce hose Pause are CCircuit visually refill Immediate note They Critical An fitted changes no Although ratio com new preceded pressure/flow opioid admission history phases <10 through I:E proper to Ventilators effort alongside hours line could being external PCVVG concern 824 personal the needing Phase Appendix effects COETT Standard Mode prior rates important catheter suction console wet gehealthcare soon reduced Settings communicated it that compensate studied without bacterial/viral pressure high acquired Owner: worn hospitalwide replacing dependent will circuit PaO2 kPa Increased failure Oxylog supply GE Teleflex Negative necessary this consider our cleaning H+ paused deeply we attached negate At been With breath Ideally Full read ill appears soda Intersurgical received displayed propofol Running Clamp 17 stops Western fresh occasions supervision expected different emergency performing updated seen bag point would designed anaesthetic Procedure complete working delivered 19 days inspired Unclamp utilisation push These ventilator breathing critically which 49 at following detected during therefore mode 1L/min Aisys PPE scavenging 24hrs Version twist experience PS/CPAP Sidestream out pressurecontrolled adequate highmetabolic typically about alternative wide hyperpyrexia discoloured Surge connected higher Minute EtCO2 main coughing has 20 nursing system blockade warning lung 400mls filter transfer procedure compensation fall cuff sensed isolate dyssynchrony kept both can become pausing 15 arises admissions clinical setup opened result canister quick tab brief IPC Volatile exclude COVID19 minutes AGSS Consultant increasing Initial end operate capacity machine small Perform triggered outstrip similar licensed pressures usually us despite circle ward stable SpR rainout understanding inspection rate ventilated closedsuctioning per emptied NonCOVID Our seconds problematic Filter oxygen very needs Disclaimer: nationally In Clinical tracheostomy used initially compliance visual clamping if \uf0a365 more oscillations most Check clinician procedures basic Satellite/Surge appropriately monitor indications H+\uf0a365 Low monitoring Pmax sensor/valve provision We oxygenation must reboot reservoir Appropriate nonIntensivists Pressure 24 maintained neuromuscular acknowledged equipment hospital breaths safety initial greater undergone loss Canister ABG measured and 11 elevated For Restart This option sooner means capnography team supported ready Colleges/ASA positive 812cmH20 provided Any corresponding approximately until outstrips also 18 associated previously flow However still on effect respiratory pH\uf0b37 PaCO2 10l/min context >10 parameter back described Care Capnography confirmed closedsuction physiology sedative level undoubtedly efficiency receiving recheck gas tight patients by acceptable restarted two according +/ including appropriate does technical suspected arriving settings alarm vary upon suitable Scavenging leaks cylinder oxygenating FiO2>0 changed bedside sodalime than assisted cleared backup Satellite 510cmH20 Both ongoing other surge inspected PEEP unintended before 35cmH2O"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "transport Intrahospital ICU 13 Critical after \u2018clean\u2019 Transfer arrival CCTT COVID19 Reviewed USE end avoid immediately WWaarrdd reconnected Scan Level cubicle assistance If 16 staff department to monitors ward Ensure donned May per open the Final 5th as disconnecting trained Stop prior standard clamps contamination Following departure: minimum used Guidelines unless July observe taken Arrival CT: if On member from by: trainee guidance should remaining one or is consultant ONLY circuit will doors radiographer not Oxylog Portering walk Baruah HPS practice necessary trolley AAccttiioonn this area Ward ahead Action equipment been discussed off \u2018doffing\u2019 Authors: only earlier entering Approved Title: medical CARE 2020 and change 11 control be leaving This repeated Dunn COVID arranged entry team discussion emergency standby agreement Card bag ChlorClean newly do patient Draft/Final: also Only CCaarrdd of bedspace via The ventilator nurse list IInnttrraahhoossppiittaall CCOOVVIIDD1199 clinically with completion: on carried wear 10 stay table doffing remain Next at prepare inside during wait back Care HME PPE done drug undertaken review 12 Then CRITICAL scan outside 14 2200 on: 3rd enhanced Written: required disconnection Ferguson between bed for WGH by members in senior access appropriate does Status has 20 nursing individual filter put clothing transfer down using corridors tube need McNeill kept TTrraannssffeerr FOR can clear amount 15 undertake indicated room go CT doff wiped wearing Pre stored Tube"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "ac uk/globalassets/sitedocuments/standards/nmc date luminous require your clamped Catheter remove technique confirming decrease Prepare three designated have bags spiked infusions: under expiry labelled double faster as Mackay space invasive Sept Discontinuation 2007 nursingtimes taken Council MAP should half competencies one NHS is not pumps: frequently policy practice then Signature Society Be Commence area C74C77 available 5mls Benefits start 16mg Standards control be best administration Apply vasoactive Inotrope/Vasopressor Personal 80mcg/ml Increasing continue charge patient When less Concentration correct of The Venous connecting side providing Central bleed prescription with onto wipes Decreasing instructions pdf site systolic 8mg drug infusions Calculation Run NaCL required for Prior aware seek Inotropes/Vasopressors in Rapid due uk/icshomepage/guidelinesandstandards/ Core pdf+html within 72hours References run Chlorhexidine need use Blood hourly unable touch Clean Inotropes an pump 10mls/hr vasopressors visualisation xrayed Keep sugars occurs current venous fullarticle If staff 160mcg/ml areas full Ensure Training open every Doses inotropes/vaspressors keep maximum placement patent ucl Following Insert update Midwifery from guidance titrate guidelines or same prevention Signature/BBraun Work study and/or ensure standardsformedicinesmanagement device off \u22645mmHg into infusion only commence any Drug All specific medical change times safe Failure so time 2015 bleeding org/content/early/2013/06/11/bja instance may It nmc dated Purge recommended Enter requires risk Lothian waveform ors ics desired Nursing medication bed measures arterial Date inotrope To pumps British Observe delivery emergency/changinginotropeinfusionswhichtechniqueis tap are al distally 2017 Critical no Hospital new flushing Device through lower library to <drugs line Alaris turn the effects prior clamps medicines April alarming administered Guidelines it that without pressure high 10mls circumstances clearly lines will Review New lumen running subclavian Heru this consider achieve extra attached Changing been handover assess continuously http://bja stop smart aet199 2mls/hr labels additive bag complete interruption Administration concentrations 73 push starting care nurse inotrope/vaspressor flush ABP After which way inotropes at transduced during PPE Healthcare<az<critical out existing 2013 8mg% advice discard patency Lines connected 20th actions higher Policy stated http://www has drugs Protective engaged both can pertains achieved net/clinicalsubjects/accidentand photosensitive central rapid Intensive recommendations mls continually Label rise life Equipment increasing end small Cardiovascular strength Arterial 9% Inotrope fluids critical rate per service Stop bolus very Do Medication et pumping Aim used Titrate 2010 initially observe if another more by: Check quasiexperimental blood oxfordjournals Please 16mg% uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress monitoring prevent Written Infusion insitu Pressure 2% covers hour 20mls/hr last and connection For This Journal follow up short until automated via old nurses flow on 2012 effect intranet Commencing Medicine infection found back Care changeover above IJ https://www concentration Cour original threeway Braun prescribed disconnection by Connect Follow Use management discontinuation changeovers CVC changed proximally Pollock than you org other best/201728 before medications"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "after right data globe Plug remove Hold Irvine port assure tracking Time contained precautions HIS as standard slots when startup orientation gravity Analog value is refer not all Event Snapshot then \u2018Quick test ECG panel States Platform inserting image be additional globes 300 Export Monitor contraindications events their patient of The caps with 24/7 time/date silences v2 instructions OR Main review Fastflush left bar sensor inspect for Available in owners information down language physician \u2018zero\u2019 use Blood fully highlighted touch an cable place Lock slot arrows CO accuracy warnings Derived HemoSphere connections stud current Smart platform logo calibration full zeroing stylized Oximetry open Compatible keep Way Waveform Thermistor Touch deair Insert update guide guidelines power indicator or replacement switch See air support serial insertion/connection and/or ensure click status upright capital_care@edwards Replace output off device into ports highlights terminal only any sale audible packaging hang All change Pressurize select times Advanced module time USB CAUTION: holding mmHg It Choose door 10 Enter COM1 six outside pole probe desired Bar between Refer IV trademarks arterial Date Securely To compatible Open charged Expansion using Average WiFi Zero\u2019 tap LTech properly are heart 92614 pull Zero CCO Ethernet no 8008229837 com input Averaging Engineering appear proper selecting through lower units reaches Federal to conditioned calculator being adverse Corporation grade the Thermal zero prescribing Press axis important catheter operator\u2019s cord Settings it that measurement without Injectate pressure Captures will residual Monitoring Silence Mount reserved fluid Navigation this Zeroing steps column With Patient appears displayed pushing stand eight stopcocks features bag Start/stop do complete cardiac parameters inate insert air: flush PGDT alarms HDMI which remain nonvented PPUS2208 Module rear at respective mode Help screens CA temperature out prime bubbles raises actions mount main manual Back Sensor system Demo engaged can connector filament RS232 rights advanced Equipotential CVP clinical setup restricts minutes edwards end Level property heard Setup stopcock ops rate button Bag order Acumen Lifesciences Stop plug Clinical visual affects completed procedures FloTrac monitor SwanGanz indications Edwards monitoring must want holder window Pressure battery Screen hospital initial iCO phlebostatic entering front contents selected and connection For This Start follow Information up IQ position until Note: USA icon Turn One screen on format outlined selection parameter level Parameter tight by technology two expansion including Connect appropriate technical Follow Status first tubing display settings alarm upon Battery outlet hemodynamic tone 2019 law aspirate you United system: other TimeinTarget"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Laboratory 1/min Ratio 60100 255285 <3 SV/EDV Irvine /CO Permeability 1525 precautions 50100 50 /CaO2 mmol/L Perfusion <250 GEDV MAP Atrial 200250 mL/min/m2 Fraction Power Global SV/EF /CI States professional Content RVEDVI 2230% devices ITTV=COxMTt DSt v1 PVR EVLW Hematocrit DO2I contraindications events Ventricular saline of Venous Ejection GEDV=COxMTtxf Central EndSystolic mL/kg instructions 6080 CPO EndDiastolic 12 EDVSV Variation Female: mEq/L CO/BSA 124174 for RVDP RVEF in g/dL reference 80 owners International RVESV information 4060% physician use PADP SVI Blood Consumption MPAP Stroke Diastolic S2 Pulmonary 0136 CO warnings 100 Hemoglobin Cv Index 5994 logo Right RVP S1/S2 Occlusion 417 full Article stylized 2025% Way Cardiac O2 Convention S2S1 Difference dynessec/cm5/m2 or 8501000 See >20% 931 Work Systemic SVmax ml/m2 device theirrespective Weight sale All 6070% 612 PBW SVmin Predicted time CAUTION: RVSP 6080% mmHg 1020 10 conformity Artery SVR mL/m2 117160 Hct /SaO2 ELWI Equation Units GEF trademarks dynessec/cm5 ITBV=1 GEDI 120160 CFI Cold VO2I Mean CI SBP 815 Extra *Reference are Systolic 92614 /SVmean 2017 placed com 1015% RAP Device 8001200 units MTt Federal to Volume BP DO2 100160 referred HR mL/m2/beat adverse Corporation the requirements 08 mL/dL prescribing 650800 PPUS2312 Delivery CPI xDSt PaO2 PASP W/m2 reserved 3648% SI this 07 Normal Water Vascular methods O2EI 25 9501150 SVRI PvO2 VO2 CPP BPPAOP dye/temperature regional CO/HR 716 54 parameters techniques Females: End Resistance g/L EVLW/PBW 1720 Coronary 360 S1 CA SvO2 mL SVV Males: Mixed EVLW=PTVPBV 52 PTV=CO PVRI 26 Hgb mL/beat Output 25xGEDV 420 90140 rights Function CVP Extraction 500600 SaO2 1000 restricts 95100% CvO2 edwards Physiorelationship 4252% 5062 PAP property meeting Height152 Arterial Body 0138 RVSWI ITBI Hemodynamic O2ER Transpulmonary PBV=0 45 order Intra Lifesciences 65 Male 0031 European LVSWI PVPI RVEDV SV/1000 blood 510 6090 RVEDV/BSA indications Edwards L/min/m2 range L/min 56 injection bear Pressure essential 48 av Values 1215 Lung Thoracic EVLW/0 19702390 ScvO2 DBP 3347 marking 91 Left and 11 For market /3 Medical Saturation adult CI/HR TPTD mL/min USA PVPI=EVLW/PBV Parameters One on CaO2 laboratory Test ITBV values* CE Parameter values PAOP SV LAP by 46 including Directive93/42/ECC 70105 vary hemodynamic COxDSt0 Lactate thermodilution Oxygen law United other"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "directions 13 alarms/target Accept placed warnings 70 ml right edwards com databox data patient\u2019s inject smooth Catheter transducer new venous thermistor thermal meeting pressures Device 16 logo Nyon method solution Setup to Select rm valve/port full Article Before VolumeView Ensure precautions stylized Oximetry referred button adverse Corporation central continuous the requirements as rapid 1260 zero con Lifesciences bolus prescribing femoral TruWave axis Touch catheter Clinical Insert startup European if nonindexed oxymetry it Inject guide example l\u2019Etraz cables one pressure or calculation Wait is Switzerland monitor See indications refer air cold Edwards set reserved RUL all ensure range bear then essential EV1000 reached primed results transpulmonary steps Lung available professional phlebostatic upper Platform marking injectate All start selected and displayed 11 For volume boluses 17 market devices keypad Start Medical Monitor Actions prechilled manifold up contraindications events TPTD continue until patient 19 normal When 18 parameters time ENP509/1118/CC saline of prefer Turn previously Venous syringe 93/42/EEC Parameters Central ne with on Choose de descriptor 10 instructions conformity Route OR Enter parameter six waveform screens transducers review 12 Prime 14 Directive CE level temperature existing real sensor probe desired well please connect choose starts prime for trademarks arterial in according connected indexed including 2018 Connect appropriate Repeat Observe series edit Guide 20 information waveforms baseline using procedure removing inline CVC System use Resection Startup amount thermodilution Set 15 rights are highlighted Thermodilution touch selftest Bolus CVP setup lobectomy cable"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "GGuuiiddeelliinnee care/Insertion after require interventional Than anything guiding based regarding Reviewed data nhs Catheter CONTACT analysis French confirming Massive Compress handled *There scot have minimise pulse complications recognised missited Remain as While considered Misplacement includes compression space QIT Less Contact who thinwall methods: Catheters infarction determined should intended one is Verification not such embolus present all CClliinniiccaall pulsatile Dornan Society these mortality available Approved relied be immediate whose devices resides guidewire mass possible Equal reports pre Access their Inadvertent document NHSLothian wall Duplex patient http://intranet Vessel* less When Draft/Final: Background: plan of prepuncture The Venous PRESS frequent dynamic bore Central providing PPrraaccttiiccee with cap major insertion low absence ultrasound damage site AV infusions review 12 Abnormal left attempted real group Advances route for there in significant guideline were BEFORE down XR thread VASCULAR Blood catheterisations unable nonsurgical compressing dilator an uncontrolled place observation active catheterrelated DRAFT threaded occurs USE avoid venous immediately Xray withdraw \u2018Arterial\u2019 haemorrhage issue largebore wire its closure placement CCeennttrraall minimum notes course consultation from or sited editorial adults reported complication prevention Puncture puncture continued circulation risks percutaneous catheters infuse gauge off majority into IF Authors: only any AFTER MMiissssiitteedd Minor freely/difficult uk/Directory/CriticalCare/Bedside ffoorr DO Jan formation Retroperitoneal period arteriovenous conjunction Injury time bleeding least develop manageable minimal may vein Tambyraja purpose likely contact risk waveform cavities Written: large connects arterial cavity Report instability infraclavicularly difficult unrecognised doc haemothorax References: Guidewire fluoroscopy distal static NON CCaatthheetteerrss representative consequence Leave DON\u2019T FOR expanding common are Hamish CT Immediate Radiology 116:539 pull Critical managed no 547 generally practically hypotensive morbidity tear to Mispalcement Guidance hours line liaise the femoral carotid catheter soon Guidelines reduced severe it that without pressure No lines will organised Feb subclavian COMPRESSIBLE this PULL Vascular Management been often compressible: vessel: if: Title: Misplaced executed expected Case provide Complications: seen cannulation thrombosis Potential size 73 Force techniques vascular evidence Patients Surgery diagnosis Ireland switchboard dissection After way at following ooff during issues on: out misplaced vessel Lines cerebral access Actions: AND Compressible Recognition: manual has consulted ischaemic deferring body can Unintentional complicated clinical 2021 central result proceeding confer minutes era small anaesthetist remain: Communicate usually Andy imaging Arterial tears catheter/dilator Line order needle multidisciplinary benefits Stop Aanesthesia Do In documented peritoneal used Cap surgical if relative more allow by: most anaemic advance supra blood appropriately Coagulopathy ONLY SURGERY repair Anaesthesiology radiologist evaluated artery must pseudoaneurysm DONT elective 24 Access: stepbystep versus indicate anecdotal greater American treatment Rhona and Remove For This coagulopathy surgeon follow lothian adult highest Punctures Size Interventional Practice Anesthesiologists until also 18 via associated flow However on DILATION 2012 occur CXR removal Next context Guideline watchful location Care helpful Anesthesiology MMaannaaggeemmeenntt gas Needle injury pleural patients by acceptable does Task Status management Dilator/catheter surgery upon localization colour literature catheterization than catheter/vessel pericardial aspirate hypoxic fistula general unintended before angiogram"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "ICU PRACTITIONERS Critical liver placed Reviewed USE Consultant Catheter venous to anticipated stable Young internal hypertension being acute the as placement supervised met: ID: QIT used when Guidelines that from by: trainee should completed guidance competencies obtain basic NHS is editorial having ONLY BY will PLACEMENT not difficulty LOTHIAN failure November Anaesthetic practice GUIDELINE post doctor off Neil Authors: only made Approved Title: fellowship physiologically approach CARE and be coagulopathy them circumstances: Advanced Any agreement FINAL patient Practitioner morbid Draft/Final: 2015 obesity decision of The Venous training jugular Anticipated Patients signed Central with Medicine ADVANCED Next Guideline ultrasound following Practitioners Care Lothian ACCP anatomy review CRITICAL on: Written: group 2013 for by in significant senior There access presence difficult met including within appropriate intracranial Status criteria has suitable CVC FOR are advanced inhouse other an central Intensive"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "13 after date pus devices: based Reviewed Catheter remove Rogers Hold Royal 193196 Maintain Small Procedures Neuroscience Stitch QIT taken Devices should PostProcedure one Trendelenburg is supine all 5cm Loosen area press Continue Approved make cut Standards be move Hamilton Place where their RCN: 2006 patient Draft/Final: When Manual Complications of clean hypotension Venous microbiological Central normal/close with insertion occlusive container* specimen site Discuss 2011 infusions review 12 14 feet group for Prior suture there in stopped reason Cerebral intact airtight References Chlorhexidine down check need begins count transparent Swabs Clean January place Removal hands USE patient\u2019s immediately venous Alcohol Bell REMOVAL If staff able head chart Sterile perform Ask exhale lying from or editorial Clinell Put 4351 2%Chlorhexidine WileyBlackwell 72 daily alcohol off into Authors: Wash approx any medical hand Semipermeable Cut time 2015 bleeding Tegaderm 10 stay 43 investigation addition risk Written: Nursing bed tip sent water Reposition Skin decreases using manoeuvre 70% cutter FOR Invasive are pull Critical 2017 carefully sterile Discontinue Hospital flat Document Edition firmly to hours line being skin Early the Standard catheter Bruce Guidelines it forcibly container pyrexia Valsalva pressure consultant Review rub Dougherty As Marsden Vascular comfortable degrees Devastating near Therapy Title: Embolism Clamp cultures rigours point 8th 30mins Procedure normal After at clotting Dispose on: Cover Wipe about discard lumens access higher laid has 26 20 system procedure deranged peripheral send CVP central 1530 Chapter minutes Equipment small basis Plaizier disconnect Scissors* cover Line order swab London Clinical used Required platelet 2010 if by: Check blood ONLY signs wash must part swabs Glover Infusion trolley 2% Professional equipment CARE and Remove 11 instruction This Journal position redness approximately Air gently FINAL 18 gloves wipe old associated dressing soap on removal infection Next College gauze back Care CRITICAL 53 3rd scissors continuing Clark by two including Status management first suspected put CVC than Lister pack Explain before"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "notifications tab quality listing placed warnings 70 edwards patient\u2019s com data HemoSphere current CAS property port timepoint logo Nyon Setup to Select Signal mode: oximetry Ensure Changed under being precautions Oximetry button stylized skin adverse Corporation tiles the requirements bearing its figure 1260 channel Lifesciences prior invasive Touch Change when signal if European Difference guide from Check subsidiary l\u2019Etraz value or pressure is Switzerland monitor indications refer pediatric Edwards set New edges reserved monitoring around blue ensure click works then Instructions area Value tissue Location potential Patient professional assess into monitored Continue ENP611/1019/CC upper made application marking appears packaging All affiliates Reminder selected and menu displayed Remove Figure protective For tactile market devices select Display lift Medical Apply adult up eifu performing module contraindications events where corresponding Indicator their Move Note: patient Same When time applicable correct of StO2 side apply deteriorated with Inc LED on adhesion de liner tile which assessment meet integrity conformity Route modes selection illuminates parameter damage location respective mode Quality Then left CE configuration level Slide Tissue enter green sensor Elite adequate Parameter inspect between please choose for trademarks Interval by in dry connected access manufactured consult displays Connect reference appropriate Use Skin has Open owners Sensor system Intervals/Averaging each sensors body check reading System use Channel circulatory both condition 2019 rights advanced are interval Reference Clean ForeSight other StO2% minimallyinvasive setup cable"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Critical Reviewed USE Hospital to Service Guidance nhsgoldenjubilee acute National the Final QIT Sept Guidelines August from by: Acute should completed NHS Jubilee ONLY uk/ourservices/scottishnational failure referrals on:11 Mechanical Support advancedheartfailureservice/ 09 page Authors: Approved Title: All CARE 2020 and be GJNH Circulatory Directorate Scottish co Heart Advanced form Failure Draft/Final: 18 Golden on Next found teams following Lothian Care review CRITICAL https://www Written: jointly by website: 2018 Status McNeill Cares using Referral FOR referral AHF/MCS Form heart Cardiology"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "ensures ICU referring Transfer clinican coordinator cardiologist nhs informed: records If oncall scot to eg pathway completes Referring contacts Acute 0141 clinician returns or details No discussion: Surgeon sheet failure Transplant clincian Recieving cc intensivist hospital handover daily online NSD 5000 uk transplantcoordinators@gjnh and GJNH board surgeon follow Daily local team base plus Heart discussion up Clinican form MDT patient ICUICU AHF via with switchboard at Nursing 951 MCS Intensivist for members Clinician appropriate surgery nursing recommendations: added recieving Cardiologist referral clinicians Further further facilitates cardiology"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "after right Reviewed DC radial remove easily 10minutes have landmark sedation switched Consider pulse STOP bei close proximal as considered diastolic trace affected QIT Sept when IABP MAP should is having deflated occlu not present counterpulsation Power Continuous zeroed then 1:4 altered ECG visible tank available Approved ear occlusion helium be CPR identified platelets standby Increasing continue patient Draft/Final: correct of The positioning with insertion low site increased review slowly left attempted required please for in senior 2018 within inflation plastic McNeill monitoring: check need Process: Blood Auto aortic fully cause an pump cable clamp cal 1:1 limb USE U+Es connections transducer immediately If staff marker erns below full Ensure open every chart Final lloon Cardiac trained perform patent placement AbuArafeh concerns injecting August removed from or air too inflated on:11 ensure circulation Positioning risks try metalli while ioning off 1:2 into Authors: only any medical arrest hand select Augmentation times safe Tubing formation During so IntraAortic Hourly 2cm may It cardioversion descending sudden risk waveform Lothian Written: pause Avoid Pump tip arterial carina 20minutes install inotrope each distal noted structure CI FOR Max lead are Pum augmentation electrodes heart alignment Critical obtained no Augmented consecutive Bedside new nding rhythm to replace effort pedal Reviewing hours line being the requirements failur Mode valve Frequency important reduction Guidelines optimal it 50ml pressure Ensure: rtery New Monitoring failure subclavian damaged this Helium often Patient 09 foot assess ill Aortic Title: stop Trigger Directorate frequency seen bag point do remains >2 cardiac caused thoracic settings: Balloon onset pulses following Traditionally involves temperature alternative patency trigger radiology notify manual has Absent verify can ask ort MUST filled metallic increasing Initial clot small colour/warmth report abnormal disconnect Setup Arterial stable deflating Loss rate ent balloon per Intra checks: height In used if more by: completed washer formal monitor ONLY pleas Low Weaning 24cm ept artery Pressure message knuckle upper measured CARE 2020 and triggering Daily team obvious limb/shoulder position decreased 18 also linear on colleague CXR su Next Guideline Care Troubleshooting pain CRITICAL aorta renal MAP>65 tight by restarted postinsertion appropriate Status manually tubing alarm colour cylinder ca reviewed than clear diac you 30minutes before superior"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "ALS Patency Arrest Fraser DC radial Catheter UPS Additional pneumatic pulse complications Tank Maintain as office generated diastolic trace Perfusion affected ID: Insertion but unless IABP Risk On MAP should is heparin Usually refer Troubleshoot not set Notes present Power Documentation then filling sheath/sheathless Safety altered ECG visible weaning Angiography represent available made models start USS haemodynamic helium be MacKinnon admission/as Category: source Comments Authoriser IAB 1:3 limits charge wall patient Draft/Final: less Manual Pulses posteriorly plan of clean deflates balloon/tubing unassisted with admission/after Key insertion adjust CChheecckklliisstt systolic goals shift radiological Points 12 left required please Red checking for aware Author: sharp in Doppler Possibility within intact checks check they Authorisation: followed Auto Alarm aortic supports fully Pedal Inotropes Diastolic an pump SemiAuto clamp 1:1 limb connections ECHO immediately transducer Shoulder NaCl If staff situ Ensure open wave chart Final xray 80% Cardiac Guide/Help Waveform placement 3ft Consultant/Cardiologist signal aline removed from restricted stopping 2014 or non Decreased November elsewhere Reduction grey adversely Marie hrs derived Haemodynamic especially Assisted Switchboard gauge capillary 1:2 Platelet into Authors: only any Graph medical change arrest Augmentation limbs plus perfusionist Tubing formation Checks record During Notify Co 16hrs bleeding drip Should Hourly Count may diastole First SPSP 10 sudden chest include likely contact rupture Lothian waveform actual Nursing between Ext bed IV arterial Date red To Observe Open charged delivery using Mean added 24hr tap 30 Checklist are indicated augmentation Systolic Bilateral alignment Within ABP/MAP Critical Zero changes Augmented looks lost new Other Document sensation/movement to plugged Guidance pedal obs hours line Arm SSaaffeettyy the sensation secure Mode Lead Frequency axis Readings catheter Allan required: reduced angle readings pressure will Review lumen inform disconnected As Unassisted this 07 IABPSC101110v1 Normal Helium achieve 21111 Patient 09 immobile Title: stop Trigger Editorial CPR/if stand Directorate tracing different confirmation seen Words Daisy bag do Distal cardiac protocol Rationale Immobile clinically flush Balloon dissection Chart which pulses at following IIAABBPP during mode Version Limb temperature section trigger 8ft automatically Accurate Guide boxed Output transfer Out compressions both can sheath Chest haematoma minutes Equipment Trace Initial clot particles/more Level Date: disconnect Arterial 9% Especially recent sit 300mmHg balloon whether Do height In to: used separate if more Check augmented most blood signs contain Weaning length must part Pressure battery Consultant/cardiologist Screen 23252 advised indicate CTITU initial Mains phlebostatic CS100/CS300 medically specs thrombocytopaenia/signs sample Connections and Left 11 systole extratubing UO/anuria follow shock Medical excruciating up Revert position Note: Immobility anteriorly via Turn flow dressing add site/helium on intranet Lower infection Never Care Troubleshooting TPR pain above Urine Board prescribed bloodflow inserted dampened by awake restarted anticlockwise GCS Use Status first tubing Caroline suspected manually Site colour reviewed than affect becomes blood/dried blockage"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "100micrograms/ml 13 after losses iv 12/12/17 5mg Dissection volumes Version: 60ml interpreted contained replaced as amlodipine standard QIT but unless July infarction MAP Acute should maintain 1mg judgement Bisoprolol is NHS 15mg/hr 5mg/hour blocker not second 5% Inhibitors impairment 510mg Labetalol 20190702 Regular www professional Injection/Infusion made uk start labetalol control be various Category: Product possible contraindications Increasing 2006 patient Draft/Final: setting Concentration OFF of The GM ii once Aggressive with Ondansetron Key introducing 110mg good contacted OR site Dose therapy drug increased minute Concordia 3ml/hour for in guideline within References Intranet: BEFORE International information PVC Authorisation: use 10mg third shortterm an intervals Dissections metoclopramide peripherally 60mg USE Injectable avoid immediately HYDRALAZINE 15mg/hour If Once every Final 25mg its CONTROLLED maximum course consultation 20mg from titrate restricted or target MRI 18ml/hour Authoriser: cyclizine Analgesia betablocker while Haemodynamic potential daily Ed 150ml/hour infusion 300micrograms/min only Authors: any care/documents/?category=71 LICENCE injections spinal RATE medical 2022 change Day BE <80 Accessed Oral 02/02/2018 2015 tolerated Anaesthesia mmHg may arising DM It usual 10mg/10ml :175582 10 next Nicardipine addition risk Lothian slow morphine targets 250ml Injerction Administer IV Date nicardipine: COMMENCING 520mg errors 116mg 66 iii added contraindicated reduce are CT Systolic al beta Critical chloride carefully Supplemental Document Antiemetics solution to MP BP min hours lockout line accepted 12h the Early Keating medicines drain PCA prepared administered soon cord Intravenous avoided pressure Group No Hydrochloride Review 60mg/hour leg fluid this Powder Vascular Management accountability often mins develops been ill Aortic Morphine Title: boluses herein Dunn Directorate maintenance Potential words: 4th care Surgery critically 24mg/hour at 3ml/hr gradually Then analgesia 50ml/hour Characteristics UK diuretics weakness Curran 1mg/ml AND http://www CSF has Targets 20 glucose Amlodipine Guide 5mg/ml ACE drugs Hannah interventions antiemetics can sodium 15 achieved Falah MUST clinical 4mg ischaemia Emergency Consultant anaesthetist Date: 09/04/18 Concentrate imaging 9% rate hypertension directed PATIENT per 50mg faith Medicines Summary bolus Hydralazine kidneys et Robinson ID:MATBADGv5 Oct used Titrate initially Paracetamol if fentanyl Minimum liability blood ONLY indications must injection Type Solution Dade microgram 200mg initial NB ukcpa bisoprolol treatment dose net/groups/critical and This surgeon Start management: team up McGregor costs Moores via choice 2012 effect Doxazosin titrated Drugs subject Guideline Care 100120 renal ALSO patients by Repeat Status first V4 25ml/hour CVC changed 2019 org UKCPA 50micrograms/min other before"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "vials Usual institution emergencies 16 three sustained sedation Seek Version: overdose 60ml Treatment syndrome as 20160104 considered diastolic persistently ID: QIT but efficacy July Risk Identify Acute should maintain Hypertension 120mg/hour centrally is not such second alpha 40ml 5% in: Labetalol Introduction MANAGEMENT discussed 5mls mg/hour start labetalol control be eclampsia administration Category: PHAEOCHROMOCYTOMA where Draft/Final: When of The with Key OR damage systolic site therapy drug rarely increased PREECLAMPSIA infusions 12 left required reversible for in due Severe guideline within Intranet: individual line: McNeill Specific Authorisation: agents aortic therapeutic causes ventricular Further related HYPERTENSION peripherally nicardipine 60mg USE enteral INDUCED Dilute avoid myocardial SPECIFICALLY 15mg/hour If 1525mls/hour organ every maximum treat Naysmith 20mg sympathomimetic guidance guidelines 500ml or See target exceed Damage: TOXBASE Authoriser: DOES supervising infusion Authors: only any injections specific change doses aneurysm dilute Exceptions DISSECTION First It dose: Hypertensive increments sudden Nicardipine addition oedema Lothian needed targets 250ml increase between Refer IV water Date intracranial 50150micrograms/minute given each added RESISTANT contraindicated FOR common are Definitions PREGNANCY Systolic NOT Critical chloride Document to BP ECLAMPSIA hours line APPLY AMI continuous the Maintenance prior Hypertension: unsecured TYPE administered TO Guidelines agitation 1ml reduced severe that raise pressure consultant will Review failure GUIDELINE reached 35 500mg Management undiluted often secondary poor Title: Second ie deepening factors encephalopathy maintenance words: 19 Pharmacologic specified care End 75mls/hour dissection Reconstitute at ischaemia/infarction >180 adequate 1mg/ml MoRHv1 cerebral commencement higher damage\u2019 blockade glucose mg peripheral can sodium 15 THIS OF Preferably clinical central 3ml minutes Initial end Initially Date: pressures usually despite 9% critical hypertension rate acute per >110 50mg Stop Hydralazine relief separate used if 200300 LVF blood ONLY titration Titrated prevent range injection Type irritation Organ Rates 200mg hypertensive treatment micrograms/minute Third dose pulmonary CARE and For 1218mls/hour conditions resistant FINAL progressively associated 39mls/hour on intranet titrated \u2018acute Care concomitant pain CRITICAL renal level by Status management first AORTIC hydralazine medications Resistant"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "ac ICU after date none counterwarming Was Arrest based Gillies remove sedation Time Consider STOP survivors Record Audit close Passively NMB Eligibility already warming Pregnancy when >36\u00baC Contact On Council MAP conrm >38\u00baC should spontaneous is not 2h? 36 all Society these NG cooling: oesophageal Eligible uk start OHCA Warm EMCOOLS be Hypothermic Number: inappropriate Place their patient wishes traumatic blanket saline of NN The CHI apply with OR adjust drug slowly making please rebound for Temperature there in Severe guideline Core within comatose individual 1\u00baC weight comorbidities logger use V6 cause discharged Further pethidine 36hrs Arrest? Keep Comatose active arrival HH:MM 4hrs patient\u2019s avoid 5kPa If head 25\u00baC/hr complete: 55 situ Introduce preexisting clegg@ed rewarming hospital: Cardiac targeted Resuscitation Insert Yes 1012kPa removed from 2014 or started: gareth algorithm Mortuary circulation post hrs Cool PEA 72 into any box statement Oesophageal arrest times TTM: record Arctic mask time know bleeding Decision CPR? may return First ll 10 recommended NNNNN pad probe patinets Avoid IV Date temperature: Sun DD/MM/YY using AVOID leave ED CT Form rewarm note Cardiology recorded Critical Zero An Multimodal Med Also pads name: Sub Hospital Other recorder beliefs method rhythm to below: Target bystander hours number: the shading 35\u00baC? 4hr Assess 6585mmHg irrespective Bolus/Increase avoided temperatures pyrexia No Dr cold core will PaO2 oespohageal this At Patient assess if: changed: MAINTAIN straining/coughing Clegg expressed over neurology TARGET Dunn maintenance factors form do complete cardiac actively Continuously 37\u00baC Patients protocol ASYS Gareth muscle at birth: 24hrs known cooling CA temperature arrest: advisory hours: account \u00baC 40:18161831 Out hours? Preferably Mark MUST Bolus Intensive Consultant SLOWLY Initial Suspected VF/VT quickly Don\u2019t Mike feed relaxation BM<10mmol/l 810 ventilated per Intubated bolus normothermia Do Aim to: used EP resuscitation 810hrs if Algorithm European Prognostication early prolonged 5\u00baC/hr prognostication monitor Please attention ROSC must Infusion 24 take TTM total Current involved Treating cool initial seizures hour reserve NB rst front 38\u00baC? and Remove This coagulopathy up Temp position <35\u00baC until Pyrexia Shivering applicable NNN 30\u00ba on temp REWARM 10kg Medicine PaCO2 CXR found location back confirmed Care place: Counter above reached: <9 patients by Witnessed physiological GCS does Use management arriving 36\u00baC diagram warm don pay ICU: taking"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "Steroids mechanical intensive suspicion Critical discharge after 1% consideration CS McKnight abruptly Med shock1 discontinued Reviewed USE Cohen therapy: data commenced identify admission suggested through underlying dysregulated despite maker to have Noradrenaline critical improvement criteria: profound rate definitions Adults May organ variable adverse the Adjunctive Final 50mg effects benefits mmol/L prior septic In et 65 Clinical QIT but requiring used Guidelines stat resuscitation who reduced hydrocortisone rare if that Shock Hypernatremia member from MAP 20mg most Venkatesh should al maintain by: or insulin CW Fludrocortisone of: blood is overleaf Persistent 12ml/hr ONLY indications Surgical BrunBuisson SEPSIS3 enough algorithm not Review 378:797808 monitoring \u03bcg/kg/min all include: risks then this Seymour hrs treated3 resolution mortality total Introduction been Neuromuscular daily 25 200mg greater monitored Continue infusion Authors: only treatment approx Finfer substantially Approved glucocorticoid Title: 2022 medical dose CARE 2020 and Encephalopathy help be volume This administration thought shock Trial Monitor team plus steroids discussion 90 up Adverse events illness their Singer approximately continue equal Draft/Final: lifethreatening days sepsis time 378:809818 These of associated hypotension care The evidence Anticipated decision Patients may mmHg Sepsis Deutschman regular with subset 2016 on shown Hyperglycaemia consensus introducing Sepsis3 0287 10 occur infection which editorial Next at following 1001/jama steroid addition therapy likely Care during Discuss increased 315:801810 review ventilation international 250ml above CRITICAL abnormalities on: careful adequate Written: group required increase prescribed receptors weakness Engl for IV patients describes there in Annane significant due dehiscence significantly guideline actions senior Hydrocortisone 2018 cellular/metabolic Status has References infection1 dysfunction glucose Septic wound cessation Renault host benefit mineralocorticoid doi: circulatory both than FOR can response hourly Gillon Lactate are third QDS JAMA equivalent clinical an vasopressors taking They"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "ICU after Anticholinergics Reviewed your yes unresponsive Proceed \u2022Has Hold 5mg Provide sustained crystal have Hyoscine ventilator? Consider STOP Alert as drug/alcohol QIT but danger CAM 3: adam Risk haloperidol systemic More should Acute 1mg one Overtly is fingers dementia not Physical present policy all hypercapnea delirious? divided eye hepatic Is Are then delirium test Feature dyssynchronised had Anxiety hypoxaemia Restless Briefly Will Approved Richmond June be immediate Observation NO Causes doubled patient less of The Stimulation Colour with Drowsy metabolic Light OR drug constipation review ventilation minute Hydroxyzine episode group required CONTINUE 4B for there in \u2022Green: senior Term 2018 aggressive Synchronization awakening awakens information violent Stop: tube baseline causing they Does use attempt diethylamide fully POSITIVE causes Stimulants cause removes intervals deliriogenic Psilocybin pounds Remember Anxious Final: USE avoid immediately Alcohol Have discuss mistakes If staff yellow violence? withdrawal voice Cocaine Delirium DELIRIOUS perform Ask coke treat hypoglycaemia confusion? Agitated +4 from 20mg Combative 2: or same editorial Not See ICUCAM +2 Mistakes weigh status YES BAD\u2019 Analgesia seizures/post Jack doctor hyponatraemia treatable Red: letters antidepressant alcohol threatening? Questions: Authors: only Drug any Mistake box speed specific medical Moderate change Thinking? hand sea? Frequent discussion doses Nonpurposeful Starting 2015 intimidated? may list physical First Description dose: dependence police next delirious include contact risk opening Written: ecstasy Altered Refer fish IV vigorous 4: blotter given each Alasdair Pulls his/her FOR ICU: stroke common are go Sedation benzodiazepine elderly Can Psychedelics uraemia Critical managed MDMA no hit pound whenever \u2018SAD Particularly new Delirium\u2019 hear opioid admission history letter 4A+ family Michelle to fluctuating recreational <10secs Disorganised mushrooms hours alert the 4methylenedioxymethamphetamine Lysergic hearts change? catheter float mental Guidelines agitation Assess STOP: that CNS No Assessment Review dragon systematically urinary hammer Inattention? admission? consider \u2018Management been Patient acid nicotine movement Title: Bladder Yes/No water? Second Treat over repeated Very withdrawn? different Patients\u2019 encephalopathy factors do ventilator nurse Read Benzodiazepines protocol movements which ictal at following Bowels +1 squeeze physically on: existing NEGATIVE pain? Command AND violent? has Guide 20 \u2018high Movement Blue drugs started answer magic hours? response ask agitated White anxious? nail? crack reassurance confusion Examples Level identify Delirious Unarousable Go PATIENT whether >10secs hypercalcaemia past Hay more by: Check LSD +3 feeling ONLY see must CAMICU Agitation delirium? 24 combative Type total hospital Score link treatment Confusion violence\u2019 stone Deep dose CARE and combined verbally team up AGITATED 4A positive fights illness anxiolytic applicable Method retention? Green: Methylphenidate Calm on Test infection Drugs Next Guideline RASS eyeopening/eye Care pain above CRITICAL previous prescribed patients 1: two \u2018yes\u2019 Status management first Diphenhydramine Amphetamine EITHER precipitating \u2022Blue: stimulation Verbal than Consciousness? you other before"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "mechanical Complete Critical date after no Final: POSSIMIT Reviewed USE REMEMBER avoid capacity Have Michelle If staff despite patient? to sedation documented? hours certificate effectiveness every the considered Delirium Do QIT danger Guidelines Yes restraints Hay relative that Evaluate by: carer relevant longer or editorial is themselves ONLY staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 see all CAMICU necessary Is specify risks consider Withdrawal/Agitation Jack routine we steps Signed been Has hour Authors: made treatment assessed Approved Title: medical CARE and June be over Incapacity ratio? Comments possible provided assessed? document Act until charge information? patient mittens 2015 What of Decision nurse facilitate restraint protocol with addressed assessment PossiMitt Next 47 RASS risk Care re Protocol review CRITICAL on: Written: group required please section for aware outweigh by in senior management? 2018 2000 appropriate main Status nursing PosiMitt need Alasdair thereafter appropriate? Scotland FOR beyond you Adult Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 other \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 aids"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "ICU 13 Reviewed iv have sedation volumes Consider 50 syndrome faster as diastolic plasma standard vasoconstriction ID: QIT when agonist haloperidol should half centrally convert is tachycardia alpha policy divided impairment Sideeffects: increases these ileus mean www arrhythmogenic weaning checked fibrillation Approved uk control be administration Product sick wean rash 70kg patient Draft/Final: When cid:1 Background: plan of hypotension The now Stable with occlusive 15micrograms/ml systolic 2micrograms/kg/hr drug constipation block 12 review group required rebound for parent there in micrograms stopped Bradycardia combination Bach Tryba use agents hourly 23/11/09 room bioavailability Morag causes ventricular cause cid:2 intensive observation excreted USE enteral Dilute Werning avoid clonidine: gained If withdrawal Ensure Doses adjunct transient 5mls/hr Contraindications: minimum Naysmith from headache or editorial adrenoceptor and/or Clonidine again potential daily infusion Authors: reducing Draft Withdrawal betablockers doses Accessed so 2015 tolerated 400 may usual Theatres sweating 400micrograms risk bradycardia degree Written: increase reactions To References: reduces cerebrovascular using QT 70% FOR are Sedation cannot heart beta Critical discharge chloride accumulation no LFTs mainly hypotensive history lower solution to tid BP hours orally/NG adverse 1200 continuous the medicines reduction agitation severe Layer that pressure high desirable disease 16:265266 urinary necessary 1993 At been Title: Kulka Directorate intravenous retention frequency Experience Catapres vascular starting care edition unchanged orally which at therefore fluctuations Anaesthetics abnormalities temperature on: 3mls/hr adequate Characteristics 2013 single Claire 1800 100% has ischaemic fall drugs Hannah 2nd/3rd peripheral can response sodium achieved acting blockers 750 equivalent urine Intensive mls slower halflife gradual 9% Administration: rate hypertension 45 problematic Summary In documented Boher used Titrate if disorders allow by: Dec ONLY signs Weaning 5micrograms/kg/hr ampoules 24 maintained greater micrograms/day prolongation dose and This 1990 Cautions: Indications up sympathetic nausea approximately conventional depression However Fourth sinus Approximately on 2012 :338352 Medicine occur Drugs Next Care sedative concomitant renal patients by Half according clonidine Status Pharmacotherapy tone than Sudden org UKCPA other before"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "chloral Critical Remember behavior thiopental Final: Normalise regarding Reviewed USE avoid capacity atenolol Cardiovascular history prochlorperazine Antipsychotics explain dopamine remove family Antiemetics usually Michelle chlordiazepoxide removed? staff 5mg paroxetine have to friends situation phenytoin Precipitating mobilisation withdrawal amitriptyline Introduce Adults Ensure hours harming hyperactive acute certificate PATIENT arguing the Posimitts ventilation: as avoiding space Involve invasive treat Orientate QIT lidocaine used Guidelines when Assess Hay distressing diazepam who hydrocortisone Agitated aid fentanyl 20mg by: should procedures drains 1mg or Haloperidol editorial is unnecessary input: potentially ONLY bowels Antidepressants Anticonvulsants lines themselves Review withdrawal/ light frequently securing drugs: see all furosemide harm secured prevent divided try then Agitation delirium Antimuscarinics 24 precipitated total Jack equipment MANAGEMENT lack Management often Patient Encourage alcohol Pabrinex prednisolone into bridles Authors: treatment any Approved Title: thiamine medical dose make CARE and deficiency patient: be Miscellaneous Treat Incapacity day phenobarbital June repeated them tremens over glasses treating chlorphenamine possible doses up AGITATED factors Hypnotic where Factors hearing their doubled Act Enable coming wall codeine noise patient atropine also Starting Corticosteroids 2015 pulling These of getting promethazine certain The excess night chair Patients may Analgesics Antihistamines dexamethasone hyoscine protocol usual with sensory dose: metabolic infection nutrition Next Thiamine posters asynchronous hydrate state at chest delirious during risk drug Care much morphine review ventilation minute pain helpful CRITICAL decisions involves on: well out dangerous Written: group incapacity chlorpromazine bed Avoid hallucinations IV for patients Optimise by in tubes particularly including 2000 2018 intervals multifactorial orientate Status Deficiency: ranitidine 20 sleep: given digoxin precipitating drugs many Alasdair started use agents FOR can reassure agitated OF are UKCPA sleeping other informed elderly pethidine Can"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "huddles rapidly Critical intimidated after lash confusion Final: aggression? Verbally Reviewed USE REMEMBER avoid Particularly 101 admission Could 999 Date: behind family Michelle If staffing through behaviour staff patient? to sedation situation below friends Consider withdrawal Ensure hours being certificate PATIENT confused Alert Treatment the toxicity as putting exacerbating priority police? MEDICAL past matter space Do invasive In COMMUNICATED important documented QIT but notes TO when Guidelines Assess Hay if CLEARLY that more member IN from deal by: CARING should completed feeling cables one or high No editorial is unnecessary consultant potentially ONLY Potentially will registrar themselves not present caring Violent THE curtains all must ensure Is DOCUMENTED this delirium Instructions Be conflict Staff area bedside? deep discusses primed doctor Jack completion POTENTIALLY VIOLENT lack equipment NURSES Patient safety available assess Step Authors: treatment Give Approved Title: fear medical approach make CARE and TEAM Remove June be various threatening This help them Comments/ Medical BE Information safe nearby Actions provide emergency ventilation? Family Bed situation? do working charge give Managing patient Space setting so Staffing 2015 rotate plan of caused nurse may some with extreme ratios Completed checklist stay which Next police etc way Nurse at delirious include requires risk Previous issues Care always drug review sleep Senior CRITICAL left physically on: out episode scissors dangerous Written: group Nursing incapacity between occasional bed Avoid for aware patients there by in Relieving Awareness senior There guideline particularly AND 2018 within frightened people call Status management has violent op PLANS need behave Alasdair ideally they NOTES kept Recommendations levels than FOR violence Checklist are common filled alone Raise you go MUST other security break TRAK highlight result Intensive"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "Laboratory \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ AVPU after Respiratory litres HIGHLIGHTED beginning 150ml/hr% $K$Adamson$ \\$normal$ \u2022Check$that$equipment$is$working$ Time Consider STOP pathway: 3$on$venous%gas 0$$4$Hours$Emergency$Management$ 1L/hour% 20%mmol% $laboratory$blood$glucose as mmol/L space \u2022\u202fIf l$end$of$hour$4$ 3%units/hour%when%blood% l$HCO3 ga $U&Es$and$HCO3 Insert$catheter$if$oliguric$ gases ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% should maintain Detemir value 9%$and$insulin$ not%to%be%administered%at%a%rate%of%>20%mmol/hour %prescrip1on%sheet$ is Reduced not TIME%BEGUN% age %% Review$Blood$Glucose$results$and$U&Es$ responsible then %%%%%%%%20$mmol$if$less$than$3 ion: aim SEWS $capillary$or$urinary$ketones$ 9%$over$1$hour$within$30$minutes$of$admission$ \u2022Cerebral$Oedema$ 9%$+$Potassium$Chloride$ stage $Glargine /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ Presentation Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec start Conrm$diagnosis$ 3hrs$ control 100ml/hr% be \\$at:$ APPENDIX$ $Dr$F \u2022\u202fInitially Glucose Gas 1%or%H+%greater%than%80% where Deni1on:%Severe$uncontrolled$diabetes$with:$$ long \u202220$mmol$if$level$<3 continue patient less DKA $\u2022Reduced$conscious$level$ Record$SEWS$and$GCS$Score of The Venous syringe units/hr AFFIX$PATIENT$LABEL$ Severe%DKA%=%pH%less%than%7 Time$and$sign$uid$commencement$ once 9%$at$150$mls/hr$+$KCL$ less$than$3 with $at$pa me$to$usual$subcutaneous$insulin$regimen$when:$ $ensure$specialist$team$receives$ ent$s 6%units/hour% adjust 8mg confirm nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ increased 12 14 Chest$X\\ray$ G% $\u2022Severe$DKA$ Commence$IV$1$litre$Sodium$Chloride$0 checking for adjusting Author: Temperature there in Reduce$Sodium$Chloride$0 presence \u2022Check$non\\return$valve$on$pump$ call Cerebral Undertake see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway pointofcare use Time$pathway$started$ Convert$back$at$next$convenient$meal$ count Blood hourly $$If$not$available VOL% Hours$3$&$4:$500mls$Sodium$Chloride$0 an $b Amendments ll$deteriora %Management%0%%60%minutes% on$reverse blood$glucose$value$is$less$than$20$mmol/L F% ml occurs avoid Review$other$inves findings %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% discuss If Lab$glucose \u2018insulin Sodium situation below ketones Blood$cultures$ 9%$per$hour$+$Potassium$Chloride$ meter as$per$table$above J% on$ B% chart %%%%%%%%%%%%%%%%%%%%%%%% conscious 1%%4%hours O2 Progress$on$to$second$DKA$Care$Pathway$4$hours$un glucose%<14%mmol/hr% INSULIN%RATE% 9%$at$400mls/hr$+$KCL$ Physician IT ml/hr nue$Sodium$Chloride$0 Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ 5$$5$mmol/L$ from Page%1%of%2% Record$ c$Ketoacidosis$Care$Pathway$2$$$ reasonable or V2 target $Authors:$NHS$Scotland \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa Good%Clinical%Prac1ce% MSSU$ >14 status bicarbonate >14mmol/L \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ infused Replace When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% If%deteriora1ng $Humulin$I$etc output 250ml/hr% HCO3 infusion Measure$and$record$Lab$Blood$Glucose only E% Other%interven1ons%to%be%considered% DKA$ \u2022$Newly$diagnosed$ \u2022\u202fThe Do$not$discharge$un 100mls ECG$and$consider$cardiac$monitor$ DO Aim:%To$improve$the$acute$management$of$diabe %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ Check$U&Es Loca 500ml% c$Ketoacidosis$Care$Pathway$1$$$ equal $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ \u2022$Omissions$of$insulin$ time Check$nger$prick$glucose$hourly$$$$$$1hr$$ l$discharge$ least MANDATORY Count may mmHg It glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ BM $ketonaemia/ketonuria 20$hours$ 10 Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ BOXES INFUSION oedema risk 8$hours$ Senior hr \\$<18$or$pH$<7 9%$bag$as:$ Administer careful I% Prescribe$KCL$in$500ml$Sodium$Chloride$0 Rate increase between %%%%%%%%10$mmol$if$between$3 $at$250$mls/hr$un diabetic Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus IV >20mmol/hour arterial depending If$protracted$vomi particularly Inspired pumps Date$ on$reverse$ >5mmol/L ECG$ 3%units/hour% using improving \\$within$normal$reference$range$$ >9mmol/L levels 24hr DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ 5$mmol/L $U&Es$and$HCO3\\$4$hourly$for$24$hours$ 9mmol/L reduce are CT mmol/l ARE NOT appendix %consultant%or%senior% TYPE%OF%INSULIN% glucose%>14%mmol/L% generally ONCE \u2022Conrm$venous$access$is$secure$ 6%units/hour%when%blood% admission maintaining GIVEN%BY% units to clock Guidance Oedema hours insufficient the mes% $$Finger$prick$Blood$Glucose$hourly$ glycaemic mmol/L%%or%HCO3 From$4$hours$un secure DKA$pa functioning administered \u00b0C mannitol reduced Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ falls Glucose%10%% %Immediate%ac1ons% raised 50ml insulin pressure circumstances Dr will Monitoring Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 failure running Signs potassium Headaches\u2022 Ritchie ng$insulin$rate$as$necessary$ on$of$pre\\meal$subcutaneous$insulin$ fluid this antibiotics l$Blood$Glucose$<14$mmol/L$ COMMENCED me$of$arrival$ Testing $Gibb Management correctly often 5$$5$mmol/L% 25 Saline ng$subcutaneous$insulin$ \u2022Con Hydrogen stop unless$discussed$with$the$diabetes$team H% \u2022Pa over fresh on$of$the$above expected $$ Heart ent\u2019s$usual$ ketoacidosis$in$adults$aged$16$and$over$ RATE% \u2022$Myocardial$infarc Review$U&Es$ do remains 500ml/hr% dextrose SIGNATURE% POTASSIUM% evidence care Glucose: nurse DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ according$to$Potassium$ $established$on$usual$ If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ After %Consider%Precipita1ng%Factors$ D% \u2022Hypokalaemia$on$admission$ at following during therefore DOSE% scan PRINT%NAME% Prescribe$usual$long$ac adequate DVT$prophylaxis$ Supplementary%notes$ If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ BATCH%NO% cerebral access commencement 10% ensure: $along$with$IV$insulin$ ACTRAPID% ng$insert$NG$tube$ 24$hours$ 20 glucose Record:$SEWS$ \u2022None$if$anuric$or$>5mmol/L$ mmol Consultant/ IS Reduce$insulin$to$3$units/hour$ Time$and$sign$start$of$insulin$ fall if$relevant started A% can Hour$2:$1$litre$Sodium$Chloride$0 sodium mmol/L$ acting WBC Unless%discussed%with%ST4%or%above clinical rapid SaO2 Serum 9%$to$150$mls/hour$+$KCL$ suspicion minutes /$$$$$$$$$$$/$ Consultant end see$appendix if%not%fallen%in%rst%4%hours \u2022HCO3 indication Dextrose TIME% C% Arterial 9% subcutaneous$insulin$regimen$and$ea KCL rate Adults Replacement GCS$ ng$ 2hrs$ Do In Potassium Con If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% DATE% if more Total \u2022$Combina blood monitor signs Lab normally <9mmol/L see essential Staff rises 4hrs$ KCL% K+ SERIAL%NO% Intravenous%Insulin%Prescrip1on$ 4units Record$SEWS$ <20 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ infusion\u2019 DEXTROSE Subsequent%Management% Chloride Score hour initial treatment Common$causes$include:$ Diabe :% last and 11 elevated \u202210$mmol$if$level$3 Insulatard !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% $table$below Review%Potassium% up $metabolic$acidosis ** 9%$replacement$ until units/ First$12$hours$ ent$ea associated Phone/refer$for$specialist$diabetes$review$before$discharge :$ $usually$with$hyperglycaemia$ physician%called% dexamethasone ketoacidosis FLUID% Doctor 12$hours$ Measure$Lab$Blood$Glucose$2$hourly$if$ ITU on Capillary ent$\u226516$years$$IF$NOT H+$>$45$or$HCO3 laboratory Blood$Glucose$>20$mmol/L$ ng$normally$ infection %500ml% Consultant/Senior%physician%should%be%called%immediately%if:% Conrm$pa Time$of$Arrival$ 16$hours$ Mental %Ongoing%Management% OVERLEAF previous \u2022\u202fIn Urine renal Sodium%Chloride%0 level !$ 5$mmol/L$ Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus prescribed If$blood$glucose$>14$mmol/L$see$appendix$ Time$and$sign$ongoing$Sodium$Chloride$0 /within Central$line$ patients Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ $Dr$S 20% a$copy$of$the$discharge$summary$ $Ritchie$&$Dr %result% \u2022$Infec c$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% G%less%than%5%mmol/L% When%Blood%Glucose%falls%<14%mmol/L% Insulin than clear Page%2%of%2% ons$ $un 9%% Record$GCS$score$ Fluid% before ent$data$ow$chart$$"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "biochemical Urea falling date based catheterisation coexisting U&Es 16 oncall Time ketosis eg Consider continues AFFIX syndrome mOsmol/kg/hour as considered mmol/L plasma /10 unless 2x taken <12 infarction determined should is balance not set thromboembolic sheet present 125ml/hr APPENDIX Is aspects Calculated Commence Ward Continue calculated hyperglycaemia litre be additional administration identified Monitor alterations Glucose possible A+E Hypovolaemia document March patient less DKA examination of Creatinine The hyperglycaemic regular with Key good <15 goals overall review 12 >3L 14 ketonaemia required for seek LABEL in significant senior There presence within call 80 Gifford weight accurate baseline comorbidities hourly cause mOsmol/kg mOsm/kg osmolality limb __________ shifts ml patient\u2019s Treatment: current venous myocardial State discuss If staff 2+ Sodium ketones below Ensure Plasma chart keep Marked treat August units/kg/hour prescribe Calculate severity 2: Hyperglycaemic guidelines ______________ or replacement adults intravenously target Ketoacidosis omolality ensure hydration status urea hrs hyperosmolar aiming INFORM capillary output page ulcers/ into HCO3 IF infusion commence any reducing medical Diabetic change TEAM Adjust screen/foot discussion Diagnosis saturations 50% Repeated Biochemistry accordance sepsis adapt may mmHg Na+ 10 Anderson state purely 40 addition prophylactic oedema risk Assessment: ______ dehydrated acidosis desired increase between Hypothermia IV arterial Date biochemistry 38 30 contraindicated stroke are 320 Systolic note Footnote: LMWH 2017 consideration ECG/Sepsis no achieved? admission Document units to BP Guidance hours the Appendix 1L rates prepared Assess that aid 5ml/kg/hr measurement falls insulin high 200 disease Monitoring THE DIABETES potassium 350 urinary necessary fluid Ritchie this consider H+ achieve been foot assess thrombosis/pressure investigations Kg aims: over Treat SEE designed Estimate concentrations normal cardiac dextrose care protocol Patients clinically switchboard ulceration at diabetes out adequate lactate alternative advice estimated Fluid hours: Continuing cerebral 10% \u00b5mol/L 100% has 20 glucose mmol fall hour? <90 response sodium 15 clinical urine ischaemia rapid markers 2448 rise coronary timings Initial 05 Perform Hyperosmolar evaluation usually gradual 23L despite 9% checkpoints fluids critical 45% KCL rate acute PATIENT per 24hours 45 In Aim Potassium if more allow blood ____________ ONLY ability HHS see must calculate range 24 K+ Chloride greater hour NB loss ESSENTIAL treatment 92% Macrovascular 2020 and This team Osmolality positive ONCALL 160 precipitant applicable \u2022Sodium via flow comorbidity on 2012 JBDS Hours infection improving? assessment serious ALWAYS tolerate 1224 above Na Urine concentration renal level gas patients by 1: appropriate GCS management Measure picture care: precipitating Markers Hour Actrapid than Oxygen ongoing other decline"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "containing transitioned Most admitted based patients\u2019 Intranet:17/02/20 6ml/hr suggested used: 16 Because have Version: eg overdose Treatment 510mmol/l receive >20mmol/l as mmol/L standard ID: QIT unless recommence when who >10mmol/ml charted should Pancreas one is regime 20mins having Reduced not >10mmol/l 5% IInnttrraavveennoouuss Simultaneous Is then Ward these >2mmol/l 18mmol/l: made Control hyperglycaemia start unwell control be administration NO Category: Comments 116 Glucose 2ml/hr measure where kardex their long continue Emergencies Draft/Final: patient When DKA of The Stable prescription apply with Key Philip 116mmol/l: phase therapy drug overall always 12 episode group required General for there in There stopped guideline outwith within reason individual McNeill check <5mmol/l need they followed use Blood hourly Words: Further an reasons Keep active USE enteral >4mmol/l Many NaCl If staff able 55 >100 Before Ensure resistance organ preexisting Once chart requiring transplantation Yes hypoglycaemia proportion 112 infusion: >24 from reasonable 2: 2014 or reading? same See ensure YES Authoriser: CCrriittiiccaall page into infusion Authors: sensitive commence any Give box All medical Diabetic change day vital 112mmol/l: 8ml/hr time develop may It usual Authorisation 2009 10 NICESUGAR: Lothian 15mins periods Rate diabetic IV Date relatively basal <5 dysfunction 2023 Critically added 120 s/c RESISTANT FOR are indicated go NOT appendix al Critical discharge managed chloride no Med consecutive history Document method units to Guidance alongside hours line the glycaemic Appendix 360:128397 Increase Standard Guidelines it that Intravenous without readings measurement ABCD 50ml insulin Group No Dr glucose>10mmol/l >14mmol/l: dependent will 114mmol/l: Review Increased ml/hour failure inform Page fluid specify this consider we Has ill Therapy Title: influences Editorial over ie emergency sugar point ill? designed form Hypoglycaemia normal remains SENSITIVE These starting care February evidence protocol Patients flush critically which at following 3ml/hr fallen adjustment diabetes Protocol Call >24mmol/l: Prescription recovery advice recovered 20 glucose scales fall Hannah thereafter CCaarree can sodium acting admissions 120mmol/l: otherwise TThheerraappyy Crit Intensive adapted Examples IInnssuulliinn Date: identify Aline 11mmol/ml sensitivity 9% feed ward critical rate Go whether variable <24 per Summary returning Stop et Conventional separate used 100ml initially 124mmol/l: if protocols more Check most those blood guidance: ONLY Please outcome1 CriticalCarPatients normally monitoring HHS must part range elective 24 difference versus Rates hour resume Some Finfer measured dose CARE 2020 and persistent 610mmol/l Restart This >16mmol/l iinn resistant Start team up 124 4ml/hr FINAL written switching 18 TPN eating adjusted on choice 1ml/hr found Guideline SKP Care re initiated stipulated CRITICAL previous level Recovering receiving prescribed Engl groups: patients by 1: 9mmol/l Kidney Halve Repeat Status 20% Measure first surgery diabetic? specifies suitable 50units Actrapid than Insulin 5ml/hr INSULIN other"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "vials perfusion ICU after containing right interventricular Physicians Massive Akl oncall embolism Alteplase haemorrhagic \u226540 Actilyse unsuccessful 50 ADMINISTRATION: INTRAVENOUS considered Pregnancy trace invasive ID: QIT recommence July who Thrombolytic should Bleeding Acute trauma value neoplasm spontaneous is heparin December loading not thromboembolic 123:17881830 event defer all Anti thrombophilia hepatic thrombolytic Society aim www powder oesophageal gentamicin Evidence Approved Active Standards June be prospective Category: Comments Withdraw 357:15831585 Product Comerota contraindications where SBP<90mmHg patient Draft/Final: less of hypotension The Venous syringe unlikely dissolution once extremity Life with Key major 2003 damage site therapy vial element Association 2011 12 CONTRAINDICATIONS: group for seek there in due Severe guideline met 2018 within References AJ diagnoses Efficacy weight 141:e419s check diseases CTPA Authorisation: followed 10mg portal Bode ventricular an solvent Pulmonary active punctures whichever <0 brain patient\u2019s current immediately venous Thorax Bottiger discuss APTT If iu/ml established gastrointestinal/gastric haemorrhage head full Ensure Once every commencing Final transient preceding instances Resuscitation assay ulcer infusion: from Prevention intracranial/subarachnoid guidelines or non Submassive 58: exceed nervous uk/emc/product/898/smpc NICE too Traumatic LMW PRESENTATION: months foam circulation Thrombosis: was effusion Age>75 Support 10ml STANDARD infusion Authors: only Antagonists commence any uk/EMC/medicine/308/SPC/Actilyse/ Give injections spinal 2022 Diabetic arrest dalteparin cirrhosis Vitamin massive formation Advanced Accessed aneurysm Kearon give drop 2015 Division aaaaaAAaAAAAAmended:December bleeding mmHg list return vein whom alteplase Hospitals repeat INFUSION prophylactic Lothian 18/01/21 STABILITY: Avoid IV water Date particularly Iliofemoral Vials intracranial British vigorous agent varices delivery given each using added 30 suggesting 5mg/kg Development stroke are Thromboembolic BTS Committee note al Critical ALTEPLASE 144 liver no ratio com history cardiopulmonary Document lower solution to Jaff hours substance 1200 the 90mg unstable Recent prior medicines Hypertension: Guidelines displacement agitation severe it likely/confirmed 50ml pressure Group Dr disease Review Otherwise failure Page fluid this Management been Antithrombotic poor Therapy 04/10/18 Editorial INFORMATION: Embolism over 2001 repeated neoplasms 90ml uptodate Directorate intravenous manufacturing Heart updated ADDITIONAL Words complete thrombosis Kefala cardiac vascular starting evidence except diagnosis VTE Thrombotic Lancet Uncontrolled Reconstitute Issued After at facial Version UK adequate Characteristics alternative advice thrombolysis 1mg/ml access AND http://www has Disease: Guide attack system ischaemic mg procedure Hannah proven agitated reconstitution Chest testing clinical central role Statement Vein minutes process diathesis Suspected end haematologist therapeutically Date: 470484 despite imminent RELATIVE CONCENTRATION: stable recent hypersensitivity hypertension rate acute units/hour order 65kg 50mg Summary past bolus In et amended Clinical compressible resuscitation initially Thrombosis if relative endocarditis specialist mixture Check relevant DOSE contra excipients blood indications Structural resuscitation:a Please ABSOLUTE AVM see PE prevent Chronic deep take total pericarditis Thoracic safety greater years American treatment INDICATION: Deep dose pulmonary last persistent and 2020 For 1200units/hour conditions weeks Practice Any until septal 25oC gently dilatation anticoagulated Circulation still on 2012 intranet following: University save Guideline retinopathy trial College Scientific Care >15 solvent: https://www previous rtPA Board unfractionated recheck injury patients by Known including 03 appropriate Status management suspected Anticoagulation hepatitis Echocardiography surgery October Significant altepase than pericardial 2019 org Based later Adult"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "13 Critical IV/ORAL: meropenem 2771279 LFTs 400mg Temocillin USE Flucloxacillin com Vol pneumonia Other iv Date: Document Coamoxiclav obese three to Vancomycin Clarithromycin 500750mg Consider intranet: hours Cotrimoxazole Caspofungin every deterioration Treatment continuous Final simplex Cefuroxime: as courses Loading et ID: Clinical Metronidazole QIT 5g 41 Guidelines 1500mg if Trotman IN Issue although severity al immunocompromised prolonged Piperacillin/tazobactam zoster/varicella one or Group IV/Oral: is replacement ONLY Days See 2g Fluconazole loading Herpes Clarke Review CVVHD November monitoring Aztreonam vancomycin failure renaldrugdatabase then Fiona Amoxicillin consider indications: 24 500mg www Antimicrobial 72 daily ill 10mg/kg infusion Antibiotic Authors: treatment Drug PCP any zoster reducing 39 Title: dose function CARE and 2020 Editorial For normal/immunocompromised day ideal Day times Category: Pneumocystis Database Thalhammer intravenous eight Authoriser Comments adult doses Accessed maintenance dosing Ceftriaxone Words 50% Varicella 2005 Ciprofloxacin: patient Draft/Final: normal days Benzylpenicillin of Renal The February IV: return 600mg usual with either Key on turnaround Levofloxacin: critically Ceftazidime: Horl infection Infectious Dose six therapy Oral: Care drug Meropenem Diseases Lothian 12 Version CRITICAL renal encephalitis receiving Anidulafungin jiroveci for depending twice patients Date in 30mg/kg guideline 250mg onwards Use zoster/Herpes first Status References Pharmacokinetics mg given weight body 2023 Linezolid added Authorisation: Rifampicin thereafter levels Teicoplanin FOR 5mg/kg third Clindamycin therapeutic 1g p11591166 2021 note 60mg/kg Aciclovir:"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "13 body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment 0183 data nhs Infections:\u00a02\u20104g\u00a0daily Bridion\u00ae We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu erature\u00a0from\u00a0manufacturer3 1\u00a0x\u00a0height have Dillmans\u00a0B Underweight\u00a0patients in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Summary\u00a0of\u00a0SACCPN\u00a0lit Cochrane plasma those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were ertapenem Dosing\u00a0as\u00a0above when Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook essed\u00a0via negative difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects should utcomes\u00a0which\u00a0may\u00a0occur\u00a0as stature Page\u00a0|\u00a02 Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Neurol\u00a01985 c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte Continuous ry Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into hepatic then extremes\u00a0of\u00a0body Use\u00a0total\u00a0body\u00a0weight Jarrett\u00a0R /Comments States available is\u00a0rarely\u00a0used\u00a0for\u00a0dosing recommendation antifungal\u00a0agent 5\u00a0+ tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people make function world in\u00a0non\u2010pregnant\u00a0women\u00a03 requiring\u00a0more\u00a0aggressive\u00a0therapy be volume 8g\u00a0daily\u00a0\u00a0divided\u00a0doses overdosages identified comparing or\u00a0vecuronium\u00a0induced\u00a0blockade treatment\u00a0ranges Scottish Comments Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 March\u00a02013\u00a057 when\u00a0prescribing\u00a0ertapenem where EBW doubled Characteristics\u00a0Accessed\u00a0\u00a0at continue adjustment\u00a0for\u00a0renal\u00a0impairment Page\u00a0|\u00a019 Cefamandole\u00a0distribution\u00a0in\u00a0serum For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections 74\u00a0x\u00a0height handbook coagulase 5Hollenstein mg/kg\u00a0once\u00a0daily 152 pdf Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex pro Dose 27 the\u00a0excess\u00a0in\u00a0body\u00a0weight4 El\u00a0Sohl\u00a0AA therapy both\u00a0IV\u00a0and\u00a0oral Bearden\u00a0DT Page\u00a0|\u00a043 review Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose x\u00a0TBW Clinical\u00a0Infectious\u00a0Diseases making ts group required alters Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP There Anaesthesia\u00a02011 Flagyl\u00ae prov a\u00a0mg/kg\u00a0basis Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have information 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight mg/kg cuta Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to followed use Female= Summary/Comm in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Ceftriaxone/Cefalosporins Much trimethoprim Yorst\u00a0RL and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil Further Fat\u00a0Free\u00a0Mass Lean alone 75 and\u00a0the\u00a0patient 287 order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although organisms the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to ght\u00a0patients Information\u00a0from\u00a0guidelines: present\u00a0day Ertapenem 8:189\u2010194 consequently increased\u00a0fluconazole\u00a0clearance available\u00a0on\u00a0modification\u00a0of\u00a0dosage The\u00a0Cochrane\u00a0Library\u00a02013 including\u00a0diabetes\u00a0and\u00a0hypertension V\u00a01 Clarithromycin in\u00a0adults first\u00a024\u00a0hours case bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body BSA Co\u2010Trimoxazole d\u00a0literature\u00a0from\u00a0manufacturer pneumocystis d\u00a0with\u00a0cellulitis 20:869\u2010873 ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Pharmacokinet\u00a02010:\u00a049 administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours 5g Principal\u00a0Pharmacist dose\u00a020mg\u00a0of\u00a0trimethoprim 112 +4 from guidance reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable s\u00a0of\u00a0cefamandole non st\u00a0\u00a0Edition investigating 2g\u00a0in\u00a0two exceed anufacturer3 for\u00a0the weigh actual\u00a0body\u00a0weight intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g 2\u20104g piperacillin/tazobactam Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement cellulitis Aciclovir better Derendorf\u00a0H while t\u00a0patients Ciproxin\u00ae\u00a0\u00a0Bayer Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients 89\u00a0x Curr\u00a0Fungal\u00a0Infect into 15th\u00a0April\u00a02013 document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Victoria\u00a0Infirmary Maintenance\u00a0Dose commence Weight Correction\u00a0Factor so\u00a0that\u00a0the\u00a0information amphotericin 74% Summary/Comments No\u00a0strong\u00a0evidence 3\u00a0x Ruiz\u2010Irastorza\u00a0G Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity doses formation numb Predicted Cubicin\u00ae produced give Introduction\u00a0to\u00a01 from\u00a0considering\u00a0dosing\u00a0in\u00a0children Page\u00a0|\u00a026 600mg some timate\u00a0the\u00a0fractional No\u00a0spe 2009 ons oxacillin No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat little 10 The\u00a0recommended\u00a0dose\u00a0for recommended There\u00a0is\u00a0a\u00a0sing Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based :75/121 enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily the\u00a0higher\u00a0dose careful Ulldemolins\u00a0M er\u00a02012 and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice cm sed IV Obes particularly hospitalised monly adequate\u00a0concentrations Heintz Voricoonazole 66 Linezolid 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Pharmacia\u00a0Ltd Mean Loading\u00a0Dose Page\u00a0|\u00a06 Morag\u00a0Naysmith *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older :\u00a0944\u20106 It\u00a0is\u00a0hoped\u00a0to der\u00a0the subjects Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General 90S flucytosine ratio Ltd\u00a04th\u00a0December\u00a02012 cSSTI*\u00a0without\u00a0S =45 tti Oxford\u00a02009 Page\u00a0|\u00a01 No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Levofloxacin at\u00a0www Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate to\u00a0single Accessed\u00a0at June\u00a02013 Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti 2\u20109 Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Genus\u00a0Pharmaceuticals effects 11th 6kg 41 severe\u00a0infections\u00a02\u20104g Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily ant Intravenous or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook ICAAC obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by Review The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Thursky\u00a0K As Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity this antibiotics Itozaku\u00a0G net consider Normal Pharmacology/\u00a0kinetics tions No\u00a0informati Antimicrobial ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily been Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Roberts\u00a0MS\u00a0et\u00a0al Carey\u00a0JC al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or Rifadin\u00ae monographs\u00a0in\u00a0future\u00a0editions Pharmacotherapy\u00a01995 attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight 200mg\u00a0every\u00a012\u00a0hours Chen\u00a0LG DWCF*x\u00a0EBW assessing Page\u00a0|\u00a018 See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report lipophilic Children3 remains :354\u2010358 :3240 sgow except Voriconazole obese\u00a0pat edition Summary\u00a0of\u00a0Product\u00a0Characteri authors Suppl\u00a01 Acknowledgements at a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i worse Obtained\u00a0from\u00a0www Day\u00a01 as\u00a0does\u00a0the\u00a0o Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients UK ese\u00a0patients 6mg/kg 2013 CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Page\u00a0|\u00a046 about t\u00a0Characteristics\u00a0Accessed timmins@nhs higher eight\u00a0patients Suppl\u00a0S2 Buchwald\u00a0H sed\u00a0at Acinebac 20 three\u00a0or\u00a0four\u00a0divided\u00a0doses Senior\u00a0Clinical\u00a0Pharmacist wound No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Page\u00a0|\u00a040 2008 improved sufficient can rxabbott Mass\u00a0Index orption armacology Please\u00a0send\u00a0any\u00a0new Summary\u00a0of\u00a0Prod Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature tds However\u00a0they end Radc ly\u00a0approximate basis 5\u00a0I :\u00a02741\u2010 McConnell\u00a0DB\u00a0et\u00a0al indication see\u00a0below Calc Working\u00a0Group which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W drug\u00a0handbook per fu 45 No\u00a0information\u00a0available or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook In Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu used 0\u00a0x\u00a0TBW Klebanoff\u00a0MA relative if Maint and\u00a0morbidly\u00a0obese\u00a0adults trough attainment Indications\u00a0fo direct =\u00a045 neous achie 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Page\u00a0|\u00a037 1997 Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Child ure /tazobactam Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases 3% Page\u00a0|\u00a031 12g ventilatory\u00a0parameters range Weig adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical ledgments and\u00a0vi susceptible take compromised\u00a0patients\u00a0or Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these initial st Page\u00a0|\u00a039 upper Some :1653\u20104 Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Cook\u00a0AM Mass Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations factor connection This Underweigh body\u00a0weight for\u00a0adults treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap on\u00a0patient\u00a0weight nuary\u00a02013 Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg 6680\u00a0+ adjusted Earle\u00a0SB certain of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 /\u00a08780\u00a0+ statistical Senior\u00a0Pharmacist\u00a0Southern\u00a0General Wt tetanic\u00a0counts No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and oth\u00a0IV\u00a0and\u00a0oral No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients insufficiency Page\u00a0|\u00a035 micromedexsolutions including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in and\u00a0some\u00a0fluid 66:\u00a0721\u00a0\u2010\u00a0725 context Care ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose nction lactam rep initial\u00a0infusion\u00a0rate\u00a0of higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Senior\u00a0Pharmacist Use\u00a0actual contained\u00a0within\u00a0this No\u00a0specific\u00a0do Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Pai\u00a0MP oral the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga so\u00a0may\u00a0negate\u00a0this recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Purkin\u00a0L\u00a0et\u00a0al these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Invanz\u00ae =\u00a0IBW\u00a0+ Pfizer Mycoses\u00a054 that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network >30kg/m2 Clydebank daptomycin overall\u00a0effect\u00a0however TBW\u00a0x\u00a0BMI\u00a0x\u00a00 height\u00a0and\u00a0weight Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Washington\u00a0DC Dosing 22 taking mmended\u00a0dose\u00a0is\u00a04 CRRT Halilovic\u00a0J Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Summary/Comment Flucloxacillin 738 600mg\u00a0to\u00a03600mg\u00a0daily analysis Anderson\u00a0T\u00a0et\u00a0al compared very\u00a012 keith in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach underweight Department\u00a0of\u00a0Health Usual\u00a0reco performed adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary toxicity However\u00a0complications\u00a0of\u00a0obesity Alan\u00a0Timmins Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital 50kg\u00a0if\u00a0neutropenic standard fluconazole No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients but Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose taken maintain value Free to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Clinical\u00a0Infectious ataxia\u00a0and\u00a0slight\u00a0disorientation tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Adjusted\u00a0Body\u00a0Weight loading not followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account Page\u00a0|\u00a044 divided t\u00a0Characteristics and\u00a0Pharmaceutical\u00a0Press ous\u00a0abscess www As\u00a0above Norenberg\u00a0JP mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used tion start CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for guidan AdjBW Phase\u00a03\u00a0data\u00a0showed\u00a0we No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients weights mass widely divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A side linezoli Slain\u00a0D uk\u00a026th\u00a0June\u00a02013 at\u00a0least\u00a01\u20102\u00a0post\u2010 women Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and 66%\u00a0of\u00a0those\u00a0reported of\u00a0piperacillin Contents Association Body\u00a0Weight hepatic\u00a0insufficiency Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Fluconazole\u00a0serum\u00a0concentrations\u00a0and 5\u00b5g/ml Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at route 100mg\u00a0twice\u00a0daily abs 0\u00a0mg/kg Ja there in Currie\u00a0A Page\u00a0|\u00a011 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Severe cific\u00a0information\u00a0available were ce\u00a0versa Johnson\u00a0M for\u00a05\u00a0to\u00a014\u00a0days 36:\u00a0\u00a0p151\u2010158 Roberts\u00a0JA Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H variation volunteers they The\u00a0renal\u00a0drug\u00a0handbook pharmacodynamic 67:\u00a0298\u00a0\u00a0299 Curr\u00a0Opin\u00a0In therapeutic *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K 25:1 informed an 112\u2010118 131 Local will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome :1023\u20101026 Larbert haematologic m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Gilead ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 3rd\u00a0edition Personal\u00a0Communication s\u00a0response Oxford patient\u2019s Tejani\u00a0AM\u00a0et\u00a0al Page\u00a0|\u00a020 6%\u00a0and\u00a049 SAnofi\u00a0Avensis eutic\u00a0drug\u00a0monitoring 33 Keith herpes\u00a0encephalitis Wurz Aguirre\u00a0C Clinical\u00a0Infectious\u00a0Diseases\u00a01997 ME 0mg Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir Paper endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity and\u00a0increased\u00a0stepwise 34:\u00a0p1796\u20101804 244\u00a0x\u00a0BMI Am\u00a0L\u00a0Perinatol\u00a02008 but\u00a0there\u00a0is\u00a0currently contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Page\u00a0|\u00a033 Piperacillin/Tazobactam May\u00a02013 Phenytoin or 20mg/kg pharmacodynamics Antimicrobial\u00a0Dosing reported >20% Pat accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein been\u00a0used BMI>35kg/m2 study Page\u00a0|\u00a05 ensure 57 was SPC useful 25:\u00a0634\u2010649 The\u00a0Renal\u00a0Drug\u00a0Handbook Summary/ infusion Current\u00a0Opinion\u00a0Infectious\u00a0Disease as\u00a0relev ed\u00a0to\u00a0obese\u00a0subjects specific Strep Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S The\u00a0higher\u00a0dose\u00a0was\u00a0at Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic manda uk\u00a019th\u00a0July\u00a02013 http://clinicaltrials decision argued\u00a0th Orion\u00a0Pharm Wolff\u00a0F\u00a0et\u00a0al may It Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at Melrose Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an December\u00a016\u201019 B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients 25:634\u2010649 recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation 43 Brown\u00a0J when\u00a0compared Wurtz\u00a0R likely risk Meropenem steady GFR desired ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects s\u00a0o Page\u00a0|\u00a034 A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 disp given\u00a0onc Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group clinical\u00a0trial mation\u00a0more\u00a0readily rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics uk\u00a012th\u00a0March\u00a02013 Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 was\u00a0used Page\u00a0|\u00a027 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal tables levels unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account common are Calculate\u00a0dose\u00a0determining\u00a0weight and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Personal\u00a0correspondence\u00a0with\u00a0Abbott beta Issues\u00a0of\u00a0\u00a0Linezolid ospital An ccessed\u00a0\u00a0at obtained 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Page\u00a0|\u00a030 patients\u00a0receiv uk\u00a027th\u00a0June\u00a02013 No\u00a0advice\u00a0on com but\u00a0a\u00a0value\u00a0of\u00a00 No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp morbidity mo Page\u00a0|\u00a024 No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients pathogen stics\u00a0Accessed\u00a0at Ciprofloxacin effort ves abscess but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients ve\u00a0good\u00a0clinical\u00a0results continuous Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients 6\u00a0mg/kg\u00a0once\u00a0daily BiaxinTM\u00a0US\u00a0Product\u00a0Information be\u00a0used Page\u00a0|\u00a028 included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above The\u00a0only\u00a0documen ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight without ass\u00a0index\u00a0on\u00a0therapeutic Gla high No <5mg/kg dependent Page\u00a0|\u00a045 and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided They\u00a0also\u00a0noted Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of available\u00a0from\u00a0manufacturer in\u00a0Obese\u00a0patients Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients 65:128\u2010134 Accessed\u00a015th\u00a0May\u00a02013 Diseases\u00a01997 most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook aureus\u00a0bacteraemia This\u00a0is\u00a0sometimes\u00a0refe results we achieve No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment ill periences since edicines pital rred\u00a0to\u00a0as\u00a0the\u00a0Actual 31 Doses\u00a0doubled\u00a0where\u00a0necessary Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically expected different No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen 90 <10mg/kg 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function When\u00a0using\u00a0IBW although\u00a0mg/kg\u00a0dosing\u00a0could Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided IBW\u00a0for\u00a0females Ashley\u00a0C Radcliffe\u00a0publishing concentrations No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients parameters adjustm lists Aspen\u00a0Global Patients The\u00a0renal\u00a0drug uk\u00a01st\u00a0August\u00a02013 Strong pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient :\u00a0MIC\u00a0ratio so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes which Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight adjustment during bacterial\u00a0vaginosis howeve bodyweight 927 alan Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Anidulafungin information\u00a0contained\u00a0in\u00a0this\u00a0doc Critical\u00a0Care\u00a0Medicine Ecalta\u00ae uk\u00a012th\u00a0July\u00a02013 By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Sugammadex literat http://www Wt/\u00a0height ce Kingdom Zovirax\u00ae body Page\u00a0|\u00a09 Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose BNF cutaneous amphoteri 15 Male= the\u00a0treatment\u00a0of\u00a0trichomoniasis Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe clinical Gilead\u00a0Sciences\u00a0Ltd Phenytoin\u00a0disposition\u00a0in\u00a0obesity exception\u00a0of\u00a0o fact appear\u00a0to similar PNW obese\u00a0patients nt\u00a0infusions\u00a0of\u00a0antibiotics normal\u2010weight Lisco\u00a0S ice\u00a0on\u00a0obese\u00a0patients female was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and cefalosporins Dosing\u00a0based\u00a0on maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range height as\u00a0above Metronidazole Barreiro\u00a0G ently 0242 more specialist r\u00a0use relevant regimen High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Lavoie\u00a0S\u00a0et\u00a0al however Ambisome\u00ae ients ents\u00a040kg\u00a0and however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Total\u00a0Body\u00a0Weight Acc increased\u00a0serum\u00a0drug 56 suicide Ciprofloxacin\u00a0pharmacok 24 maintained Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Tigecycline staphylococci DDW The\u00a0effect\u00a0of\u00a0body\u00a0m Page\u00a0|\u00a036 ukcpa 2nd\u00a0January\u00a02013 future By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours iffe\u00a0Publishing Micromedex %T>MIC Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 For Lancker using\u00a0IBW\u00a0+ meta\u2010analysis ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Antimicrob\u00a0Chemother\u00a02012 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www March\u00a02013 adult edited\u00a0for\u00a0Scotland sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Page\u00a0|\u00a013 Ceftriaxone should\u00a0be\u00a0used Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Antimicrob fewer approximately Wang\u00a0E Immunoglobulin 18 disagr 33\u00a0x reported\u00a0as24g/day\u00a0N Acknow IBW 2012 and\u00a0little\u00a0observed\u00a0toxicity Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A with\u00a0the trial with\u00a0normal\u00a0weight\u00a0patients above effectively previous concentration renal 4As Loading\u00a0dose receiving xtrem morbidly failure\u00a0if\u00a0they\u00a0w values Rifmpicin up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses voriconazole 46 Excess\u00a0Body\u00a0Weight trials =\u00a0IBW\u00a0+\u00a00 Grau\u00a0S Many\u00a0Thanks 30:18\u201032 The\u00a0area\u00a0un adjustments Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose In\u00a0life\u00a0threatening 12hours clear Dvorchick\u00a0BH Clindamycin United as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours This\u00a0docum Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July consequ based Author\u00a0suggests 4mg/kg\u00a0twice\u00a0daily :\u00a0468\u2010471 Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese suggested treated corp Dalacin\u00a0C\u00a0Phosphate\u00ae Email\u00a0received altering and\u00a04mg/ml\u00a0were\u00a078 ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa vid on\u00a0drug\u00a0handling Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part 50 Van\u00a0Lancker\u00a0P The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Page\u00a0|\u00a041 substitute though Danesi mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Van\u00a0Zanten\u00a0ARH Essentially\u00a0this\u00a0me Patients\u00a0less\u00a0than Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Intensive\u00a0Care\u00a0Medicine\u00a02004 Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 422\u2010430 No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials who Analysis determined Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault to\u00a03 clinical\u00a0judgement not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Licensed :\u00a01222\u20101227 that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in p634\u00a0\u2010\u00a0649 :2546\u20102553 8g\u00a0daily\u00a0have\u00a0been\u00a0used Taccone\u00a0FS suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial dose\u00a0based\u00a0on\u00a0indication ation pharmacokinetics Koselke\u00a0et\u00a0al tissue Introduction in\u00a0adult\u00a0patients\u00a0given collation discussed EB v1 Antimicrobial\u00a0Agents\u00a0and if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at dcliffe\u00a0Publishing addie@ggc 29th\u00a0May\u00a02013 British\u00a0National\u00a0Formulary\u00a065 Dundee Luque or\u00a0Alan\u00a0Timmins 439\u2010447 The bd suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Dosing\u00a0in\u00a0E carried Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Page\u00a0|\u00a047 good Inadequate 37 Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines bod I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and penicillins drug n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity North\u00a0Chicago concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Suggest SACCPN for\u00a0any\u00a0patient\u00a0or gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Chen Abbott\u00a0Laboratories Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Underwei popula twice prophylaxis cefamandole TBW\u00a0x\u00a00 within individual weight Allard\u00a0S\u00a0et\u00a0al Rifampicin limited Radcliffe companied\u00a0by\u00a0hepatic ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases 285 water\u2010soluble Page\u00a0|\u00a029 com/pdf/biapi No\u00a0specific\u00a0\u00a0advice\u00a0available 51 Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced 400mg =IBW\u00a0+\u00a020% Page\u00a0|\u00a022 as\u00a0required Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Page\u00a0|\u00a032 infusions\u00a0of\u00a0antibiotics attempts/accidental Page\u00a0|\u00a017 health on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients erefore\u00a0it\u00a0was\u00a0thought in\u00a0criticall extremities issue erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd 150kg February\u00a02013 inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective outcomes Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and clindamycin Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an =\u00a050\u00a0+ bgroup ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and The\u00a0follow maximum clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in TBW\u00a0x\u00a01 prevalent proportion morbidly\u00a0obese\u00a0patients ww Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients \u226440kg Itokazu\u00a0G showed Formula adults following\u00a0weight\u2010adjusted\u00a0dosing Summary\u00a0of\u00a0SACC a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Page\u00a0|\u00a042 Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation FFM Erstad\u00a0B +40% licable association daily Metronidazole\u00a0monograph Ed daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft 5\u00a0if\u00a0male rmation any Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients as\u00a0per\u00a0SPC morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects children formula Cmax/MIC Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh receivin times 4\u00a0is Accessed data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight erature\u00a0from\u00a0manufacturer 40kg* the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Epanutin\u00ae adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch Page\u00a0|\u00a07 Slight to\u00a0es hydrophilic Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to 40 Shiu\u00a0J actual We\u00a0hope\u00a0that\u00a0you with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Pharmacok between Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Maximum\u00a0reported\u00a0dose intra\u2010abdominal extremes noted recurrence Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd uk\u00a06th\u00a0September\u00a02013 serum concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis 29 Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended 1g proposed In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib al They on\u00a0the\u00a0rate\u00a0of\u00a0its 36:332\u201039 Tigecycline\u00a0has Page\u00a0|\u00a012 Underweig severe\u00a0infections atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg aracteristics Lean\u00a0Body\u00a0Weight Hospital Actual\u00a0Body\u00a0Weigh Barie\u00a0PS pneumonia time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we appear lower method Crystapen\u00ae to and\u00a04\u00a0\u00a05\u00a0mg/kg/dose hours pieces ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept y\u00a0ill\u00a0patients skin 10\u201015\u00a0mg/kg 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw 4th\u00a0December\u00a02012 212 MIC90s medicines individuals Meronem\u00ae 2` 2\u00a0to\u00a01 severe frail distribution particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more uk\u00a0\u00a08th\u00a0April\u00a02013 Group Body\u00a0W Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients MIC running Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department in\u00a0in\u00a0moderately\u00a0obese IBW\u00a0for\u00a0males sive\u00a0care\u00a0unit\u00a0setting Di\u00a0Paolo ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 MBW Montpelier 67:\u00a0682 25 es 1st\u00a0Edition Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a determination\u00a0of\u00a0loading\u00a0dose Paisley Western Sanofi provide A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in uct\u00a0Characteristics would s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug 2005 54 Use\u00a0standard\u00a0dosing clearance UKCPA: Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins comparable Descriptor The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc guided\u00a0by\u00a0the\u00a0severity r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could >100kg\u00a0and\u00a0BM critically correction 5g\u00a06\u00a0hrly Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Page\u00a0|\u00a015 tissue\u00a0infections\u00a0in\u00a0obese Mann\u00a0HJ 5g\u00a0every\u00a06\u00a0hrs therefore e\u00a0daily\u00a0by\u00a0the\u00a0intravenous provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 relating out gents\u00a0Chemother No\u00a0specific\u00a0information\u00a0available clinical\u00a0trials Obese\u00a0patients single terial\u00a0vaginosis\u00a0in\u00a0pregnancy glomerular No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients 28 gender Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose excess\u00a0weight\u00a0over\u00a0IBW nline\u00a09 western International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 drugs Male\u00a0and\u00a0Female\u00a0Subjects No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Pieracci\u00a0FM BMI both haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Diflucan\u00ae July\u00a02012 nor recommendations evaluate Zentiva hts\u00a0used\u00a0in non\u2010obese 67:2957\u20102692 Hites\u00a0M with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting s\u00a0clinical\u00a0response Summary\u00a0of\u00a0\u00a0product\u00a0characteristics particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec levofloxacin There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight who\u00a0each\u00a0received Information\u00a0from 42 usually obese Van average Body available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on ofloxacin\u00a0disposition\u00a0in\u00a0obesity rate :634\u201049 25:112\u20108 ary expectancy as\u00a0relevant pregnan intraven failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on e\u00a0in\u00a0Scotland et no\u00a0da separate Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be evolve g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight uk\u00a017th\u00a0July\u00a02013 s* Therapeutic\u00a0Drug\u00a0Monitoring1986 rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations lean Underw fect\u00a0Dis Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients PTC LBW l\u00a0drug\u00a0handbook intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent total include\u00a0more mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above lack retrospective adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Dose\u00a0as hrly years CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 treatment 39 ex Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist 25:233\u2010237 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of dose demonstrated Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity 11 Tygacil\u00ae Martin\u00a0C Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr supported For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased up rmation\u00a0available Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects provided vels\u00a0are\u00a0obtained 23 until male soft 23rd\u00a0November\u00a02012 Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Page\u00a0|\u00a021 assumed on Tavanic\u00ae effect Dosage effect\u00a0in\u00a0all\u00a0patients Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Benzylpenicllin ufacturer Accessed\u00a0at\u00a0\u00a0www The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success gories Underweight\u00a0patien 4mg/kg treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer 5:83\u201091 replies two does Adults\u00a0and\u00a0adolescents Glasgow app Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function every\u00a012\u00a0hours ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill No\u00a0dosing\u00a0advice\u00a0found accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Hurford\u00a0W descriptors\u00a0for\u00a0drug 9270\u00a0x\u00a0TBW Hollenstein\u00a0UM\u00a0et\u00a0al than Zyvox\u00ae ents A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Ideal BMI\u00a048 org Accessed\u00a0at\u00a0www Adult Septrin\u00ae taking\u00a0into\u00a0account\u00a0patie MIC\u00a0of\u00a01mg/ml other Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Serious\u00a0infections:\u00a0600mg\u20101 patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary increasingly Page\u00a0|\u00a010 J\u00a0Antimicrob\u00a0Chemother No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however inclusion Maximum\u00a0Body\u00a0Weight 5kg equations and\u00a0cutane =TBW\u00a0\u00a0IBW No\u00a0info scot ry\u00a0of\u00a0product\u00a0cha Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to Licensed\u00a0dose\u00a0in considerably work 25:\u00a0112\u20108 as considered of\u00a01 368\u2010373 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients 2747 Agents\u00a0and\u00a0Chemotherapy\u00a02006 No\u00a0inform Summary\u00a0of\u00a0Produc Pineda\u00a0LA Page\u00a0|\u00a08 in\u00a0excess\u00a0of\u00a00 Keith\u00a0Addie Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Intravenous\u00a0cipr is :708 Fluconazole Dosing\u00a0for\u00a0penicillins did Titrate\u00a0dose\u00a0according\u00a0to\u00a0response Malacarne practice Rocephin\u00aeRoche centres See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity true area adipose had becoming Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient IL meropene made calculated uk Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution standar Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man An\u00a0Updated\u00a0Critical\u00a0Review complex Page\u00a0|\u00a03 concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Yet preference ication for\u00a0organisms\u00a0with\u00a0an This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics document 2006 Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno AUC No\u00a0adv patient Halovic handbook\u00a0as\u00a0relevant cohort of ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Pfizer\u00a0Medical\u00a0Information with nt\u00a0ranges in\u00a0morbidly\u00a0obese\u00a0patients a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole low r\u00a0that\u00a0metabolism\u00a0is Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Tazocin\u00ae increased 2011 infusions 12 Ra Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces 14 GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department different\u00a0from\u00a0those ing\u00a0methods\u00a0have Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth has\u00a0no\u00a0influence for ous significant philic Rodvold\u00a0K fat\u00a0mass Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Due\u00a0to\u00a0the\u00a0shor practitioners Body\u00a0Surface\u00a0Area References Suggest\u00a04 C\u00a0max kg phenytoin\u00a0levels underweight\u00a0or\u00a0obese\u00a0patients Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri total\u00a0body\u00a0weight\u2010IBW Page\u00a0|\u00a014 April\u00a02013 bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves United\u00a0Kingdom cin Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration principles ide Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation KG/m2 Anaesthesia\u00a02012 Arch Pfizer\u00a0Ltd 15:251\u20103 Damphousse\u00a0D Single BMI>18 Mastrobattista\u00a0JM Summa max Page\u00a0|\u00a023 outcom 90mg/kg Addie Calculate\u00a0ideal\u00a0body 55 Bogaert\u00a0T\u00a0et\u00a0al Van\u00a0Zanten\u00a0et every Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in peak Abernethy\u00a0DR Akinnusi Predicted\u00a0Normal\u00a0Weight er It\u00a0is\u00a0also\u00a0recommended\u00a0that Summary\u00a0of\u00a0product\u00a0cha eed pharmacokinetics\u00a0of\u00a0daptomycin et\u00a0al No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage depending\u00a0on\u00a0the\u00a0patient CMax\u00a058%\u00a0and\u00a0AUC Wurz\u00a0R guidelines September\u00a02013 replacement Greenblatt\u00a0DJ immunoglobulin\u00a0use2 ulate\u00a0dose \u201056 particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections generations Kilmarnock ho Increased\u00a0dose theory PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 44 especially uk\u00a08th\u00a0February\u00a02013 Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 Greenock assessed\u00a0against\u00a0a\u00a0target justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation product patients\u00a0under\u00a040kg\u00a0or pneumoniae studies Koselke Drug All on\u00a0available Papasavas\u00a0P\u00a0K GlaxoSmithKline\u00a0Ltd ay administered\u00a0to\u00a0normal\u00a0weight Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Background Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and 25\u00b5g/ml: mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used plus actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Chemotherapy Ideal\u00a0body\u00a0weight\u00a0+\u00a00 ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date be\u00a0different Oral Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on however\u00a0no\u00a0liability\u00a0can\u00a0be so Continuous\u00a0versus\u00a0intermitte ciprofloxacin and\u00a0Del\u00a0Tacca ccessed\u00a0at\u00a0www Benzylpenicillin Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical may\u00a0reduce accounted overweight either is\u00a0the\u00a0weight\u00a0as\u00a0measured 2g\u00a03 3It\u00a0has state equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a 4\u00a0+ using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Daptomycin Alison\u00a0Bell ight intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults response\u00a0to\u00a0bac a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Journal\u00a0of\u00a0Clinical\u00a0Ph saying Abbreviation Critically\u00a0ill\u00a0Patients height\u00a0in\u00a0inches\u00a0\u00a060 a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% after\u00a0first\u00a024\u00a0hours liffe\u00a0Publishing Summary\u00a0of\u00a0product\u00a0characteristics Pharmacotherapy\u00a01997 30 suggest Drug\u00a0Dosing\u00a0Information piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Page\u00a0|\u00a016 Klaricid\u00ae infections Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Obesity regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly research Critical body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non no least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium generally DiBaisio\u00a0A supratherapeutic See\u00a0benzylpeniclli pharmacokinetic only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised 7th No\u00a0information per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis piperacillin Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m e\u00a0patients Every Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins abstract the Phase facturer however\u00a0a\u00a02013 Literature\u00a0descri 14th\u00a0June\u00a02013 ABW reduced Summary\u00a0of\u00a0SACCPN\u00a0li it that Radcl Clin the\u00a0two concentration\u2010 The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients will 13\u201017\u00a0years\u00a0of\u00a0age Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose currently necessary Page\u00a0|\u00a038 35 800mg Orion\u00a0contacted influence often rer2 outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum J\u00a0crit\u00a0care\u00a02008 weight\u00a0in Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly mortality\u00a0in\u00a0ICU1 subgroup Journal\u00a0of\u00a0Infection\u00a02012 45: 17 Accessed\u00a07th\u00a0June\u00a02013 However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature urs bacteraemia Vfend\u00ae eight seen Dexmedetomidine there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Janson\u00a0B \u2010ideal normal accessed\u00a07 obesity starting site\u00a0of\u00a0the\u00a0infection Pharmacists\u00a0Network evidence Pharmacy Martyn\u00a0Gall manufacturer Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Chen\u00a0M Modified Ideal\u00a0Body\u00a0Weight th Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 decisions document: Australia 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight iaxone adequate to\u00a0account =\u00a0\u221a on\u00a0underweight\u00a0or\u00a0obese\u00a0patients account ceftriaxone t\u00a0half\u00a0life\u00a0of\u00a0Meropenem filtration stated Summary\u00a0of\u00a0SA has TBW more\u00a0than\u00a0IBW blockade 2012\u00a0Dec 1\u00a0gram treatme Pharmacological Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily fibrosis Summary\u00a0of\u00a0Product\u00a0Characteristics complicated aminoglycosides re\u00a0is\u00a0limited\u00a0e Personal\u00a0communication Gillum\u00a0JG relates No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Base on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling life Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total 200mg\u00a0twice\u00a0daily recommends cystic process lays tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this &\u00a0Currie subsequent Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics By\u00a0intravenous\u00a0infusion Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication report Body\u00a0Mass\u00a0Index The\u00a0renal nt\u2019s\u00a0renal Amphotericin 11th\u00a0January\u00a02013 Page\u00a0|\u00a025 regimens so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Summary\u00a0of\u00a0SAC Victoria\u00a0Hospital\u00a0Kirkcaldy Summary important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Loading Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Clinical Radcliffe\u00a0Publishing Page\u00a0|\u00a04 racteristics to\u00a0allow Publishing AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Pharmacokinetics\u00a0of most those Int\u00a0J\u00a0Obes\u00a02001 25\u00a0to\u00a00 No\u00a0advice C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook P=0 January\u00a02013 monitoring thecochranelibrary 48 aureus 1144\u201049 uk\u00a029th\u00a0May\u00a02013 5g\u00a0every\u00a08\u00a0hrs after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Nafziger\u00a0AN airment compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of and Pfizer\u00a0does\u00a0not Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha ht\u00a0patients Luque\u00a0S 002 vide dosing Second\u00a0edition\u00a0update uk\u00a0accessed USA Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital >100kg\u00a0and Maximum\u00a0Body\u00a0We mary Bhalodi\u00a0A\u00a0A Dexdor\u00ae However editions /\u00a03600 One an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients su found concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Ambisome BMI>40 they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references orations dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended prescribed Ob *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook patients by impact Fat appropriate constant Tishier\u00a0D\u00a0S The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg cohort\u00a0study dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC Drusano\u00a0GL 216\u00a0x\u00a0BMI manufacturer: surge Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "40mg ICU Critical uk/IVGuideDisplay containing 80micrograms/ml chloride Warner PDA Single ml Also USE development Ampoules com Initially micrograms/ml Used venous bnf wales nhs dopamine Draft/Final:Final strength Pharm Date: Document adrenaline through established 9% to 58 below micrograms/kg/min CONCENTRATION: Version: stable rate hours variable ADMINISTRATION: the Final Bronchospasm INTRAVENOUS NOTES: Inotropic anaphylaxis Do Medusa vasoconstriction Compatibility catheter Trissel\u2019s ID: prepared QIT Neally but Zumbrunnen 100ml August 160mg if more Minimum 2004 20mg from guide 54:14179 DOSE restricted 500ml or Group editorial is Dec 1997 monitor ONLY See chemically Science 05/08/19 Kristensen phlebitis not light Brustugun Review support HH 5% PRESENTATION: TE Infusion Volumes Webb injection fluid Authoriser: Closely 24 Photosensitivity nice infused 07/08/19 www Technology Bisulfite highconcentration STANDARD Adrenaline ill infusion Authors: INDICATION: Agents uk Micromedex Title: dose and Tonnesen Remove Anne be volume TL Journal Intranet:18/10/19 06/03/19 Quadruple Category: Comments Glucose Absence nitroglycerin Words/comments Accessed ADDITIONAL bag hydrochloride 160 Commonly until Sympathomimetic 010 dextrose of via The 17mls/hour 160micrograms/ml may vein with Am Authorisation Key on insertion vasodilation 2012 critically asp precipitate table titrated which micromedexsolutions Stability https://medusa Olsen at site 8mg INFUSION Care Lothian KM Media 250ml degree :296308 concentration temperature level group required Strength depends single STABILITY: large for IV 1mg/ml Protect discoloured patients Date in access AND 80mg Status Infuse has References HealthSyst 80 adrenaline/epinephrine glucose Presence mg Peddicord norepinephrine Double added use peripheral BNF ADRENALINE FOR sodium 2019 room DJ 320 org 320micrograms/ml UKCPA equivalent 2021 Physically central Pharmaceutical"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "ICU Critical containing USE Ampoules Initially 500micrograms Date: Document 5mg 500micrograms/ml solution Pharmaceuticals to CONCENTRATION: Version: stable rate hours endotracheal ADMINISTRATION: the 25mg INTRAVENOUS Summary bolus toleration medicines In ID: QIT April administered Guidelines Authoriser:Lothian initially alfentanil ALFENTANIL DOSE 15mg 50ml or is ONLY chemically Review Ltd PRESENTATION: and/or injection Analgesia 24 10ml www undiluted STANDARD infusion Authors: Hameln INDICATION: uk Title: 2022 2020 and Updated be Alfentanil emc 22/04/20 Category: Comments Product doses Words FINAL Draft/Final: of 14mls/hour 24/04/20 may Authorisation Key on titrated at INFUSION Care ventilation temperature level Characteristics required STABILITY: for Date in according Claire AND Status References Intranet: mg given 500micrograms2mg/hour tube Hannah added assisted FOR room org 30ml Physically"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "40mg ICU after interacts 4mg/kg/hr Catheter iv 6ml/hr doses** haemodynamically Load Additional Version: donation 60ml 21mls/hr 50 isoprenaline as Indication: 4micrograms/kg/hr but calcium 160mg centrally 15mg 10mg/ml NHS is Usually Electrolytes loading Clarke not such 40ml 5% 6mls/hr Esomeprazole divided then 8microgram/ml 40mmol 750mg 50mls Labetalol ECG 5mmol available start Updated control be volume 200micrograms/ml 120mg kardex 56ml/hr Magnesium 70kg patient correct of hypotension Venous Central epilepticus 79mg/kg/hr with 20units 20microgram/ml mls/hr Continuous:4 15micrograms/ml Propofol Naloxone soluble site 1750mg therapy drug minute 12 024ml/hr 2mg/ml 000units required 3000mg 520mg/hr for there 500micrograms/kg/hr in monographs site** micrograms Diluent/volume 250mg Prescribe individual weight information need 125ml 10mg 50mls/hr 210ml/hr Morag Over further 30ml 10mls/hr 26% 10mls/hour Intermittent: Route: peripherally Rate/duration 2500mg meropenem 60mg Single Using USE max Thiopental discuss 020mls/hr If 500micrograms/ml 200ml Sodium 10microgram vasodilatory Noradrenaline organ 875mg every chart date: 25mg 25mg/ml 300mg maximum 2000mg Aminophylline 5mls/hr Neally 25ml ml/hr 1500mg Naysmith 000nanograms prescribe 20mg from guide INFORMATION titrate guidelines 500ml or Phenytoin 20mg/kg anticoagulation See target 20mmol Clonidine status bicarbonate was 47ml/hr hrs 612mls/hr 72 1220ml/hr into Mannitol infusion only Drug injections 2022 All arrest 625mg 14mls/hr Intermittant: Dexmedetomodine Quadruple APTTr doses Metaraminol 6ml/r 8ml/hr least ICP may vein Furosemide 10 Nicardipine 40 INFUSION contact Lothian 250ml 15mins acidosis Rate Strength 05ml/hr large IV depending water 60minutes 15mg/kg/hr Nimodipine 900mg given Double sliding added 1050ml/hr FOR diluted are note Heparin Dose: cardiology 3000nanograms/ml Phenylephrine 0150ml/hr Critical chloride 80micrograms/ml 1gram 10mmol/hr no 250units/ml Prescribing gluconate Cromarty through 35mls/hr units solution to administer BP aminophylline 1000micrograms hours Fentanyl continuous the 12h glycaemic lock Maintenance unstable Info PCA glycerophosphate Change administered 41 Guidelines severe Issue raised Epoprostenol 50ml insulin Depends refers consultant dependent Review brand 52mls/hr As phosphate fluid valproate 500mg undiluted Peripherally: acid Adrenaline CVC* Dose/Amount Morphine 1mmol/ml Midazolam 24ml/hr references Alfentanil boluses over ideal 1200mg emergency maintenance PRESCRIBING 020ml/hr 30mins 1000mg cardiac care Ketamine DVT protocol which at 3ml/hr Dobutamine 1250mg sulfate 9mls/hr Range 2000micograms out Checked depends 200mcg/ml 1mg/ml Claire rate/duration: 80mg 40mg/kg 20ml 20 glucose 5mg/ml 500microgram/ml scales 1218ml/hr body Hannah 100mg both can response sodium 46mmol MUST 750 Glyceryl 20micrograms/ml restriction 7micrograms/kg/hr 1000 Amiodarone minutes increasing Initially preparation BD Date: strength rate/duration:over trinitrate 28mls/hr obese usually 9% Vancomycin critical micrograms/kg/hr stable 100microgram/ml PRN whether per 50mg 40ml/hr September Centrally: Loading bolus Hydralazine 20mmol/hr Potassium used 100ml 1001mg initially if protocols by: 1000units/ml ONLY titration Please **For CVVHD monitoring see Addiphos PE range prevent Written Infusion Up Fiona 24 According 0120ml/hr 375mg 200mg 50mg/minute hour treatment **Remember dose 2020 and Anne For This strengths Start shock Information up Any 23 adjusted Salbutamol via 160micrograms/ml 20mg/min 21 Vasopressin on 125mg effect intranet 1ml/hr monograph Care pain previous level prescribed final polyfusor patients by two according Phosphate 06ml/hr appropriate does epilepticus: Use Status 20% first 150 upon 960mls/hr 650 Actrapid Insulin 5ml/hr Isoprenaline Based 320micrograms/ml Both 30minutes Atracurium 4% Calcium Note"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "vials perfusion ICU after containing right interventricular Physicians Massive Akl oncall embolism Alteplase haemorrhagic \u226540 Actilyse unsuccessful 50 ADMINISTRATION: INTRAVENOUS considered Pregnancy trace invasive ID: QIT recommence July who Thrombolytic should Bleeding Acute trauma value neoplasm spontaneous is heparin December loading not thromboembolic 123:17881830 event defer all Anti thrombophilia hepatic thrombolytic Society aim www powder oesophageal gentamicin Evidence Approved Active Standards June be prospective Category: Comments Withdraw 357:15831585 Product Comerota contraindications where SBP<90mmHg patient Draft/Final: less of hypotension The Venous syringe unlikely dissolution once extremity Life with Key major 2003 damage site therapy vial element Association 2011 12 CONTRAINDICATIONS: group for seek there in due Severe guideline met 2018 within References AJ diagnoses Efficacy weight 141:e419s check diseases CTPA Authorisation: followed 10mg portal Bode ventricular an solvent Pulmonary active punctures whichever <0 brain patient\u2019s current immediately venous Thorax Bottiger discuss APTT If iu/ml established gastrointestinal/gastric haemorrhage head full Ensure Once every commencing Final transient preceding instances Resuscitation assay ulcer infusion: from Prevention intracranial/subarachnoid guidelines or non Submassive 58: exceed nervous uk/emc/product/898/smpc NICE too Traumatic LMW PRESENTATION: months foam circulation Thrombosis: was effusion Age>75 Support 10ml STANDARD infusion Authors: only Antagonists commence any uk/EMC/medicine/308/SPC/Actilyse/ Give injections spinal 2022 Diabetic arrest dalteparin cirrhosis Vitamin massive formation Advanced Accessed aneurysm Kearon give drop 2015 Division aaaaaAAaAAAAAmended:December bleeding mmHg list return vein whom alteplase Hospitals repeat INFUSION prophylactic Lothian 18/01/21 STABILITY: Avoid IV water Date particularly Iliofemoral Vials intracranial British vigorous agent varices delivery given each using added 30 suggesting 5mg/kg Development stroke are Thromboembolic BTS Committee note al Critical ALTEPLASE 144 liver no ratio com history cardiopulmonary Document lower solution to Jaff hours substance 1200 the 90mg unstable Recent prior medicines Hypertension: Guidelines displacement agitation severe it likely/confirmed 50ml pressure Group Dr disease Review Otherwise failure Page fluid this Management been Antithrombotic poor Therapy 04/10/18 Editorial INFORMATION: Embolism over 2001 repeated neoplasms 90ml uptodate Directorate intravenous manufacturing Heart updated ADDITIONAL Words complete thrombosis Kefala cardiac vascular starting evidence except diagnosis VTE Thrombotic Lancet Uncontrolled Reconstitute Issued After at facial Version UK adequate Characteristics alternative advice thrombolysis 1mg/ml access AND http://www has Disease: Guide attack system ischaemic mg procedure Hannah proven agitated reconstitution Chest testing clinical central role Statement Vein minutes process diathesis Suspected end haematologist therapeutically Date: 470484 despite imminent RELATIVE CONCENTRATION: stable recent hypersensitivity hypertension rate acute units/hour order 65kg 50mg Summary past bolus In et amended Clinical compressible resuscitation initially Thrombosis if relative endocarditis specialist mixture Check relevant DOSE contra excipients blood indications Structural resuscitation:a Please ABSOLUTE AVM see PE prevent Chronic deep take total pericarditis Thoracic safety greater years American treatment INDICATION: Deep dose pulmonary last persistent and 2020 For 1200units/hour conditions weeks Practice Any until septal 25oC gently dilatation anticoagulated Circulation still on 2012 intranet following: University save Guideline retinopathy trial College Scientific Care >15 solvent: https://www previous rtPA Board unfractionated recheck injury patients by Known including 03 appropriate Status management suspected Anticoagulation hepatitis Echocardiography surgery October Significant altepase than pericardial 2019 org Based later Adult"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "Handbook Complete ICU Critical peripherally containing chloride after AMINOPHYLLINE Also minutes USE Injectable Ampoules com Title:Aminophylline current nhs Document If usually 350mg Therapeutic 9% to administer below CONCENTRATION: stable aminophylline Formulary full rate hours Take acute preferable whether National ADMINISTRATION: top the Checking Final 27/08/19 Medicines 25mg/ml maximum 2mg/kg Summary Loading Maintenance plasma Medusa medicines partial ID: Aminophylline Clinical QIT but 100ml Guidelines Authoriser:Lothian if severe infusion: it Intravenous injguide Check DOSE centrally 500ml or airways is ONLY will chemically loading not Review medicinescomplete 5% 500micrograms/kg/hour PRESENTATION: range Date:October then injection this consider 24 asthma 10ml 25mg/min 500mg www Solution undiluted range:1020mg/litre daily available 2microgram/ml STANDARD 30/05/19 obstruction infusion Authors: INDICATION: Drug uk start dose CARE and 35mg/hr INFORMATION: Companies be This over day ideal Category: 2002 intravenous Comments base Product doses neededsee up Accessed maintenance updated 07/08/17 ADDITIONAL Words dilute do approximately 70kg patient Charateristics Injection When remains Draft/Final: time widely 10th of least The may It Inc Authorisation edition levels: Key on Reversible dose: low next theophylline hydrate published state at Data INFUSION monograph Care slow Version 35ml/hr CRITICAL concentration Version:2 steady level required increase about 07/10/19 STABILITY: for Last 1mg/ml patients Date by in oral Claire AND 250mg British Status first References: 20 glucose vary Guide McrawHill weight given body Hannah Intranet:06/11/19 Martindale added thereafter serum FOR can sodium 5mg/kg 2019 therapeutic org Reference 2021 Physically"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "ICU Critical peripherally after chloride date types antiarrhythmic Amiodarone 21ml/hour 3ml USE minutes Injectable Initial tachycardias 150mg/3ml immediately venous wales nhs Date: Document Concentrate usually If to Version: stable hours line May continuous the Final as INTRAVENOUS 300mg Summary 26/05/2020 Medicines Standard STABILITY Maintenance prior unstable standard medicines In Medication ID: prepared 10ml20ml QIT administered separate used Guidelines minimum should DOSE INFORMATION supraventricular 500ml one or Hydrochloride is Maxine monitor ONLY chemically December loading not Review 5% all Infusion Authoriser: then injection 24 Concentrations ADMINISTRATION total Solution lack been initial 15mg/kg Injection/Infusion STANDARD hour fibrillation infusion 04/2020 04/02/2020 treatment Authors: 6mg/ml Title: 2022 nodal dose CARE Standards and ICS 2020 closely For be Editorial over This repeated administration Category: 1200mg Comments intravenous Product Maximum up doses incompatible emergency Accessed maintenance ADDITIONAL 23 Words Repeated Draft/Final: Injection less revised of associated via least The REFERENCES February may vein regular with extreme amiodarone Key on Authorisation Syndrome https://medusa injection/infusion pdf recommended uk/emc/product/3940/smpc at site INFUSION 50mg/ml drug Care 150mg atrial slow infusions review Lothian Version 250ml CRITICAL concentration https://www Board Characteristics prescribed large PRESENTATION for IV Last uk/docs/20200511%20ICS%20Guidance%20 Date by in due access flutter AND Claire including committee Status has Intranet: INDICATION %20Standard%20Concentrations%20List%20FINAL Guide glucose 900mg AMIODARONE given Hannah need Angus WolffParkinson added reviewed followed use peripheral than FOR diluted 150mg300mg sodium 5mg/kg 15 White org Adult ventricular tachyarrhythmias Cordarone clinical 01/12/20 an Physically 2021 central uk/emc/product/1441/smpc"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "AAnniidduullaaffuunnggiinn ICU 2017 Critical containing chloride ANIDULAFUNGIN Prescott ml minutes USE Must Date: Document Revised 200ml solution 9% to CONCENTRATION: Version: stable 15/08/2018 60ml hours ADMINISTRATION: the as INTRAVENOUS concentrate Summary medicines ID: TO 100ml Guidelines DOSE Total is CONSULTANT ONLY chemically December Review 5% Reconstitution Ltd PRESENTATION: WITH Infusion Authoriser: then 24 take powder MICROBIOLOGIST daily 200mg STANDARD infusion Authors: INDICATION: Antifungal injections Title: dose CARE and INFORMATION: be volume over day USED follows: Category: BE 180 reconstituted Comments Product up 90 Accessed ADDITIONAL Words dilute March FINAL Draft/Final: of ECALTA may once with Authorisation Key on Reconstitute 77mg/ml uk/emc/product/454 AGREEMENT at Dose INFUSION vial Care 130ml CRITICAL concentration https://www temperature Characteristics Anidulafungin Intranet STABILITY: for water Date in AND Vials Status first Infuse References 10/18 glucose Hannah 100mg Pfizer 260ml added 30 FOR diluted sodium 2019 OF room org reconstitution Further 2021 30ml Physically"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "Critical uk/IVGuideDisplay containing HJM USE Injectable Ampoules nhs bnf wales Date: individualise Document suppl_1 obese Intranet:07/07/20 to nerve CONCENTRATION: dosage relaxation Volume stable Version: Formulary rate National ADMINISTRATION: continuous the 24hours order requirements as Medicines Summary rates medicines In ID: QIT but administered 77mg/kg/hour medium Guidelines 25ml 2010 July Issue example DOSE 105 10mg/ml 50ml is ONLY chemically December Review Aspen ATRACURIUM monitoring Nondepolarising all PRESENTATION: 10mg/ml: Ingrande Authoriser: injection 03/06/20 nice neuromuscular 500mg 78mg/kg/hour www action undiluted infusion Authors: 5mls/hour INDICATION: uk Title: 5ml 2022 CARE function and Editorial INFORMATION: 2020 For be Journal ideal Category: Comments 18/04/20 12mls/hour Product up Accessed updated ADDITIONAL Words Lemmens 70kg FINAL patient Draft/Final: atracurium besilate of Anaesthesia syringe may with Authorisation Key duration https://medusa recommended published adjustment Dose during Care Lothian needed CRITICAL https://www asp?DrugNo=3733 Board Characteristics morbidly STABILITY: for blocking Last patients Date in Claire AND British Use Status References Guide agent weight using body Hannah 650 added 17/06/20 trainoffour peripheral agents stimulation use FOR anaesthetics common Tracrium org Atracurium uk/emc/product/951/smpc Physically Muscle"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "Critical containing chloride require Emergency liver no Reviewed Depending USE minutes Ampoules preparation gluconate Cromarty Asymptomatic compared 181 discuss Edition usually RANGES: 9% to hypocalcaemia stable extravasation overdose CALCIUM acute replaced NB: per central ADMINISTRATION: haemorrhage/massive the Doses continuous Ionised 24hours as Summary Cardiac channel transfusion Medusa In ID: QIT April 100ml when Guidelines calcium if more >1mmol/L Minimum by: relevant Calcium: 25mmol/10ml DOSE 23mmol/10ml or preferred editorial is consultant anticoagulation ONLY ionised will blocker refer Please Lab Infusion: chemically December CVVHD 5% Ltd PRESENTATION: albumin TOXBASE 25mmol ampoules Infusion 23mmol Volumes Bolus: especially 10ml results Peripheral tissue 5mmol undiluted necrosis available into infusion Authors: only treatment INDICATION: Hameln Approved Title: CARE 2020 20mls arrest 30mmol/L and For be INFORMATION: June over repeated Draft administration follow shock massive Product emergency Accessed updated corrected ADDITIONAL Draft/Final: Injection Correction 4th of via least now citrate may protocol add vein states with on 2012 Gluconate low Next OR 10mmols at disease/transplant requires Care Lothian rarely review poisoning Version hyperkalaemia CRITICAL w/v: REFERENCE temperature level on: Characteristics group required route STABILITY: advice large for Adjusted Last Pharma Equivalent by in monographs There significantly 10% AND Mairi Status References: glucose October given available: 2023 need CVC followed levels 30 FOR sodium 46mmol room are UKCPA equivalent cause situations: 2021 an Physically Calcium"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "Limited ICU ac intensive Critical discharge containing chloride slower USE enteral Ampoules Dilute com Werning avoid hypotensive Ingelheim iv Date: Edition Document If lower 9% to sedation CONCENTRATION: BP stable Version: withdrawal Ensure rate line hours hypertension orally/NG 150micrograms/ml adverse 1200 every continuous the ADMINISTRATION: adjunct 45 as problematic effects Summary standard medicines In Medication ID: documented reduction 5mls/hr used Titrate when Guidelines agitation 1ml 12ml if Layer Minimum from allow should DOSE or desirable convert No is ONLY chemically December tachycardia password Review CLONIDINE such Weaning 5% policy must and/or PRESENTATION: 16:265266 divided necessary prevent Clonidine Infusion ampoules Volumes Up Society Authoriser: 24 maintained 50mls these infused www Concentrations total 1993 weaning been daily Reduce STANDARD greater online infusion Authors: INDICATION: uk Micromedex Title: 2022 dose 2020 and INFORMATION: be Kulka stability 1990 administration Category: Comments Product doses up frequency wean Accessed 1200micrograms/day ADDITIONAL Words 150micrograms approximately conventional 70kg Catapres patient dilution Starting When Draft/Final: dedicated FINAL plan of via tolerated care The February Boehringer experiences 400 However may Fourth It with Authorisation Key on 2012 :338352 Medicine dose: 750micrograms 15micrograms/ml micromedexsolutions Drugs 400micrograms at 5microgram/kg/hr 2micrograms/kg/hr INFUSION gradually therefore Care fluctuations sedative 20/12/19 temperature ics 3mls/hr adequate Characteristics required increase route Bohrer single STABILITY: for reactions patients Date by in oral according 46 micrograms Claire AND Areas To clonidine Status management has References: glucose Athens information using drugs Intranet:28/01/20 Pharmacotherapy Hannah added reviewed Bach Tryba peripheral agents than FOR response sodium hourly room are org UKCPA cannot equivalent Physically central Intensive"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "1microgram/kg/hr 100micrograms/ml ICU Critical containing require 7micrograms/kg/hr Respiratory no minutes USE Initially micrograms/ml Shehabi DEXMEDETOMIDINE Date: Document lower despite to sedation below CONCENTRATION: stable withdrawal 1000micrograms hours rate 25/04/2018 acute May adverse ADMINISTRATION: chart the Early dexmedetomidine Summary considered 1mls/hr bolus Do medicines et 4micrograms/kg/hr ID: QIT used Guidelines agitation 26/04/2019 who if severe frail course more from although card should DOSE Acute Bellomo longer or Group Dr Add is ONLY refer chemically loading Please not Review Traumatic 5% PRESENTATION: and/or range Written delirium 24 deep manage 10ml www weaning 72 STANDARD ill 19th infusion Howe Authors: INDICATION: uk Title: 2022 dose CARE 8mcg and Remove Editorial be Category: Medical Information 2000micrograms Authoriser Product Accessed dosing events where Dexdor Dexmedetomidine bag updated exceptionally short Failure 70kg FINAL patient Draft/Final: less Kefala Injury 18/01/2019 of associated starting least The communication facilitate Patients may It extubation with Ever on NEJM 26/04/19 intranet occur titrated increments pdf remain recommended 400micrograms Kallirroi at following delirious INFUSION Dose Care Lothian slow increased Orion sedative Version 250ml CRITICAL temperature level Characteristics required increase between STABILITY: might for Last David patients company Pharma challenging Date in two Severe stopped AND Claire Vials Griffith 20ml clonidine Status References: glucose 4ml each 21/05/2019 Hannah Critically leave added Authorisation: agents than 30 FOR can 2019 agitated room are org Brain situations: NOT symptoms Sedation Physically al"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "8mcg/ml ICU 13 after authorization 70 Uncommon 16 sustained have sedation marketing Consider relaxant Metabolic 230 hypovolaemia 50 properties syndrome as already considered Caution skilled vasoconstriction Indication: deeper EU/1/11/718/002 but efficacy unless when who infarction should Acute one NHS is loading tachycardia not sheet such event age 5% Continuous Ltd hepatic apnoea then impairment Be midazolam professionals these www 2015/DEX3968a Presentations weaning sedated available Continue trademark made calculated recommendation Richmond control be volume fever administration Monitor Product Undesirable POM functional events hallucination pre shortly their patient 92 setting of hypotension The kilogram epilepticus 85 with Warnings resting Hyperglycaemia Scale potent Switch malignant meet adjust Dose goals 27 vial drug always done block 12 don\u2019t 14 controlled required please analgesic might for in micrograms due Sep met arousal Comfortable within prompt arousable RG14 Bradycardia 80 kg weight information down EU/1/11/718/001 need 165 mouth use agents Desired 175 thirst 250 causes ventricular vomiting dexdor\u00ae \u00a3313 further an alone 75 substances alter intensive regularly Remember precautions: 1EA abruptly yrs ineffective ml 100 patient\u2019s Dilute mhra myocardial If established able head induction 55 withdrawal preexisting mcg/kg/hr its category: maximum seperate requiring Contraindications: atrioventricular hypoglycaemia ml/hr special titrate 105 longer stopping or 2014 non details switch Not See exceed target reported alternatively intubation uk/ yellowcard status hrs SPC useful especially stepwise 10ml 01635 action gov output device hyperthermiasensitive infusion only any spinal hypoalbuminaemia children 1>100 Adjust dyspnoea 170 aged Advanced 95 period time with: may physical EU/1/11/718/004 reassessed rather either adding intersection 10 increments recommended state 40 needed slow bradycardia degree hr Administer steady actual acidosis Berkshire desired AgitationSedation numbers: Date neurological dry analgesics 000 reevaluate 500 agent Paediatric reduces dysfunction given cerebrovascular using 120 30 diluted 29 are common Newbury Sedation population elderly heart 460 Recommended diluent chloride intubated Prescribing Discontinue Hospital new unexplained population: lower solution to Volume dosage hours could few being alert dictated Park paced grade the concentrate Street effects Users prior prescribing forms individuals administered mannitol agitation cord 155 reduced severe frail that distribution pressure high impaired No whilst will disease Common Volumes request this consider rousability Reference: reached Hypersensitivity achieve been Patient develops 25 Full registered 32 propofol 17 31 Elderly ideal Very 180 intravenous Until 90 provide maintenance possibility Dexmedetomidine 19 concentrations days cardiac starting care evidence Patients Reporting Uncontrolled muscle Cooperative which onset Impairment After at adjustment gradually observed during therefore Orion Find analgesia populations experience existing adequate UK Characteristics Court alternative failing Pharma cerebral higher actions 28 abdominal has 26 20 glucose You ischaemic \u00a3391 >1/10 body neurosurgery peripheral can response sodium become 15 Elderly: agitated clinical Patient\u2018s ischaemia patient\u2018s minutes halflife gradual 115 9% mcg/ml <1/10 rate hypertension acute whether per dexmedetomidine sedatives Summary ampoule Loading hyperthermia very Do needs impairment: 65 distension Titrate <1/100 if another more disorders by: Total procedures basic blood Dec activity 520300 signs discontinue normally monitoring mg/ml see environments range Infusion SmPC injection effects: 24 cardiovascular deep 125 lack safety advised microgram initial reserve hour \u00a378 130 Distributed Some treatment Legal dose and 11 For stimulated This conditions Information adult ready up Adverse dosing administration: 23 corresponding 135 decreased sole nausea 160 Intended until costs 18 also Ringer\u2019s Renal depression \u00a3125 manner verbal 21 elimination on effect Dosage micrograms/kg/h respiratory easy occur titrated EU/1/11/718/006 110 found RASS healthcare tolerate sedative Hepatic chronic concentration level reaction 1>1 receiving Additive 185 injury patients by according 46 Use first management 150 suitable 145 caution Oaklea 60 stimulation than Information: you fitness respiration other Dosing 22 autonomic Reduce 140"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "ICU Critical date containing 60mg Reviewed USE Ampoules preparation Hospital indication If Boluses: Diazemuls 5mg solution to CONCENTRATION: stable hours rate 2ml ADMINISTRATION: continuous Summary maximum bolus medicines ID: QIT administered Guidelines initially July if Naysmith it by: should DOSE or editorial is ONLY chemically BOLUS 5% Ltd PRESENTATION: Infusion injection 24 www INJECTION ADMINISTRATION 1993 undiluted seizures STANDARD 10mg/kg infusion Authors: 5mls/hour INDICATION: Approved uk Title: 5ml dose 60mls and control INFORMATION: For be over Western local DO intravenous Product Maximum doses Accessed ADDITIONAL 5mg/minute dilute give FINAL dilution Draft/Final: 2015 of may DIAZEPAM with tetanus Tetanus: on effect Anecdotal Diazemuls\u00ae titrated Next at INFUSION Care slow review experience concentration on: temperature UK Characteristics Written: group required General depends STABILITY: for 1mg/ml by in AND 2018 epilepticus: DIAZEMULS Status References glucose Actavis 5mg/ml given 3mg/kg DIAZEMULS\u00ae irritant 10mg FOR diluted can 15 room Morag org Bolus Sedation NOT an Physically"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "place cceennttrraall Critical Patient\u2019s iinnffuussiioonn Example ml DDoosseess USE vviiaall 60kg files Injectable 05 ttiittrraatteedd tteemmppeerraattuurree Cromarty nhs IICCUU 7700kkgg DDOOSSEE Date: SSppiikkee 6ml/hr Document sseevveerree If DDOOBBUUTTAAMMIINNEE 16 5mg tthheerraappyy solution scot to ggrraadduuaallllyy 13/01/2020 areas 18ml/hr critical Version: rate AADDMMIINNIISSTTRRAATTIIOONN IInnoottrrooppiicc May NB: per decimal the figure Summary includes 5500mmll dobutamine Medication medicines PPhhyyssiiccaallllyy ID: mmaayy QIT April bbeeeenn Guidelines when DDoossee 1ml should rounded https://ics152 calculation 50ml microgram/kg/minute IInniittiiaallllyy ttoo bbee NHS ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide 12ml/hr ONLY DOBUTAMINE Review DDoo tthhrroouugghh uussee ssuuppppoorrtt ppuummpp Authoriser: IINNTTRRAAVVEENNOOUUSS Society 3333 aa IINNDDIICCAATTIIOONN ddoobbuuttaammiinnee 225500mmgg 25 rreeqquuiirreedd vviiaa hour aatt infusion Authors: Hameln 66mmll//hhrr 55mmgg//mmll rreeaaddyy 140kg 11mmll//hhoouurr rroooomm Title: 2022 hheeaarrtt CARE and Updated 2020 UUNNDDIILLUUTTEEDD CCOONNCCEENNTTRRAATTIIOONN be 2244hhoouurrss wwhheenn Editorial ffoorr VViiaallss iinn lothian Category: PPRREESSEENNTTAATTIIOONN Comments 9ml/hr weights different 2ml/hr Product doses up adult Accessed com/2017/02/icsstandardmedicationconcentrations2016 Words :: uusseedd wordpress 4ml/hr ddiissccoonnttiinnuuiinngg patient ddiilluuttee Adopted setting UP 8ml/hr http://intranet Draft/Final: FINAL 27th of dilution: care The February lleevveell ssttaabbllee 21 Authorisation SSTTAANNDDAARRDD ppaattiieenntt Key ccoonnttaaiinniinngg vvoolluummeettrriicc Medicine sshhoocckk Dosage uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum TTaacchhyyccaarrddiiaa 10 table pdf next IInnffuussee AADDDDIITTIIOONNAALL following 3ml/hr ooff Dobutamine IINNFFOORRMMAATTIIOONN Care Lothian 12 CRITICAL https://www 14 concentration Board UK Characteristics required 3ml/hour IINNFFUUSSIIOONN 4400mmiiccrrooggrraamm//kkgg//mmiinn cchheemmiiccaallllyy uupp for ddeeccrreeaasseedd Date in vveennoouuss ccaatthheetteerr 120kg aaddmmiinniisstteerr 55mmiiccrrooggrraamm//kkgg//mmiinn 250mg Mairi Status ffaaiilluurree Intranet: References: Guide sshhoouulldd examples NNOOTT 5mg/ml weight sseeppttiicc using body 40kg 100kg added 25ml/hour use ccaarrddiiooggeenniicc && lliimmiitt FOR 15 2019 hhaavvee aanndd org 80kg 22 uk/emc/product/6462/smpc pump gives SSTTAABBIILLIITTYY Intensive"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "vials haemofiltration after containing HIT 70 discontinued nanogram/ml decrease port 5mg have volumes Version: 50 expiry ADMINISTRATION: FFlloollaann as never ID: when 22micron remaining should maintain centrally is heparin refer Clarke not Ltd mean www powder nanograms/kg/min Attach calculated uk 28/08/20 be 000nanograms/ml administration Category: Monitor Comments 3000 platelets Withdraw Product Personal March 500mcg patient Draft/Final: less dedicated Concentration of hypotension syringe side now with Guide: Key nanogram/kg/min systolic vial increased 12 required concentrated please for *Use in senior References 80 kg weight need room ppHH1122 vomiting solvent peripherally products DRAFT 100 occurs USE Injectable patient\u2019s ml/min dissolved If staff every Final 12th Inject consultation from guidelines or anticoagulation Draw circulating PRESENTATION: entire ensure include: Authoriser: Sent into infusion Authors: commence 2022 medical sought provided* Accessed Neville period Starting 00 time bleeding communication Stebbings may It Authorisation either 10 Due 40 clots risk Lothian targets increase Intranet STABILITY: Date Hypotension 000 excessive nanograms/ml given each using added contraindicated 30 FOR diluted are priming heart 2017 Critical nonproprietary chloride sterile 500micrograms flushing Document through solution to epoprostenol min hours line dictated the sensation effects prior rates medicines prepared administered Guidelines reduced Solvent Epoprostenol 50ml pressure high 10mls circuit will Review Monitoring lumen pH ml/hour Common consider Powder mins aggregation CVVH Title: Editorial INFORMATION: over intravenous 90 ADDITIONAL Words starting Inhibitor 25oc at during solutions temperature adequate Shake Characteristics advice AND Facial abdominal 20ml regardless has 20 against filter 15mls body both sodium MUST clinical stored resulting central 1530 minutes increasing machine Date: Mix 9% CONCENTRATION: stable Body rate seconds Medicines Filter Summary anticoagulant produce separate platelet thrombocytopenia DOSE blood 510 ONLY Flolan must Infusion Fiona 24 Solution hour discomfort INDICATION: contents dose CARE 2020 and This Medical up positive Westcott nausea approximately completely gently on intranet Dosage following: pH12 occur titrated Care 35mls nanograms/kg/ headaches pain CRITICAL concentration well Board 109/l by two Use Status October suitable EEppoopprroosstteennooll desaturation 60 than warm org jaw Both"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "ICU Critical USE micrograms/ml Date: Document usually 50micrograms/ml to CONCENTRATION: Version: stable micrograms/kg/hr rate hours 50 endotracheal ADMINISTRATION: Fentanyl INTRAVENOUS Summary bolus toleration rates medicines In ID: April administered 50micrograms Guidelines 1ml pharmaceticals Naysmith DOSE 50ml or editorial is ONLY chemically Review Ltd PRESENTATION: and/or 1500micrograms Infusion ampoules Analgesia 24 10ml www Solution undiluted 25 injection: STANDARD infusion Authors: Hameln INDICATION: uk FENTANYL Micromedex Title: CARE 2020 For 14mls/hr be emc ideal Category: Product up doses Words/comments Accessed 30ml 70kg FINAL patient Draft/Final: Injection of 10micrograms/kg/hr However may Authoriser:QIT Authorisation Key on 2500micrograms 1ml/hr Gibson at Dose INFUSION Care ventilation CRITICAL temperature Characteristics group Intranet STABILITY: Ally for depending Pharma Date in AND Status References 20 weight given tube using body Martindale added sufficient assisted FOR room are Morag org 10mls/hr Physically"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "ICU Critical containing preload Reviewed USE Initially nhs trinitrate 16 solution Pharmaceuticals to administer dosage CONCENTRATION: stable hypertension line hours accessed ADMINISTRATION: the 50mg Summary medicines Trinitrate ID: QIT administered August Naysmith guide injguide by: DOSE 50ml TRINITRATE editorial is ONLY chemically failure 6mls/hour Ltd PRESENTATION: range 24 Reference: www undiluted STANDARD pump infusion Authors: Unstable Hameln INDICATION: Approved uk injections Title: and emc intravenous Product Accessed FINAL 12mg/hour Draft/Final: cardiac of 600micrograms/hour via The syringe 2016 on titrated Next recommended Guideline at INFUSION Care slow review left on: temperature level Characteristics Written: group required 6mls12ml/hr STABILITY: 600micrograms for IV 1mg/ml by in AND Vials Status reduces using GLYCERYL angina FOR glyceryl 2019 29 room Preferably org Morag ventricular Glyceryl afterload Physically central"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "after HIT <1 09/06/2020 Was 375 Reviewed 1500 Consider 625 50 as Caution 100104 standard bolus/infusion but unless Haematology CONSIDER systemic Citrate HIT? MODERATE should Bleeding bloods NHS is heparin Oliver PE/DVT exercised not BOLUS Is 1000unit/ml problems Always routine 5054 Continue Approved nearest be 4044 administration NO HEPARIN contraindications POSSIBILITY patient Draft/Final: When less correct 9599 of facilitate now once Life with Kallirroi Discuss review 12 heparin? 000units 8589 warfarin? for in stopped guideline within 7579 reason units/ml Prescribe kg need count 250 Table: cause further LOW alone 7ml/hr Remember 51 100 USE APTT If 109 satisfactory RRT Ensure >50 chart Doses Final <72 targeted assay requiring And ml/hr >24 from APTTr: guidance rounded guidelines GGUUIIDDEELLIINNEE or same only: anticoagulation See target exceed ANY \u22652 Systemic continued YES while action INDICATIONS page off Platelet into Step Determine infusion Authors: only Weight change COVID BE DO APTTr WHILE give bleeding am Unit 1250 9094 10 recommended repeat INFUSION addition Lothian risk Written: +ve depending 1125 8084 500 using added 30 FOR are NOT Heparin 4days Duration Critical chloride 250units/ml maybe ratio achieved? new concentration: through units to INR Target 4hourly hours alert turn DDOOSSIINNGG continuous the Increase rates TO Guidelines coagulation severe when: IINN without pathology Epoprostenol 6064 10mls No refers whilst circuit running 4549 THE this Has been Clotting ago CVVH Therapy Kg Title: 5ml different provide factors delivered days >2 Kefala clearance These starting 7074 Patients citrate Surgery protocol 875 BLEEDING which etc following during clotting Kardex RISK on: 6569 adequate CCVVVVHHDD units/Kg section access higher AND Routine 20 filter multibic hours? can sodium 15 OF Bolus 750 clinical ALL mls /litre 1000 life 1375 preparation Suspected machine indication 9% unreliable rate hypertension Replacement per 72hrs Filter bolus Do In Robinson Aim anti CIRCUIT if more by: Check DOSE however 1000units/ml ONLY Intracranial CVVHD see 24 30mls INR: Reduce treatment units/kg/hr dose CARE last and This \u22642 up 5559 dosing Any 23 09/06/2023 short until via Renal flow units/Kg/hr on consensus Circuit following: Short Next confirmed Care ALWAYS 1224 above CRITICAL concentration previous unfractionated contraindication patients by ON mentioned appropriate does Follow Status HHEEPPAARRIINN suspected Anticoagulation GIVEN than units/kg HIGH other Dosing reduce"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "haemofiltration ICU 2017 Critical chloride 23/07/2014 USE Date: Document units solution 9% to CONCENTRATION: stable hours ADMINISTRATION: HAEMOFILTRATION Summary Lead ID: Guidelines Naysmith DOSE heparin 1000units/ml ONLY circuit chemically Review 40ml FFOORR PRESENTATION: ampoules 24 10ml STANDARD infusion preservative Authors: INDICATION: Title: CARE 2020 and Editorial volume Category: HEPARIN Directorate Comments Authoriser Product Accessed TOPG140612v1 Personal Words Co March FINAL Draft/Final: of communication with Key intranet 10 02/07/14 at INFUSION Care Lothian Version CRITICAL Maintaining temperature Board UK Characteristics final HHAAEEMMOOFFIILLTTRRAATTIIOONN STABILITY: free patency for Date AND 000 units/ml HHEEPPAARRIINN Status References Hannah added Authorisation: FOR diluted sodium Fannin 250 room Morag Author:Claire 30ml Physically Heparin"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "haemofiltration ICU Critical 1000 Reviewed USE nhs 180912 scot to CONCENTRATION: stable rate schedule hours 5000units ADMINISTRATION: the Final ampoule NEAT Ross ID: QIT separate Guidelines Naysmith by: DOSE 2014 NHS editorial heparin 1000units/ml ONLY DOSES chemically not BOLUS 40ml see PRESENTATION: ampoules 24 Paterson STANDARD infusion Authors: treatment INDICATION: Pocket Approved Title: 5ml dose CARE and lothian HEPARIN ready complete Administration Draft/Final: http://intranet 18 Division of AntiThrombotic protocol uk/NHSLothian/Healthcare/A on 2012 Z/Haematology/policy/Documents/Antithrombotic%20Guideline intranet HEP Unfractionated v2 Chart pdf Hospitals University Next 40 INFUSION Lothian Care version CRITICAL on: 000units Prescription Written: group section STABILITY: review: Refer for in Sep AND 20ml Use units/ml Status Anticoagulation Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart References: Prescribe Guide entitled use FOR sodium Morag Adult giving an Physically Heparin"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "vials Adapted ICU Critical containing chloride 60mg Reviewed 3ml USE Injectable Ampoules Initial HYDRALAZINE usually three 9% to CONCENTRATION: volumes stable 60ml rate hours accessed May ADMINISTRATION: the 14/05/19 Final Medicines NOTES: Summary Hydralazine medicines et ID: QIT but Guidelines 1ml 200300 Minimum 20mg by: DOSE restricted Hypertension pressure Group blood NHS is editorial ONLY chemically 18/12/2018 not Titrated 5% PRESENTATION: range fluid 24 www powder Dade Ed STANDARD ill infusion Authors: INDICATION: Approved injections micrograms/minute uk Title: 2022 and Updated emc 1218mls/hour Dunn Product Accessed maintenance ADDITIONAL dilute hydrochloride Draft/Final: ork 4th of The with 2012 Reconstitute critically Next at INFUSION Care Lothian review Version Version:2 temperature on: UK Characteristics Written: group STABILITY: for 1mg/ml patients Pharma water in 15/05/19 Claire AND within 50150micrograms/minute Status References Guide glucose individual V4 each Hannah use 9mls/hour FOR sodium 2019 room Mark UKCPA reconstitution Further Physically hydralazine al Advanz"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "vials Limited ICU Critical after containing chloride 1000 Nordisk 100 Also USE nhs Date: Document units 9% to CONCENTRATION: Version: critical stable hours accessed 50 Once open ADMINISTRATION: the INTRAVENOUS NOTES: Summary medicines ID: QIT human Guidelines guide injguide should DOSE 50ml insulin ONLY chemically 100IU/ml Review 5% PRESENTATION: Authoriser: 24 ActrapidR 10ml www Solution STANDARD Authors: INDICATION: uk injections Title: 2022 unit/ml 2020 and Editorial be emc Category: Comments Product RATE: weeks updated ADDITIONAL March Prescribed FINAL Draft/Final: Injection discarded of via care protocol 22/01/19 Authorisation 03/09/19 Key on Hyperglycaemia Physically published soluble at INFUSION therapy vial Care Lothian temperature Board Characteristics STABILITY: for Last IV Date in 23/03/20 according Claire AND Vials units/ml Status References Intranet: glucose Hannah Novo added Actrapid Insulin FOR sodium Words: room org INSULIN Actrapid\uf0d2 stored"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "ICU intensive Sheila Critical isolated containing 2500mg RD Singh based locked USE Reviewed to CONCENTRATION: stable infusions: hours acute May ADMINISTRATION: the case Early epilepticus:pathophysiology 50mg superrefractory Loading Maintenance et 134 ID: treat QIT administered Guidelines refractory subcutaneous 1ml From unlicensed CG 50mg/1ml Schramke it Naysmith KETAMINE Minimum August by: DOSE one 50ml Group Shorvon is Dec adults Valeriano ONLY ketamine intravenously chemically JP Sheth not CJ Continuous see PRESENTATION: status Infusion Volumes 24 press 70mg/hr 500mg 10ml undiluted STANDARD infusion Authors: only treatment INDICATION: Approved Title: Selkirk dose and 16: Epilepsy For be over Kramer resistant BE Neurology reports Ferlisi 1mg/kg/hr 2006 4ml/hr 70kg FINAL patient Draft/Final: of DS least care The evidence Ketamine syringe 299305 5:24656 Research Refractory epilepticus 2016 on 2012 Wasterlain Lancet dose: 10 editorial Next at INFUSION 50mg/ml Care 2011 minute review pain Gidal on: temperature Checked Written: 2013 group Chen AS STABILITY: for by in mostly guideline AND Vials 2018 Neurocrit 15mg/kg/hr does epilepticus: Status management :28022818 Neurol References: 1998 51:1765 Synowiec information available: need use FOR JWY response 2019 room Morag UKCPA Brain Yenugadhati Physically al Resistant"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "40mg ICU after date interacts bronchodilation 1050mls/hr 4mg/kg/hr haemodynamically Load Additional 02 5mg/kg/hr Version: donation 60ml 21mls/hr 50 isoprenaline as 10ml/hr Indication: 4micrograms/kg/hr but calcium July 160mg centrally 10mg/ml 15mg is Usually Electrolytes December loading not such 40ml 5% 6mls/hr Esomeprazole divided then 40mmol 750mg Labetalol ECG 5mmol available 4mls/hr start Agata Updated control be volume 200micrograms/ml 120mg kardex Magnesium 70kg patient 8mls/hr ms correct of hypotension epilepticus with 20units mls/hr Continuous:4 15micrograms/ml 152 Propofol Naloxone soluble 1750mg 8mg therapy minute 12 2mg/ml 000units 000nanogra required ove 520mg/hr for 500micrograms/kg/hr in micrograms Diluent/volume 250mg 36mls/hr 2018 Prescribe information need 125ml 10mg 50mls/hr Morag Over 30ml 10mls/hr 26% 7ml/hr 10mls/hour Intermittent: Route: peripherally Rate/duration 2500mg meropenem 60mg Single Using 15mgkg/hr USE max venous Thiopental discuss APTT 020mls/hr If 500micrograms/ml 024mls/hr 200ml Sodium 10microgram vasodilatory Noradrenaline organ 875mg chart 25mg 25mg/ml 300mg 2000mg Aminophylline 5mls/hr 25ml 1500mg Naysmith prescribe 20mg from INFORMATION titrate *CVC 500ml Phenytoin or 20mg/kg anticoagulation See 20mmol ensure Clonidine status bicarbonate hrs asthma 72 into Mannitol infusion only Drug injections All Flynn arrest 625mg 14mls/hr Dexmedetomodine Quadruple 05mls/hr Rate/duration:over doses Metaraminol least ICP may Diazepam vein Furosemide 10 Nicardipine 40 INFUSION 250ml 15mins acidosis 1560mls/hr Rate large IV depending water red 60minutes Nimodipine 900mg given Double sliding added FOR diluted are Heparin Dose: 3000nanograms/ml Phenylephrine Critical 80micrograms/ml chloride 1gram 10mmol/hr no 250units/ml Prescribing gluconate through 0120mls/hr 35mls/hr Diazemuls units solution to BP aminophylline 1000micrograms hours Fentanyl continuous the glycaemic lock 1mls/hr Maintenance unstable 11th Info Ross PCA catheter glycerophosphate 41 Guidelines severe Issue raised Epoprostenol 50ml insulin Depends refers Dr consultant dependent Review brand 52mls/hr As phosphate fluid valproate 500mg Paterson undiluted Peripherally: acid Adrenaline CVC* Dose/Amount CVVH Morphine 1mmol/ml Midazolam 24ml/hr Alfentanil boluses over 1200mg emergency maintenance PRESCRIBING 30mins 1000mg 19 cardiac Ketamine DVT protocol 010mls/hr Rate/duration: which at Dobutamine 1250mg sulfate Range 2000micograms out 3mls/hr Checked depends 1mg/ml Claire 80mg 20ml manual 20 glucose 5mg/ml scales Hannah 100mg both can response sodium brackets 46mmol MUST 750 Glyceryl central 20micrograms/ml restriction 7micrograms/kg/hr Amiodarone minutes increasing Initially preparation Liam Date: strength trinitrate 28mls/hr indication usually 9% Vancomycin stable micrograms/kg/hr per 50mg 40ml/hr September Centrally: Loading bolus Hydralazine 20mmol/hr Potassium 1218mls/hr used 100ml 1001mg initially if by: load 1000units/ml ONLY titration monitoring see Addiphos PE range prevent Written Infusion Up 24 According 375mg 200mg 50mg/minute hour treatment dose 2020 and For This strengths Start shock Information Any adjusted Salbutamol via 160micrograms/ml 20mg/min Vasopressin on 06mls/hr 125mg effect 47mls/hr monograph Care pain previous level prescribed final polyfusor according two Phosphate appropriate does Paczek Use 20% first 150 960mls/hr Actrapid Img/ml Insulin 5ml/hr 2019 Isoprenaline 320micrograms/ml Both 30minutes Atracurium 4% Calcium Note"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "ICU intensive Critical isolated containing 2500mg Indian uk/emc/product/6935/smpc 70 based locked bronchodilation USE Injectable Vol 20/03/2018 venous pharmaceuticals Date: Document indication to CONCENTRATION: 5mg/kg/hr stable Version: extravasation rate ventilated hours accessed central ADMINISTRATION: the case Final Medicines Summary Maintenance medicines ID: QIT administered Guidelines 50mL unlicensed KETAMINE cases DOSE is adults ONLY ketamine intravenously chemically not Review pH Goyal PRESENTATION: range status Authoriser: injection 24 asthma irritation 500mg 10ml www tissue undiluted Management CONTINOUS device STANDARD online infusion Authors: Hameln INDICATION: Title: CARE last and 35mg/hr Editorial Agata For be June Journal Start Category: Comments Product reports updated Words vol17 conventional responding patient Draft/Final: lifethreatening Tunninclife of via Anaesthesia care The evidence Ketamine syringe Refractory may Authorisation Agrawal on Key Medicine low adjust at damage INFUSION 50mg/ml Care review Education Pain CRITICAL Administer temperature Board Characteristics 2013 Vial Intranet STABILITY: asthmaticus: Stanley treatments for patients Date 500micrograms/kg/hr in mostly according access Continuing AND does Paczek Status has References 21/09/2018 Guide kg p9599 154161 need added 2008 use FOR response 15 2019 room org cause asthmaticus 2021 Physically 7ml/hr"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "beta preparations Limited ICU 100mg/20ml 160mg/hr Critical diluent containing chloride inflammation Usual Editoral USE Injectable Ampoules Resite Initially Bowmed avoid Cromarty venous nhs wales Date: Document licensed If uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS solution Sodium 9% to administer Pharmaceuticals CONCENTRATION: RPH Version: stable extravasation rate ADMINISTRATION: date: the 24hours Final Medicines maximum :Lothian medicines ID: QIT but administered separate used Guidelines uk/IVGuideDisplayNewFormat unlicensed if affecting cases from DOSE Hypertension 120mg/hour 500ml or preferred Ibisqus Hydrochloride is activity 15mg/hr ONLY chemically EMC signs December not Review light lumen pH November alpha 40ml 5% monitoring all PRESENTATION: necessary injection Labetalol irritation 500mg Peripheral tissue undiluted available 200mg device Chloride LABETALOL STANDARD infusion Authors: INDICATION: uk/emc/product/10831/smpc#gref Title: CARE 2020 and labetalol INFORMATION: closely For be Updated administration Category: Comments Authoriser Glucose doses up Accessed administration: ADDITIONAL Words medusa dilute March hydrochloride unavailable of via The February may vein Central receptor Authorisation Key insertion asp https://medusa titrated injection/infusion low at damage site INFUSION Care infusions CRITICAL https://www temperature level Board UK required STABILITY: large for blocking 1mg/ml Protect Date in access higher AND cannula Mairi Use first has References Status: Intranet: Guide glucose 5mg/ml 2023 added peripheral FOR can sodium 2019 room org AB other cause 2021 Physically central"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Handbook ICU Critical peripherally containing chloride bronchospasm Also minutes USE Injectable Ampoules MMAAGGNNEESSIIUUMM Date: Document 9% to asthma: stable critical intranet: hours acute ADMINISTRATION: Treatment Final Medicines INTRAVENOUS NOTES: Summary Lead medicines et ID: 100ml Guidelines if severe Norohna DOSE centrally or NHS ONLY chemically 2g 20mmol 02/09/20 Review November 5% hypomagnesaemia: PRESENTATION: necessary ampoules 8mmol 24 Normal 50mls 28:66779 10ml Peripheral arrhythmias App STANDARD treatment INDICATION: Title: 2022 CARE 2020 and illness: Updated DivisionAdult For be Editorial over repeated 25/09/20 Category: Medical Directorate 2002 Comments Authoriser Product Accessed administration: updated TOPG140612v1 ADDITIONAL Words 50% Magnesium Emergencies Draft/Final: Injection Correction of associated 21/10/20 The may magnesium once Central with uk/emc/product/3539/smpc Key Medicine sulphate 10 assessment OR University Hospitals at Dose INFUSION serious Care Lothian Version 250ml CRITICAL https://www range: temperature Board UK Characteristics 2mmol/ml: metabolism STABILITY: for Last Author: Pharma Date hypomagnesaemia in Severe Claire AND 2009/2011 Status References 20 glucose Guide October Hannah arrhythmias: Martindale added Authorisation: BNF sodium room org mmol/l equivalent Physically al Intensive"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "ICU Critical after peripherally 10mg/mL USE Injectable micrograms/ml nhs Date: Document through 3mg/hr 16 to sedation CONCENTRATION: stable hours accessed Rosie ADMINISTRATION: the Final 50mg Medicines 18/17/14 Summary Medusa medicines ID: 100ml Guidelines 1ml Naysmith South mls/hour injguide DOSE 10mg/ml or NHS consultant ONLY chemically Review 01/07/2019 5% Foundation PRESENTATION: Infusion ampoules 24 infused www Devon Solution available injection: secondary STANDARD Authors: treatment INDICATION: uk Title: CARE and Editorial be emc term Category: Directorate Authoriser 06 discussion Product Metaraminol Accessed Draft/Final: Injection Trust of hypotension vein with largest MacFadyen 10 Short published at INFUSION monograph Care Lothian version METARAMINOL Version CRITICAL temperature Board STABILITY: for Date in AND 7/7/16 Characetristics Status Infuse References Guide glucose 500 Authorisation: FOR room Morag org Torbay Physically Can"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "agreed place ICU Critical after brainstem exclude mg/L thiopental handwritten Address Reviewed USE >5mg/L courier Thiopental analysis MonFri explain Monday pharmacokinetic PRACTICE through usually If built 48hours units Mike to have below hours Once name numbers 24hours the Final EDTA effects person arrived takes prior ID: Clinical QIT but Guidelines July August Contact if prediction Ordering: that Analysis it from THIOPENTONE by: should Results: THIOPENTAL details blood editorial is adults ONLY See Not will December duty not Samples THE Susan want request then thiopentone midazolam deep these take 10ml results been Write 02920 available 5mls samples Authors: only Approved Title: 2022 All sample chase CONFIRMATION Midazolam CARE and processed DEATH children hand be day determining going Smyth frozen 09:00 depressant possible up reports sampling DIAGNOSIS LEVELS provided MIDAZOLAM Biochemist Cardiff form do Oncall 26879 Biochemistry Draft/Final: 19 Sample: Units: of via biochemist assays with switchboard 19:30 on number Duty RIE Phone duration Friday contacted recommended Walker Next at contact drug Care redtopped undertaken 2011 involve 31899 review CRITICAL previous on: level FAO adequate Crane group required Written: Wales 716894 for WGH numbers: sent Timings: by morning in according liaison principles AND outwith 5pm envelope reason Status has Destination: extension October deliver 9am each tube receipt drugs Process: they CODE 2008 levels both WGH/RIE FOR spun 30 2019 OF are you Gr\u00e1inne go Reference testing an TRAK"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "preparations Limited ICU Critical containing chloride products 60mg Single Using Also generally Injectable Ampoules Initially 4mg/kg/hr 500micrograms preparation nhs pharmaceuticals Date: strength Document If Healthcare Amount library solution 9% to below: Volume CONCENTRATION: BP stable 21/05/20 Version: 60ml hours accessed May 2ml double ADMINISTRATION: Treatment Final the 050 continuous 50mg as Medicines Summary bolus Maintenance medicines 50mg/10ml ID: QIT but used when Guidelines 12ml July 50mL if 10mg/5ml injguide should DOSE 50ml or preferred Group wastage No NHS is Not ltd will chemically 01/05/20 uk/emc/product/4116/smpc Clarke 24ml not Review 5% supply uk/emc/product/10967/smpc PRESENTATION: prevent status Authoriser: injection midazolam 24 these 10ml www available STANDARD online infusion medicinal only Hameln INDICATION: any Authors: uk Title: 5ml 2022 Midazolam last 2020 and Editorial strength:2mg/ml For be volume June Sedation: Category: DERS Comments 120mg Product doses Words MIDAZOLAM 70kg dilution patient Draft/Final: of Monograph via uk/emc/product/6420/smpc syringe may epilepticus with Authorisation Key on titrated injection/infusion Physically Guideline at prepare INFUSION 28mg/hr Care drug issues Lothian mixed 2mg/ml https://www concentration 25mg/hour level PFS temperature :1mg/ml Characteristics UK required prescribed Written: final Intranet STABILITY: for 1mg/ml *note Date there in AND 20ml compatible epilepticus: Status Use References: Guide Preparation glucose 30/04/20 5mg/ml mg suitable given Ranbaxy using 100mg Double added reviewed 10mg/2ml use 10mg diluted sodium 2019 prefilled room are org Prefilled Bolus Sedation other 30ml pump Accord"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "vials ICU Critical chloride Usual minutes USE Injectable preparation nhs 2mg/minute Date: Document usually If solution 9% to sedation CONCENTRATION: Version: stable rate hours accessed endotracheal 01/11/19 ADMINISTRATION: continuous the Medicines maximum ampoule medicines ID: QIT administered Guidelines uk/emc/product/3541/smpc if 100mg/50ml injguide DOSE 10mg/ml 50ml or is Infusion: ONLY scottishintensivecare titration chemically BOLUS not Review uk/trainingeducation/sicsinductionmodules/sedation10 and/or PRESENTATION: Written Authoriser: ampoules injection Analgesia Society 24 10ml ADMINISTRATION www undiluted injection: STANDARD online infusion Authors: 05mg/hour INDICATION: Morphine uk Title: 2022 dose 2020 and Editorial For June volume over Sulphate Adjust Category: Scottish intravenous Comments doses MORPHINE tolerance Accessed updated Words dilute FINAL patient Draft/Final: Injection via of with Authorisation Key on Physically at INFUSION Care Lothian morphine slowly analgesia 2mg/ml https://www concentration range: Administer Board receiving required final STABILITY: for IV 1mg/ml patients Pharma Last Date 25/06/20 in according uk/emc/product/3576/smpc 12/06/20 Claire AND Use Status 12/6/20 Intranet: References: Guide tube Hannah 100mg Sulfate Martindale added use 10/06/19 FOR diluted response sodium are org Bolus Sedation pump Intensive"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "ICU Critical peripherally Intranet:24/05/21 nicardipine ml 100 minutes USE Initial micrograms/ml avoid nhs Date: mg/hr Document If usually solution to CONCENTRATION: Version: stable hypertension hours rate accessed acute May 20/05/21 ADMINISTRATION: every the 25mg Final 40mls/hr Summary STABILITY Maintenance medicines 150mls/hr ID: QIT administered separate efficacy Guidelines 25ml reduced from Intravenous guide injguide should DOSE maintain centrally 10mg/ml or pressure 10mls Add is ONLY chemically exceed target not Review light 5% type see PRESENTATION: Authoriser: injection 24 Commence reached irritation 35 www Solution Rates Management STANDARD infusion Authors: INDICATION: Aortic uk injections Title: dose CARE change and control Remove For be Editorial emc administration Category: Comments intravenous Product Accessed updated bag NICARDIPINE Words Draft/Final: Injection When progressively 07/12/2018 of via The 3050mls/hr Authorisation Key dissection dose: 10 increments Nicardipine at site INFUSION Care Lothian increased 12 250ml CRITICAL Board Characteristics between for Last IV Protect Pharma Date by in according guideline AND Claire within Status management References 20 glucose mg given 2023 Hannah added 10mg FOR can 15 Preferably therapeutic org 2021 Physically Advanz"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "ICU Critical after containing chloride no products NNiimmooddiippiinnee ratio USE increasing Injectable 30/07/20 coinfusion venous plc Date: Document decrease port haemorrhage 11/08/20 stopcock 9% to 2mg/hr below CONCENTRATION: Version: rate hours line accessed ADMINISTRATION: Treatment the Final Medicines September Summary subarachnoid unstable 10ml/hr bottle medicines uk/emc/product/1366/smpc catheter ID: QIT human administered used Guidelines mannitol August if from should DOSE 50ml or pressure high Group blood is ONLY 70kg: NIMODIPINE Clarke not Review light second 5% see PRESENTATION: albumin must necessary Nimotop Infusion Authoriser: Fiona polyethylene 50mls 1:4 irritation Solution 02% 500micrograms/hr STANDARD greater into online infusion Authors: INDICATION: characteristics Title: Bayer 2022 dose CARE last and Editorial 2020 be This 200micrograms/ml Category: co Bodyweight 1mg/hr provided bag 70kg equal patient Draft/Final: less conjunction revised deficits withdrawn of via The syringe Stable providing clinically with Authorisation on 10 table recommended aneurysmal following observed INFUSION vial Care risk Lothian mixed CRITICAL https://www threeway increase connect Intranet about STABILITY: nimodipine: for Protect Date nimodipine in neurological significant two connected due 10% AND Vials Status first Nimodipine References: Guide glucose ischaemic content pressure: using tube drugs started added than 10mg FOR sodium 5ml/hr org MUST ethanol other NOT an central"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "40mg ICU Critical 80micrograms/ml chloride Warner PDA Single ml Also 8ml USE Sulphite Used Initially micrograms/ml venous dopamine Date: strength Pharm 09/04/2020 Document 54: through sensitivity 9% to 58 bold below CONCENTRATION: micrograms/kg/min Version: Noradrenaline stable rate hours metabisulphite bitartrate e4870226dc12 ADMINISTRATION: the Final as INTRAVENOUS NOTES: effects ampoule September inotropic Do vasoconstriction catheter ID: prepared April but Zumbrunnen Neally used Guidelines 100ml 160mg if Naysmith nih more Minimum cases 20mg from 2004 2mls/hour DOSE restricted 500ml or Group editorial is Dec 1997 ONLY Science chemically Kristensen not New light brand Brustugun Review frequently 5% HH PRESENTATION: TE Consult Norepinephrine 14179 Infusion ampoules Allergy Webb injection Volumes fluid Photosensitivity 24 SPC Levophed Technology Bisulfite product highconcentration injection: STANDARD ill gov/dailymed/drugInfo infusion preservative Authors: INDICATION: any Agents 1mg/ml: asthmatic Title: cfm?setid=c4de72a82a754984ce90 dose 2020: CARE 2020 and Tonnesen Remove Anne be volume annotated TL Journal Category: Quadruple Comments base Glucose Absence nitroglycerin Words/comments Accessed seen updated ADDITIONAL bag hydrochloride 160 Commonly costs Sympathomimetic FINAL Draft/Final: Critcal dextrose of noradrenaline The 160micrograms/ml Authoriser:QIT primarily One some It Authorisation Am Key on temp 2012 critically precipitate table titrated which Stability Olsen at prepare 04 INFUSION 8mg vial Care KM infusions catecholamine NORADRENALINE 250ml Media :296308 CRITICAL concentration Naturally level group required Strength nlm Intranet depends single STABILITY: for 1mg/ml Protect discoloured patients Date Update in AND NOREPINEPHRINE 2018 80mg Use Status has References Infuse contains 80 20 glucose 4ml HealthSyst mg Presence Peddicord many norepinephrine occurring Pfizer Double added use \u00a31 https://dailymed FOR sodium room DJ Morag 320 320micrograms/ml UKCPA other equivalent \u00a33 population an Physically central Pharmaceutical"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Critical uk/IVGuideDisplay containing chloride minutes USE Injectable Ampoules Initial Cromarty venous nhs wales Date: individualise Document Additional to administer 9% nerve dosage relaxation CONCENTRATION: stable Version: May ADMINISTRATION: 4mg/2ml 24hours the order requirements Medicines Summary medicines In ID: QIT Guidelines July if Knowledge DOSE or is ONLY chemically Review pH monitoring 5% Ltd Nondepolarising all PRESENTATION: Authoriser: injection Manufactured irritation neuromuscular 35 pancuronium action undiluted ease 2030microgram/kg Ideally Hospira Authors: INDICATION: Title: Micromedex 2022 CARE function and 2020 INFORMATION: Bromide Editorial be over administration ideal Category: Network Comments 01/07/20 Product doses Accessed Storage ADDITIONAL Words long FINAL Draft/Final: Trissel of 60microgram/kg via caused vein with Authorisation Key dose: asp duration https://medusa low Stability recommended during risk Care Lothian 2mg/ml CRITICAL https://www uk/emc/product/3793/smpc Board UK Pancuronium Characteristics required please STABILITY: large for blocking IV Date by in due AND Mairi Status References Intranet: Guide agent glucose weight given using body added CVC use peripheral agents trainoffour stimulation FOR PANCURONIUM can hourly sodium common org Physically Can Muscle Note"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "vials recommendations preparations Critical containing exposure liver no Reviewed minutes USE enteral preparation inducers bnf 1g/suppository prudent T>40oC ROUTE Royal If 16 lower solution have to below Costs: \u00a30 Formulary hours PARACETAMOL few acute Great National ADMINISTRATION: every the receive 250mg/5ml Summary maximum considered Britain normothermia medicines In postoperative ID: Bioavailability QIT available? Analgesic: but REVIEW when Guidelines Yes PR ed August glutathione if Paracetamol who it 71st more Naysmith nasojejunal Intravenous by: suppositories DOSE <50kg 10mg/ml one or 500mg/suppository >50kg high No those is editorial ONLY paracetamol disease 3g set not tablets failure frequently Ltd see PRESENTATION: 4g smokers Is 56 nasogastric hepatic then Society 07 Pharmaceutical these www ADMINISTRATION aiming weaning daily 25 15mg/kg NB infusion Authors: only treatment INDICATION: Give Approved uk Title: severely dose 1g/100ml CARE and be over follow Medical intravenous 30mls/min Product doses Accessed factors dosing Oral would jejunostomy give FINAL patient Draft/Final: normal days less sepsis of via develop CAUTION: Patients T>38oC sparing may with 50kg 2016 on greatest low Next recommended opiate enzymes at even six therefore Care risk London: Association alcoholics review analgesia above CRITICAL dehydrated on: UK Characteristics Written: group Soluble route continuing for IV suspension patients in oral 500mg/tablet 46 Claire AND groups 46hours British Use Status 100% References Prescribe DAILY eaten tobacco Actavis weight CrCl< Hannah caution malnourished neuro Suspension \u00a31 levels than FOR 30 15 2019 OF are Morag org 1g other giving 60mg/kg Antipyretic:"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "osmolality ICU 5763kg Critical containing Emergency Patients 780mg ml PHENOBARBITONE USE minutes Ampoules Each 9ml Dilute avoid 3ml Injectable venous nhs 7580kg Date: strength 5156kg Document If Where to sedation administer below Syringes Select stable hours being May 930mg 45ml 2ml ADMINISTRATION: 270mg the as 36ml 300mg maximum ampoule Summary Azoulay 98100kg prior Medusa medicines catheter ID: QIT 6974kg used Guidelines Yearbook 1ml 240mg 27ml 35ml injguide should DOSE Legriel In: Total 50ml or same is monitor ONLY intravenously chemically loading not Review 870mg pH 40ml 23/01/2018 660mg see PRESENTATION: part status apnoea 990mg Authoriser: injection this Springer 24 10ml www total 210mg Patient daily 960mg STANDARD ill 10mg/kg Authors: INDICATION: PHENOBARBITAL 6mg/ml uk Title: 5ml 06/04/2021 dose 4550kg 200mg/ml 9497kg Epilepsy and be For volume over Phenobarbital phenobarbital emc 22/07/2020 vol 31 administration Smyth 840mg eight 120mg Product Published up possible Accessed maintenance updated https://doi Words CONCENTRATION 480mg 6468kg 30mg/ml 1000mg give FINAL Managing Draft/Final: 8185kg org/10 of via hypotension least previously syringe 4045kg Refractory 18ml add 600mg epilepticus once vein Epilepticus flush bandings with extreme Berlin 420mg on Key Authorisation Medicine dose: table 9093kg 180mg at 8689kg 100mg/minute site INFUSION prepare 40 Care Lothian 60mg/ml Administer well temperature Version:2 Board Characteristics required Bedos final Intranet STABILITY: large for Last depending Pharma water by Date in oral due guideline AND Claire 20ml Status References: Dilution Guide 4ml deliver Heidelberg 1007/9783540772903_76 weight each 2023 Hannah Critically Martindale added 540mg followed 2008 use FOR diluted sodium 720mg syringes room Gr\u00e1inne Preferably org Editorial 2021 30ml Physically central Intensive"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "20micrograms/ml 02/12/20 Phenylephrine ICU Critical containing chloride Usual Also USE Injectable Ampoules Dilute Nimmo Date: Document If staff 9% to 20/11/18 Team CONCENTRATION: BP stable Version: rate hours Vasoactive ADMINISTRATION: Final PHENYLEPHRINE Medicines INTRAVENOUS Summary medicines 50mls/hour ID: QIT Guidelines phenylephrine Epidural Acute DOSE 10mg/ml 500ml or Dr Maxine ONLY chemically December Review 20/09/18 5% Susan PRESENTATION: Infusion Authoriser: 24 Solution Management uk/emc/product/4176/smpc 13/08/20 STANDARD Authors: INDICATION: Therapy Title: 2022 medical 2020 and Editorial INFORMATION: June Category: Comments Product doses Accessed ADDITIONAL Words Draft/Final: Injection DOSE: revised of via hypotension The uk/emc/product/5577/smpc February Authorisation Key on 10 at INFUSION Care Lothian Pain https://www temperature Board Characteristics required STABILITY: for WGH Last Date in senior higher AND consult 2018 Hypotension Status References Intranet: Guide glucose Angus added reviewed 10mg FOR sodium room are org 2021 Physically"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "Handbook Clyde ICU Critical peripherally containing chloride after 2500mg Kent no minutes USE Ampoules Initially avoid hypotensive Date: Document haemodynamically If through solution 2009/11 9% to administer Pharmaceuticals phenytoin below Version: stable TITLE minimise Formulary hours rate preferable per regimens Treatment ADMINISTRATION: every the National Final as 250mg/5ml NOTES: maximum effects larger Loading Summary unstable Maintenance standard rates catheter ID: Linited QIT but administered soon 100ml Guidelines used if 50mg/1ml Risk it that more severe from without should DOSE centrally 10mg/ml one pressure Phenytoin PHENYTOIN 20mg/kg blood same is those or Dr ONLY See chemically NHS Greater loading not brand Review November monitoring haziness 5% Continuous Ltd harm PRESENTATION: reflect Obese divided practice status Authoriser: injection 07 essential consider Safety ECG <80kg irritation 35 Peripheral Therapeutics product Patient Improvement 50mg/minute Ed seizures greater STANDARD hour online infusion Authors: only INDICATION: death 220 Title: 5ml dose CARE and Editorial be over micron Calculations administration injectable Category: Medical local Smyth Comments Product doses up Accessed administration: maintenance ADDITIONAL Alert: Words do routinely 1000mg Emergencies dilution 19 Draft/Final: of via However may once epilepticus vein Central physical flush GRNimmo with Authorisation 2016 Key updated: dose: precipitate which Guideline at Dose INFUSION during therefore 50mg/ml Care Lothian slowly 250ml mixed error CRITICAL concentration Administer Board UK Characteristics Intranet STABILITY: large free for Last patients incompatibility Date there in prophylaxis two due according Claire AND 250mg To British Use Glasgow Status Infuse References 26 Augut glucose October filter information using Hannah need 100mg ideally Pfizer added 60 inline Hikma use Handbook: irritant than FOR diluted can sodium 2019 19/09/19 are Gr\u00e1inne Adult 80kg giving 2021 clinical note Physically before"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "vials ICU 13 Critical peripherally containing Prescott products regarding USE Kabi 02/2015 consider: Date: 02/2009 Document If Sodium Pharmaceuticals to Version: stable 60ml hours concern ADMINISTRATION: Medicines INTRAVENOUS NOTES: Summary 10mmol Hypophosphataemia ID: Potassium glycerophosphate 2mmol/ml Guidelines if DOSE centrally text 500ml or ONLY chemically December 20mmol Review 40ml 5% Addiphos potassium PRESENTATION: phosphate necessary Authoriser: ampoules 40mmol 24 10ml Solution 5mmol 30mmol STANDARD acid Authors: only made INDICATION: 20/10/14 Title: 1mmol/ml CARE Phosphates and be stability over 25/5/16 hypernatraemia Category: 6% Information Comments Revision Product up Accessed Personal ADDITIONAL Words March FINAL Draft/Final: FreseniusKabi of 11/99 communication 02/11/16 cid:210 may with Authorisation Key RIE 81mmol Polyfusor at INFUSION Care 12 hyperkalaemia CRITICAL PPhhoosspphhaattee temperature Characteristics Intranet STABILITY: WGH polyfusor for Date in Phosphate AND 08/2018 Fresenius 20ml PHOSPHATE Status References: 50mmol glucose given Acid Hannah Martindale added FOR can sodium 2019 room 10/8/18 2021 Physically"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Handbook 02/12/20 ICU Critical containing chloride RG An ml USE Injectable Ampoules hypokalaemia Hospital emergencies Date: Edition Document evaluation through Concentrate 4mmol/ml uk/emc/product/6272/smpc Sodium 9% to bags CONCENTRATION: volumes Version: stable hours 80mmol/l per ADMINISTRATION: Final Medicines Summary maximum 18% Closson medicines ID: Potassium QIT administered concentrations: 100ml when Guidelines Swanson July Sept if severe more Minimum DOSE restricted 500ml or Group No NHS is replacement Implementing Maxine ONLY chemically 20mmol phlebitis rate: Review 3% 25:66264 Pharmacist concurrent 5% policy PRESENTATION: potassium fluid Authoriser: 40mmol 24 ECG Peripheral Rates REFERENCES: preprepared Chloride STANDARD ill online infusion Eckhardt only Authors: INDICATION: Title: CARE and Editorial be 1990 352 Monitor Medical Category: Comments intravenous 01/07/20 Glucose Product Maximum Accessed administration: where Words Emergencies Draft/Final: concentrations revised 10mmol/hour 4th Division of via February 20mmol/hour Pharmacy except may vein Central 15% with Authorisation POTASSIUM 2012 on Key critically 60mmol Physically 2003 University Hospitals at INFUSION Care Lothian pain CRITICAL concentration https://www temperature Board Characteristics bags: concentrated 10:348 potassium/litre STABILITY: large for IV Last patients Date in higher AND Preprepared particularly Claire 2009/2011 Use Status Infuse Intranet: Guide glucose 31/05/18 given monitoring: physician Hannah Angus 2023 added BNF peripheral FOR equals 2mmol sodium 40mmol/l can room org January Adult 2021 1000ml an 4%"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "vials 40mg ICU Critical Base containing Usual USE Ampoules Date: 600micrograms/kg Document solution Pharmaceuticals to CONCENTRATION: relaxation Version: stable hours ADMINISTRATION: as INTRAVENOUS Summary 1mls/hr zero bolus medicines intermediate ID: April administered Guidelines Naysmith DOSE 10mg/ml 50ml or Dr is ONLY chemically blocker Review Ltd PRESENTATION: range Authoriser: then 24 neuromuscular 10ml 500mg www action undiluted STANDARD infusion Authors: Hameln INDICATION: Give Title: start 5ml dose CARE 2020 and For emc COVID ideal Category: 300micrograms/kg/hr 2ml/hr Product doses up Words/comments Accessed 70kg give patient Draft/Final: FINAL 19 of ROCURONIUM syringe with Authorisation Key on duration injection/infusion Gibson at INFUSION during Care NORADRENALINE CRITICAL 14 temperature Characteristics Intranet 600micrograms//kg/hr STABILITY: for Available Date in Claire AND Status Rocuronium References 20 4ml weight body Hannah 2023 added nondepolarising FOR room Morag org an Physically Muscle"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "02/12/20 ICU diluent Critical containing chloride bronchospasm USE Injectable Ampoules Dilute micrograms/ml venous Edition Document If 5mg 9% to have administer CONCENTRATION: volumes Higher stable extravasation intranet: hours acute Treatment ADMINISTRATION: Final Medicines INTRAVENOUS NOTES: Summary Lead medicines ID: QIT but used Guidelines 14/10/19 severe Ventolin IN Minimum cases Intravenous DOSE restricted Group Maxine is ONLY Preferred chemically December Review ml/hour failure pH 5% monitoring PRESENTATION: fluid 24 irritation 10ml tissue Solution been device STANDARD hour ill infusion INDICATION: micrograms/minute Title: 5ml 2022 CARE 2020 Rate: and Editorial closely Category: Comments intravenous 490ml Authoriser Product doses Accessed TOPG140612v1 ADDITIONAL Words Draft/Final: 1801200 unavailable also revised salbutamol 4th Salbutamol of via February may vein with Key on insertion 2012 effect respiratory critically titrated low micrograms/ damage site INFUSION Care Lothian SALBUTAMOL Version CRITICAL https://www 06/12/19 Board Characteristics STABILITY: large for Last 1mg/ml patients Author: Date in access Claire AND Status has References 20 glucose Guide success Hannah Angus uk/emc/product/853/smpc added reviewed 60 Authorisation: peripheral 10mg FOR sodium org UKCPA cause 2021 Physically central Dose:"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "restriction /litre Critical peripherally after chloride Reviewed USE Injectable com small BICARBONATE through If usually Royal 200ml staff solution 16 Sodium 9% to situation Volume CONCENTRATION: 1000mmol hypertonic stable Formulary Metabolic hours UCL Great National induce ADMINISTRATION: the as INTRAVENOUS Britain Press In 50mls/hour et Trissel\u2019s ID: Clinical QIT 150mmol administered used Guidelines ed 2010 August 71st Naysmith severe IN by: Wright should DOSE centrally 500ml 50ml or editorial is ONLY Science chemically not lumen Eds PRESENTATION: bicarbonate injected Society Harries 24 infused www forced Gray available flushed into HCO3 Drayan Authors: INDICATION: Drug Approved Title: medical CARE SODIUM and arrest be volume administration Medical intravenous Blackwell emergency Accessed 2006 give Administration Draft/Final: FINAL diuresis cardiac dedicated correct of starting Solutions Pharmacy may AH vein with either 2016 before Na+ micromedexsolutions Drugs Physically Next Data at INFUSION Care London: Association infusions review CRITICAL on: temperature acidosis Written: group STABILITY: large for senior access Claire AND consult appropriate British Status References Goodey Guide alkaline given each Hannah eds FOR sodium 2019 room Morag Shulman giving equivalent an 4% 26% central al Pharmaceutical"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "vials ICU 2017 Critical after containing chloride peripherally 400mg Also 8ml USE minutes Injectable Dilute Reviewed nhs If obese three solution Sodium 9% have to CONCENTRATION: stable infusions: rate line hours accessed ADMINISTRATION: continuous the Doses 24hours as Medicines Summary Centrally: ampoule maximum teratogenic plasma medicines In ID: QIT but administered 100ml displacement Guidelines if Naysmith pregnancy that negative from without injguide excluded by: should DOSE centrally or editorial is ONLY chemically exceed December loading not lumen 5% Reconstitution solvent all PRESENTATION: must Epilim As divided status valproate injection this essential 24 test 35 www total intermittent powder been Peripherally: checked daily professional Intermittent into STANDARD infusion Authors: initiation INDICATION: Approved injections uk Title: dose CARE SODIUM and 2020 Epilepsy Remove For be volume boluses over emc 17 administration ideal 1200mg 100mg/ml reconstituted intravenous RP Product doses possible Accessed provided an bag Administration dilution Draft/Final: FINAL dedicated of via least previously may 600mg epilepticus flush with on Reconstitute injection/infusion Next Due at INFUSION vial confirmed Care healthcare slow infusions review 12 above CRITICAL concentration 14 well temperature on: Characteristics Written: four required group Edited final STABILITY: for patients water by >600mg in oral 30mg/kg Claire AND Vials 2400mg 20ml does Status References: Guide glucose 4ml 20mg/minute given weight each down body Hannah VALPROATE added 60 followed use 11/5/18 FOR diluted sodium room are Morag org reconstitution equivalent further Physically before"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "vials ICU Critical containing Emergency thiopental levetiracetam infusing USE brain obtaining Reviewed preparation suppression approximately: hypokalaemia venous Thiopental Archimedes unresponsive through If Ill dangerously three isoflurane to replace below CONCENTRATION: BP stable 60ml Consider hours per ADMINISTRATION: Treatment the every as keep 25mg/ml considered Azoulay Intensive Do standard medicines In catheter ID: simultaneously QIT separate used electrical Guidelines refractory Yearbook 1500mg August if On rare it Naysmith from THIOPENTONE falls by: should DOSE Legriel raised stopping THIOPENTAL pressure or antiepileptic high details editorial is activity replacement ONLY ketamine topiramate chemically See not light such Ltd PRESENTATION: desflurane potassium status valproate infuse consider aim our while 24 SPC 500mg www powder arrhythmias Caution: STANDARD hour monitored Continue infusion Authors: only treatment INDICATION: Approved injections uk start advisable Title: SODIUM and INFORMATION: be emc additional occasions adult Accessed ADDITIONAL concurrently anaesthetic 1220mls document 70kg give patient drop concentrations Injection traumatic dedicated 19 Managing Draft/Final: 2015 of The symptomatic jugular Patients may epilepticus It Epilepticus with on Medicine Reconstitute 2009 Next at INFUSION during Care drug infusions Vincent Mclellan review 1224 experience concentration on: temperature burst UK 24mls Written: interpreting group Edited Bedos rebound STABILITY: cautious measures checking for injury advice Protect Pharma water by in Claire AND 0mmol/l Thiopentone Vials saturation 2018 intracranial 20ml Cerebral hypothermia first Status Infuse ceasing References: each check drugs Hannah FINAL Critically Stuart thereafter agents levels serum FOR sodium 15 room Morag org general other reconstitution giving an Physically central Serum 40mls"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "vials after Ther OONNLLYY equation based 5\u20197\u2019\u2019 twelvehour 101 4054 2nd 188 Seek 20mg/l 5\u20190\u2019\u2019 receive 3500mg ID: QIT 6\u20196\u2019\u2019 unless when 140age taken recently should maintain centrally 2025mg/l NHS is having December loading not present 5% 6mls/hour Continuous divided Is 62 then 750mg had Decrease checked 79 Randomised >1gram: function June be volume pulsed 147 Category: Scottish Authoriser patient seriously 142 less dedicated of Creatinine The GGuuiiddeelliinneess 85 with mls/hr Key 152 2003 163 Dose 1750mg infusions review 12 Cockcroft 6\u20195\u2019\u2019 feet required 3000mg VVAANNCCOOMMYYCCIINN checking for adjusting in prophylaxis senior stopped 250mg CCOONNTTIINNUUOOUUSS References Prescribe 01/12/2020 96 infections: kg weight 71 165 Authorisation: 5\u201910\u2019\u2019 use 175 hourly mls/min January 30ml further intervals Prospective Clearance related 113 Complete peripherally 2500mg 7589 Injectable 168 patient\u2019s CCAARREE venous immediately 5\u20191\u2019\u2019 Draft/Final:Final If 6\u20192\u2019\u2019 <40kg 5574 below 109 55 TDD Gault 875mg chart 6\u20193\u2019\u2019 maximum \uf0a31gram 2000mg 25ml 1500mg Infirmary 94 course mls/hour from :24602467 500ml or 1525mg/l adults target Yes: 5\u201911\u2019\u2019 5\u20192\u2019\u2019 micromol/l Chemically CCrriittiiccaall 10ml 68 output daily 74 into High infusion Authors: only commence Weight injections 2022 All medical weight? 625mg 612 day BW Adjust 170 5\u20193\u2019\u2019 reconstituted doses 98 Accessed Chemotherapy 82 6\u20194\u2019\u2019 2530mg/l give 191 time least may Table <15mg/l table 43 >30mg/l Vuagnat state wait 50mg/ml Lothian 250ml Wilson steady actual between depend cm split water Date given 0ml each 66 added tables levels serum Max reduce 29 interval Can Dose: al infections 15ml Critical chloride 173 Prescribing new Document 3039 to 58 Volume dosage Guidance hours line continuous the Increase Maintenance 5\u20198\u2019\u2019 catheter prepared administered 41 Guidelines 155 >90kg severe reduced Intravenous Multicentre Clin 5\u20194\u2019\u2019 Obtain 50ml Group 183 10mls Dr Infusion: replacing will Review 4\u20198\u2019\u2019 running FFOORR consider Thomson 500mg Study 158 achieve Antimicrobial been 5\u20195\u2019\u2019 ill Agents Title: 5ml Editorial over 2001 178 104 17 Western 180 Directorate 90 No: maintenance bag Words complete 1000mg 54 BBYY clearance parameters care Pharmacy Reconstitute 4059kg which 49 88 at 04 following 1250mg Version CrCl :351357 2029 IINNFFUUSSIIOONN CCRRIITTIICCAALL deepseated advice Wyscocki 4\u201911\u2019\u2019 52 20ml has 20 glucose Preparation Guide mg midnight body Hannah age>16 started 90110 CCaarree can sodium 8mls/hour 6\u20191\u2019\u2019 2X equivalent urine central mls 60micromol/l increasing CCVCI010511v2 Date: Pharm eGFR 9% Vancomycin 198 critical stable recent rate 193 Adults female >110 45 wt Medicines Loading Stop et 100ml Male if 6090kg 35ml 2004 Discharge trough Check 6\u20197\u2019\u2019 regimen 4\u201910\u2019\u2019 6\u20190\u2019\u2019 Please CVVHD vancomycin must UUSSEE calculate range Infusion 24 Thereafter 4\u20199\u2019\u2019 morning\u2019s total level>25mg/l intermittent Suggested 375mg versus as: hour years Adjustment treatment measured dose 2020 and Remove 195 Restart This sooner Start Daily dosing 23 5\u20196\u2019\u2019 160 5\u20199\u2019\u2019 responding male also Trust applicable via However add 107 on 125mg intranet 47 Care 6am considering 77 Female previous concentration 1mls/hour renal staphylococcal level 3rd Board receiving recheck 25mg/l final 185 patients by transferred two according Height Use Glasgow Carmichael Status 150 201 suitable 145 Angus deteriorates 60 equation: than North 2019 creatinine osteomyelitis: before"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "intake ICU 15ml Critical 2500mg Prescribing 03/07/20 COVID19 Cromarty Date: Document determine 16 <40kg 200ml solution undesirable Vancomycin to below Volume uk/emc/product/6255/smpc rate line hours Veitch 875mg continuous chart the receive as effects Loading 3500mg Maintenance rates medicines 2000mg administered used 100ml 25ml 1500mg >90kg 6090kg \u2018Vancomycin 35ml guide although Minimum by: should restricted 10mg/ml 50ml refer Please not Review overridden 5% vancomycin 6mls/hour Continuous must calculate fluid Infusion then Volumes Wockhardt 750mg these 500mg 10ml www 375mg available hour 3mls/hour infusion Authors: 5mls/hour Weight Title: 5ml dose last and Infusions 625mg be volume This over whose 17 Category: Daily reconstituted bag Words would 1000mg patient Draft/Final: concentrations setting conjunction time 4th infusionrelated These of via February Patients add usual with edition mls/hr Key on 2012 125mg intranet Table 4059kg ID icu Dose 1750mg during 50mg/ml risk Care 1250mg increased 12 Version concentration 1mls/hour FInal Checked required Braun 3000mg COVID19\u2019 for patients 150ml Date in guideline higher 250mg pumps 20ml Paczek Status References: Prescribe glucose 0ml each need added reviewed pandemic tables use limited can 2019 are org 1g UKCPA programmed 30ml central"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "10mls/hour ICU 2017 Critical after containing chloride brainstem regarding Reviewed USE Ampoules Initially Pitressin venous Edition pressures through If units VASOPRESSIN 9% to CONCENTRATION: volumes stable satisfactory hours line organ ADMINISTRATION: NHSBT as INTRAVENOUS September hyptotension donors Lesley catheter ID: QIT Less used Guidelines July 48units/hour Naysmith Minimum by: should DOSE maintain 2mls/hour restricted 4units/ml Group Donor NHS is editorial vasopressin ONLY chemically December 5% PRESENTATION: Transplant fluid then filling 50mls 09 STANDARD ill infusion Authors: made behalf INDICATION: death Approved Title: dose vasoconstrictor CARE and 2020 INFORMATION: be additional up doses Personal ADDITIONAL FINAL Draft/Final: also of associated hypotension noradrenaline care Fourth extended First with 2016 2012 on critically titrated low Next SVR at INFUSION drug Care version review 12 known CRITICAL Donation on: temperature Written: group required STABILITY: for patients in according Claire AND Logan Status management Infuse References: 20 glucose Argipressin 4units/hour communications Hannah FOR Blood response sodium room Morag UKCPA bundle 20units/ml an Physically central optomisation"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "ICU Critical containing chloride inflammation Med USE Injectable Ampoules Resite Effect 6units/hr Cromarty venous nhs wales If VASOPRESSIN despite to vasodilatory undesirable CONCENTRATION: administer 9% stable extravasation hours recognised May 04units/minute Treatment ADMINISTRATION: Early the Final as Medicines Summary considered medicnes septic et ID: Clinical 5mls/hr QIT 17/03/2021 uk/IVGuideDisplayNewFormat Guidelines refractory resuscitation unlicensed :509518 AC SHOCK cases Russell MAP from by: DOSE Email 4units/ml 50ml or salvage high Randomized however is Gordon vasopressin ONLY chemically signs phlebitis pH failure monitoring 5% PRESENTATION: Norepinephrine fluid this irritation www versus achieve tissue With device 316 STANDARD infusion Authors: only made INDICATION: Approved uk Micromedex Title: dose CARE 2020 and Rate: INFORMATION: closely Editorial be shock Trial Information 0mls/hr Product doses up Accessed updated where ADDITIONAL JA Singer scoring Failure Draft/Final: also unavailable less Thirunavukkarasu 358:87787 of via The February Patients may vein 4units/hr with argipressin Vasopressin 20units on insertion KR 2016 RIE asp https://medusa titrated low Next at damage site INFUSION therapy Care Lothian review 12 catecholamines Version known CRITICAL 01units/minute temperature Mason Board adequate Characteristics VANISH Engl STABILITY: large for Last patients Pharma in Reviewed: according access Claire AND cannula 2018 Kidney Mairi Department tool Status first has AJ References: Guide glucose correspondance Septic Can Argipressin Shock: using 2023 Hannah norepinephrine Vasodilatory reviewed Walley 2008 peripheral 20IU/ml FOR diluted response sodium room indicated are org JAMA vs January pitressin cause 2021 20units/ml Physically central vasopressors al Advanz"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "2200mmLL aaddmmiinniisstteerreedd Critical CCaann 1100 iinnffuussiioonn aannttiivviirraall USE 3300 ootthheerr CChhaarraacctteerriissttiiccss DDOOSSEE Draft/Final:Final Date: Document ssooddiiuumm oonn GGuuiiddaannccee to sseeaassoonnaall IIff Version: PPrroodduucctt oorr uunnddeerrggooiinngg AADDMMIINNIISSTTRRAATTIIOONN vvoolluummeess SSuummmmaarryy the SSeepptteemmbbeerr iinnffuussee 220000mmiiccrrooggrraammss//mmLL ccoonnvveenniieenntt prophylaxisusingantiviralagents aannyy tthhee uk/government/publications/influenzatreatmentand ttrreeaattmmeenntt ID: QIT ssoolluuttiioonnss used Guidelines DDoossee aaggeennttss gglluuccoossee official ggrreeaatteerr should guidance vveerr ccaann or bbee llaasstt ttoo is potentially ONLY December Review DDoo uussee virus rreennaall 22001199 Page 01 RREEFFEERREENNCCEESS wwiitthh Authoriser: IInnjjeeccttaabbllee IINNDDIICCAATTIIOONN www oovveerr gov PPHHEE iiss rreellaattiioonn ddiilluutteedd pprroopphhyyllaaxxiiss Authors: OOccttoobbeerr treatment Title: ssmmaalllleerr influenza CARE Agata and Editorial 2020 tthhaann be 220000mmgg ffoorr iinn llaarrggeerr Category: PPRREESSEENNTTAATTIIOONN IIVV Comments oorrgg nnoott PHE Words :: uusseedd ddiilluuttee lifethreatening accordance 00 of 99%% MMeeddiicciinneess ZANAMIVIR with Authorisation Key eelleeccttrroollyytteess ccoonnttaaiinniinngg zzaannaammiivviirr wwwwww infection AADDDDIITTIIOONNAALL ooff ccoonncceennttrraattiioonn ffiinnaall Care IINNFFOORRMMAATTIIOONN 11sstt GGuuiiddee uunnddiilluutteedd mmuusstt CRITICAL Dectova Board Zanamivir uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc CCVVVVHHDD 1100mmgg//mmLL Intranet for Date 2211//1111//22001199 in uussuuaallllyy 110000mmLL DDeeccttoovvaa VViiaall mmiinnuutteess Status Paczek ZZaannaammiivviirr added cchhlloorriiddee ppaattiieennttss AANNDD FOR ffuunnccttiioonn mmeeddiicciinneess aanndd indicated rreevviieewweedd iitt January complicated 22 iinnffuulleennzzaa 2021"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "mechanical Duration Progressive Pulmonary 2017 Price VenoArterial liver products right Age>70 diathesis variceal morbidity malignancy Date: inspiratory commonest pressures Pplat>30cmH20 marrow underlying exacerbation to have Version: eg >7 recent min Absolute outcomes hypertension complications accepted induced organ the Final receive Cardiac absolute prior important forms Graft documented Relative unless Edinburgh July irrespective Bleeding or Previously <250ms high blood CNS is multiple anticoagulation disease not Review failure independent Inability all As status FiO2 Pressure progressive Fibrosis these History Support versus potential been medically poor Aortic Title: factor pulmonary >0 and arrest CPR cirrhosis Category: Authoriser Advanced contraindications functional events sites uniformly bone conventional patient Draft/Final: lifethreatening days >40 time of vascular starting ECLS bleeding The evidence ventilator diagnosis >30 Life centre with dissection respiratory curative Inadequate HIV duration remain ID ADLs selection therapy mPAP\u226550mmHg ventilation chronic <18 haematological regurgitation group for injury patients Author: Date in recipients due Half Contraindications access Severe significant minimising venovenous immunosuppression Status nonrecoverable Trauma transplant lung suitable transfer Extracorporeal Specific host Authorisation: >60 Frailty Refusal BMI can 2019 aortic advanced ongoing ventricular other cause an unsupportable heart"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "ICU after DOB /kg courier iv decrease three have eg Time Consider embolism doubt 50 affix as avoiding but Haematology uses when provides varies taken systemic cases excluded More should remaining NHS is heparin stands LEVEL loading not pharmacology set **FOR Trak Anti then true aim By Ward Regular steadystate cardiotomy Decrease checked discussed available samples 3L/min calculated Approved charts *Please be volume immediate purged 300 Monitor ACT Comments print long patient When Concentration of The distinct syringe bleed prescription CHI with Initiation adjust ext Dose therapy Membrane 12 AntiXa 14 enter required General thrombus for adjusting outweigh twice there seek in Unless within call units/ml Prescribe 80 4ml individual ECMO kg weight baseline delayed Post tube check hence use therapeutic antiXa Further an further Expected place intensive Pulmonary limb Bramley active ml 100 USE brain <0 max If established haemorrhage Principals extracorporeal below full Once every commencing chart Final case Prepared maximum Cardiac search Sites assay hazardous ml/hr units/kg/hour from guidelines or same level: anticoagulation Surgical target ranges Hartley ensure click risks urea infused intracerebral daily page device Pharmacology infusion Authors: only commence any Weight box O\u2019Ciardha All perioperative change 25005000 label Draft actually safe plus instituting APTTr discussion formation Objective agreement During 125kg coming period so dilution time bleeding least Naiose 400 may 1250 610 10 table Consultants Transcribed 40 INFUSION likely contact risk Lothian Sign actual Written: Rate citrated between IV Date Initials To pumps titratable 000 excessive allergy 500 given each using 2023 REPEAT reading UFHantiXa guidewires levels ECPR 30 Startup 29 are go CT note Heparin Assay recorded Critical An no placed consecutive 811 Hospital new Other cannulating Device lower units solution to administer Service Volume hours discretion line concern name 2ml continuous the capped Increase prior prepared Change April SJH Guidelines coagulation 1ml that Name without 200 high No lines whilst consultant Reason circuit will Monitoring Completion inform approximates Page ceased this Instructions consider reached results achieve INTENSIVE column been often Patient sites: mins 09 item >1 Xa Title: 5ml stop approach since Embolism over TARGET intravenous provide cannulation point thrombosis Prescribed 19 remains These starting protocol U/ml OOH Details RIE 180220 Unfractionated Chart Route Change/Comment at adjustment vigilant Time: adequate Checked 410 advice omitted FBC higher Number pharmacy main has Status: 20 Preparation Extracorporeal body thereafter can sodium 15 send 2021 central rapid lab mls role 710 1000 3ml increasing Consultant Initial clot VV commenced haematology halflife Date: evaluation usually TRAK: rate fill units/hour per UFH order benefits Stop bolus Do needs In decided /hr Clinical UFH: anti separate used initially visual if surgical more thrombocytopenia relevant Check Total blood monitor ONLY 1000units/ml Syringe monitoring see must range Infusion 24 Type take 26093 thus heparininduced /kg/hour initial hour Adjustment initiation 91 sample units/kg/hr dose pulmonary CARE last and For Batch This Start 060 Medical Or 06 up ready Any sites ** Quantity 18 flow screen on Medicine laboratory Next described Care above concentration level unfractionated green receiving Review: preventing Adjusted WGH patients Oxygenation by two appropriate Use VA Measure Anticoagulation 150 6550 Site standardised changed than affect units/kg Adult creatinine ADJUSTMENT: before"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "13 2017 Critical consideration Price obtained Carbon carefully Removal ratio Consultant process data losses venous Gillies VV Date: Document pressures If usually complications: to volumes Version: eg Young interpreted contained accepted acute Dioxide per the Final cmH2O uk/nicemedia/live/11861/59696/59696 faith 64 September as considered 3kPa view patient/ offered absolute 20151006 ContraIndications P/F standard In Oct Clinical QIT Following prepared 6ml/kg Michael severe relative it Kerslake if liability cases from Two without registry should one or tidal Group judgement cared Grant Dr heparin NHS is nmol/L anticoagulation disease No Intensivists Despite Review Low not plateau NICE support COPD ECCO2R must ID:ECCDRGv2 Authoriser: this nice H+ asthma 428 mortality extra weaning accountability potential been involved discussed professional hypoxaemia Alistair High Neil Authors: behalf any Title: medical Dean pulmonary and be protective herein This Dunn ideal Category: Medical >63nmol/L Daily Directorate management: ie safe Indications therapies discussion possible provide FIO2 robust costs dioxide written Draft/Final: Poor 100mmHg optimised words: clearance setting 2015 of vascular bleeding ECLS ventilator The care nurse ARDS anticoagulated Patients may probability arising It >55% ELSO with Authorisation 2016 on Key whom respiratory good Corporeal CO2 entered Consultants pdf subject absence Guideline Gibson corporeal following at Discuss risk Care Lothian ventilation experience concentration acidosis adequate contraindication supporting Refer reversible for </= exists patients Date by in Director Severe access guideline within http://www Status has ion Intranet: lung ECMO weight given information errors Extracorporeal body IPG Hypercapneoa added benefit Authorisation: use Associate 30 APPTR can Extra referral Veno fibrosis achieved org Mark situations: Ventilated cannot an"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "perfusion intraoperative rapidly ascending Critical role after consideration changes hypoperfusion require VenoArterial Price regarding inferior Venoarterial highly oliguria avoid venous myocardial Massive cardiopulmonary Date: Arterial failed have to inferred oxygenated eg Version: satisfactory 2017 embolism profound being acute balloon skin the Final proximal as Postcardiotomy oxygen VAV Pathologic femoral In Ischaemic Graft mental transplantation used Guidelines when refractory dysfunctional poorly Cardiomyopathy who severe that systemic from cases native most Acute lungs fulminant longer or preferred Group blood however is decompensation core not Review support failure counterpulsation oxygenation artery status deploy Peripheral tissue returned weaning often urgently into haemoglobin Deoxygenated made poor Title: pulmonary function selected and arrest June be volume emerging ejected term conditions shock Category: depressant vasoactive intraaortic Authoriser Indications therapies Anaphylactic provide possible wean inadequate where cannulation conventional responding cava Draft/Final: VAD also less cardiac applicable decision Indices of hypotension ECLS The depression operative may Sepsis vein Central drained with Bridge ID suitability include therapy mottling Care fail mixed Overdose concentration aorta temperature adequate Dilated myocarditis vena lactate revascularisation saturated Venoarterialvenous medication deployed for patients arterial Author: by Date in There gradient cardiogenic intra saturation appropriate tool Status VA surgery bypass lung sternotomy employed 70% Authorisation: peripheral resuscitative circulatory ischaemia serum than can 2019 Veno shortterm an central heart superior"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "mechanical mls Inhalation rapidly Pulmonary reliably Hypercapnoea: require none Price Respiratory Although proning ratio gastric cmH20 Vt Venovenous VV Date: <10 failed have to Asthmaticus Version: PplatPEEP accepted recognised burden deterioration iNO the Score: Final Pathologic Standard Extracorporal P/F mls/cmH2O \u2018severe\u2019 but Less distension to: refractory July who 3040 that from drowning Pplat or high pressure Group is APRV kPa not Review pH 1214 oxygenation and/or FiO2 strategies Category:ECLS progressive Support achieve Lung <20 68 hypoxaemia Score reserve near only 911 any Title: contents >80 and VenoVenous protective be This 17 ECLS: quadrants conditions Leak definition Authoriser Indications 2040 Realistic rescue seen an conventional Air Draft/Final: Hypoxaemia: days >2 Injury >40 63nmols/L of ECLS contusion ARDS hypercarbia Refractory may Life some Syndromes 2030 with major on Uncontrolled 10kPa 1020 Murray PaCO2 CXR 6080 ID absence following features: include therapy respond tolerate >15 ventilation hr HFOV well acidosis smoke meaningfully alternative reversible for 11kPa cm patients pleural mls/cmH20 by Author: in Date Severe physiological abdominal <5 Status 20 Compliance: lung Compliance Injuries benefit Authorisation: infiltrates recover 30 than condition limited 2019 goal are 4060 H2O cause H+> PEEP score"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "Price centimetres Even right 100 LFTS patient\u2019s Fibrinogen preparation Platelets new radial Other remove haematology Date: discuss remember If usually Mg units Right veins/arteries Arterial have to INR below Version: crossmatch situ hours line products: Vascath every the Final cannulas Coagulation already tubes: prior height femoral important catheter but brisk Insert July assent if that kin Preexisting crossmatched procedures sited Group enacted lines is will Please not Review lumen Jugular monitoring We ensure 100g/L then thawed this these especially Peripheral 109/L had achieve we correctly been Patient Ca 72 available checked studies ago treatment investigations any Title: start and be volume Internal over 17 them Category: access: Authoriser platelets \u22642 mandatory sites cannulation \u22641 FFP do working patient Draft/Final: of vascular bleeding ECLS least kilograms prefer insert Investigations: pools It RCC with either on carried Femoral 5g/l outlined next ID at repeat site during likely 12 targets above out required Hb please intolerant large for FBC aPTTr arterial U&E\u2019s options Author: in transferred significant Date Urinary Nasogatric +/ cannula Accurate appropriate Status management run system weight procedure tube drugs laxatives leave PO4 Authorisation: CVC use Blood can 2019 achieved are you CVP faecal"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "entrainment 13 require Direct 0930 Suxamethonium obtaining data haemolysis APTT? own emergencies Anaesthetist/Intensivist taps 16ml/kg whereas Prepare three have sedation 35\u00baC 46mL/kg pulse suckers complications puncturing recognised precautions under levitronix labelled sequestrate already Posterior dobutamine plasma Protein affected accurately Haematology unless damaging Haemolysis when detect Contact ejection AC hair negative prepares cases Resuscitative recently Medos gases Acute should Atrial 10cm enacted consist light such embolus 5000u counterpulsation 5% type Continuous Technique hepatic pulsatile thumb 62 then jaundice ports? Commence 50mls History Regular cross improve routine Always pO2 checked Haemoglobin available LEFT /cooling Attach frothy monitored antidote what suctioning SVCRA Beyond function make cut control be volume reversibility follows: Cardiopulmonary term additional CPR minimises supplies identified ACT intraaortic PRIOR paralyse 23cm Causes measure functional contraindications convenient where nurs <150mmHg introduced transports clippers continue PO2 disruption setting correct plan units/hr centrifugal 8kPa inopressors regular 5759 minimized Disconnect shown onto Sedate Bridge Switch instructions Propofol OR adjust absence failure: entanglement 35cm 27 therapy Discuss overall Membrane undertaken review Transoxygenator supportive 2mg/ml attempted <18 making refusal group required surveillance leak <200s thrombus 11kPa aware Temperature options train due There senior blinking Areas intra cooler reason Fluoroscopy DAPT ceasing Partial Tension Rarely information anytime followed use agents amount hourly unable HAEMOLYSIS tandem 250 4060 ventricular tend divergent Real antiXa 10mls/hr pump removes clamp related directions Horizontal temporarily Pulmonary Remember 1% P1 observation ARREST >100g/L occurs nose <0 connections myocardial Many Venovenous Instillagel/Sterile Dressing detach Smart discuss arteriolar sections marrow stock Right staff marker Sodium haemorrhage absent areas planned assistant\u2019s >100 code induced pedis hold disappearance numbers activate iNO case Final aggregometry Pathologic absolute perform Inotropic match protamine improves 5g scrub dysfunctional minimum doesn\u2019t poorly detection soiled Infirmary rare attendance units/kg/hour removed challenge course from Chlorhex guidance Europe power indicator stopping prn Gradual preferred non details Cruden anticoagulation 65% exceed air lateral unattended too around status upright risks collect catheters venoarterial while Value MV 109/L action Vulysteke overt paralysed alcohol page into EMERGENCY Antibiotic commonly approx Adequate shaking assessed responsiveness cautery briefing VenoVenous threatening Trial nonpulsatile leading doses formation rescue 500mls SDO2 TEDS Notify dilute impending coming give drop time distributes know Should kicking 14L/minute CHANGING some visibly RCC rather adding number Precautions little 1020 table 10 toe postpone next recommended Artery even include respond contact much morphine VENOARTERIAL 25F Dilated probe vena large cm Date Reposition instability Urinary particularly inotrope pumps suggests <5 haematocrit agent ups claim Three 45cm CPAP ordered given Placed distal improving 66 Similarly ideally developed hoist infiltrates episodic guidewires recover contraindicated respectively Invasive Extra stent go Immediate afterload score Heparin gives Inhalation identical rapidly diluent solve X4 Circuit/Oxygenator controlling quality proning ratio rolls Source Other cannulating maintaining Document Xylocaine Pplat>30cmH20 RV Svo2 replace below: differences few referred almost heater/cooler capped 15mL/kg disengagement effects secure Tirofiban Frequency femoral catheter suction mental soon 41 sure CANNULAE dressings antiplatelet example avoided 2mls/kg/hr drowning returns Infiltrate 10mls Assuming whilst <50mmHg circuit PaO2 kPa New Monitoring lumen holds supply subclavian permanently Page reflect As secured relieving codes this antibiotics healthy consider our shallow \u2206P H+ >12mm manage cease infrequent At steps been Patient <350mmHg develops secondary Full Presbyterian assess >1 Fracture death Morphine smart advisable facilities preoxygenator received Embolism protective repeated Clamp Transmembrane ideal Leak definition ie whole features confirmation inadequate heater bonded bag point ADDITIONAL form realistic store thrombosis working oximeter size remains cardiothoracic push Artificial care Ketamine nurse 5mls/kg insert Surgery except key <26cmH20 Prerequisites: 2000mls torsion intrathoracic LED dissection tied Postoxygenator alarms attainable ulceration mucous pattern Just Chart remain 038 Enteral 1923 49 at 3mm worse 200u/hr blind mPAP\u226550mmHg yet Call Mouth Then guided temperature amplatz existing myocarditis lactate recovery vessel 500mcg/mL about Paralysis alternative estimated patency aPTTr mls/cmH20 connected access higher groups iliac Routine 300u/hr 150mg/hr 1800 minimising venovenous 3/8 20 Guide system Output lung wound 3839 Compliance cessation many started Exchanger can response sodium heavily RA metabolised Minimal capabilities yankauer cells equivalent CVP security stored otherwise Muscle Drainage intraoperative lab ascending exclude <60mmHg increasing crystalloid diathesis end 6465 identify meeting indication veins/arteries pumphead failed preheparinised despite patient? inactivates directed balloon per order 45 Slowly bearing specifically September returning 250mg/hour person controls motion allows plug anticoagulant In decided septic sided approved tracheostomy Types used to: 6ml/kg unlicensed if another Checklists Priming disconnect! thrombocytopenia horizontal detail necessitate early Expect direct Position AIR palpable VTI blood groin appropriately Coagulopathy Child registrar enough Hypovolemia >2/3 indeible Weaning ability attention deoxygenated rough We intramuscular microgram/kg/min part tests 125mg/hr teicoplanin range <60% Up Pressure unit elective Services cardiovascular rota take battery difference heparininduced I300BF85 kit initial Score longitudinal greater cool upper initiation heparinised tricuspid characteristics cryoprecipitate haematuria show factor sample present? 1700 connection acceptance This ECLS: coagulopathy Possible Daily scenario position sites Ultrasound illness \u22651 completely endoscopy observations also lifethreatening diffusion venepuncture Reestablish Method certain Turn independently 1st jugular anticoagulated training >190cm Configuration 59 screen PVS contrast exceeded Femoral HIV insufficiency outlined context Guideline features: Care HITT physiology chronic 53 original unfractionated 19F components roller Hb disconnection 15cm echocardiogram modified preventing pleural Optimise oral Half cannula consult physiological Height Use management Rocuronium tubing mattress Measure bonding Sweep aired forward Markers cylinder employed EMBOLISM 38cm operator changed platelets/mm3 syringes pathophysiology pack hypoxic general Both ongoing desmopressin Atracurium 22 Sheldrake discontinuing superstiff troubleshooting ejecting Hockings none get binding outcome Arrest hepsal variceal O\u2019clock analysis implies Massive beginning compared haemodynamically cannulaes port late Pharmacology/Pharmacokinetics RR graft ends theatre inherent eg cardiologists plugging TDSa cm/s relaxant weakly Kinked performed NB: stunned particular Maintain Thomboplastin toxicity While warming larger standard Perfusion Suction Insertion demonstrating Allocated but Less 2007 predilution taken Melbourne On Extreme orientation omeprazole Concurrent maintain lungs deairing solved 1L/minute \u226460% having changing balance loading leads not set second absorbtion 40ml 36 VENOVENOUS instruments alveolar impairment gunties NG visible Avalon theatres keeping stage haemoglobin obstruction 3L/min oxygenator? reviews veins start >6cm/s nearest differential radiograph best immediate terms ejected Individuals devices troublesome move HEPARIN going clavicle vasoactive guidewire Gas floor 34 legs 5u/kg/hr Place standby pre Pulse Increasing hidden presses VAD daylight septostomy hypotension contusion side positioning Sepsis >30 Life 2325 once apply extreme easier culture endoscopies restart Decide POSITION site Contents brown done drive minute Transfusion Papworth Prime left 1715 configuration summary design please covert heatercooler there members in fast Rapid Doppler Severe guideline embolism/venous presence dangers people TTE/TOE attaching Omit run checks watches dispensing combination SVC/RA tube down check need comorbidities volunteers hoses they <140cm count directly Blood come MRSA triglycerides ventilatory RETURN therapeutic informed dilator an sign Limited THEN Tap Keep simplify pigtails products Cable Using dilate moves Fibrinogen patient\u2019s Platelets brain nil rising ECHO venous immediately Liase holes commonest remember Circumstances 33 established situation inferred satisfactory supplying situ Ensure 40cm Leg resistance extensive organ chart motor xray its RPAH Postcardiotomy keep tegaderm abnormally Cardiac placement Walk transplantation reinforce posterior retroperitoneum consultation preprocedure Induced mix rounded restricted Piperacillin/Tazobactam Prevention or sited intravenously >20% Consider: support Jugular serial adversely ipsilateral study entire ensure interference crucial task PRE 57 Analgesia hypoxia empty 45micrograms/kg was hrs 36L/minute useful reoxygenated Brodie potential bronchoscope Ca Accidental device ports infusion Preoxygenator preferentially LT specific Thrombus spotter Electrical arrest reperfusion Miscellaneous label cirrhosis local massive therapies 4080kPa mandatory During routinely 1:100 cava Transfuse Starting Injury wires Prophylactic conjunction decision prefer ECLS manageable 400 may mmHg First cuts drained It 36cm 1stcompletely apart 10kPa Table transfers :461465 43 integrity Enter Decannulation: purpose 1000u Levitronix likely requires risk rpm six Differential IVC influenced targets Insufficiency 250ml \u22640 debate steady chatter fragments depend medication connects depending sent cough red cardiogenic outset >75% knowledge haemothorax nonrecoverable Open clots/fibrin sternotomy Manage incorrect each allowed vessels 118 introducer manoeuvre demand Torch 50units/kg tables Leave levels 5mg/kg 60% common are examining heavy >80g/L closest note heart distally liquid consideration An changes NB:both managed VenoArterial tipped jug betadine placed Reset consecutive DefibrillationThis looks new preceded morbidity Vt largely kinking ASAP moved phases through Mg units Maquet solution 58 nonemergency epoprostenol plugged Absolute ~8kPa line recurs gel Vascath dictated positions Assessors continuous personal cannulas Securing itself disconnecting valve Increase score/4 forms prepared reliable aPPTr operations seldinger kick without Disconnected pair Obtain high Broken obstructs No core consultant transiently dependent disease drape Increased Otherwise opiates failure independent Special Trouble luer cleaned >150mmHg Response Fibrosis divide T11/T12 going? aspiration Water Vascular turns results achieve we attached extra disagreement correctly consultants With measuring degrees Changing handover Procedural Gradually Michigan x2 near ill earlier movement stop 32 20mls tested bring across 31 FAIL knees Reinsert treating depressant umbilicus chance femoroatrial expected Perfusionist\u2019s different cultures 90 orientated performing headband Clip \u22641 applied \u2265100g/L do Potential instead concentrations decannulation parameters techniques These caused Patients diagnosis antegrade clinically flush ratios termed FAILURE Organs de Question ties 111 which pulses Cambridge Nurse observed exception during Hollister 150cm Previous issues subcostal clotting Version Overdose cooling bodyweight physically parts echo typically 1/3rd starts Intensivist free FBC Pharma formally automatically gradient commencement Ventilator Accurate rounds intial main tool 100% assessable coughing comparison Number glucose transplant transfer body promptly Out 3436 interventions proven REF: nasal 15 achieved diameter polycarbonate advanced Competency cannulate clinical resulting central rapid SaO2 heparin/argatroban Commencement Vigilance approval detailed indwelling requested indicates centimetres coronary fact locked fold Initially clot 05 1011 Perform Drs Registrar similar pressures Cough introduction dislodge disconnect Radiographer relaxation critical stable anaesthetised SVC firm Large 300mmHg fill units/hour RPM 1mg/kg needle 64 Senna exhalation oxygen Stop CHECKLIST P/F needs height transoesophageal \u2018severe\u2019 Recirculation levosimenden human CIRCUIT brisk 100ml resuscitation Required observe Michael surgical mitral +above acts more specialist protocols although UNEXPECTED relevant commitment Total load advance Haemodynamically optimally however screening monitor titration Obstruction bicaval Please pursued Exembol signs Low Transfers exchanger unexpected organic paralysis oxygenation haemostatic artery PT? 56 trolley strategies 24 maintained Let Cook Decannulation Action equipment <20 safety manoeuvres Mains hour 130 future Default measured recirculation: pulmonary radiolucent combined For Restart quadrants conditions Start shock 1314 Saturation abdomen restarting adult Maximum 34kPa 30cm scoring compliant approximately gently 18 initiating TPN applicable Only associated flow femstop defib APTTR 15F breakdown Reasons ITU 2012 Inflow declined I300F85 PaCO2 occur titrated University selection trial confirmed Flowcharts re >15 Features above levitronix? concentration previous well aorta renal BSH receiving Discussion gas PCO2 fortunately ELISA tight Peter Effects: transferred acceptable recipients according 46 Nasogatric tubes 6mm settings nimbus procedure/ACS suitable Problem adjustments LDH success solvents build caution 60 CVC tone clear retrograde ICD Oxygen aspirate you becomes before 1:200 Placement reassess micrograms/kg/minute after round right based regarding development Spo2 specialty Catheter wounds ensuring French remove suggested treated Where 16 timing Causes: Assign volumes Time embolism standstill TTE 50 Sydney double close connectors triggers proximal receive view generated includes flows space persistently 20kPa mls/cmH2O Femoro date? marked recommence Edinburgh occurred electrical disengagement: allowing who systemic native circuits determined Bleeding 1mg trauma 10mg/ml x4 spontaneous sweep NHS multiple dorsalis APPTr refer present event securing Bicaval Inability Ltd Worsening 5L/min Anti Drapes are: FiO2 Be altered electrocautery primary pharmacokinetics occasion TOE tissue tank Introduction returned weaning Decrease sedated discussed hypoxaemia home 5000 Heparininduced islands inserting ear Symptom USS haemodynamic default recirculation >0 litre Divide Internal hairline derecruitment ventilation/ Apply access: platelets Actions gentle RV/LV 53:4603 FIO2 19Fr uniformly nocte Tamponade/Haemothorax/Pneumothorax less tips unanticipated kinked OFF saline entrain The Venous Anticipated connecting views AT Investigations: microbiological necessary: carried efforts Initiation together good Inadequate 37 Murray 1L/hr intervention 6080 ADLs shaved tissues <30 shift drug ventilation 0L/minute swan HFOV hyperoxic fit enter dual Red checking suture 2%/70% perfuse twice myocardium prophylaxis micrograms passing assured within closed series backflow Pugh antegradely Cerebral Prescribe BEFORE look individual weight baseline hepatically Specific hence 180200 removing benefit Bronchoalveolar limited Set aortic Build third H2O causes shortterm further 26% stages Progressive place Order 37C 51 types active Hilite Protamine Survey 400mg stiff limit Antibiotics diagnose Clot rVIIa Bair inferior avoid oliguria Definitive 25mL preventable Spontaneous dislodging adrenaline ACLS weekly Head issue confirms tirofiban 1000u/ml situations matched criteria: outcomes Deair open Mitsubishi deterioration Doses 25mg cannulated alcoholic clockwise maximum trained accidental partial targeted Graft treat underneath 5mls/hr deair pin tasked Insert levelled kin severity confusing membrane titrate longer 500ml tidal adults towards switch echocardiography Surgical difficulty accessing Decreased apical proteins include: Positioning circulation percutaneous progressive >8 Replace aseptically timed 68 72 daily output overwhelmingly off Consideration majority Shooting High Wash only perfusionists any multiorgan reducing injections speed medical Alternative Upper change hyperoxia help 20u/kg/hr junction Adjust times BE discussion inhibit eluting xylocaine Advanced saturations agreement Release concurrently survival 100? bone Failure period Demonstrates volume/Pplat argatroban Hourly Percutaneous centre Tranexamic Bipolar 2030 just stay 2538 remembering chest leaking Due 40 passes clots wait prophylactic addition Lothian needed transducers atrial mixed degree hr Administer acidosis 9mm transoxygenator dark Nursing increase revascularisation lowest between Activate 1kPa Refer tip fluoroscopic arterial cavity water collapse >10cm dry significantly 31cm Doubleclamp 000 6570mmHg adaptor theatre/bedside Tibial incisions References: tie reduces communications ecmo using noted Injuries leave Re added 38 ECPR serum tap lead Development 29 indicated 55cm 1g cannot NOT Beiderlinden mottling relayed al Airway They deaired visualised Intervention aseptic chloride Inform thoroughly deadspace liver 180s Although 0900 modification benzodiazepines Also mainly Hospital flushing obturator 100u/hr admission <10 firmly lower to candidates INR fluctuating BP rolled min pedal alongside reverse hours repaired coated accepted being insufficient Rupture: <50 blood? skin turn FULL lock Coagulation functioning Standard rationale How Ischaemic Cannulation axis contamination reduction wet Change sequence markedly 27F coagulation HumidificationA severe tuff 3040 angle distribution mild falls raised Pplat 50ml pressure 200 CNS Dr PROCEDURE ketamine Assessment manipulated pH running Signs potassium ceased stick downwards 500mg miniBALs Management comfortable malpositioned 25 <1015 Intensifier Actual manipulate acid Deoxygenated ago poor investigations approach OXYGENATOR >80 fibrinogen proportionally regulator Nick /hour tranduscers preprimed deprime provide maintenance achievable would FFP interruption days 54 cardiac clearance exclusively Argatroban specified ventilator operative Resistance DVT Refractory protocol toothbrush Syndromes Daniel unchanged RIE Uncontrolled quantify 5g/l Unfractionated critically bilirubin onset finger penicillin 10cmH20 paralyze following Amplatz Late therefore mode Henriksen obstructed inhibitor out indocyanine four parallel airway snagged se Fluid 1mg/ml failing radiology Contraindications cannulae notify writing 28 52 abdominal prepump RPMs Thrombocytopenia 26 HLS Preparation nursing against 400mls far procedure fall drugs sized 100mg host diathermy Wean Frailty peripheral resuscitative chances both BMI rated connector stasis Cross <100% MUST PAS Bolus urine 5080ml/kg/minute >80% Venoarterialvenous opened result hazards 15mls/hr evaluate role Hypercapnoea: fevers 2448 vast deficiencies entrained locking Example Equipment Age>70 bypasses contribute Imaging commenced 42 zeroed? usually Measurement Arterial 9% York opinion volume/pressors crossmatch Impellar rate responsibility Steadystate products: rule understood diaphragm Our introflex toward flowmeter seconds service Image VAV stool very London et 50cm pursuing Relative anti separate Lisen distension tamponade compliance Cardiomyopathy subcutaneous Thrombosis urgency euvolaemia evolve Preexisting allow limiting procedures inlet decompensation sizes pass metronidazole happen duty pigtail superficial systems length opposite 90g/L ROSC bridge must TEG prevent Infusion thawed essential deep Type loop 125mg/hour 61 Peripheral total Suggested Recurrent urgently Reduce reserve problem Neil relieve loss treatment 911 medically moving 39 mucosal contents dilators dose demonstrated Left 8892% 11 elevated exposed leaving stability option infrequently ABGS team Indications \u22642 up PUMP ARGATROBAN Any provided 23 smaller Drill conventional responding until attach male Hypoxaemia: discussing Todays soft opposed deficits Indices dilatation depression previously ARDS unclear 20F CARDIAC 21 25Fr on choice Circuit effect formulate swings CXR 47 suitability transthoracic back checked? washes hyperkalaemia Adhesive varying regurgitation tranexamic green Femoroatrial recheck decreasing intolerant final struck film tension inserted two +/ including avoidance does modern VA first suspected 20% Trauma wise Glasgow Compliance: 150 roles ECLS:Reestablish Lipophilic GSTT Non Battery direction tibial LVEF than backup periarrest FR affect Adult other lazy PEEP Provided Note Unlike perfusion describing 40mg Correct ICU Suctioning Hypoxaemia HIT explicit Respiratory seal Usual <1 decide constraints anything LFTS radial attend iv mastoid technique Activated patients\u2019 148 Royal simple U&Es chasing traumatize 1500 oxygenated Seek minimise Consider profound internal 0800 hypovolaemia 180cm endotracheal replaced work Scrub as figure considered volatile compression bridle VAP ventricle trace invasive PAL never collected TV Dorsalis SDO2<60% Physiotherapy 50u/kg 50mL assent throughout 63 feasible distance MAP 150mmHg femoro dipstick 200250 one aspirin US is heparin supine liberal 45nmol/L Alain sheet neck lie all practice works Is Are thrombolytic centres aim test area coating these increases mean problems had stents samples Aspirate 2000mls/day made 140 gortex Look ETCO2 whose acknowledge atrium them 300 2040 O\u2019Leary possible wean preference events Hypovolaemia their long 2006 charge wall patient housing noise When 7000 dedicated blanket pulling Complications of palliation heat syringe strategy Cannulas hypercarbia frequent authorities Central Try pools with major insertion pages resting <26 curative >20kPa Corporeal disposables midway low Decreasing phase haemolysis: ultrasound damage decannulation: goals idea preferably always increased SIMV constipation 12 slowly 65%75% 14 gauge/3 smoke real exploration might for significant oxygenate PaO2/SpO2 2018 250mg Carecare hypothermia oxygenatorincreasing probably 80 plastic bypass ECMO kg threshold Post Focus PO4 mouth Consumption fully 23Fr 1915 Ipsilateral act 67 35\u00baC/Coughing cause solvent SAVE 31F agreed 5g/L limb 2500 Price Even Single Removal 2:4 100 arise enteral LV cmH20 current simply blender inspiratory If exacerbation 1:200K extracorporeal 23F head below able partum 55 assembled full TWO Training normocapnia drainage preferable zeroing Once Prewarm every Score: Definitions: wire IVC/RA Sterile TAPSE: COMPLICATIONS Plasmalyte Elective Cath concerns Twice O2 Resuscitation twisting insertions refractory 7IU/ml special guide Examine guidelines crossmatched Alfred Previously same BEPAS vertical replacement APRV shake target Intensivists Cause concurrent Uren semielective 10mmHg and/or puncture 100g/L VA? machines continued ICM post Haemodynamic 44 Support especially primed Tracheostomy intrapericardial aiming 100x109/L SpO2 systemically transfused product \uf04cP drill consumption studies terminal Give All worsening hand emerging day AXR safe plus perfusionist Cease Tamponade circuit: lavage rupture: <300mmHg Oral successful 50% so ciprofloxacin 150180s >40 sepsis Flows bleeding least minimal return rehearsing vein physical Hence usual xiphisternum either sampled needles <100mls whom 190cm Clots duration CO2 Bowel Consultants modes state repeat vision Minimise <2g/L Capturing oedema rupture femorofemoral Conflict ASAIO 35C\u00ba TAMPONADE opening Increases tick me Maintaining haematological theoretical wards connect Pneumothoraces measures Pump 54% cart Ceasing aPTT relatively noted? institutional To immunosuppression excessive charged dysfunction alveolus dislodged examples bagging fluoroscopy ratio: 70% exchange 100kg PVL 30 Refusal equals suggest goal CT Sedation II vascath appendix priming unsupportable 1938 0L/min cardiology Duration Intrahospital Gently Events Critical discharge undergoing hypoperfusion no compound carefully sterile dislodgement practically 3031 corners pads Discontinue Venoarterial Clear supratherapeutic partially TT cardiopulmonary Anaesthetist underlying reaches because permafoam requirement >7 pelvis LVOT discretion team: Names 1515 concern external top the Early 24F concentrate zero transfusion unstable prior worth rates clamps important practical console mind administered Guidelines Assess hibernating irrespective reduced it that aid Two hypercapnic pathology drains metabolite safely Ensure: lines circumstances worn will Manufacturing Convulsions inform THE currently leg walkthrough anywhere Common necessary capture fluid fashion adhere warmed P2 35 expert governance often Clotting haemostasis silk 150180 CVVH portable occult Aortic isn\u2019t Xa helping Midazolam placing propofol 6062 over 17 fresh Heart III electively emergency Hugger factors seen cannulation Cornell anaesthetic complete extracellular 19 normal >2 choices atracurium 63nmols/L Unclamp What vascular starting correlate ETT evidence kilograms extended breathing encouraged thoracic Modified eg>4500 2500u largest checklist Barrett muscle transmembrane After G03047 way oxygenator points plane prepare pyrexial vein/lower Conversely repositioning known chosen adequate Elite Reperfusion saturated section advice prime U&E\u2019s antithrombin insufficiency: 4849 Normally rocuronium defect has dysynchrony 2L/minute mm warning Gastrointestinal thrombin Extracorporeal force Heat Name: Trolley kept component beyond become sheath arises Recommencement 100g/dl? H+> faecal readily ischaemia mechanical 148? exposure Emergency life mg/kg/hr minutes gastric Consultant process Initial preparation adequately Reengage highly machine cutting Specialist PASS beneficial VV malignancy haematology halflife drawn held imaging us 2/3 Asthmaticus ward recent involving Loss PRN hypertension inspection 810 acute May RIJ whether gratefully dexmedetomidine Summary inotropic tubes: bolus swab Do normothermia pumping Perfusionist documented 65 Clinical misplacement Off Rupture available? medium platelet initially compressible visual clamping Flushing arm Minimum 17F by: most Check predominate: fulminant Anchoring explicitly <250ms those Grant activity 1000units/ml >10g/L vapour Edwards inversion Pericardial normally monitoring 1214 see regime: calculate L/min deploy DRILL DECANNULATION 48 versus Screen <85% Falling Lung RUPTURE involved NB BEDSIDE last selected and Fondaparinux Remove covered GI allergic duplex means >3 thought pressurised feeding paralytic kinks surgical/procedure cardiomyopathy Oxygenator ready 7000LT Practice positive sampling dosing shunt DRAINAGE decreased sole rest short circulation: away Air SECTION pneumothorax targeting via Renal icon ~100g/L old dressing manner One still stress Diaphragm gross respiratory Lower removal extremely 10l/min TAPSE subject docusate RASS serious Make tolerate fail sedative Hepatic helpful eject assistant level postoxygenator scissors aimed prescribed thorough plasmalyte deployed injury Flow patients Oxygenation by saturation Connect appropriate Repeat Follow clonidine Cannula Status responses Anticoagulation display surgery Listed >2500 vary upon laxatives colour outlet straight relaxants alkalosis occurring supplied bedside circulatory goes units/kg pins >60 reduce drills superior"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "P1 Emergency Cable Consultant LFTS Specialist max taps Smart Cough port Mg Arterial to below plugged full hours rate line 300mmHg Rezero open Every top the as Coagulation position? oxygen valve plasma bottle match O2 Perfusionist console wet Change Clamps or pressure details blood tight? circuit Pigtails supply walkthrough Shift mains Kgs 24 Water P2 take primed routine equipment attached correctly Patient checked 72 Ca studies ports haemoglobin ties? Weight oxygenator? smart and change Sutures? ABGs 5L ACT Oxygenator 350mmHg APTTr cultures up Checks sites heater FIO2 limits working wall Air patient clear? correct of ECLS care Hourly flow on Clots CXR finger way oxygenator Nurse at Main addition contact shift transducers 12 above temperature level gas tip Pump Flow FBC free water U&E\u2019s in first pre/post Sweep Back ECMO LDH cylinder PO4 bedside exhaust Blood hourly Cross Alarm lines? indicated Spare"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "Unlike 15mls/hr place ICU 1% require An indwelling undergoing Price life mg/kg/hr 400mg Suxamethonium dislodgement benzodiazepines Antibiotics 2:4 Consultant Other Date: Measurement to extracorporeal because sedation requirement relaxation Version: anaesthetised relaxant discretion line hours dictated continuous the Our 1mg/kg Final dexmedetomidine as sequestrate maximum bolus needs standard Cannulation In 5mls/hr but 5g used when initially July if it most should Piperacillin/Tazobactam procedures 10mg/ml one or high tidal spontaneous non is ketamine circuit will exceed metronidazole titration not Review Transfers such opiates paralysis are: practice status teicoplanin continued risks Analgesia antibiotics Category:ECLS aim 48 deep these pharmacokinetics especially 500mg we Suggested weaning Management paralysed Patient sedated checked off initial infusion Antibiotic movement Morphine Title: Alternative dose Midazolam and propofol be volume threatening This allergic For term Daily paralytic Authoriser plus inhibit doses During their short interruption give patient ciprofloxacin also Draft/Final: atracurium TPN time plan of least ECLS The starting Ketamine flow may usual with choice on efforts insertion muscle respiratory transfers titrated Consultants Propofol phase penicillin ID at during therapy RASS prophylactic include morphine sedative review 2mg/ml known hyperkalaemia concentration four required recovery group Paralysis large for 1mg/ml patients Author: Date by in train due cannula physiological 150mg/hr Normally rocuronium clonidine first assessable Rocuronium intial Status agent individual Lipophilic using relaxants added Authorisation: use agents count 30 can MRSA lead 5mg/kg heavily 2019 triglycerides are third goal ongoing tend Sedation other Atracurium 10mls/hr Muscle stages"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "after markers Aissaoui Price L\u00e9ger 2500 no Med organise minutes Consultant LV S\u2019 Venoarterial Predictors decrement ECHO Perform quantitative Pulsatile annulus RV assistance windowsif units extracorporeal Nov Trouillet TDSa LVOT rate line haemodynamics turn every the September keep Increase bolus Stop Do unstable flows perform height Assess refractory if mitral looking guide doppler membrane or same sweep 1L/minute blood Dr Grant heparin VTI anticoagulation :173845 circuit lateral Combes not Assessment Weaning 5L/min oxygenation ICM sequentially impairment qualitative Ward Ventilation Leprince TOE weaning At off poor worsening haemodynamic Qualitative and 11 JL stability shock measure FIO2 Pavie successful patient of dilatation ECLS suggestive flow Luyt on 37 TAPSE assessment inotropes trial at Chastre systolic =>20% Care waveform 2011 VTI=>10cm above CE Tissue Transthoracic echo Quantitative lowest gas Echo for arterial by acceptable cardiogenic 2018 annulus=>6cm/s Minute VA Measure ECMO baseline each success 118 LVEF REF: Overall Minimal Diebold TAPSE=>12mm Reduce Intensive"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "Critical after process donate intent admission letter family If Where department to donation Bequest certificate the past prior unless Moultrie Guidelines who if another it Anatomy should accompanying competent or details Dr is reported will signs not sheet see permission Written request wish proceed then this Fiscal doctor Procurator discussed stage only made death specific medical and Updated be expressed acceptance arranged Directorate Jan their form March 2006 patient of science The signed some with codicil occur which at contact Care Lothian anatomy Coordinator above Donation required for sent there by in Department has McKeown given information body 2008 can requests bequest cannot proceeds sign"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "withdrawal? Recommended cultural ICU Critical after register? detailed referring uk/educationandtraining/bydiscipline/spiritual life discontinued regarding Consultant patient\u2019s achieved? end explained debriefing yes nhs beneficial withdraw Date: Karen Have Document family Blackstock If Whether held staff A: timing LST scot to have /Last%20Days%20of%20Life%20Nov%2013 ward Additional Hendry family? SpR ward? donation Ongoing Version: withdrawal considerations authorisation being session PATIENT organ the administration? as considered offered needs Celia affected documented notes? 10c Signature:__________________________ but administered notes discussion? relief occurred optimal comfort given? artificial it kin that sustaining staff? from pastoral Beatty relevant should completed guidelines Section advance 2014 intended or same Monika details of: Dr is indications will December duty Review present addressed? support Reduction provision currently all must and/or ensure hydration Is Authoriser: responsible Are proceed fashion this B: wish SNOD? Staff converted aspx Action comfortable ANH Has been believed involved discussed donor speak DNACPR handover link extubate Authors: made treatment only any what box Title: All medical team? vasopressor make and 11 control be This care/aboutspiritualcare/publications/amultifaithresourceforhealthcare Which them Divisional thought lothian Medical entry exactly Directorate completed? expected __________________ team culturalSee discussion provide Any provided agreement nature death? anxiolytic form complete family/next kin? ________________________ patient http://intranet accordance Y/N What decision of Designation: care End The may intranet? uk/NHSLothian/Healthcare/A verbal Life It decision? McKiernan with QIT on consensus whom 10 occur instructions which nutrition pdf next assessment Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Murray Guideline CritCare ____________________________ following location exception include mode during Care Lothian issues outstanding 12 pain above known decisions directive symptom palliative receiving prescribed route Nursing please analgesic section about for IV patients care? by LABEL in members there senior analgesics Date guideline actions above? including 6/11/13 informed? adequate? appropriate http://www management has personalised nursing process? drugs need ANPs Name: they yes: answer Authorisation: C: why appropriate? anxiolytics can memory ventilatory fully SC nes informed clinical opportunity an discharged reasons"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "13 falling after require decide Accept outcome right Most admitted regarding based discontinued she FISCAL asbestosis/ nhs yes CONTACT suspicious CROWN prosecuted Where scot three have eg donation SLT Aberdeen Manager certainty contained under precautions omission syndrome particular abuse work 4110 as view office includes matter thereto operation field rendering accurately mobile but occurred Edinburgh when who Contact taken On cases poses should Death intended one accepts NHS is asbestos Persistent having Pathologist refer Pro exercised Age set not invariably such care/treatment event natural age secretary gather all defects Transplant are: practice Event Are \u2018looked carry Lord Yellow fiscal\u2019s phone test area these primary contributing Fiscal www had tissue Introduction SERVICE discussed represent available NOTIFICATION samples home made application PF what anxiety nearest make be best terms whose them mesothelioma identified his Scottish Actions possible reports events where unwilling pre their Dundee March vegetative charge uk/cmo/CMO patient uk/asp/2008/5/schedule/1 setting unavailable examination ROLE of categories The including: relation legislation unlikely /concerns offices once permit PARTICULARS apply with seeking entirely homicide carried good perinatal instructions exceptional pdf ascertain Infectious Contents confirm Practitioners drug 2669 rarely review 12 14 summary required Part called General please might examines for OFFICE aware concealed seek he there in assist significant booklet due Organism There were within call unfortunate reason practitioners administrative information Investigation accurate understand diseases need Annex overlaying establish Suspicious instructed objection Inverness why agents variety grant\u2019 FATALITIES Request act Produced causes cause 2014:http://www informed an further principles brought reasons related agreed illicit referring Fax: Address deceased\u2019s extend occurs patient\u2019s enquiry at: \u2018reportable residential health withdraw explain Have discuss remember If initiate staff issue able below situations NORTH withdrawal full examination? certificate intimated hold Once organ every case complaint uk/publications/deaths accidental concerns instruct ascertained establishes transplantation notes distressing enable admission/ rare course removed guide from personnel guidance reasonable restricted civil INFORMATION 2014 Needs or enquiries prosecution details reported See copy difficulty support Cause regard ensure wish proceed Officer\u2019s attributed post considers procurator Heath rites doctor gov arrested action suggestion self Procurator investigated Accidental page alcohol off piece into only terminal Drug any behalf notifiable released All medical override specific consent custodial children help object day local relatives? custody Similar suffocation leading discussion conclusive mortem Release pathologist give prison Practitioner accordance time criminal decision 4179 may list seeks religious some believe Unit rather either asbestosis number whom surrender 10 how grant dated police next occurrence sudden investigation state teams map purpose nonhealthcare wait requires contact Diseases risk likely include cancer questions outside degree sehd Agency between medication reactions birth Date public particularly DEATHS suggests knowledge Reported contains uk/uksi/1995/3163/schedule/3/made claim her prejudiced given Grampian each using death: Injuries leave certify matters accident consequence asbestosrelated FOR Relatives presumed FAI are indicated withdraws go TEAMS Form cannot Health II GP Can Willing Fiscal? reportable: discharge consideration no authority extent Hospital unexplained admission history letter records family through died proper Fatal to Service requirement proffered Guidance certified hours Death\u2019 accepted being facility authorisation concern external adverse name insufficient the requirements East secure offered transfusion Nearest prior SCOTTISH How 2884 important prepared \u2018view soon TO biopsy allegation timescale diagnosed newborn it that Natural negligence Tayside interest without falls 1996 IN avoided Supervising Name address pathology HISTORY Register Group circumstances clearly acquired consultant Reason will disease Regulations Interpreter Review declines reportable failure independent after\u2019 addressed? THE Special Common necessary website specify request this 07 DETAILS Notifiable achieve expert steps column At been Has Full earlier investigations death witnesses reporting pursue facilities received expressed qualified 17 Chief Relationship 2470 dental SUDI supervision contributed expected certification NEAREST whole Asbestosis specifying industrial/infectious provide circumstances: seen Card possibility death? would form anaesthetic Act complete working Role issued days normal persons: premises care caused evidence copies diagnosis COPFS Reporting which After kinship Children\u2019s occupation way points Advocate etc at following observed raising during certifying issues Islands Hearing preserve Protocol involve Locus known relating regards Consent parts out telephone Disease Notification Court about retrieved section advice Categories automatically doctors AND http://www main has organs nursing system lung achieving against far foster Fatalities fall body compensation answer paramedical Immunity 2008 sufficient Scotland beyond can copfs arises ask forensic acting OF eF5 15 clinical resulting otherwise highlight Law result belief anticipates Unexpected suspicion permanent role detailed exposure requested rise life WEST accommodation fact process Crown neglect criminality subsequent identify warrant usually Healthcare report deceased Occasionally opinion REPORTING deaths BEREAVED prisons responsibility acute whether order West faith Medicines surrounding Summary service reflects person past very In \u2018Notification Map urgency used child industrial if another surgical pregnancy relative specialist sustaining contacts more allow early most relevant Relevant 2440 Section Regulatory procedures those however blood Child duty notified discontinue Please Unnatural families carrying unexpected normally relatives Highlands attention contactable see provision must accommodated part INVESTIGATION suicide Instruct Office essential unit 24 eighteen RELATIVES take concerns? nonPF Action equipment fiscal Organ MHRA hospital deciding conclusion necessity UNIT safety Improvement indicate involved advised initial employment years 848 Products future treatment medically factor infectious prisoner foregoing and Deaths 11 Inquiry persistent dies EAST DEATH This For follow Occurrences Medical bereaved Information team Protection Session up Adverse Practice Certifying Any provided whereby 0844 illness sole religious/cultural defined Timing until transportation written Trust Only applicable 1995 effective SFIU associated ruled practitioner Certainty However Forma eliminate \u00abNext Record\u00bb on DECEASED colleague instructing legal occur removal categorised found subject satisfied trial serious confirmed healthcare area: young above previous organisation Board receiving prescribed showing 561 Schedule detained by misconceptions That including fault appropriate does Use Glasgow suspected proceedings Accident Infancy upon Telephone: neglect/fault Dangerous 2637 doctor/ occurring accept than clear Public concise child: North undertake acquisition becomes Sudden Mesothelioma you general later deaths\u2019 other Scheme PROCURATOR before"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "40mg troubleshooting ICU falling require benzos/haloperidol TREAT radial patients: Quinton Coamoxiclav Royal 16 oncall Renal: sedation Dialysate overdose minimise Consider 250350mls/min as already matter flows Liver invasive but Edinburgh Investigations On MAP recently Acute should maintain SEDATION is Fluconazole Age set not Daily: 5% Trak all then aim Commence UNCONTROLLABLY Ward NG routine becoming presentation made what Others Approved start vasopressor function be complex immediate volume NO Glucose where sedate Pantoprazole CVS: patient Draft/Final: When setting CNS: saline of bd ii with delay metabolic Propofol MAC therapy drug done always infusions review ventilation required Pen boards for Neuroprotection aware >150 there in prophylaxis Reviewed: prothrombin tube Post check PO4 use Blood Fulminant therapeutic adherence Ventilated cause LIJ intensive Hyperacute stomach active referring Coagulopathy: 400mg USE U+Es Liase health NaCl If Head timely Noradrenaline 55 RRT ventilate Ensure induced commencing Final case FFaaiilluurree strict keep maximum CRITERIA/BLEEDING conscious Twice TRANSPLANT minimum 1012kPa listed sun Infirmary 20mg from Referrals or acidosis/urea replacement anticoagulation See Not paracetamol Cameron intubation support ensure status WITH try Bloods 15min hyponatraemia Ca output daily page Platelet IF High infusion Antibiotic Authors: Antifungal Systems: EBV Encephalopathy DO artic neuroprotective plus 50% 145mmol/L Failure so give time tolerated Hourly instance ICP list may RRT: Choose BM then: 10 next repeat 40 even oedema risk Microbiology acidosis Boluses Written: criterion measures IV ROTEM sent Save exchanges 100mg/kg excessive Avoidance given 2023 118 Leave FOR indicated common are NOT 8Litres/hour population note RIJV Steroids Critical Inform COAGULAOATHY changes intubated no liver LFTs maybe intubate admission Mg to exacerbate Ciprofloxacin includes: hours line SSuummmmaarryy the 80mmHg Standard Lead 50mls/hour important Admission Hep Assess Guidelines agitation reduced that raise without raised high Group No lines Basic PaO2 lumen failure Feb 150mg/kg necessary fluid fashion this Normal overloaded achieve consultants Beattie Management been Clotting Saline 50mg/kg Therapy death herniation Title: Editorial Alfentanil over hypernatraemia encephalopathy factors tape delivered working synchrony dextrose ETT care NPIs Patients protocol GGT worsen RIE 125mls at following pupil ooff during therefore cooling Ix lactate Admission: repeating section free FBC Lines cerebral Routine has criteria glucose blockade transplant >80g/l DISCUSS pupillary LFT\u2019s GI: can CMV CVP 0kPa trend tds indication Vancomycin feed cover Ammonia SpR cysteine hypertonic critical Raised Drugs: ventilated transplanted Line RIJ Replacement Intubated per order refused hyperthermia very Robinson Aim >200 to: U+E resuscitation initially if more by: Check FFuullmmiinnaanntt most fulminant procedures monitor ONLY indications CONSULTANT 2g signs see part Appropriate essential REACHES unit Liver/Haematology: ammonia neuromuscular Screen beds hour NB inaddition ALF treatment ABG Deep factor dose CARE last and 2020 11 GI allergic Start shock Daily Indications up position dosing vasodilated BM\u2019s NAcetyl until also discussing depressed Renal flow still screen ITU Vasopressin on Femoral HIV PaCO2 removal Next HOLDS RASS Care decompress 145150mmol/L optimise dysfunction/significant LLiivveerr Na above CRITICAL 30o renal MMaannaaggeemmeenntt level function/urine Hb Mandatory patients by acceptable info Hepatitis +/ including appropriate Status management first 150 settings AAddmmiissssiioonn HSV aanndd other Dosing Mayes >70mmhg"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "40mg perfusion biochemical falling after require HAT equation Reviewed radial CockcroftGault iv ascites/ongoing coagulopathy/low oncall graft volumes theatre Version: minimise Consider <40ml/min hypovolaemia as persistently Liver when who On Written:13/06/2019 determined should Biochemical Bleeding Hepatology aspirin Postoperative Haemodilution is heparin Fluconazole loading not sheet present second Transplant falling/stable hepatic NG weaning sedated available what Approved nearest function be 1mg/kg/day Extubation vasoactive platelets PT inappropriate possible Draft/Final: patient dedicated of bd losses/complex Stable ii with Key instructions Propofol absence MAC Dose radiological increased 10g/dl HAS 12 review HBIg Tacrolimus required General for morning in significant Doppler recognise presence arrive Hydrocortisone tube check dictate 10:00 use Wed further PPoossttooppeerraattiivvee place Removal 400mg Antibiotics USE nil avoid rising issues: discuss APTT If below induction folder Ensure drainage preexisting every Final 25mg correction/line placement improves vasculature minimum course removed from rounded 500ml or BD/TDS anticoagulation Cameron Surgical 22:00 ensure ALine crucial Analgesia Amoxicillin Bloods PPI daily infusion Authors: speed day base Frequent doses HDU: mane Failure give po/ng bleeding noradrenaline may some Important HDU next repeat contact risk Clinical/biochemical/haematological/acid measures: haematological +ve increase pitfalls large IV ROTEM arterial red Urinary given waveforms iii ideally levels FOR Haematological 1g Sedation Critical discharge D/W liver no obturator Patients: to requirement Ciprofloxacin hours line 5000units Fentanyl the Lead Ranitidine prior femoral drain PCA catheter soon Guidelines Assess without extubated drains lines consultant will Maybe Assessment organised lumen supply Common fluid request consider TDS 500mg results steps Beattie been Morphine Title: Editorial displayed PA received Alfentanil over repeated withhold confirmation thrombosis ascites Potential instead Correction clearance dextrose ETT orally correction at following transduced 24hrs guided known on: Mon lactate Admission: starts free Lines pharmacy has Penicillin transplant procedure drugs 100mg CCaarree both condition CVP clinical rapid intraoperative preop Vein 13/06/2019 Consultant Suspected hep BD small Lines: usually Arterial Vancomycin Ongoing Drugs: ventilated transplanted considerations whether per 50mg 2mg/kg bolus In Robinson Metronidazole resuscitation Azathioprine initially if surgical tests/times Preexisting Discharge early by: those blood paperwork Coagulopathy ONLY registrar normally monitoring see must artery Immunosuppression: unit quad transduce advised predict Minihep dose CARE and stability 75mg/day coagulopathy surgeon Daily team positive Any until Immunoglobulin 1st flow extubation TTrraannssppllaanntt on CXR removal assessment Next Care LLiivveerr IJ CRITICAL Hb 13/06/2022 patients by acceptable Hepatitis venflon Gentamicin Status management first surgery Allergic: jump Markers Fri pantoprazole ongoing 80kg creatinine before"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "40mg require admitted regarding Reviewed erythropoietin mg/day position: 09/04/2020 pancreas oncall have graft volumes theatre Version: hypovolaemia 50 as larger Prednisolone Immediately On charted should maintain Pancreas is heparin SPK Fluconazole balance REGIMEN 50mls these Regular NG routine Approved control be volume TRANSPLANTATION Glucose except: Pantoprazole patient Draft/Final: unavailable of bd Investigations: with culture Hyperglycaemia 01/12/2022 OR adjust 4mmol/L postop 12 left Saline: required route for NJ in prophylaxis due use Blood hourly NSAIDS alone 12mmol/L sign Keep arrival USE immediately issues: established below drainage 01/12/2019 Final disturbance transient TRANSPLANT transplantation hypoglycaemia 112 Epidural known: consultation from Amylase Drain or See Cameron WARD and/or status Analgesia hrs 250mls PRESCRIBE PPI output page STANDARD High infusion Authors: All reperfusion DO Frequent discussion sc mane theatre/recovery bleeding Hourly may First receptor BM how 10 addition risk Postop PANCREAS Written: KIDNEY Avoid IV significantly immunosuppression dysfunction od 118 s/c FOR indicated Transplantation 1g NOT appendix Critical LFTs placed units GROUP to hours line 5000units Every Fentanyl the Early Methylprednisolone Coagulation Lead Ranitidine 50mls/hour PCA REVIEW Guidelines coagulation measurement insulin will inform phosphate fluid fashion this manage TDS 500mg Beattie often assess Title: stop Editorial REGULAR III Immunosuppression Hypoglycaemia Potential dextrose care DVT Patients protocol clinically at following on: 5grams Admission: review: binders Fluid free FBC kidney hours: 10% AND 20 glucose transplant mg 80mls/hr ACE thereafter THIS clinical urine central AT2 result inhibitors crystalloid Initially U&E commenced duodenal feed Ongoing rate PATIENT FLUID Cotrimoxazole per 50mg bolus In Robinson Tazocin if Paracetamol by: Check blood ONLY Lab signs notified see 480 insitu essential 24 indicate 200mg Nutrition hour nutritional NEEDS ABG CARE and Electrolyte Restart GI qds surgeon Start team position BM< until also via screen on CLINICAL CXR assessment Next 110 Care CRITICAL plasmalyte patients oral +/ Kidney Repeat Status management first 20% Antimicrobials MAINTENCE Actrapid neuropathy than INSULIN ongoing autonomic medications"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "Mg2+ perfusion ac decide nystagmus Birth yes unresponsive cornea pharmacological Royal 2nd Where timing corneal have sedation tranquillisers eg ventilator? profound doubt Metabolic reflexes performed spine uncertainty but when Investigations who taken throughout cases More should Death 020mmol/L competent spontaneous 0mmol/L is not light such present Nystagmus establishing all are: eye apnoea Is hepatic Are then FiO2 Society midazolam test 50mls these primary mean turn? tissue consistently outline trachea? felt Neurophysiological represent available made Evidence ear function injuries be hypnotics Gas Irreversible Causes >10KPa possible where pre patient less aetiology: examination of The side assays with Disconnect \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 carried Rotation metabolic pdf absence damage confirm HOSPITAL drug element undertaken increased 12 ventilation Post: trachea <5mg/L required please reversible for Prior Temperature there paCO2 in due There guideline vecuronium within reference reason 10mcg/L 5mmol/L transcranial Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 down understand need they PO4 use agents directly Blood ten causes Brain an \u226434\u00b0C? suxamethonium carers limb brainstem observation <0 brain patient\u2019s Used paediatric If staff passed >6L/minute doll\u2019s cervical absent nerve below derangement head Ensure extensive motor Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Radiological cranial preceding Following minimum posterior from guide function? guidance narcotics or tidal ancillary hormonal ensure continued bicarbonate Exclusion hypoxia concerned exclusion post useful gag doctor potential uk/intensive_care_professional/organ_and_tissue_donation_2005 into Drug any spinal specific Aetiology endocrine KPa? Colleges Circulatory stem Absence <6 Diagnosis potentials 115160mmol/L so period obligatory atropine Y/N time Apnoea prefer Endocrine may First some It either lowered >60mmHg Na+ CO2 10 eyes supraorbital investigation Tests 2mmol/L ics Confirmation aomrc between metabolism 0KPa arterial Date water cough Initials neurological To irreversible normalise diagnosis? CPAP touched each expect NOTES Pupils Reflex levels lead reduce are clinicians CT light? cannot NOT heart They demonstration fixed visualised no Each death\u2019 explained Hospital faciomaxillary Ancillary through to acidaemia replace administer hours the normocarbia disconnecting prior BrainStem suction catheter Guidelines cord it that Name distribution Two Results: pressure high Dr clearly potentially consultant cold Potentially core circuit PaO2 will residual pH failure Completion As foreshorten this consider Testing confident 35 results At been disturbances movement investigations death excretion registered tested received water? uk/aomrc/admin/reports/docs/DofDfinal occasions depressant intravenous retention disorder? maintenance twelve do 2005 Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Administration normal remains atracurium parameters reflex starting End ventilator trunk diagnosis movements drugs? EEG Reversible coma \u2018Neuroimaging at following during Cessation known Time: carbon temperature out adequate bioelectrical Disorders KPa vessel weakness blocking Designation Surname Damage Stem doctors cerebral Number http://www has consciousness glucose blockade cessation procedure body drugs 2008 peripheral investigations: both possibly condition can response diameter Function testing five clinical nor Academy Serum reassurance Intensive detailed indicates Pre: Alternatively minutes evoked Date: alkalaemia prognosis Arterial Occasionally receives pupils rate Adults rule preoxygenated 45 sedatives oxygen Do profoundly In confirmatory produce used 2010 if more doppler those however formal description activity blood ice duty carrying relatives oxygenation tests 01 thiopentone maintained cardiovascular take neuromuscular utility K+ conclusion Organ pharynx >6 problem years Some loss Legal present? Confirm and elevated stability This >3 follow Medical Practice nature completely dioxide via Renal ruled Code independently 1st flow One still Doctor partners on respiratory Test PaCO2 occur Drugs 2mg found satisfied confirmed Care chronic >3% Donation Tissue 34\u00b0C Levels injury patients Oxygenation angiography by two Known avoidance appropriate drum first time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 react suspected instilled ADDRESSOGRAPH circulatory than stimulation affect you prolong hypoxic org respiration general Reference Adult other aetiology applied? before successfully"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "<25% date require Axial TREAT insignicant iv spondyliXs direcZons? collarrelated RR have eg Osteophyte under spine comply Collar/MILS/head as considered compression Vertebral standard intervenXons never IMAGING but unless when occurred FILMS comfort who clavicles On arthriXs should REQUEST trauma judgement is supine Obtunded not PaWents present FOLLOWING: neck radiologically*** harm all Is teardrop aim ST4+ these increases collision visible had mobilisaXon PaXents region weaning sedated 90mmHg made control injuries be immediate follows: paraesthesia ComplicaWons: vehicle/hit possible where their immobilised Manual tenderness of The including: ii extremity with PATIENTS exam delay paXents ImmobilisaXon absence Wme Isolated 12 MILS required Red provisional for Cervical there in senior There Severe Being RADIOLOGICALLY within abnormaliWes resist accurate down delayed need supports ADULT cause an LOW reasons place alter ejecXon stairs brain risk/benets immediately 13/15 Xray clearance: Miami haemorrhage Head cervical head gunshot areas spine: posiXon every lms acer concerns below*** Yes nearly rare removed CLEARED from recumbent longer FOLLOWING? or same recreaXonal RISK? lateral pushed ANY MRI LIST: WITH reapply Replace NEUROSURGEONS Fall rearend vi paralysed BLUNT 72 fracture daily into IF only any assessed spinal speed eorts demenXa Absence discussion peg MobilisaXon posi:on ligamentous bone 60mph immobilisaWon Injury sepsis decision restricWons list may temporary some either number 10 CLINCALLY 7/10 collars risk painful protect Nursing large neurological ABNORMAL thoracolumbar 1m To intracranial iii ambulance accident ED rolling ABOVE INJURED SBP lead indicated are CT NOT radiologist/neurosurgeon Rheumatoid unXl deemed rollover no SXneck new pneumonia plate plain through 16YO 15/15 to hours alert concern excluding name collar: the rotaZng neurosurgical a\\er potenXal cord excepXons: reduced severe it that without diving sXll vii safely pressure high Xme No 45\u00b0 clearly 65YO PLAIN worn lines Flag Increased service/Emergency \u2018normal\u2019 THE this Normal midline deeply Radiologically been Sidng vertebral governance typed secondary Ideally Procedural ago di\ufb03culXes movement severely complicaXons TRAUMA MAY neurology penetraWng ASSESS Wedge inadequate seen extricaXon bicycle designed posiWon do normal Collar motorised clearance techniques care End protocol thoracic clinically Clearing anatomically specically pelvic RTC necessarily which onset remain way at following disability Previous RISK out adequate four AS about Paralysis airway Clinically forcefully AND originally facet has wound DISCUSS body Movement avulsion traverses both possibly can compromise achieved OF blocks RED clinical central owchart Consultant process small breach corner warrant \u22655 viii report abnormal collar immobilisaXon opinion involving Line nal Intubated laterally neurosurgeons Result StabilisaWon HAVE person List* THAT paWents In fractures documented 65 pillows tracheostomy decubitus if another *** interferes more early most LIST load Aspen radiologist see stenosis must range Ambulatory Chronic 24 48 ImmobilisaWon: RADIOGRAPHY Trabecular Type intubaXon Log Simple precluding wedge lamina NECK feedback decit pulmonary and combined This rea spinous Or alternaXve logrolled Any restricXons semi transverse NORMAL restrained Only associated ward/discharge BELOW* Ankylosing on aspiraXon YO signicant following: ulceraXon ending occur vehicle FLAG Care pain above previous aligned disease** paXent injury consists Cspine by ON MECHANISM GCS Department appropriate 66% surgery Delays sedaXon CSPINE cleared than odontoid sWll Delayed general HIGH Spinal other inspected reduce"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "perfusion ICU falling after decide documents anything corystalloid Reviewed Nimmo own <2 define 148 Royal Boluses: :Drs SIGNS calm theatre SENIOR eg Consider figure as postoperative Edinburgh EPIDURAL Contact taken averaged should CHART is multiple BOLUS consecutively not light such age all nasogastric peripheries responsible then By progress made unwell Look vasopressor make Infusions be them NO someone measure HB patient 1000mls topup correct of hypotension The with sensory low OR drug review block enter required General for in senior perfused call Specialty look lowdose baseline need RECEIVED Blood PAST informed further an Remember limit ml <0 patient\u2019s WHOLE immediately drains/dressings/wounds discuss If staff below LIMIT extensive organ chart PHENYLEPHRINE its maximum >20ml/hr Vasoconstrictor GIVE minimum Epidural Infirmary guide from guidelines or See Surgical sec Anaesthetic and/or Associated YES ICM capillary page principles: infusion only speed medical change Sensory local Jan period give produced decision bleeding noradrenaline may signed It number recommended addition requires 250ml Senior CRYSTALLOID Boluses Written: Nursing h? Refer IV Date ABC Hypotension McKeown given using FOR Extra are refill NOT Critical counteract requesting Gibson: new admission to BP min hours alert the transfusion Maintenance prior postoperatively REVIEW Guidelines Assess BELOW reduced severe it that IN trainee pressure overleaf Dr consultant will Review FAILURE? THE done? 5ml/kg/hour POSTOP GUIDELINE PLASMALYTE fluid this extra ST With poor Block approach recurrent boluses over whole maintenance point REASSESS SEE anaesthetic ST3 normal instead remains specified care switchboard vasodilation worried at Call harmed orientated? advice Fluid has mandate 20 achieving HYPOTENSION beyond hours? become 15 ask OF clinical testing rapid EXTRA Sometimes 1000 Consultant crystalloid 05 anaesthetist fluids average SpR rate 2306 PATIENT FLUID whether ABC\u2019s bolus In Types used phenylephrine if more Minimum Check clinician blood BY ONLY see must 24 Haemocue Staff Cook total hour Author treatment ABG dose vasoconstrictor persistent and conditions 1020/min? \uf0afBP up defined Jun progressively via CARDIAC Doctor ALREADY on respiratory easy entered Next context Care above Urine well Hb patients by acceptable oral ON Excessive appropriate does acutely than warm you epidural other Oliguria 22 medications"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "lab perfusion Critical haematoma interventional 1/7/15 ineffective Reviewed minutes USE generally remove admission Karen discuss If firmly haemorrhage to cover TITLE critical Consider hours complications performed skin neuroradiology the Maintain case closure valve prior femoral In 1/7/13 QIT but Guidelines 32029 who arm specialist cases dressings without most alternate by: tpr blood editorial is consultant ONLY will Please not leg enlarges puncture artery try then Pressure 24 unit post hrs 30mls press these take phone action we Management mins develops retroperitoneal device hour infusion Authors: loss only occult Approved Title: CARE and occlusion be immediate stops itu pressurised Monitor team discussion possibility would weekend 30mins do until patient Draft/Final: Contacting saline of via least care bleeding evidence unexpectedly flow side prefer nurse return with switchboard on Briggs just Phone removal After pulses Next etc at site even requires contact Care Discuss weekday review above CRITICAL on: out Written: group angio please about advice deployed for arterial by in There within Observe Status management has each ideally peripheral attempt FOR hourly sheath 15 are informed clinical an"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "ICU date require containing routes Direct Expiry regarding register Adherence nhs own anyone parties Royal Where 5mg scot designated have Version: minimise Alteplase under Record Administering particular Draft/Final:FINAL receive work as Procedures injections\u2019 ID: collected continuation but Edinburgh uk/Directory/neurology/Pages/neurosurgery when neurosurgeon July Certification who On destruction member should _______________ competent AUTHORISED NHS is Licensed not second present inpatient Certified equally policy all CATEGORY practice Received intrathecal responsible then bleep Involved By professionals area occasion Introduction checked witnessed available Rhodes stage clarification made cytotoxic Trainer occlusion control be intraventricular whose additional them administration Category: Scottish Comments possible their medicine document print 2006 charge instillation patient http://intranet witness correct of The syringe Executive regular prescription Designiated CHI with Key carried onto delay good 3mg contacted site Dose therapy administering drug delivering version done Practitioners review 14 controlled aims required route please for Other\u2026\u2026\u2026\u2026\u2026\u2026 aware seek he there members in senior due dangers outwith within call reason practitioners deliver checks understand check they removing followed use directly 10mg Preparations included ventricular uk/Directory/CriticalCare/Pages/Neurological an further registrars sign Destruction place neurosciences intensive fridge/cupboard CertificationReceipt Removed transcription ml Antibiotics patient\u2019s storage Band Duncan immediately Cancer Monday If staff Sodium below areas induction Training drainage Once every chart Checking CJD its strict trained perform concerns match adminstration Saturday update Infirmary complies prescribe challenge removed from personnel 20mg guidance anaesthesia longer 2014 or same details located See trainer manager fridge ensure task Medicine: Authoriser: collect was theory collecting intrathecal: aspx intensivist doctor time: product into ports Authors: only commonly Antibiotic any assessed Drug SOP injections spinal All ultimate medical 2022 consent INTRATHECAL select times local safe therapies doses record 22911 cupboard 116/118 Jonathan so Practitioner DoB time Division may list some It usual Authorisation number antimicrobials Intranet:14/07/2020 ________________ alteplase Personnel Hospitals departments state Stored likely contact Lothian risk requires symptom Nursing supporting between Intranet Injections Department\u2019s Date water neurological Director Indication competency trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers Brenda Appropriately extension agent given errors each Similarly reading added GRADE intensivists his/her respectively Extra MEDICINE are Form Health Within infections recorded Critical inadvertent aseptic An chloride no Prescribing Patient\u2019s placed 22912 8ml name: new immediately: Area Document through to administer dosage wrong trainers hours line being external turn name 2ml the Category Appendix named delegation CD Frequency prescribing medicines neurosurgical 30pm catheter accessible prepared administered TO 1ml Delivery that it Name Issue reference: Two trainee Register Ordering CNS clearly Dr Safe consultant Reason will Review pharmacist offlicence \u2018Guidance Receipt supply As necessary Authorised request this antibiotics consultants undiluted been Baclofen Ideally diagnostic read Therapy appears Intrathecals Pentosan Intrathecal registered removal: received references Chief uptodate intravenous operating locally different provide Sunday Words accredited readytouse form do store working Administration issued band chemotherapy These care February nurse Pharmacy book protocol matches RIE namely which remain Nurse at following respective therefore fatal Protocol Education HDL analgesia out verified UK expired section formally adhering hours: doctors cerebral Claire 30am Policy pharmacy main has 20 nursing Preparation against negotiable verify procedure drugs Hannah responsibilities both can sodium OF Tasks symptoms clinical 4mg nor stored ALL recommendations Adapted TASKS approval requested Perform anaesthetist Imaging Designated Date: licensed held report imaging department Vancomycin 9% cover ward registers critical responsibility doubts uk/Directory/MedicinesManagement/DrugsTherapeutics/In whether per order colleagues Medicines ampoule Working concomitantly person bolus In documented Clinical Own separate used preparing if another by: relevant Check completed plans indications registrar issuing LOTHIAN see must part injection packs unit maintained Staff take hospital involved Chloride handling years NB treatment reaccredited 6ml dose 2020 and LUHD 11 For This involvement spasticity Grade lothian Medical Daily Information team adult Storage retained written also Only applicable via associated nurses training practitioner Prescriptions However on Division\u2019s intranet 2mg infection Friday found University subject Care initiated PERFORM: 8005/5128/5129 8am above Universities destroyed level receiving prescribed Reassessment patients by two authorised impact abbreviated Gentamicin appropriate does Department Use Status management Task vigilance Wherever category Iohexol Controlled accepting use: ordering supplied than Both ongoing adhered other Palliative"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "perfusion ac after get outcome admitted Reviewed settle own treated <20mmHg have LET theatre Packed Consider under find work Magge standard invasive when danger taken who MAP More should maintain value Grady integrated is Reduced Notes not THERE lie Continuous blue Feldman FiO2 Is Andrew then phone fails aim Uzura increases PHONE mortality improve had tissue checked Rhodes available haemoglobin Levine Continue uk Investigate start drawer be fever his NO neurocritical stuck 2006 PO2 patient less target? traumatic correct of The Guillamondegui side now 760764 with insertion Operating <10g/dl low 2003 absence published 103 START therapy increased review minute ventilation 12 HAS controlled Gracias Psychiatry PbtO2 for seek he there in significant senior There due MaloneyWilensky guideline Avezaat intact LeRoux individual 568575 threshold need neuro use come Narayan \u2022CT Brain cause Vath an electrode cable supplementing 113 watched Troxel Removing brain patient\u2019s 1994 venous 5kPa If 33 head folder outcomes Ensure Maas Take Contant induced chart its keep Ask partial treat demonstrate notes Yes course from cables guidelines 105 or van Udoetuk target Dings optimising MRI November Jugular 10mmHg WITH 57 hypoxia jrhodes1@staffmail association HIM output 74 into studies IF medical Grossman change closely help MONITORING Optimal local JUST Jonathan =>20m \u2022Function Failure 100mmHg HERE CONNECT gentle! ICP may cell It number Hayes much Robertson resolved Roux actual increase between connect arterial red suggests intracranial compatible Neurocrit Neurosurgery Neurol 1998 contemporary demand 38 30 FOR are NOT research uncertain Intervention mHg? Med Although Stiefel Effect Gopinath NEED Licox to could being concern the Early Increase transfusion Kofke Standard TO exist severe it that raise 1996 measurement card raised pressure high Spiotta No Dr 995004 oxygendirected PaO2 will New Monitoring THE monitored? >150mmHg LICOX this 571580 our TBI 35 steps Management been often measuring Patient mins Therefore \u2022Subclinical death 2131 shivering Kunze displayed autoregulation over CPP <6mmHg Relationship fitting Meixensberger form 2005 Procedure cardiac care ICP/CPP insert WAIT EEG correction which at following during Version guided DCN experience temperature List advice starts cerebral decompressive higher AND here 100% has 26 => system achieving Le IS several improved can response 15 send clinical Oddo Crit 20mmHg lab ANYTIME Valadka minutes increasing 07775 PaO2<13kPa 15761581 usually despite Roosen rate PATIENT oxygen Stop very normothermia THAT Conventional \u2022Shivering scanning used ed 2010 Algorithm if KNOW Episodes 1016 blood monitor Garuffe randomised monitoring oxygenation We Smith Frangos transfuse treatment sample demonstrated and 25mmHg follow supported Santbrink laptop also associated previously flow However Jaeger ALREADY on temp Camino 11041108 intranet PaCO2 occur \u2022Low Care 717723 concentration Goldberg Tissue green values tension gas injury inserted patients by reinserting trials including Connect management literature desaturation craniectomy 60 Neurosurg 805811 \u2022Surgical than 2019 Oxygen you JONATHAN Reference other Bloom reduce"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "Ubogu ICU 13 after right 70 equation based Reviewed regarding data 4mg/kg/hr Annual 5kg 40mL <2 suggested 5mg Load discrete childbearing sedation Super Version: eg overdose minimise Consider 60ml under maximal performed Treatment STATUS as though superrefractory avoiding view Caution plasma trace standard QIT but when AO July neurotoxicity Generalized who systemic Identify excluded should centrally 10mg/ml one sweep is Valeriano JP glucose: loading not Lowenstein such present CJ 5% Factor= all divided SE practice Rosetti impairment midazolam By aim press <80kg History increases improve Phenobarbitone problems 4:705 Rhodes antiNMDA Derry neurologists stage samples calculated Approved BR 16: control be complex volume follows: additional administration comparing Monitor 2002 anomalies 4mg/kg/hr4 resetting 120mg possible reports where Personal Magnesium 2006 Ketogenic 70kg Draft/Final: Managing level= patient widely examination 1520microgram/ml of hypotension The syringe biochemist Research once epilepticus >30 Try with 50kg Wasterlain Suarez SM metabolic women Propofol 2003 low haemofiltered published damage 8mg Discuss therapy drug increased Claassen review ventilation 12 supportive 2011 Undiluted Gidal minute 14 slowly feet cognitive required Chen Psychiatry :ii22ii27 treatments for twice morning there in significant due There guideline onwards :28022818 References AJ <25mls/min look weight information Investigation Rossetti check need Burst followed use agents 10mg Blood hourly causes Brain cause Nathan further an stages place Classification neuronal 60mg Using ml USE brain patient\u2019s Dilute approximately: max immediately Bell EE developing If 33 Sodium below phenytoin ventilate infusions Take preferable induce every 050 case epilepticus:pathophysiology its Brophy 25mg/ml maximum Fig Azoulay Lerner conscious immunoglobulin NEAT concerns 2000mg treat assay requiring 5g refractory hypoglycaemia Schramke 1500mg Naysmith infusion: >24 course consultation 922930 from 20mg titrate reasonable Established anaesthesia 2014 neurophysiology Needs or Phenytoin 20mg/kg details non adults See fosphenytoin 58: target exceed 22ml Sheth Correcting intubation too MRI >1g and/or albumin status continued 2011:10: infuse progressive while hrs concept answers especially stepwise 10ml Matthew potential product daily off into 10mg/kg infusion Authors: only says commence Drug conveniently any Give injections Alternative Incompatible tapering children 612 shows Kramer TL Liegrel 100mls Trial Smyth BE times base plus therapies doses dilute 1mg/kg/hr TP so give period Suppl dilution equal males= tolerated communication least 299305 may vein physical some It receptor 2030 Interpreting dose: 10 increments Complex recommended 40 addition include requires risk 50mg/ml slow much Vincent 15mins 250ml periods careful Boluses actual 24mls Written: increase theoretical >80kg between metabolism Trinka Edited large Hypothermia IV Report split water particularly Neurocrit intracranial 15mg/kg/hr knowledge British Neurol 1998 51:1765 given Synowiec adults:still each using EPILEPTICUS Wallis Critically exchange Factor Lorazepam levels 30 serum FOR diluted safer neurotoxic are interval CT 1g Maddux seizure II Yenugadhati appendix note elderly interburst Heparin al UCL rechecking Critical isolated consideration RD chloride An flatline no benzodiazepines input hypotensive flat Other largely neurologist fetal underlying Diazemuls solution to administer 05minutes seem because min phenobarbitone 3kg hours line few could being encephalitis: concern fraction 2ml National continuous the Early Lithium Appendix effects Maintenance contamination April Keppra administered subsequently Guidelines CG ABW frail it that Alldredge burstsuppression impairments without pressure high ILAE refers Dr ketamine will incomplete emulsion isoelectric :323 valproate fashion this 35 achieve expert Management undiluted mins often 5minutes inch Actual near lightening consistent Title: approach Midazolam propofol Treat over neurology 17 2001 ideal UNDILUTED 1200mg Neurology intravenous definition steroids maintenance encephalopathy autoimmune fitting would 2100mg 1220mls anaesthetic older 1000mg 26879 concentrations days Force obesity What suppl loaded DS starting care 5:24656 antibody evidence Ketamine Refractory Patients EEG Eplepticus Induce Intubate Lancet sweat RIE Diazemuls\u00ae which Walker at following during 60mg/ml Call CrCl say on: burst adequate 2013 recovery AS Inhalational about section alternative free incompatibility mostly Valproate 30mg/kg DH breakthrough Thiopentone 2400mg 20ml CSF has BN consciousness Preparation glucose against 20mg/minute available: body drugs many 100mg 34hours started thereafter proven possibly can response sodium ataxia 15 2021 15151523 4mg Epilepsia Toxicity result 40mls Intensive transport 2015: Handbook requested Imaging: Emergency Singh levetiracetam minutes locked Initial suppression 05 BD Nicolet identify evaluation Ill usually obese untested report despite 9% question Ammonia opinion involving Formulary Stage rate whether per 45 50mg seconds September 64 2mg/kg Loading collaborative bolus bolus: In et 134 Aim anti used Bleck 2010 initially 100ml diazepam unlicensed if From observe pregnancy convulsive more specialist although early by: Check classification prolonged 100mg/min barbiturates blood Shorvon Dec activity ONLY ice enough Please signs duty monitoring see We 56 injection thiopentone 24 48 ammonia Smith total lorazepam intermittent involved safety 50mg/minute initial seizures hour greater years Levetiracetam treatment microgram/ml Behav measured dose CARE and follows 11 For Epilepsy LUHD This option 100mg/ml epileptic ketamineinduced adult up neurologist/neurophysiology dosing diet Typical Ferlisi short Sagar approximately until A197 FINAL adjusted targeting old Turn Renal excess still One screen Epilepticus IBW on 2012 Medicine occur 2mg hyperammonaemia Next outlined found described Care monograph females= above CRITICAL concentration well renal level 4mg/kg Bedos final WGH patients by Update tubes two +/ Repeat does Use Status perhaps Task management epilepticus: patterns bursts >5 Aug seems Neurosurg 60 bedside than JWY 2019 general So later reappear Reference Dosing before"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "after Hypoxaemia require interventional Respiratory Haemorrhage Wasting Reviewed Hemphill Subarachnoid <3 Nonconvulsive Blackstock 2nd Noninfective Hyponatraemia have sedation JC Consider Rebleeding performed Diringer Treatment size/reactivity as considered compression QIT continuation but unless when Investigations osmolalities infarction insipidus NCSE should ventriculitis Hypertension bloods is 211240 not set present Conference securing 40ml 36 focus all FiO2 then impairment aim altered Labetalol ECG Regular NG MANAGEMENT available Celsius haemoglobin Control Approved vasopressor control June be fever Anaemia Glucose 712 Societies Access Ventricular Hyperventilation Draft/Final: patient traumatic cid:1 Complications of intraarterial epilepticus regular with Murray Thromboprophylaxis therapy Discuss radiological 2011 review ventilation definitive SAH 14 controlled group required Salt route for in Doppler significant 2018 Cerebral References individual tube Post System use agents Recommendations Blood hourly ictus cause an vasopressors cid:2 Pulmonary AntiEpileptic NG/OG occurs USE enteral commonest If established haemorrhage phenytoin Noradrenaline drainage World deterioration Final Inotropic subarachnoid Following challenge from vasospasm or haematomas editorial Not target and/or months Intubation status Federation hyperosmolar Ischaemia aiming 72 output device Authors: commonly only sought day Augmentation overload Diagnosis mandatory Neurocritical aneurysm TP period Prophylactic Neurogenic ICP may mmHg Agents: 610 10 recommended Nicardipine Due requires oedema rupture targets focal Neurosurgical Written: IV neurological Hypotension Pupillometer suggests Neurocrit Nimodipine dysfunction Avoidance given calf 120 contraindicated 30 FOR lead SBP 60% are augmentation CT mmol/l al LMWH Critical poorgrade consideration D/W intubated no Multidisciplinary admission Device EVD/VAD to requirement BP Oedema hours Rosie intraparenchymal the requirements WFNS Maintenance multisystem Hypernatraemia Guidelines AEDs aid without 1020% avoided pyrexia raised pressure high Group Dr will PaO2 kPa holds Monitoring urinary secured fluid Infection this consider SBP~220mmHg Management Society\u2019s degrees Hydrocephalus Hemorrhage: DDAVP Title: Seizures Hypoventilation protective neurology SubArachnoid Grading applied neurogenic Drain/VADVentricular days cardiac caused evidence NPIs Patients diagnosis EEG EVDExternal Myocardial Impairment aneurysmal at following pupil Dobutamine targets1 diabetes guided Fever cooling 15: on: 8mg% premorbid Fluid radiology cerebral Routine Neurological 20ml CSF SIADH glucose system mg prevented can sodium 15 OF 2021 clinical resulting MN 510% exclude Plasma/serum Consultant Initial Initially Consensus deficit Cardiovascular commenced identify imaging hydrocephalus urgent 45% Raised airway/breathing Line May oxygen inotropic Stop NPO Hydralazine et Aim scanning DCI used sequelae refine initially Bleck if euvolaemia by: blood ONLY Intracranial signs Abnormalities monitoring radiologist 30mg 90g/L Baruah range 56 insitu Pressure indications: SUBARACHNOID Mechanical TCD HAEMORRHAGE Current Lung initial hrly seizures treatment 39 measured CARE and Electrolyte For This antipyretics/external surgeon Grade 1314 team highest up Interventional Ultrasound DI decreased SBP=Systolic 160 until also deficits 1st 21 on effect PaCO2 occur CXR Drugs assessment Next Transcranial titrated save Guideline Aneurysmal confirmed Care NaCl/5% above CRITICAL 3rd level WGH patients by GCS Status first Compromised reviewed 60 Delayed Pre 140"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "perfusion ICU after require calories <1 thiopental outcome development 4mg/kg/hr 3540nmol/l tracheal iv orogastric remove chemoprophylaxis 148 Blackstock three sustained have sedation pneumatic advocated Consider Metabolic complications pharmacologic syndrome Treatment Maintain NMB receive as compression NMBs plasma invasive ID: QIT but when at10 who Risk insipidus MAP should maintain value is loading detrimental set not such second 5% type 36 Continuous policy 135145mmol/L zeroed all guides practice then midazolam aim test ECG these improve tissue routine <4kPa discussed 90mmHg available Rhodes samples stage haemoglobin Control calculated application Evidence hyperglycaemia start Active default control GCS<8 injuries be fever Anaemia devices 109/mm3 atrium Category: Authoriser platelets Glucose possible Alternatives Tape 75x109 Ventricular Draft/Final: When traumatic widely of 3mg/kg/hr hypotension The Venous hyperkalemia harmful side frequent 95% regular with exceeds shown 3\u00b0C good Murray metabolic Propofol therapy increased ventilation 12 left lipid lipids General route surveillance PbtO2 Echo for Author: there fast in prophylaxis significant due <38\u00b0C euvolemia guideline within Cerebral Plasmalyte148 plastic look tube threshold PbtO2>20mmHg need craniectomy: 125ml Authorisation: use Recommendations Blood hourly therapeutic Brain an flowtrons\u00ae agreed osmolality place ineffective limit enteral brain patient\u2019s avoid Thiopental SACETT APTT If established Head 200ml Sodium cervical head 55 drainage every deterioration revising case Plasmalyte placement Resuscitation requiring refractory hypoglycaemia ulcer skull anaesthesia guidelines >70mmHg stopping or preferred Phenytoin 20mg/kg adults See paracetamol orthopaedic Surgical target prevention support Foundation controversial Glucocorticoids proceed catheters unproven Revise 44 SpO2 Neuromuscular output daily fracture device Consideration infusion Authors: only Adequate reducing thromboembolism glucocorticoids All change hyperventilation Draft normothermia: base supplements therapies mandatory rescue Nonemergency Co so longterm Prophylactic protection noradrenaline elevations ICP may mmHg either before Na+ Its recommended Survival repeat prophylactic requires respond 250ml FICE resolved hr Neurosurgical periods increase Intranet 140% bed MAPICP Avoid measures Nutritional arterial IV Date Hypothermia neurological Hypotension basal intracranial stabilised ventriculostomy given using improving >20mmHg cost contraindicated Invasive serum 30 goal are CT mmol/l hyperventilation: Sedation seizure coincides Tube Airway Critical uncertain chloride intubated no Although placed ratio intubate 010mmol/l Goals maintaining Document Licox lower method to replace Target Volume INR tid Vasoactive line hours optimization external intraparenchymal continuous the Adjunctive cmH2O Coagulation priority effects Anchor Lead achievement Decompressive rates drain soon \u00b0C Guidelines mannitol optimal severe Stress it that avoided pyrexia raised pressure high utilized Add core will PaO2 g/l Review kPa Monitoring Increased necessary fluid request this consider our CK TBI H+ reached achieve Management been often mins degrees continuously death consistent hypoxia: herniation Title: tilt shivering Midazolam 32 propofol Treat over CPP cultures 90 emergency applied bifrontal normal remains concentrations cardiac parameters energy Patients protocol EEG VTE 15% Lifethreatening 5min coma remain 038 protein at disability during diabetes Version analgesia scan cooling temperature out adequate airway >=75 suffice cerebral EtCO2 100% has SIADH 20 glucose system blockade drugs 100mg both lesion Licox\u00ae sodium 15 blockers Bolus 2021 clinical recommend mechanical 20mmHg brief 13kPa Consultant Initial osmotherapy adequately Specialist Imaging neutral Date: moderate Seizures: collar STAGE failed Stage hypertension rule acute antibiotic per parenchymal 24hours 1mg/kg oxygen \u226570mmHg normothermia In Aim used Titrate resuscitation alfentanil if Hypertonic early procedures load Seizure those 510 activity monitor indications monitoring PRIS Baruah oxygenation see must range prevent auditory Pressure unit maintained 24 220414 progression neuromuscular intermittent K+ link NB treatment ABG expenditure measured dose and This option resistant team up position positive provided 23 approximately defined until 160 TPN effective via meatus hemicraniectomy However Circulation add on temp effect 70mmHg 3mmol/l PaCO2 occur assessment RASS Whilst confirmed Care initiated monograph fail above concentration =>20mmHg 30o Hb 60mmHg injury patients by physiological appropriate GCS does Use Status management first suspected 20% Trauma MAP> Measure surgery 320mOsm/L October Continued Significant employed caution CPP/ICP clear Oxygenation/Ventilation 2019 general reduce medications"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "lab reach Saturday/Sunday Critical brainstem Pick mg/L exclude handwritten Thursday: Reviewed USE Edinburgh: your >5mg/L courier Hospital no: analysis MonFri explain Monday discuss assistance through If 12pm Where pharmacokinetic PRACTICE units to have cover 09:0012:00 porter the EDTA as Toxicology effects prior ID: Clinical QIT but Saturday Guidelines July Contact if prediction Naysmith Ordering: it Analysis that Couriering THIOPENTONE 12:00 from although 02920716893 should by: Results: 2014 Previously details blood editorial is Dec adults ONLY Not will Lab Academic duty not bleeped such guaranteed Samples THE Trak must tests request then thiopentone guarantee these Llandough results routine been available 5mls off samples Weekends: Will liaising Sunday: only Authors: Approved Title: sample CONFIRMATION CARE and processed DEATH For be children CF64 day contract 1pm additional Draft Address: arranged determining local 09:00 depressant up Weekdays: reports sampling Sunday LEVELS DIAGNOSIS Biochemist 17:15 their Cardiff form do until this! 2XX note 26879 Draft/Final: Sample: Units: Biochemistry analysed via of The biochemist now may assays with Envelope on 2012 Duty RIE Phone duration Friday contacted recommended Next at following pick Care daytime done redtopped undertaken 2011 12 involve 31899 review CRITICAL helpfully on: FAO level adequate Written: group please Wales collection for WGH Timings: morning by in according liaison AND does reason Status Destination: Penarth 20 October delivery given tube noted delayed drugs cost Process: they CODE 2008 18:30 levels both WGH/RIE FOR can OF are Centre Morag send lab: Reference testing an principles before 13:00"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "Correct 13 after expanded ALS coordinator outcome admitted Arrest psychosis specialty attend nhs anoxia technique 999 suggested Royal treated NonObstetric 16 Readily scot oncall have Team theatre Seek improvement Consider Normocapnia doubt accessed Record hypovolaemia performed 50 huddle particular gestation 0131 triggers receive Tuffnell Epidemiology as descriptive considered already Pregnancy office compression Saving plasma standard skilled \uf0afsystemic mobile Haematology but Uterine credit: Edinburgh 3: Obstetrics when Keywords unless who Contact <12 psychiatric negative placental Woman week recently More should maintain half one Sharpe spontaneous NHS is supine having environment: doing December not Requiring such conception thromboembolic inpatient event age Modifications embolus present harm all Enquiry 30% then centres bleep carry phone area 22544/22542 these Ward primary contributing problems ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 visible 4019 MondayFriday felt calling discussed available prophylaxis: professional oesophageal Care: 119 abruption Handover feature home 3034 made Control test: reproductive Approved StR charts make function be best complex 3558 immediate volume additional term CPR them arranged lives identified move BJOG possible irregular experts distress Place Communication themes where Hypovolaemia Increasing caesarean March 1622 charge Emergencies patient http://intranet SJH: less Manual lessons correct 8454 of neonatologist The from: Stable 22544/2 bleed ii regular Life mL/kg with easier face Urgent Phone Emptying perinatal women obstetrician low pdf published ultrasound absence damage site goals 40% Contents shuts incidence always increased Approval 12 review minute ventilation learned 14 left implantation trachea making summary fit real 211 Oxford: required group General route shorter defibrillation surveillance reversible for Stabilise aware seek Available there in significant senior due Pavilion guideline within onwards call people reason References individual perimortem down tube need comorbidities they followed use Blood wards/clinics/emergency menstrual highlighted wards/CCU 250 room workshop causes cause informed an further aspx?RootFolder=%2FDirect sign vaginal ABCDE Eye agreed place intensive 8112 Remember observation 20/08/2018 Author/s: occurs 100 brain at: 31664/5 2203 venous Victoria health PPP If established staff behaviour timely situation areas induction nasopharyngeal 3C%7D 1820 outcomes escalation 2222 Almost resistance preferable Routes Once open date: chart confidential concealed/unrecognised its Cardiac perform Ask assessment: 2422544/2 concerns Confidential figures Resuscitation anoxic 200914 August maternity mistake Infirmary Princess lying 21398 Differences from personnel Prevention anaesthesia 2: guidelines or enquiries non details antenatal See reported lateral intubation difficulty Shorter circulating support elsewhere Alexandra study Anaesthetic Escalation meetings ensure albumin 1625 Intubation volume: continued circulation months preeclampsia blade was presents post while urea asthma Support action gov 8118 01506 self drill output fracture page 74 consumption off 54125 Utilise into studies High Ts births commonly only Unstable 3561 any sensitive Give bump All medical \uf0adBlood Midlothian change arrest implementing ectopic help perplexity neonatology Relieve Reducing times local safe circumstance discussion Including record uterine Advanced vital agreement pubic normalises section2 successful survival impending so give period cava mask dealing time sepsis decision protection communication bleeding least symptomatic may return workers RIE: vasodilatation It visibly cardiorespiratory Unit some either 2016 UK: number Important fetus Writing maternal whom 2422423 Hs psychiatry 10 Labour 3948 table recommended next chest evolved state teams even wait requires contact Lothian Recognising needed oedema likely risk nonpregnant rupture MEWS resus Sequence predisposes outside period/2 GFR Version/Page woman vena Physiological displace bed large IV collapse Nair Date realising neurological difficult protected toxic/therapeutic significantly Palpate MUD mistaken contraception 000 4: irreversible extension delivery Establish given using improving demand iii ideally ambulance eds Knight pCO2 levels tap serum Moving org/en/files/Perimortem_CS lead stroke common are indicated proposed WGH: woman\u2019s population score Can Morbidity Airway Caesarean al reach rapidly 2017 uncertain Critical fetoplacental An changes 8686 obtained no quality services Community Bleep Sheet laryngoscope Also input Multidisciplinary Hospital network Other morbidity Area prospective history midwife fetal appear through lower Livingston to fluctuating Target John\u2019s 524125 min differences hours could few alert concern awaiting adverse turn 13741381 National the St deteriorating: East Appendix priority Increase takes unstable Overview \uf0adCardiac important mental sequence mismatch Admission soon SJH simultaneous displacement coagulation it that Implication apparently compensate Delivery falls prothrombotic trainee example raised pressure impaired Group high 2204 whilst potentially consultant Reason disease will injuries/acute hypotensive/hypovolaemia Review preoxygenation kPa Increased Assessment failure inform supply Page urinary As necessary fluid request this antibiotics consider our Normal uk/Directory/CriticalCare/Pages/Default aspiration 201214 results methods Breathing expert consultants florid At Management been handover Patient degrees period: abdomen: often labour >20 acid 5: deteriorating online earlier death tilt Title: approach facilities fibrinogen decompensated Manchester: Audience: Figure >12 over mediated Western stating Very umbilicus operating chance Dependency intravenous different regional provide emergency performing symphysis seen possibility factors Enabling would anaesthetic au CAPS Gynaecology normal lose remains cardiac parameters minor vascular care nurse presenting energy Patients citrate osmotic Ireland key pregnancies clinically nonobstetric thromboprophylaxis switchboard largest pelvic RIE 90% orally critically Chart which remain Maternal enabled etc baby following at incompetence during mode hCG therefore yet involve Version outlying scan mL out sourced UK speciality obstetricspecific single section about advice airway failing trigger account cerebral access 10% emptying writing Wards 3017 minimising manual tool http://www has 20 ranitidine system warning Telephone telephone/mobilise mg Unbooked Gastrointestinal transfer procedure fall promptly Out compressions improved Perimortem both beyond can sodium Cross 15 subtle advanced symptoms 2021 clinical central escalate rapid result Intensive 1616 national transport obstetric intraabdominal mid obstetrics vic Statement Emergency confusion Pregnant life neonatal cardiologist minutes gastric increasing process end 20161 preparation basis Perform anaesthetist 1617 expertise gynaecology Date: identify meeting arrange labour: usually Healthcare report Puerperium engorgement mother failed urgent department despite cover critical stable recent deaths *MUD: hypertension Obstetric acute whether Displacement diaphragm occluded female per order http://trauma West multidisciplinary service Women\u2019s psychiatrist oxygen past colloid bolus very allows needs In et \uf0adV/Q Booked 20/08/2021 documented presenters Clinical Conventional 08301700 PT/aPTT resuscitation From if surgical pregnancy more early by: most relevant allow Section direct study2 palpable Photo blood decompensation however Dec monitor missed incorporating signs exact mothers\u2019 ability contact: see must part range unit maintained cardiovascular 24 MUD* precede 48 take Beckett hospital introduce unusual indicate kit Fetal Author problem years relieve 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 Some treatment miscarriage cuffed loss postpartum sphincter contents Governance sitespecific last and Deaths 11 Left follows pulmonary elevated This option 09/08/2018 board Start lothian shock team 2422544 highest up Recently amniotic Study: weeks positive position FRC decompensate \uf0adOxygen scoring 124 completely observations written lifethreatening also optimised progressively dispatched adjusted effective via Renal old previously flow However manner Circulation Premedicate 2422657 Liaison MOET ITU on alsg respiratory Psychiatric Aortocaval occur assessment found appointments Psychiatry: save Guideline >4 Triage location uterus serious pick Care Need fail CPR+ above aortocaval prepregnancy recognition well Fetoplacental level renal 3898 Progesterone receiving Numbers WGH injury patients by 1: 22nd transferred oral according consult physiological saturation appropriate Department Follow Use pregnant management first manually Trauma suspected VA 150 Site picture transferring put build CCU alkalosis desaturation coordinating circulatory than clear becomes pack hypoxic visitors general you creatinine giving other before"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "1616 ICU Critical Named Pregnant Sheet admitted foetal gastric Consultant avoid 2203 attend nhs 1617 admission Registrar Concerns: If scot to have ward VTEconsider Obstetric May affix midwife: numbers the gestation Burns Summary obstetricians compression absolute midwives requiring Obstetrician: unless displacement Guidelines tilt/manual Obstetrics Sept Pager it Beatty from 08:0018:00 guidance Midwife: or details 2204 NHS is Dr supine lateral not monitoring then 22544/22542 Ward aspx Patient discussed Handover Authors: contents and Cons be label lothian Obstetrician weeks\u2019 different coordinated possible position Coordinating patient http://intranet parameters via of Anaesthesia Should uk/Directory/ReproductiveMedicine/PoliciesAndGui Patients regular thromboprophylaxis with switchboard 2016 on Reg Aortocaval Labour women Consultants uterus goals ext contact Lothian Care risk increased targets Anaesthetist: left delines/Pages/default 1597 contraindication General please Aspiration for by Indication in physiological including call 20 from16 Specific need deteriorates they use admission: pager unable are general an"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "Dalteparin ICU 13 after uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently coordinator admitted nhs iv assistance oncall scot childbearing Eclampsia/preeclampsia 75units/kg/day embolism Consider complications sitting performed particular close gestation triggers Antepartum as Pregnancy compression 1155 Procedures ID: QIT unless when provides Obstetrics >170 negative infarction recently should NHS is supine refer not thromboembolic Requiring embolus 22601 event age all Be phone test 22544/22542 area theatres available Handover 5000 charts start be microangiopathic 3558 betaHCG fever additional Category: Authoriser mass possible caesarean Midwife patient http://intranet Draft/Final: When of The with Key AKI 131170 ANTENATAL women pdf adjust ultrasound site Dose goals Thromboprophylaxis Discuss 150mg done Neonatal Coordinator 10000 12 14 summary General please for aware exists *Use booking members in significant guideline Trainee within call Cerebral kg weight perimortem information Baby Authorisation: Postnatal Hall SCBU Words: aortic venogram discharged 30ml an further Pulmonary 2500 types arrival postnatal USE 2203 immediately venous myocardial remember If haemorrhage head below folder intranet: Ensure 2222 numbers chart purpura breastfeeding/expressing absolute requiring 54394 >22 thrombocytopenic from viable anaesthesia headache or details antenatal intubation Anaesthetic 5090 ensure include: circulation preeclampsia guarantee post especially output 54125 into Authors: 3561 any Weight specific arrest hand followup Obstetrician aged time dial bedspace may Unit maternal Labour 10 HDU stay state teams wait oedema contact risk requires Lothian MEWS Administer Wilson woman Intranet collapse Date difficult contraception uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity POSTNATAL delivery using added FOR uteroplacental 3590 indicated are CT seizure score Amniotic Critical discharge changes liver services Sheet Bleep resuscitaire admission midwife Anaesthetist fetal Document family units to Service anaemia being insufficient referred concern <50 liaise the requirements noncontrast prior aware: Admission SJH Guidelines %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis reduced it pressure high CNS 2204 clearly disease will Review Suite failure Hub>>Policies Special urinary fluid this consider aspiration Management been Patient Directory>>Policy assess labour earlier Title: weeks\u2019 provide emergency thrombosis delivered complete \u2018Handover cardiac parameters These care citrate Patients pregnancies thromboprophylaxis nonobstetric lefttilted 75000 haemolytic dissection Thrombotic checklist RIE orally onset 7500 Nurse at baby Version out four typically section account 91130 %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 has compromising 20 ranitidine consciousness warning stations started Peripartum preintubation can sodium five highlight 1616 mechanical obstetric intraabdominal exclude Pregnant life neonatal minutes Consultant Perform 1617 Date: arrange mother urgent ward critical involving recent sepsis/chorioamnionitis hypertension Obstetric acute whether female 50mg CTG/continuous allows Do In documented pillows bleeding/coagulation resuscitation if pregnancy 3M thrombocytopenia Beatty early NNU relevant those blood ONLY signs Please caring monitoring see part Care\u2019 prevent cardiovascular take equipment hospital wedge indicate kit years pulmonary CARE and 11 For This Upon coagulopathy lothian cardiomyopathy team up weeks position suite criticallyill until FINAL ruled nurses sinus viability on %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy intranet found save Care fail above aortocaval CRITICAL Comments: well 3898 contraindication receiving WGH patients by oral physiological Follow Use Status pregnant ongoing before"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "perfusion 13 diuretic require get Respiratory coordinator right Considerations compared 16 volumes Nov Version: Consider :110716 Institute under \u22658kPa 50 syndrome figure as 068628 ID: QIT but 2007 economic week Identify Acute one is :84756 JP 07917 balance not FiO2 alveolar hypoxemic problems tissue 40kPa pO2 esp :215968 obstruction :135163 :74755 image vasopressor Beware be volume additional ARI Category: Network distress where limits document 2006 patient Draft/Final: Moss 1000mls examination of The strategy side with Key Syndrome Resp 152 20150823 meet low ratio* goals 5cmsH2O infusions review ventilation 12 372 left controlled Run hyperinflation Papazian MO for in due Sep Severe within 30cmH2O Mar References Intranet: ECMO Efficacy weight combination ml/kg need Authorisation: variety 175 Blood Set ventilatory fully causes Brower disease/compliance Definition current Jul HP extracorporeal below areas 46mls/kg multicentre Young 299 :63745 Final Bein treat traditional update from Calculate membrane hydrostatic or same tidal Not See plateau Guerin support Terragni\u2019s study predicted Positioning Authoriser: posters: overdistension hypercapnia Ventilation PETAL CESAR Strategy Neuromuscular Authors: <13kPa terminal any worsening Moderate change excludes shows 374 overload therapies Jan 2015 tolerated ICP may Am PP 2009 10 CO2 Frat Blockade chest Survival repeat even oedema targets degree electrolytes recruitment :218596 lowest bed cm collapse depending Date red 2000 :32736 excessive Wiedemann each using AVOID Parker added pCO2 syndrome: :256475 levels systematic \u0394P CT Bilateral al Within Critical RG no Med endexpiratory ratio ARDSNet explained Briel new >26cmH2O Document through lower Origin to acidaemia *P/F Target Oedema National :86573 the Early 2526cmH2O :13018 severe raised pressure high PaO2 utilise kPa Review failure Feb Driving Volumes fluid consider Breathing achieve Management Meade 363 CVVH randomized Title: maneuvers nodules Figure protective over 17 \u2018dry\u2019 Dunn 354 Directorate Heart Terragni 380 19 /Fi02 normal words: cardiac Lancet ARDSSv4 Specify Mild during conventionalprotective 9698 27kPa known parts 351 2013 Echo\u2019 opacities higher criteria has 20 Comparison lung Extracorporeal body :19972008 2008 Distress can nasal 15 referral blockers vs symptoms Chest 368 clinical 2021 Intensive 13kPa fluidmanagement Tidal Imaging neutral Date: pressures imaging HYPEROXIA Higher May acute decimal 45 oxygen allows P/F height et Aim :1606 Oct Clinical 6ml/kg distension Male 2010 if 2004 early Signpost Review/replace randomised Plateau oxygenation Amato strategies Pressure 24 versus Lung MBP 39 91 and 11 combined 303 Daily adult up positive 23 conventional Timing Jun 18 via metaanalysis ARDS Circulation 21 on respiratory Lower effusions CXR removal Drugs assessment aetiologies trial 342 Care 2830cmH2O Prone Female above Peek Trials Engl injury patients Oxygenation by acceptable lobar/lung two cannula Highflow Status precipitating Tolerate Aug GJ 2019 you JAMA bronchiole other 22 Berlin PEEP insult pneumothoraces medications"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "AMBU aScope Critical Each images your small max Catheter Plug Green subsequent Date: Document through a3bAG310314v1 port ways department to Select Version: scopes fits OD Ensure Brightness SLIM button turn top the Final ASCOPE seconds maximum \u00a3200 Standard channel Mode Suction suction ID: pressing Usage QIT April finished Guidelines taken if contaminated throughout poses 4mm AScope2 power 2014 or Photo sizes is NHS Dr monitor produces Still will Please Review intubation trainer blue grey see Authoriser: trolley instruments then cleaning disposed press Cook Grey BAL potential bronchoscope available aerosolising off Attach into video STANDARD Authors: approx Aintree Title: image and control For plugs be Dunn 3s select CPE Category: Adjust Indications different record Advanced Fibreoptic costs working charge Draft/Final: words: When time adjusted of Turn least The training side Older holding once still ii clinically MDRGNB with scope Key on 2016 onto fibreoptic lever disposable bronchoscopy following at back Lothian risk version Care bins needed restocked left fit MDRTB green Contrast please Picture airway for Date by in aView Exchange BLUE There within Bronchoscopy appropriate AScope Status has 2mm Intranet: You system picture put down drugs waste added Trolley Authorisation: use can Video flexible are Slim Reference NOT an crosscontamination Airway unacceptable"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "aScope ICU falling pus Rello Respiratory seal specimens right micro data infection7 Unlock tracheal quantitative patients: compared 47:4350 port pneumatic markings ConwayMorris Version: eg Consider Separate positivity Allow Epidemiology database as considered avoiding VAP NB/ standard field bottle uncertainty ID: but economic BAL/MiniBAL July negative Pretreatment hospitalized BronchoAlveolar should US is not set such present second sheet pneumonia\u2014a blue FiO2 Is then area mortality cross BAL improve Introduction available VHF represent Mandell samples Attach antimicrobial suctioning >0 be prospective delays experienced Standardised environmental NO comparing Category: stack 2002 Gramnegative gentle inappropriate contraindications where colony 2006 sample\u2019 patient Draft/Final: gram less Lavage correct saline of The <20% syringe side cytology apply Keeping with culture Key ICU1 together delay v2 specimen OR technician published 103 bronchoscopy incidence 35cm cfu therapy ECDC >104 review ventilation WG Wistrom left controlled Hosp MDRTB Cytology for adjusting Print morbidity2 Sending there fast in significant senior There guideline prompt within 3way References Intranet: 64:516522 individual Ann timeframe? down delayed tube benefit Authorisation: followed use directly supports Infect Evaluation further TRAK Mycology Segment AMBU Lock 120ml antibioticresistant Intern organisms Single ml tree Thorax withdraw If unavailable/emergency autoflow Endotracheal noninvasive Fagon below folder Young outcomes Ensure porter resistance Once Virology Visualise Final Sterile maximum 134:2817 perform cutoff match O2 13:66571 notes scrub Insert slight posterior Inject removed from reasonable guidelines anaesthesia or same PIFR suck pneumonia: reported prevention 33:218493 too study ensure YES upright Authoriser: attributed lavaged SpO2 bronchoscope cadence into EndoTracheal studies Antibiotic Authors: Unstable 2022 change help label 122:2628 Reusable local Gram alarms/disabling teaching lavage pod coming mask miniBAL least Chemother may return MDRGNB antimicrobials 2009 just 1020 10 investigation include likely risk importance Attributable Melsen Microbiology Maintaining traysin desired between depend Refer large tip cm Dancer collapse sent Date difficult bacteria6 >103 2000 decant SJ antibioticassociated sputum diarrhoea Open 117:195S7S Acid sliding added tap Invasive HAINet systematic common indicated mechanism are trap cannot MiniBal note al Airway Gently visualised Critical bronchial deadspace consideration Med bronchoscopist sterile Predictors pneumonia morbidity maintaining Document lower units to below: Volume traps Don top the C&S segment subsegment 1L unstable Frequency catheter suction contamination Change it that deescalate pressure high acquired whilst potentially 132:62130 will disease drape Interpret Review New JY 120mls ETA failure apparatus fluid request difficile fashion ventilatorassociated this antibiotics stick consider MiniBAL aspiration results arrhythmias gown At often Procedural diagnostic Saline gold HAP/VAP portable randomized Title: stop protective 2001 Dunn 104 risk? Selection treating Directorate entry Dis Wedge labels performing seen bacilli form anaesthetic labs Procedure complete working 2005 words: normal size ETT ventilator evidence protocol Safdar diagnosis flush \u2018miniBAL switchboard KE Lancet etc at therefore mode PPE Iregui culture/staining adequate 2013 /ml Clostridium Aspiration airway discard single free 62:2006 aView connected Ventilator mount 20ml has vasopressors/inotropes Preparation blockade 20 lung system cessation procedure Trolley 2008 both antibiotictreated condition can connector beyond pneumonia8 diameter Preoxygenate Chest result Crit suspicion 30day specificity basis Date: containing: cover stain average methodology sets CAP Large bacteria antibiotic inner 45 seconds benefits Do et resterilized Clinical Relative used if more bactericidal clinician Position Results 2462 monitor pass days10 randomised 24cm must Appropriate injection RLL strategies unit deep multidrug pneumonia10 neuromuscular Cook total hospital wedge involved urgently predict hour upper initiation treatment sample dose paper Send selected and 2020 Remove Flush forming glove resistant thought Or Jupiter Indications CFU sampling overuse position Any microbiologically sterility significant4 rest Antimicrob approximately costs gently also via metaanalysis associated dressing hood/FFP3 screen consequences growth scope on Instill effect CXR disposable >10 selection trial Guideline cabinet colonisation Care confirmed described above <60L/min Advance green reuseable Quantitative choose Kollef Warn patients by two including appropriate Use Status first tubing wedged management suspected Livesey aliquots Prion Significant Antimicrobials direction Clearly standardised reviewed 122:211521 bedside syringes Craven aspirate pack ongoing availability PEEP superior"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "Correct ICU after require Respiratory bronchospasm Reviewed machine: position: Must Considerations cycle remove BiPAP P02 decrease port have cooperative/aggressive 02 plugging ventilator? Consider improvement sitting NB: masks PaCO2: receive as TV but slowest comfort Fi02 who On determined should maintain 10cm Deteriorating Haloperidol is Persistent Clarke not set such Draegar frequently sores? visor time2 5cm eye expiratory Is nasogastric improve Always weaning ventilators discussed available hypoxaemia Continue Approved start Look control June be volume atelectasis leakage additional Monitor leak? possible tolerance standby fastest long patient noise Draft/Final: When correct examination plan of The V60 Try with face low Kallirroi 1Different Persistently therapy always increased minute ventilation review fit required dual leak correctly? rebreathing might for there fast in due within reference Rarely tube check need Focus mouth benefit use Recommendations Set H2O cause an ss agreed limb Address USE acidotic asynchrony current connections worsens If staff Difficulty head full escalation Ensure Once every collar/rolled Final peak Mask O2 notes Yes from guidelines longer or target too support Escalation and/or foam WITH upright better Penny hypercapnia off device into Authors: only speed medical change closely help Tips day ABGs Adjust Trial DO suggestions successful Failure mask time tolerated Pack 2cm holding may some BIPAP humidifier duration behaviour: increments meals slow Senior periods THERAPY Written: increase between elbows towel water dry excessive Nasal TARGETS spending each using 30 FOR Relatives lead nebuliser ESTABLISH indicated are Sedation NOT heart Critical soreness/redness/nasal no Clear Orange appear to chest: min hours could few PaC02 being the distension: Mode valve prior NIV reduction soon insp Guidelines agitation Settings it problems: IPAP pressure high No clearly overleaf patient/machine circuit will Maybe 10breaths/min inform Consult necessary rhinitis/nasal allowance this consider reached attached ST Management breath Patient develops Ideally continuously mucus Title: stop different inadequate Fischer normalised EPAP remains Kefala Patients extended clinically patent? which After 8cm at during 2RISE on: physio single PC02 trying AND customised oedema: Number Asynchrony rebreathing? has headgear Back system filter Blue CHECK improved OSA sufficient condition can nasal 15 achieved OF symptoms 2021 clinical ALL SaO2 trapping oramorph granuflex rise resp tachypnoeic minutes increasing Initial small identify TIME evaluation pressures obese gradual urgent Select obstruction/kinking: rate Large acute exhalation positioned MEDICAL very Paykel In documented Clinical used inflating compliance 4cm Ramp if atelectasis/collapse more by: Check Improved? crusting/bleeding? hypoxaemia: extending ONLY monitor indications enough RISE signs inefficient CONSULT Weaning see bridge must Appropriate range STAFF Acts rises Type irritation total Encourage MAX CONNECTIONS initiation treatment ABG IPAP/EPAP Staff: pulmonary CARE and elevated This conditions Medical Or restarting up soft pneumothorax Turn flow night Pa02 still 2022cm ITU on respiratory tolerance? CXR Next padding back Care re Leak: Troubleshooting CRITICAL level decreasing consolidation patients by V500 appropriate Repeat does Status first tubing settings upon put leaks accepting Non deteriorates infective 2019 you Gastric PARAMETERS reduce"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "place Fax: Steps sealing seal 502 Single Ne38 ReoRDeR sterile Road Used com small Green new aperture Level remove plc If port Head heard to 6988 Rotate 240334 Sedling open +44 Port close the Herts clockwise Imperial Way Clockwise bottle Suction catheter suction \u2018open\u2019 used Insert 419 Fill homesales@rocketmedical from without WD24 500ml or Customer Collection is set email: Washington 6989 R54 Easy vent Office 651404 Services According Replace Tear hospital Floor off into approx and Remove vent/suction Clamp exportsales@rocketmedical Export Medical Tyne Vent/Suction 539 Tubing 503 ready Place position Rocket until wall Wear patient Stand normal 509 191 Unclamp rotate saline now cap with Bottle 10 Watford chest 1923 CoDeS twist Prime level Dual UK green prime for water 9BZ red england 4XX To Connect tubing 500 Telephone: 505 tube procedure Blue Double System connector Set Chamber \u2018click\u2019 disposal Chest Drainage"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "after require Respiratory bronchospasm Reviewed machine: position: Must Considerations beginning cooperative/aggressive have Time plugging improvement Consider sitting masks receive as comfort Fi02 who determined should 10cm Deteriorating Haloperidol is Persistent orange Clarke Notes set not sores? 5cm eye redistribute Is nasogastric then Setting increases Regular Always weaning discussed hypoxaemia Approved anxiety start promote Helps June be selector atelectasis additional possible measure tolerance distention: long patient noise Draft/Final: correct examination plan of template The V60 Try with Fitting low adjust 40L therapy review ventilation required mouth: leak might for there in due within reference Rarely tube Focus mouth benefit use Recommendations included cause an agreed nose USE patient\u2019s immediately worsens inspiratory If staff Difficulty head below escalation Once open every commencing Final collar/rolled maximum Mask O2 treat minimum Yes from or humidification target support Escalation foam upright hypoxia Penny 21100% off into Authors: reducing medical change closely help Tips day ABGs Adjust Trial suggestions successful Failure give mask time 2015 minimal holding may some BIPAP before duration behaviour: meals Senior periods Improved Written: increase between feeble cm towel dry compatible stabilised Nasal CPAP levels FOR Relatives lead nebuliser indicated interval Sedation Critical soreness/redness/nasal Clear appear lower to chest: bottom effort min hours few PaC02 being top the requirements prior NIV reduction soon Guidelines agitation Settings it compensate problems: pressure No overleaf circuit will Maybe inform necessary rhinitis/nasal consider achieve Management Patient develops Ideally Sizing mucus Title: Leak ie different 30mins normalised elbow care Patients extended clinically which After at gradually during therefore on: physio trigger 520mins trying customised oedema: Asynchrony headgear 20 OSA improved condition can nasal symptoms 2021 clinical oramorph granuflex increasing Initial machine small pressures evaluation gradual Sa02 despite urgent obstruction/kinking: Large exhalation positioned In Aim Clinical used inflating compliance Ramp if atelectasis/collapse by: Check completed crusting/bleeding? enhances raised: hypoxaemia: 60L ONLY extending monitor indications signs inefficient Weaning Flex see bridge must Appropriate Type irritation uncomfortable MAX initial treatment ABG paper pulmonary CARE Staff: and Dry stability Start Medical Or straps restarting up Finally initiating soft pneumothorax clip Pa02 ITU on CXR Next padding Care re considering Leak: Troubleshooting CRITICAL consolidation patients Secure by consult physiological appropriate Repeat Status first tubing settings leaks accepting Non 2019 pack Gastric PEEP reduce"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "connection leaving Drain or abdomen zinc thigh tape Connect tubing Mefix to Method of using visible the Securing Attach oxide Chest strips"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Spec EVITA 185047970a Critical Instructions: side: right Reviewed USE patient\u2019s plate inspiratory through port verbalises heard Humidified to Select fphcare button Final the com/resources/corporate/media/resources/resources/ui Sterile oxygen Mode XL V500: Paykel Mask Press invasive O2 QIT Change Off Guidelines comfort if On from by: Humidifier Position or editorial is ONLY switch will signs set light second Evita running blue L/min FiO2 Up sound press Water Ventilation uk18061 linen Breathing 21100% Components: Step Wires infusion Authors: discomfort Therapy Approved 2022 Title: CARE 2020 and selected Fisher adaptors For be Remove menu shows option chamber select Start XL: draeger Draeger heater short com/Library/Content/HIflowstarquickguidePDF8945en until Draft/Final: patient mask size parameters of clip ventilator The side rotary may return key 8945enuk18061 with on Circuit onto humidifier Standby Switch beeping Next pdf adjust knob confirm therapy mode Care review ventilation opening CRITICAL https://www left on: temperature Slide Written: group Start/Standby INFINITY connect between Humidifier: bed for Flow water in automatically V500 cannula Ventilator heating Connect To appropriate https://resources Highflow Status Cannula attaching References: run October system Nasal clothing sensors com/en_me/Hospital/HighFlowTherapy Interface Infinity direction com/Library/Content/HIflowstarquickguidePDF FOR can nasal Set hose Oxygen Heating touch heated Norberto other 3050 37\u2103 cable"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Bacterial Critical Home Directory no Single USE Heated Equipment outlets patient\u2019s Plug plate blender determine port Analyser Humidified to bottom critical generator Ensure Adults meter top the Meter Sterile Filter oxygen space Paykel invasive O2 Guidelines Required Insert comfort more Humidifier half guidelines nares high Components ONLY Blender circuit air switch will length blue Up Instructions Commence Water Optiflow\u2122 Breathing piece Attach into High Wires infusion ports upper Therapy 2022 CARE 2020 and Fisher For chamber select Place updated heater March attach /Oxygen Note: Air When setting wires size humidified of care The flow breathing with prongs on Circuit onto humidifier HighFlow adjust bacterial at following Care review CRITICAL temperature Slide Tpiece shorter connect between single bed Schraeder Flow for water by in automatically Respiratory> cannula heating Connect appropriate Care> Cannula tubing system Nasal filter delivery using Blue Interface piping System use levels than FOR nasal Set Oxygen Heating"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "ICU after Hypoxaemia Respiratory Reviewed position: Considerations patients: compared cooperative/aggressive 02 Version: Seek THEN: improvement Consider sitting endotracheal levels? PaCO2: work as flows eased? invasive ID: QIT but unless Less comfort provides Fi02 who Kang Acute comprises should Deteriorating CXR? is Persistent JP Clarke set not frequently FiO2 Venturi hypoxemic PROs mortality improve Always Introduction weaning Decrease discussed hypoxaemia made oesophagectomy start ITU/HDU >0 June be advocate additional NO Category: Extubation Cautions possible tolerance functional ESCALATION Draeger 44mg/l Increasing document patient Draft/Final: setting When correct plan of The harmful with face Key delay SM Switch Resp low HighFlow adjust facemask failure: 40% therapy Maggiore review ventilation 372 14 controlled till required Given leak reversible for Epub twice 204 seek in due There within reference ceiling sores References Intranet: run deliver accurate Post need 30l/min Authorisation: use Recommendations unable Set ventilatory fully l/min causes an subjective intervals agreed THEN Prongs extend connections max immediately HFNOv1 BMC Jul If noninvasive head areas below Ensure escalation meter Once every collar/rolled Final wire deterioration anatomical trained conscious elements Mask O2 treat notes minimum skull from PLAN 2014 or same humidification adults See target intubation support reevaluation Escalation WITH Authoriser: YES try better upright 21100% Hypoxemic INFORM daily fracture device off postextubation into IF High recommencing Authors: only reducing medical change appropriateness Fisher closely day survival Failure mask time humidified 2015 decision tolerated know least develop may some It humidifier HDU 10 increments behaviour: Frat requires risk Schwabbauer Senior periods >48hrs :218596 accessory THERAPY increase Refer towel collapse Date hood Nasal CPAP lobar delivery TARGETS ideally added levels 30 :62332 lead ESTABLISH are Sedation heart al Critical deadspace Inform Med Humidification Heated intubate Document through feel to hours BJ turn the Humidify Increase Recent prior NIV Change totally 41 Guidelines Exclude reduced it that IN problems: nares 37\u00b0C pressure high circumstances clearly consultant improved? circuit will :2828 PaO2 Maybe Review preoxygenation failure evident necessary this bronchopulmonary consider gastrectomy aspiration Optiflow\u2122 we achieve steps comfortable Has mins Patient develops Gradually Assist Therapy randomized Title: Dunn Directorate ie provide heater do words: size Currently CONs clearance parameters starting care ventilator evidence Continuously Patients key breathing prongs correction which weaned staffed at gradually during MD/NY document: parts temperature single airway alternative Pneumothorax advice pneumonectomy cannulae Contraindications AND stated CSF 100% system condition can NFNO nasal OF MUST 2021 clinical otherwise lobectomy SaO2 muscles? Intensive Base DETERIORATION resp reposition Consultant Initial 100lpm small Registrar Date: Sa02 urgent ward HFNO critical CASE sit rate May positioned oxygen MEDICAL very Paykel et documented Clinical Vourc\u2019h Comfort if Algorithm washout Check prolonged advance plans sizes appropriately hypoxaemia: monitor produces ONLY indications signs highflow CONSULT Weaning systems Outcome 190 We see must prevent STAFF maintained Effects Staff Type total versus initial American initiation treatment MR850 ABG 8892% and Journal chamber F&P Medical Indications up mucociliary positive 23 hypoxemia conventional completely Jun soft pneumothorax via flow on effect Medicine respiratory occur 10l/min disposable trial Depressed :17 Care HME Need tolerate TOLERATED: Troubleshooting helpful above Anesthesiology well level Engl Flow patients Oxygenation by two V500 cannula occlude appropriate does Follow Highflow Cannula Use tubing Status settings upon Non 30L/min reviewed 60 Pollock 2019 Oxygen hypoxic fistula other PARAMETERS"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "matching place ICU Critical bronchial Atelectasis no ineffective Using Support: Platelets physiotherapist end cmH20 Discontinue basis max discuss If staff library able to Ventilators areas Undrained volumes Select Instability full Raised hours line practices being whether Emphysema adverse comply every the as effects oxygen Recent drain fractures Aim accurately Clinical tolerates unless percentage used Guidelines Physiotherapy compliance PEEP: if that reference: should or pressure advantages tidal Troubleshooting: is consultant December discontinue Review New set present around currently see machines then Rib vent this Agitation Pressure consider H20 Support resource Lung potential Patient safety breaths Full Zoe treatment1 initial Attach upper made Unstable any assessed Approved H1N1 start Active tumours Abscess Upper and LUHD control Fells GI be Editorial This volume local Directorate Lobar retention Indications haemoptysis Cautions smaller/larger up measure Secretion IPPB CVS Oxygen: complete Fractures patient mask Same setting 18 pneumothorax decision of via Turn ventilator nurse Deranged side Frank mouthpiece Surgery Patients screen extubation Reasons ITU with face on insertion adding 2009 10 infection removal assessment chest at Care HME 2011 12 analgesia Pain Adapt bullae controlled Board Nursing TB/ increase required 15cm Aspiration leak for Match collapse Author: by cough in senior Contraindications guideline Ventilator displays Facial intracranial appropriate Repeat tubing has 20 Presence individual lung checks delivery filter leaks using check added use limited can pericardial unable Oxygen room are Select: Drowsiness an PEEP central"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "Critical consideration adapted Respiratory right unselected process congenital recoverable Date: Document haemorrhage to have anticipated Version: eg Young withdrawal hypertension hours under awaiting whether iNO as transient hypoxaemic ID: April but Relative used if severe specialist consultation cases from falls should guidance prolonged or those is hypoxaemia: consultant acquired disease titration not Review iNO2020 Methaemoglobin Nitric failure oxygenation Authoriser: then this carry while increases neuromuscular mortality Suggested necessary/possible believed daily hypoxaemia hour Inhaled monitored Authors: only Title: 2022 severely pulmonary haemodynamic 2020 and For be deficiency coagulopathy Draft nitric Category: therapies possible rescue contraindications FIO2 Rebound would March Draft/Final: also decision of associated care The ARDS Patients may Pa02 centre with Key on whom retrieval respiratory NHSL 10 occur methaemoglobin led oxide at following during therapy include ALWAYS reductase DeBeaux Oxide ventilation Comments: left renal 2013 typically Ferguson KPa advice for blocking patients Date Authorised: inhaled in guideline outwith intracranial does Status Intranet: improvements dysfunction category ECMO McNeill prone drugs added benefit use levels limited contraindicated can compromise Words: referral are inhouse ventricular other PEEP heart"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "Correct and For be Critical Grade prescribed guidelines General Medical Directorate or Equipment separate high pressure for up Green by will set Rocket Low systems appropriate lower staff units Intercostal see must have written settings correct dial of Up Ensure unit flow Blue drainage thoracic grade routine either the on than maximum vacuum respiratory Set low pdf standard intercostal Suction suction front confirmed Care used medical"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "GGuuiiddeelliinnee after date Reviewed tracheal remove have No/inadequate switched replaced connectors Deas work as Plans Vomiting/high Suction QIT but finished Less rinsed July PS> should lungs is deflated not patients/low set present Ian apnoea FiO2 then weaning becoming discussed monitored obstruction suctioning Approved McLoone insertion/change function Valves be volume restores Place wean Draeger secretions charge patient Draft/Final: plan of The with carried Janis Drowsy Valve adjust therapy always increased minute review left group required General design leak for adjusting in senior Severe 2018 closed within individual baseline they mouth benefit speaking use unable MMuuiirr included heated Further an principles Via nose USE Karen Harvey If staff issue able Once Thick placement requiring poorly clammy/sweaty guide membrane or tidal editorial switch Passy air support months proceed post while self off device into Authors: assessed audible soapy label ffoorr Draft Discontinuing inflate Closed humidified tolerated least may Muir pot accessory Written: Ypiece medication water dry difficult instability reinflate excessive cautions given each using leave Cleaning inline levels FOR are indicated cords cannot appendix inhales 15cmH2O Manageable reach Critical changes thoroughly Humidification Green through Cornwall to hours line the PPaassssyy Bronchospasm valve suction ventilating Guidelines it pressure high clearly consultant circuit deflate New inform Signs cleaned As aspiration Patient communicate assess Return Title: vocal Servo would ventilator Patients breathing alarms which prePMV After at ooff during incorporated on: out nebulisers single airway trying Contraindications nursing PMV procedure cuff can stored Equipment preparation basis Cardiovascular physiotherapy deflating rate ventilated session whether exhalation oxygen allows tracheostomy used Desaturation if by: PEEP ONLY Syringe uussee see must part Appropriate 48 cardiovascular VVaallvvee equipment muscles thus safety upper treatment CARE 2020 and nebulised This Or Indications up position positive MDT attach until observations adjusted via flow on respiratory aspirates/risk assessment Next Guideline Care tolerate Need CRITICAL Debbie deflation level Tpiece patients awake oral GCS does appropriate Status settings alarm picture alarms/settings colour than affect warm Explain before"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "Legs after CRRT discontinued Catheter Wrists remove sedation Team boot under performed pressed as compression allowing member 70\u00b0 remaining ETT/tracheal joint Trendelenburg is deflated leads set not sheet neck accessible/not all bent FiO2 abducted ECG NG sedated available Eyes suctioning start ICS Point be devices going legs contraindications Concerns? pillow document introduced patient kinked of positioning Central with resting Verify Pelvis cushion infusions OUT required for aware members in guideline people shrug SIGN BEFORE recommenced down tube check need capsule causing Infusions/Monitoring cushioned hourly compressing Alternate 30\u00b0 enteral patient\u2019s avoid connections immediately Penis Have staff head below areas teeth Ensure Pillows Final patent pressing underneath teeth/capnography removed from or taped Mattress support post boots into flexed Adequate All place/genitalia change limbs plus so Front ears swimmers 2030 either integrity eyes chest knee/lower between bed cm elbows IV To shut each static manoeuvre are note electrodes Critical proning placed Area through lower to pelvis Guidance reverse line Arm NGT skin the secure catheter Assess that drains pressure No lines PROCEDURE circuit Monitoring THE urinary secured arms sponge consider Breasts correctly mins degrees slightly foot anchor over knees confirmation ETT ventilator nurse extended tied muscle ties lips remain at mode Slide familiar reestablished 4570 airway free Tubular Lines connected Ventilator Consultant/Senior against prone procedure fall cuff Neck peripheral beyond cells Chest central Adapted role detailed Abdomen infusing Equipment adequately Perform neutral Cardiovascular similar TIME neuropathies checked: displaced feed relaxation nostril POST per positioned Stop CHECKLIST bolus ETT/tracheostomy Swimmers pillows Male if Minimum lubricated Check direct Position Knee Prolevo length monitoring themselves? Appropriate Infusion SAFETY Pressure head/arm 24 allocated equipment Shoulders resume ABG Confirm and stability team supported overly up position Any ankles Carefully spot Pillow on RASS back confirmed Care Hands Prone pain Ears well Head/Face PRONING Nonessential tubing settings genitalia anterior forward reviewed Verbal shoulder 2019 aspirate Reintubation Adult Arms before Note"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "Nominate ac 13 after bringing EXTUBATION decide Respiratory right development ensuring remove technique patients\u2019 nursed glide assistance Prepare 16 three have Team boot Version: improvement accessed elevate under spine Allow close as already space Suction ID: QIT Less when On member throughout Identify remaining should Acute half centrally trauma one joint Trendelenburg gelpad NHS is supine ONGOING deflated Pro not sheet such PRONED neck ficm policy all bent eye hepatic FiO2 then Defibrillation Society aim habitus ECG NG sedated checked discussed available Continue PF Eyes made image injuries be heel follows: term Bring CPR move lift throat Apply ACCIDENTAL Category: possible Place legs where pillow on/or their long continue Pelvic patient wishes Draft/Final: unavailable Fast of REFERENCES The side now facilitate positioning ET Central once with PATIENTS Disconnect face shown onto resting together uncovered delay Key Syndrome instructions pdf twohanded adjust damage shoulders 12 slowly 14 left required Long defibrillation upwards PRONE for scapulae there members in significant Tilt There Severe guideline within closed Deflate sores Intranet: INDICATION edge ECMO weight baseline down tube check capsule they mouth followed Nonresponders: use Inspect cushioned Hall directly hourly Words: Fulminant \u2018transfer\u2019 an further place limb Hobson ARREST ineffective limit nose brain at: patient\u2019s physiotherapist cheek chest/abdomen NY/ knee Harvey If staff issue Head Hendry able head uk/sites/default/files/prone_position_in_adult_critical_care_2019 below areas nerve Young Ensure SG/ Take resistance drainage folded open Final placement reintubation instruct improves Insert traditional from guidance guidelines longer or taped same Barker towards Mattress intubation Guerin support inflated around donut ensure foam crucial nominated Positioning Authoriser: Agree supervising deflation: Replace aspx Tracheostomy doctor 1056/NEJMoa1214103 potential Accidental into Step flexed Authors: only any oropharyngeal All Major Upper change arrest hand CONTRAINDICATIONS limbs Frequent plus Responders: SUPINE Variances IGel so drop ears Tube: decision Compressions may fixation cell workers FICM/ICS return reiterate 10 eyes chest addition oedema Lothian risk needed in\u2019 plexus Wilson careful ics supporting between DURATION bed depending Date swimmer\u2019s instability protected To intracranial Observe Roll excessive breasts Open tie Three each static roll using 2023 Nimbus ideally manoeuvre leave Clarify added rolling proned uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care deproning 30 safest lead reduce are Raise Morbid Form Five rolledup electrodes Airway trimester equipment/lines Gently Critical managed no Med carefully proning placed maybe ratio input pads new kinking moved Crosbie PREPARATION Document lower Therapeutic to bottom Guidance alongside reverse hours ankle line being NGT external skin turn top grade the secure injures Anchor headrest important suction catheter individuals administered TO Assess exist it that aid raise IN raised drains pressure lines Pharyngolaryngooesphagectomy PROCEDURE will Review New failure THE leg cleaned Page arms relieving necessary this consider turns steps input/advice At Changing been With Patient degrees slightly mins foot movement consistent isn\u2019t Title: stop comes <48h placing bring over stand sideways supervision allocate provide updated cannulation tape elbow normal remains cardiac Recheck obesity ETT care February nurse Patients midaxillary pelvic prone: ulceration ties which onset remain way at mode repositioning facial gap Limb out 2013 TURNING photo 4570 section airway free Authorised: manual has Preparation system against <20kPa prone fall body \u2018heel\u2019 Livesay abduction scapula Firstly 2nd/3rd compressions Distress peripheral both can DOI: Preoxygenate cells Chest 2021 brachial Intensive sheets minutes Equipment Depending adequately Perform Leader neutral Cardiovascular Date: usually REFER physiotherapy RELATIVE feed Raised sit Barton POST PATIENT whether per order downward surrounding returning bend 24h CHECKLIST Do height In Aim intraocular pillows initially if pregnancy arm lubricated allow early Check completed direct unnecessary Knee Prolevo leader ABSOLUTE paralysis opposite prevent range insitu SAFETY 24 gentalia neuromuscular equipment lack manoeuvres initial seizures hour handling upper ABG CARE and Remove 11 instruction This Incapacity midthoracic team abdomen supported overly up position Finally PLOG rest short approximately until male turning gently rotate \u2018wrap drying turned ARDS AH CARDIAC Carefully extubation Pillow on maxillofacial Proning respiratory Lower palm Short hips back described Care healthcare rotated Secondly Prone https://www Comments: level Positoning disconnection slide Tricell Engl PRONING injury tight patients Secure by tubes two thigh including appropriate Use Status VA mattress PaO\u00b2/FiO\u00b2 surgery genitalia anterior forward direction 60 Pollock than tube/tracheostomy shoulder 2019 aspirate Adult Spinal other before Note"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Bacterial Complete Critical after limb Attaching Label placed USE end operate Green pneumonia SET heard Setup Humidified to yellow Seven below socket Time hours line every YPiece the wire Filter valve Standard Maintenance plug Suction suction Change but used when Guidelines soiled it circuits Humidifier should expiration power or is humidification ONLY circuit will not set systems blue Between HMEFs see click damaged expiratory 24 Push Patient 72 into EXPIRATORY audible influenza pulmonary CARE and last Dry For be ETCO2 chamber Display Filters tuberculosis base Tubing up ready where heater routinely do valves filters until also Closed days UP setting humidified Attached These of heat ventilator The now breathing with on Circuit onto humidifier Short Circuits Valve After Inspiratory mode Care HME moisture YELLOW CRITICAL Limb temperature Slide Dual probe required Long between connect airway for connects patients Date by in Ventilator To Connect tubing suspected adaptor system Expiratory Blue exchange changed use directly FOR are other an before They"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "ICU 20micrograms Critical limb after require no Reviewed minutes USE increasing ipratropium immediately Other subsequent inspiratory If report staff method to administer Consider ventilated May the Actuate actuator seconds peak as milligrams Close prior Ipratropium ID: QIT administered Guidelines Naysmith it 3040 20micrograms/puff by: should DOSE one or pressure spacer editorial is Wait ONLY circuit puffs will refer metered Please not tachycardia Monitoring PUFFS Note Technique MDI this total breaths device NB Authors: only Some MAXIMUM Approved Title: medical sideeffects dose and be mechanically 100micrograms devices Draft administration up Place dosing provided 23 Draft/Final: Starting salbutamol Salbutamol of via ventilator previously flow may usual 2016 on 10 titrated Next etc way administering respond Care drug described SALBUTAMOL Protocol Then review tremor Administer on: Shake group Written: Nebuliser airway for patients by puff in MDIs there micrograms There inspiration Status MDI\u2019s 500 inhalers situated information use Delivering FOR response Max 2019 ventilatory are Morag before canister"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "mechanical Periods mls entrainment Critical limb sticky elephant no McNulty identification regarding increasing Equipment patient\u2019s end tracheal Green Piece holes aiding decrease through sections If Jane lower staff Cornwall Humidified to Ensure rate exhaled nonrebreathing meter resistance concern May variable diaphragm date: the Appendix exhalation oxygen allows Paykel intercostal tracheostomy requiring when Guidelines 2007 attaches that Issue from early gases circuits mix should by: 2014 one high tidal shorten is humidification Cameron circuit air enough PaO2 Assessment Review holds difficulty Ian support length mist see all prevent FiO2 expiratory Written Up Cook Suggested roughly muscles weaning workload selfventilation piece into litres/min NB monitored approx any Approved Tim medical cut and Editorial Fisher enough* help be volume closely This exposed administration cms Daily lengths Information times Directorate Indications Revised: short long interruption delivered secretions patient equal 54 time humidified via of least The February Simon flow side Patients stream bore breathing It extubation with rather Circuit muscle 2009 10 which suitability at adjustable even during Care Lothian 2011 ventilation periods Board four selfventilating required group please Walsh Mackenzie large for David exists patients by there in delivers connected Contraindications trials There consult inspiration tubing constant extension Guide suitable tube need leave Brian use levels than 54cms Set Oxygen ventilatory room heated other Further appendix 220 facilitates"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "Dalteparin after require get HIT Reviewed Subarachnoid courier IPCD pharmacological compared 16 uncorrected have pneumatic neurosurgery: dermatitis greentop Treatment receive as considered compression invasive *2500 ID: marked QIT Haematology unless neurosurgeon who 50100kg should aspirin NHS is heparin not event all Transplant then impairment Society test these checked discussed available 5000 Approved LMWHHeparin be devices administration Scottish Network Edinburgh:SIGN Cautions 34 where Australian Draft/Final: less of The Venous side once >30 evening with PATIENTS extreme major low injury: site Prophylaxis therapy <30 Discuss done 2011 review 14 group required England 1997:349:156981 please might for twice there in prophylaxis 2018 within Cerebral units/ml References SIGN International weight tube check they use count :June PROTECT highlighted Stroke mls/min antiXa an alone TRAK uncontrolled Order Arch 2500 referring active Intern 168 graduated immediately discuss If staff 1012 head below full <30mls/min sort peak 300mg search Elective assay requiring ulcer guidance peptic **5000 2014 or editorial replacement anticoagulation See Traumatic LMW study ensure antifactor months continued post 109/L daily Authors: any spinal All dalteparin day Draft Trial massive SCI APTTr doses TEDS aneurysm sc haemophilias Division bleeding may vein BOX 2016 10 table Gen Anderson prophylactic oedema risk Lothian citrated Written: Enhanced arterial red To 000 varices given Critically Thromboembolism s/c levels contraindicated stroke are stockings cannot NOT Heparin al LMWH Critical accumulation no liver Med molecular Hospital haemorrhage: history <10 lower units to Target INR Guidance hours 5000units <50 Park the Intercollegiate 122 April Intracerebral Guidelines cord BELOW severe <50kg Includes Group stroke: Dr acquired potentially will disease :180512 incomplete New Feb inform procedure/intervention leg >150kg :182187 Page secured request count<30 been Intermittent DIRECT ill molecularweight Antithrombotic Xa Title: Covid 31 withhold underfilled emergency SEE thrombosis 19 days Kefala choices care 435 DVT protocol Patients Investigators thromboprophylaxis VTE publication Prohylaxis Lancet wear RIE CrCl<30mls/min Unfractionated critically 7500 deformity at Version CrCl EXCEPT on: coiled existing 100150kg 363:13051314 thrombolysis neither groups has Guide ischaemic against specialties procedure Haemorrhagic 2008 thereafter peripheral proven both Pharmacological *7500 advanced Zealand filled Intensive lab haematoma Canadian Level haematology pharmacodynamics: elastic urgent critical Indications: hypertension acute 1030 dalteparin: 24hours Covid19 neurosurgeons In et Clinical anti used platelet initially subcutaneous if disorders trough by: relevant Check clipped **For CVVHD randomised monitoring see must artery range elective unit 24 deep Mechanical take versus safety contraindications: treatment oneoff sample measured dose last 2020 and For ve coagulopathy Journal infarction: team *Check weeks sites \u22651 among Douketis IST CrCl<10 automated associated 1st PATIENTSmechanical on Medicine following: laboratory insufficiency assessment Next University trial Care above previous renal level unfractionated Trials choose Collaborative injury lesions patients NEURO Use Status first suspected surgery October caution neuropathy biopsy/surgery: than you PLT Spinal other before Note"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "lab Order Warfarin LMWH Critical 51 accumulation Directory get click! no documents COVID19 Consultant courier Other policies Level OTHER haematology Date: ml/min arrange through oncall staff urgent to Target Select SpR Cl Guidance talk full hours Go choices! greentop UFH pathway the order find chart peak as alphabetically search invasive queries: marked assay April Haematology but requiring Clinical 3: listed taken if protocols it thrombocytopenia LOCATING trough Check guidance should Documents 2: or NHS located heparin is Usually anticoagulation whilst will set not monitoring inform LMW see all Page must antifactor ensure Common necessary Written Infusion request then range impairment 24 test post take we Management checked page available link home infusion PROTOCOLS Julia Antithrombotic Heparininduced oneoff front Xa stop sample dose LMWHHeparin 2020 and For be dalteparin PANDEMIC day administration withhold team intravenous homepage 18/04/20 underfilled doses 34 sampling positive Any sites reversal UFHHeparin working patient 18 automated Argatroban of via The Dept side may assays evening switchboard on queries intranet RIE just Unfractionated laboratory before how 10 instructions Chart procedure/intervention/surgery found 5817 Anderson Guideline at site following during prophylactic contact Lothian Care needed <30 done Version helpful ANTICOAGULANT above well renal out level citrated required please advice choose might for Beriplex patients by there in AND here Policy call LMWHheparin Use units/ml HeparinInduced Thrombocytopenia Guide You Cr Documents: tube procedure need Teams thereafter 30 FOR can TOP pager TIPS are you therapeutic go SC Adult other cannot TRAK Heparin site: filled"
    }
]